|
|
| Zeile 1: |
Zeile 1: |
| | [[TempD(11)]] | | [[TempD(11)]] |
| − |
| |
| − | {{tp|p=33875972|t=2021. Does higher body mass index increase COVID-19 severity? A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33842733|t=2021. Prognostic value of fasting hyperglycemia in patients with COVID-19 - Diagnostic test accuracy meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33942025|t=2021. Therapeutic use of Guggulsterone in COVID-19 induced obesity (COVIBESITY) and significant role in immunomodulatory effect.|pdf=|usr=027}}
| |
| − | {{tp|p=34027220|t=2021. The role of comorbidities on mortality of COVID-19 in patients with diabetes.|pdf=|usr=027}}
| |
| − | {{tp|p=33933379|t=2021. Obesity and sleep apnea as a significant comorbidities in COVID-19 - A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33888449|t=2021. Comment on "Association of obesity with illness severity in hospitalized patients with COVID-19: A retrospective cohort study".|pdf=|usr=027}}
| |
| − | {{tp|p=34016569|t=2021. Impact of obesity and diabetes mellitus in critically ill patients with SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33358147|t=2021. Visceral adipose tissue area predicts intensive care unit admission in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33841894|t=2021. Serum levels of ACE2 are higher in patients with obesity and diabetes.|pdf=|usr=027}}
| |
| − | {{tp|p=33355431|t=2021. Acute Pancreatitis in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=027}}
| |
| − | {{tp|p=34056149|t=2021. COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review.|pdf=|usr=027}}
| |
| − | {{tp|p=34064553|t=2021. Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies.|pdf=|usr=027}}
| |
| − | {{tp|p=33918683|t=2021. COVID-19: Measles and Antibiotic Resistance Are a Matter of Concern.|pdf=|usr=027}}
| |
| − | {{tp|p=33920512|t=2021. Myopericarditis Associated with COVID-19 in a Pediatric Patient with Kidney Failure Receiving Hemodialysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33920814|t=2021. Molecular Pathology Analysis of SARS-CoV-2 in Syncytiotrophoblast and Hofbauer Cells in Placenta from a Pregnant Woman and Fetus with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33915771|t=2021. Minimally Invasive Autopsy Practice in COVID-19 Cases: Biosafety and Findings.|pdf=|usr=027}}
| |
| − | {{tp|p=33932720|t=2021. Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens.|pdf=|usr=027}}
| |
| − | {{tp|p=33857718|t=2021. Endothelial-Mesenchymal Transition in COVID-19 lung lesions.|pdf=|usr=027}}
| |
| − | {{tp|p=33950285|t=2021. Reaktionsmuster der lokoregionaren Lymphknoten im Abflussgebiet von COVID-19-Lungen.|pdf=|usr=027}}
| |
| − | {{tp|p=33355971|t=2021. Post-COVID-19 severe neutropenia.|pdf=|usr=027}}
| |
| − | {{tp|p=33351985|t=2021. Robust and sustained antibody response to SARS-CoV-2 in a child pre and post autologous hematopoietic stem cell transplant.|pdf=|usr=027}}
| |
| − | {{tp|p=33355979|t=2021. COVID-19 in pediatric survivors of childhood cancer and hematopoietic cell transplantation from a single center in New York City.|pdf=|usr=027}}
| |
| − | {{tp|p=33338306|t=2021. Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience.|pdf=|usr=027}}
| |
| − | {{tp|p=34008395|t=2021. Kwasica ketonowa jako glowny objaw COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33833967|t=2021. Coronavirus Disease 2019-Liver Injury-Literature Review and Guidelines Based on the Recommendations of Hepatological Societies.|pdf=|usr=027}}
| |
| − | {{tp|p=33883479|t=2021. Upper Respiratory Tract Co-detection of Human Endemic Coronaviruses and High-density Pneumococcus Associated With Increased Severity Among HIV-Uninfected Children Under 5 Years Old in the PERCH Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33836982|t=2021. Detectable antibodies against SARS-CoV-2 in newborns from mothers infected with COVID-19 at different gestational ages.|pdf=|usr=027}}
| |
| − | {{tp|p=33928439|t=2021. Critical analysis of acute kidney injury in pediatric COVID-19 patients in the intensive care unit.|pdf=|usr=027}}
| |
| − | {{tp|p=33895583|t=2021. MR Imaging Findings in a Neonate With COVID -19-Associated Encephalitis.|pdf=|usr=027}}
| |
| − | {{tp|p=33894640|t=2021. Acute Fulminant Cerebellitis in Children with COVID-19 Infection: A Rare But Treatable Complication.|pdf=|usr=027}}
| |
| − | {{tp|p=33962346|t=2021. Prediction of Neurodevelopmental Outcomes in SARS-CoV-2 Infections.|pdf=|usr=027}}
| |
| − | {{tp|p=33962343|t=2021. Isolated Third Cranial Nerve Palsy and COVID-19 Infection in a Child.|pdf=|usr=027}}
| |
| − | {{tp|p=33333463|t=2021. New-Onset Dizziness Associated With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33316688|t=2021. Neurological Manifestations of COVID-19 in Children: Time to Be More Vigilant.|pdf=|usr=027}}
| |
| − | {{tp|p=33918585|t=2021. Inflammatory Skin Lesions in Three SARS-CoV-2 Swab-Negative Adolescents: A Possible COVID-19 Sneaky Manifestation?|pdf=|usr=027}}
| |
| − | {{tp|p=33941862|t=2021. High incidence of stroke and mortality in pediatric critical care patients with COVID-19 in Peru.|pdf=|usr=027}}
| |
| − | {{tp|p=33828229|t=2021. Neonatal outcomes during the COVID-19 pandemic in New York City.|pdf=|usr=027}}
| |
| − | {{tp|p=33828228|t=2021. Italian neonatologists and SARS-CoV-2: lessons learned to face coming new waves.|pdf=|usr=027}}
| |
| − | {{tp|p=33981492|t=2021. Re-positive of SARS-CoV-2 test is common in COVID-19 patients after hospital discharge. Data from high standard post-discharge quarantined patients in Macao SAR, China.|pdf=|usr=027}}
| |
| − | {{tp|p=33954054|t=2021. Outcomes of hospitalized patients with COVID-19 according to level of frailty.|pdf=|usr=027}}
| |
| − | {{tp|p=33917837|t=2021. Contribution of Pro-Inflammatory Molecules Induced by Respiratory Virus Infections to Neurological Disorders.|pdf=|usr=027}}
| |
| − | {{tp|p=33323946|t=2021. Does the RAAS play a role in loss of taste and smell during COVID-19 infections?|pdf=|usr=027}}
| |
| − | {{tp|p=33840053|t=2021. Proton pump inhibitor on susceptibility to COVID-19 and its severity: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34079337|t=2021. Angiotensin System Polymorphisms' in SARS-CoV-2 Positive Patients: Assessment Between Symptomatic and Asymptomatic Patients: A Pilot Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33991451|t=2021. Hypoxia induces expression of angiotensin-converting enzyme II in alveolar epithelial cells: Implications for the pathogenesis of acute lung injury in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33373502|t=2021. Mucin signature as a potential tool to predict susceptibility to COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33373925|t=2021. Clinical characteristics and treatment outcome of COVID-19 patients with stroke in China: A multicenter retrospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=33939057|t=2021. COVID-19 and the pituitary.|pdf=|usr=027}}
| |
| − | {{tp|p=34034016|t=2021. Third trimester stillbirth during the first wave of the SARS-CoV-2 pandemic: Similar rates with increase in placental vasculopathic pathology.|pdf=|usr=027}}
| |
| − | {{tp|p=34058611|t=2021. Placental pathology in COVID-19 affected pregnant women: A prospective case-control study.|pdf=|usr=027}}
| |
| − | {{tp|p=34029337|t=2021. Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity.|pdf=|usr=027}}
| |
| − | {{tp|p=34086775|t=2021. End-stage kidney disease and COVID-19 in an urban safety-net hospital in Boston, Massachusetts.|pdf=|usr=027}}
| |
| − | {{tp|p=34086717|t=2021. Characterization of dysphagia and laryngeal findings in COVID-19 patients treated in the ICU-An observational clinical study.|pdf=|usr=027}}
| |
| − | {{tp|p=34043674|t=2021. Determinants of in-hospital mortality in COVID-19; a prospective cohort study from Pakistan.|pdf=|usr=027}}
| |
| − | {{tp|p=34043668|t=2021. The systemic inflammatory response and clinicopathological characteristics in patients admitted to hospital with COVID-19 infection: Comparison of 2 consecutive cohorts.|pdf=|usr=027}}
| |
| − | {{tp|p=34038475|t=2021. Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesity.|pdf=|usr=027}}
| |
| − | {{tp|p=34033655|t=2021. Acute kidney injury: Incidence, risk factors, and outcomes in severe COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34015018|t=2021. Incidence of deep vein thrombosis through an ultrasound surveillance protocol in patients with COVID-19 pneumonia in non-ICU setting: A multicenter prospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=34015017|t=2021. Current status of community-acquired infection of COVID-19 in delivery facilities in Japan.|pdf=|usr=027}}
| |
| − | {{tp|p=34015009|t=2021. COVID-19 and the kidney: A retrospective analysis of 37 critically ill patients using machine learning.|pdf=|usr=027}}
| |
| − | {{tp|p=34010331|t=2021. Profiles and outcomes in patients with COVID-19 admitted to wards of a French oncohematological hospital: A clustering approach.|pdf=|usr=027}}
| |
| − | {{tp|p=34010310|t=2021. Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury.|pdf=|usr=027}}
| |
| − | {{tp|p=34003821|t=2021. Clinical characteristics and laboratory features of COVID-19 in high altitude areas: A retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33984066|t=2021. Phenome-wide association of 1809 phenotypes and COVID-19 disease progression in the Veterans Health Administration Million Veteran Program.|pdf=|usr=027}}
| |
| − | {{tp|p=33984050|t=2021. Severe acute respiratory Syndrome-Coronavirus-2: Can it be detected in the retina?|pdf=|usr=027}}
| |
| − | {{tp|p=33984040|t=2021. Does blood type affect the COVID-19 infection pattern?|pdf=|usr=027}}
| |
| − | {{tp|p=33984027|t=2021. SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020.|pdf=|usr=027}}
| |
| − | {{tp|p=33983981|t=2021. Clinical course and management of 73 hospitalized moderate patients with COVID-19 outside Wuhan.|pdf=|usr=027}}
| |
| − | {{tp|p=33979402|t=2021. Clinical profile and factors associated with COVID-19 in Yaounde, Cameroon: A prospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33970955|t=2021. Predictors for inpatient mortality during the first wave of the SARS-CoV-2 pandemic: A retrospective analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33956891|t=2021. The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study.|pdf=|usr=027}}
| |
| − | {{tp|p=33956882|t=2021. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33951100|t=2021. The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS).|pdf=|usr=027}}
| |
| − | {{tp|p=33951071|t=2021. The association of estimated cardiorespiratory fitness with COVID-19 incidence and mortality: A cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33945583|t=2021. Evaluation of potential COVID-19 recurrence in patients with late repeat positive SARS-CoV-2 testing.|pdf=|usr=027}}
| |
| − | {{tp|p=33939733|t=2021. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33930096|t=2021. Low serum albumin and the risk of hospitalization in COVID-19 infection: A retrospective case-control study.|pdf=|usr=027}}
| |
| − | {{tp|p=33914806|t=2021. Sex differences in the case-fatality rates for COVID-19-A comparison of the age-related differences and consistency over seven countries.|pdf=|usr=027}}
| |
| − | {{tp|p=33914805|t=2021. Epidemiological, clinical, and laboratory findings for patients of different age groups with confirmed coronavirus disease 2019 (COVID-19) in a hospital in Saudi Arabia.|pdf=|usr=027}}
| |
| − | {{tp|p=33914803|t=2021. Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33914786|t=2021. Two original observations concerning bacterial infections in COVID-19 patients hospitalized in intensive care units during the first wave of the epidemic in France.|pdf=|usr=027}}
| |
| − | {{tp|p=33914762|t=2021. Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks.|pdf=|usr=027}}
| |
| − | {{tp|p=33909684|t=2021. Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry.|pdf=|usr=027}}
| |
| − | {{tp|p=33909683|t=2021. Hypertension as a sequela in patients of SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33909679|t=2021. Pathological findings in organs and tissues of patients with COVID-19: A systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=33891663|t=2021. Proteinuria changes in kidney disease patients with clinical remission during the COVID-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33891615|t=2021. Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans.|pdf=|usr=027}}
| |
| − | {{tp|p=33886663|t=2021. Clinical characteristics and outcomes of patients with Corona Virus Disease 2019 (COVID-19) at Mercy Health Hospitals, Toledo, Ohio.|pdf=|usr=027}}
| |
| − | {{tp|p=33886645|t=2021. Vertical transmission of Severe Acute Respiratory Syndrome Coronavirus 2: A scoping review.|pdf=|usr=027}}
| |
| − | {{tp|p=33886590|t=2021. Prevalence, clinical features, and outcomes of SARS-CoV-2 infection in pregnant women with or without mild/moderate symptoms: Results from universal screening in a tertiary care center in Mexico City, Mexico.|pdf=|usr=027}}
| |
| − | {{tp|p=33882097|t=2021. COVID-19 infection with asymptomatic or mild disease severity in young patients: Clinical course and association between prevalence of pneumonia and viral load.|pdf=|usr=027}}
| |
| − | {{tp|p=33861750|t=2021. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33857168|t=2021. Laboratory correlates of SARS-CoV-2 seropositivity in a nationwide sample of patients on dialysis in the U.S.|pdf=|usr=027}}
| |
| − | {{tp|p=33831043|t=2021. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh.|pdf=|usr=027}}
| |
| − | {{tp|p=33831042|t=2021. Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City.|pdf=|usr=027}}
| |
| − | {{tp|p=33831011|t=2021. Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy.|pdf=|usr=027}}
| |
| − | {{tp|p=33826662|t=2021. O group is a protective factor for COVID19 in Basque population.|pdf=|usr=027}}
| |
| − | {{tp|p=33826648|t=2021. Association of ABO blood groups with presentation and outcomes of confirmed SARS CoV-2 infection: A prospective study in the largest COVID-19 dedicated hospital in Bangladesh.|pdf=|usr=027}}
| |
| − | {{tp|p=33822821|t=2021. Heparin binding protein in severe COVID-19-A prospective observational cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33822812|t=2021. Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33788846|t=2021. Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33894790|t=2021. The role of co-infections and secondary infections in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33973748|t=2021. Coinfection of COVID-19 and pneumocystosis in a patient after kidney transplantation.|pdf=|usr=027}}
| |
| − | {{tp|p=33949187|t=2021. SARS-CoV-2 infection associated with active granulomatosis with polyangiitis.|pdf=|usr=027}}
| |
| − | {{tp|p=33876908|t=2021. Hospitalizations for COVID-19 in Poland: a study based on data from a national hospital register.|pdf=|usr=027}}
| |
| − | {{tp|p=33851808|t=2021. Subtle microvascular endothelial impairment in a young patient recovered from mild COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34105917|t=2021. Extremely high mortality rates among hemodialysis patients with COVID-19 before the era of SARS-CoV-2 vaccination: results from a large database from the North of Poland.|pdf=|usr=027}}
| |
| − | {{tp|p=33314875|t=2021. Clostridioides difficile infection in coronavirus disease 2019 (COVID-19): an underestimated problem?|pdf=|usr=027}}
| |
| − | {{tp|p=34100281|t=2021. High postdischarge mortality in hospitalized COVID19 patients with cardiovascular comorbidities.|pdf=|usr=027}}
| |
| − | {{tp|p=34060777|t=2021. Untypical presentation of cutaneous lupus in a young patient following COVID19: differentiation of COVID toes.|pdf=|usr=027}}
| |
| − | {{tp|p=33949321|t=2021. Patients with chronic venous insufficiency in the times of COVID-19 and the risk of thrombus formation - suggestions on conservative treatment of such patients based on the principles of pathophysiology.|pdf=|usr=027}}
| |
| − | {{tp|p=34066697|t=2021. Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33858127|t=2021. Plasma D-dimer : a promising indicator of COVID-19 infection severity or only an acute phase reactant.|pdf=|usr=027}}
| |
| − | {{tp|p=33887897|t=2021. Urinary frequency in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33961259|t=2021. Psychiatrische Komplikationen: Was wir uber "Long Covid" wissen.|pdf=|usr=027}}
| |
| − | {{tp|p=33904095|t=2021. Medikamentose Thrombose-Prophylaxe bei ambulanten COVID-19-Patienten.|pdf=|usr=027}}
| |
| − | {{tp|p=33904094|t=2021. Persistierende Dyspnoe nach COVID-19: Vorschlage zur hausarztlichen Nachsorge.|pdf=|usr=027}}
| |
| − | {{tp|p=33844213|t=2021. Schwangere mit COVID-19: Wie gefahrdet ist das Kind?|pdf=|usr=027}}
| |
| − | {{tp|p=34081684|t=2021. COVID-19 Severity and COVID-19-Associated Deaths Among Hospitalized Patients with HIV Infection - Zambia, March-December 2020.|pdf=|usr=027}}
| |
| − | {{tp|p=33840847|t=2021. Conditions Favoring Increased COVID-19 Morbidity and Mortality: Their Common Denominator and its Early Treatment.|pdf=|usr=027}}
| |
| − | {{tp|p=34031537|t=2021. Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=34006935|t=2021. Diffuse trophoblast damage is the hallmark of SARS-CoV-2-associated fetal demise.|pdf=|usr=027}}
| |
| − | {{tp|p=33883694|t=2021. The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime.|pdf=|usr=027}}
| |
| − | {{tp|p=33795830|t=2021. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.|pdf=|usr=027}}
| |
| − | {{tp|p=33891272|t=2021. Silent hypoxia in COVID-19: pathomechanism and possible management strategy.|pdf=|usr=027}}
| |
| − | {{tp|p=33903823|t=2021. COVID-19 in a patient receiving adjuvant breast cancer chemotherapy with granulocyte olony-stimulating factor (G-CSF) support: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33353808|t=2021. Gaucher disease and SARS-CoV-2 infection: Experience from 181 patients in New York.|pdf=|usr=027}}
| |
| − | {{tp|p=33354515|t=2021. SARS CoV2 infection in a young subject affected by arginosuccinate synthase deficiency: A case report of epilepsy worsening.|pdf=|usr=027}}
| |
| − | {{tp|p=33875935|t=2021. Metabolic stroke-like episode in a child with FARS2 mutation and SARS-CoV-2 positive cerebrospinal fluid.|pdf=|usr=027}}
| |
| − | {{tp|p=33838929|t=2021. SARS-CoV-2 associated Complement genetic variants possibly deregulate the activation of the Alternative pathway affecting the severity of infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34036488|t=2021. Characterization of Headache in COVID-19: a Retrospective Multicenter Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33829393|t=2021. Clinical and Pathophysiologic Spectrum of Neuro-COVID.|pdf=|usr=027}}
| |
| − | {{tp|p=33328588|t=2021. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology.|pdf=|usr=027}}
| |
| − | {{tp|p=33840181|t=2021. Recovering of oxygenation, physical function and disability in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33849262|t=2021. Invasive pulmonary aspergillosis in a COVID-19 recovered patient: unravelling an infective sequalae of the SARS-CoV-2 virus.|pdf=|usr=027}}
| |
| − | {{tp|p=33878852|t=2021. Blood indices, in-hospital outcome and short-term prognosis in patients with COVID-19 pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33926176|t=2021. Pneumothorax and pneumomediastinum in COVID-19 acute respiratory distress syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33856148|t=2021. Acute tracheal tear - A potential cause of spontaneous pneumomediastinum in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33935300|t=2021. SARS-CoV-2 Infektionen und das autonome Nervensystem.|pdf=|usr=027}}
| |
| − | {{tp|p=34011679|t=2021. Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers.|pdf=|usr=027}}
| |
| − | {{tp|p=33980671|t=2021. Leptin Deficiency, Caused by Malnutrition, Makes You Susceptible to SARS-CoV-2 Infection but Could Offer Protection from Severe COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33853873|t=2021. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin.|pdf=|usr=027}}
| |
| − | {{tp|p=33845350|t=2021. COVID-19 and emerging spinal cord complications: A systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=34000684|t=2021. Attenuation of antibody response to SARS-CoV-2 infection in patients with multiple sclerosis on ocrelizumab: A case-control study.|pdf=|usr=027}}
| |
| − | {{tp|p=34000683|t=2021. The course of COVID-19 infection in patients with multiple sclerosis-The experience of one center based on the population of Upper Silesia.|pdf=|usr=027}}
| |
| − | {{tp|p=33979771|t=2021. Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=33895693|t=2021. Reactivation of SARS-CoV-2 after Rituximab in a Patient with Multiple Sclerosis.|pdf=|usr=027}}
| |
| − | {{tp|p=34102605|t=2021. Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=34012547|t=2021. Do gene-environment interactions play a role in COVID-19 distribution? The case of Alpha-1 Antitrypsin, air pollution and COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33907624|t=2021. Rapid clinical evolution for COVID-19 translates into early hospital admission and unfavourable outcome: a preliminary report.|pdf=|usr=027}}
| |
| − | {{tp|p=33378608|t=2021. Microvascular Injury in the Brains of Patients with Covid-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33369366|t=2021. Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.|pdf=|usr=027}}
| |
| − | {{tp|p=33947851|t=2021. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34067588|t=2021. Neonatal SARS-CoV-2 Infection: Practical Tips.|pdf=|usr=027}}
| |
| − | {{tp|p=34106984|t=2021. Influence of thromboembolic events in the prognosis of COVID-19 hospitalized patients. Results from a cross sectional study.|pdf=|usr=027}}
| |
| − | {{tp|p=34086837|t=2021. Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33969331|t=2021. The effect of COVID-19 on the sexual and reproductive health of women.|pdf=|usr=027}}
| |
| − | {{tp|p=34104425|t=2021. Cardiac index is associated with oxygenation in COVID-19 acute respiratory distress syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=34046161|t=2021. Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement.|pdf=|usr=027}}
| |
| − | {{tp|p=33959257|t=2021. Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33832850|t=2021. Pathophysiology of light phenotype SARS-CoV-2 interstitial pneumonia: from histopathological features to clinical presentations.|pdf=|usr=027}}
| |
| − | {{tp|p=33832849|t=2021. Predictors of reduced 6-minute walk distance after COVID-19: a cohort study in Mexico.|pdf=|usr=027}}
| |
| − | {{tp|p=33910773|t=2021. Pulmonary embolism detected by CT pulmonary angiography in hospitalized COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33970408|t=2021. Cystic fibrosis improves COVID-19 survival and provides clues for treatment of SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33340323|t=2021. Smell, taste and COVID-19: testing is essential.|pdf=|usr=027}}
| |
| − | {{tp|p=33844020|t=2021. Cavernous Sinus Thrombosis Secondary to Sphenoid Mycetoma following COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33977415|t=2021. Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-up.|pdf=|usr=027}}
| |
| − | {{tp|p=33937000|t=2021. It's not just the lungs: COVID-19 and the misty mesentery sign.|pdf=|usr=027}}
| |
| − | {{tp|p=34044433|t=2021. Epidemiology and Clinical Characteristics of Emergency Department Patients with COVID-19 in a Rhode Island Healthcare System.|pdf=|usr=027}}
| |
| − | {{tp|p=34044431|t=2021. Thrombosis in COVID-19: A Narrative Review of Current Literature and Inpatient Management.|pdf=|usr=027}}
| |
| − | {{tp|p=34044430|t=2021. Presentations and Outcomes of Severe Cardiac Complications in COVID-19: Rhode Island Experience.|pdf=|usr=027}}
| |
| − | {{tp|p=33959720|t=2021. Accelerated Pulmonary Ossification as a Sequela of SARS-CoV-2 Pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=34104285|t=2021. Long COVID presenting with intermittent fever after COVID-19 pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=34104284|t=2021. Acute necrotic hemorrhagic leukoencephalitis related to COVID-19: a report of 2 cases.|pdf=|usr=027}}
| |
| − | {{tp|p=33318774|t=2021. Cavernous sinus thrombosis in a COVID-19 patient: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33824691|t=2021. COVID-19 as a rare cause of facial nerve neuritis in a pediatric patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33968288|t=2021. Alveolar hemorrhage in the setting of COVID-19: Report of a successful vascular intervention and embolization.|pdf=|usr=027}}
| |
| − | {{tp|p=33968287|t=2021. COVID-19 and arterial thrombosis: Report of 2 cases.|pdf=|usr=027}}
| |
| − | {{tp|p=33968286|t=2021. Hyperdense pulmonary artery sign - detection of pulmonary embolism in patients with suspected COVID-19 using non-contrast chest CT.|pdf=|usr=027}}
| |
| − | {{tp|p=33880136|t=2021. Fatal retroperitoneal hematoma associated with Covid-19 prophylactic anticoagulation protocol.|pdf=|usr=027}}
| |
| − | {{tp|p=33354272|t=2021. Heterotopic ossification post COVID-19: Report of two cases.|pdf=|usr=027}}
| |
| − | {{tp|p=34007372|t=2021. Diagnostic role of technitium-99m bone scan in severe COVID-19-associated myositis.|pdf=|usr=027}}
| |
| − | {{tp|p=33995746|t=2021. COVID-19 induced mesenteric venous infarction.|pdf=|usr=027}}
| |
| − | {{tp|p=33995745|t=2021. Typical Covid-19 case with primary pneumomediastinum in a 37 year old male.|pdf=|usr=027}}
| |
| − | {{tp|p=33995744|t=2021. Massive emphysema subcutis, pneumothorax, pneumomediastinum and pneumoperitoneum as uncommon complication of covid-19 pneumonia, a rare case.|pdf=|usr=027}}
| |
| − | {{tp|p=33825515|t=2021. Ocular Imaging in Patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33325809|t=2021. Pulmonary Thromboembolism in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33320063|t=2021. Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33897111|t=2021. SARS-CoV2-Zufallsentdeckungen bei Hamburger Todesfallen: ein epidemiologisches Monitoring wahrend des dynamischen Infektionsgeschehens im Fruhjahr 2020.|pdf=|usr=027}}
| |
| − | {{tp|p=33867689|t=2021. SARS-CoV-2-assoziierte Todesfalle von erwachsenen Personen bis 50 Jahre: Eine retrospektive Auswertung der COVID-19-assoziierten Todesfalle im Jahr 2020 im Institut fur Rechtsmedizin Hamburg, Deutschland.|pdf=|usr=027}}
| |
| − | {{tp|p=34057014|t=2021. Outcomes of critically ill patients with acute kidney injury in COVID-19 infection: an observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=34027292|t=2021. Comparison of the coagulopathies associated with COVID-19 and sepsis.|pdf=|usr=027}}
| |
| − | {{tp|p=34013153|t=2021. Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33965361|t=2021. Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33309013|t=2021. Persistent hiccup: A rare presentation of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33865161|t=2021. Decreased quality of life and spirometric alterations even after mild-moderate COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33848921|t=2021. Alpha-1 antitrypsin deficiency severity and the risk of COVID-19: A Portuguese cohort.|pdf=|usr=027}}
| |
| − | {{tp|p=33839588|t=2021. Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae.|pdf=|usr=027}}
| |
| − | {{tp|p=33839587|t=2021. Lung ultrasonography for long-term follow-up of COVID-19 survivors compared to chest CT scan.|pdf=|usr=027}}
| |
| − | {{tp|p=33915414|t=2021. Smoking and risk of COVID-19 hospitalization.|pdf=|usr=027}}
| |
| − | {{tp|p=33901788|t=2021. Evolution of lung function and chest CT 6 months after COVID-19 pneumonia: Real-life data from a Belgian University Hospital.|pdf=|usr=027}}
| |
| − | {{tp|p=33901787|t=2021. Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge.|pdf=|usr=027}}
| |
| − | {{tp|p=33873099|t=2021. Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation.|pdf=|usr=027}}
| |
| − | {{tp|p=33964817|t=2021. Follow-up of functional exercise capacity in patients with COVID-19: It is improved by telerehabilitation.|pdf=|usr=027}}
| |
| − | {{tp|p=33964815|t=2021. COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale.|pdf=|usr=027}}
| |
| − | {{tp|p=33957434|t=2021. The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34044224|t=2021. Pneumothorax in critically ill patients with COVID-19 infection: Incidence, clinical characteristics and outcomes in a case control multicenter study.|pdf=|usr=027}}
| |
| − | {{tp|p=34022502|t=2021. Preexisting cardiorespiratory comorbidity does not preclude the success of multidisciplinary rehabilitation in post-COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34020126|t=2021. Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study.|pdf=|usr=027}}
| |
| − | {{tp|p=34010740|t=2021. Clinical outcomes and quality of life of COVID-19 survivors: A follow-up of 3 months post hospital discharge.|pdf=|usr=027}}
| |
| − | {{tp|p=34010739|t=2021. SARS-CoV-2 infection in alpha1-antitrypsin deficiency.|pdf=|usr=027}}
| |
| − | {{tp|p=34094848|t=2021. Possible role of COVID-19 in the relapse of Klein-Levin Syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33996436|t=2021. Veno-arterial thrombosis and microcirculation imaging in a patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33996435|t=2021. Pulmonary arterial hypertension post COVID-19: A sequala of SARS-CoV-2 infection?|pdf=|usr=027}}
| |
| − | {{tp|p=33312856|t=2021. Recurrent SARS-CoV-2 infection resulting in acute respiratory distress syndrome and development of pulmonary hypertension: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34087493|t=2021. Low serum erythropoietin levels are associated with fatal COVID-19 cases at 4,150 meters above sea level.|pdf=|usr=027}}
| |
| − | {{tp|p=33985491|t=2021. Association of endothelial activation assessed through endothelin-I precursor peptide measurement with mortality in COVID-19 patients: an observational analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34098967|t=2021. Patients' treatment limitations as predictive factor for mortality in COVID-19: results from hospitalized patients of a hotspot region for SARS-CoV-2 infections.|pdf=|usr=027}}
| |
| − | {{tp|p=34091456|t=2021. Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID.|pdf=|usr=027}}
| |
| − | {{tp|p=33854784|t=2021. COVID-19 pneumonia and an indelible ground-glass nodule.|pdf=|usr=027}}
| |
| − | {{tp|p=34094570|t=2021. Successful endobronchial occlusion in empyema with broncho-pleural fistula secondary to COVID-19 pneumonia: a case report and literature review.|pdf=|usr=027}}
| |
| − | {{tp|p=33350007|t=2021. Secondary infection among hospitalized COVID-19 patients: A retrospective cohort study in a tertiary care setting.|pdf=|usr=027}}
| |
| − | {{tp|p=33955623|t=2021. Effect of comorbid pulmonary disease on the severity of COVID-19: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33955114|t=2021. Chronic pulmonary comorbidities increase the risk of severe COVID-19, but critical details remain undetermined.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33635829|t=2021. Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study.|pdf=|usr=027}}
| |
| − | {{tp|p=33869679|t=2021. Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33910207|t=2021. SARS-CoV-2 Infection in Pregnant Women: Neuroimmune-Endocrine Changes at the Maternal-Fetal Interface.|pdf=|usr=027}}
| |
| − | {{tp|p=33904434|t=2021. Neuroimaging Patterns in Patients with COVID-19-Associated Neurological Complications: A Review.|pdf=|usr=027}}
| |
| − | {{tp|p=34096013|t=2021. Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=34037979|t=2021. Neurological symptoms in hospitalised patients with COVID-19 and their association with in-hospital mortality.|pdf=|usr=027}}
| |
| − | {{tp|p=33949676|t=2021. 4C Mortality Score correlates with in-hospital functional outcome after COVID-19-associated ischaemic stroke.|pdf=|usr=027}}
| |
| − | {{tp|p=34016734|t=2021. COVID-19 Among Patients With Multiple Sclerosis: A Systematic Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33323467|t=2021. Acute disseminated encephalomyelitis after SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33310765|t=2021. Presentations and mechanisms of CNS disorders related to COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34021816|t=2021. Guillain-Barre syndrome associated with COVID-19: an atypical, late-onset presentation.|pdf=|usr=027}}
| |
| − | {{tp|p=33982145|t=2021. ADEM post-Sars-CoV-2 infection in a pediatric patient with Fisher-Evans syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33846880|t=2021. Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features?|pdf=|usr=027}}
| |
| − | {{tp|p=33954827|t=2021. The relationship between COVID-19's severity and ischemic stroke: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33864172|t=2021. Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33860395|t=2021. COVID-19-related refractory status epilepticus with the presence of SARS-CoV-2 (RNA) in the CSF: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34100130|t=2021. The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34021817|t=2021. Symptoms of gait and coordination impairment in a patient with COVID-19 interstitial pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=34021438|t=2021. Impact of COVID-19 on chronic migraine treated with erenumab: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34099946|t=2021. Mielitis transversa aguda asociada a infeccion por SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33867185|t=2021. Programa de rehabilitacion neuropsicologica en pacientes con sindrome post-COVID-19: una experiencia clinica.|pdf=|usr=027}}
| |
| − | {{tp|p=34103174|t=2021. Alta frecuencia de trombo endoluminal en pacientes con ictus isquemico tras la infeccion por coronavirus 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33994625|t=2021. Recomendaciones diagnostico-terapeuticas del grupo de trabajo de expertos de FACME ad-hoc sobre el manejo de la trombosis venosa cerebral relacionada con la vacunacion frente a COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34045055|t=2021. Sindrome de Parsonage-Turner postinfeccion por SARS-CoV-2: a proposito de un caso.|pdf=|usr=027}}
| |
| − | {{tp|p=33994626|t=2021. Alta Frecuencia de Trombo Endoluminal en pacientes con ictus isquemico tras la infeccion por Coronavirus 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33309682|t=2021. Sincope aislado como forma de presentacion de infeccion por COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34090845|t=2021. Neuropsychological rehabilitation program for patients with post-COVID-19 syndrome: a clinical experience.|pdf=|usr=027}}
| |
| − | {{tp|p=33942794|t=2021. COVID-19-Associated Ischemic Stroke in a Patient on Therapeutic Anticoagulation.|pdf=|usr=027}}
| |
| − | {{tp|p=33942789|t=2021. Concurrent Stroke and Myocardial Infarction After Mild COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34053847|t=2021. COVID-19 in advanced Duchenne/Becker muscular dystrophy patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34049779|t=2021. Clinical outcome of SARS-CoV-2 infection in 7 adults with Duchenne muscular dystrophy attending a specialist neuromuscular centre.|pdf=|usr=027}}
| |
| − | {{tp|p=33332756|t=2021. Post-COVID-19 fatigue and anhedonia: A cross-sectional study and their correlation to post-recovery period.|pdf=|usr=027}}
| |
| − | {{tp|p=33866390|t=2021. Non-aneurysmal subarachnoid haemorrhage in COVID-19-authors' reply to Kawada T.|pdf=|usr=027}}
| |
| − | {{tp|p=33352286|t=2021. Neurological issues in children with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33352277|t=2021. Stroke in patients with COVID-19: Clinical and neuroimaging characteristics.|pdf=|usr=027}}
| |
| − | {{tp|p=34036855|t=2021. Unravelling Pathophysiology of Neurological and Psychiatric Complications of COVID-19 Using Brain Organoids.|pdf=|usr=027}}
| |
| − | {{tp|p=34031638|t=2021. Gender-based differences in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33996101|t=2021. Reinfection or relapse of COVID-19 in health care workers; case series of 2 patients from Pakistan.|pdf=|usr=027}}
| |
| − | {{tp|p=33891697|t=2021. Smoking and the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33851085|t=2021. The first kidney transplantation after recipient and living donor recovered from COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33332825|t=2021. Elevated liver function tests in COVID-19: Causes, clinical evidence, and potential treatments.|pdf=|usr=027}}
| |
| − | {{tp|p=34068824|t=2021. Alcohol Consumption Is Associated with Poor Prognosis in Obese Patients with COVID-19: A Mendelian Randomization Study Using UK Biobank.|pdf=|usr=027}}
| |
| − | {{tp|p=33830208|t=2021. Persistent post-covid symptoms in healthcare workers.|pdf=|usr=027}}
| |
| − | {{tp|p=33936783|t=2021. Loss of Smell and Taste are Newly Emerging Symptoms in COVID-19 Patients Necessitating More Insights into their Diagnostic Evaluation.|pdf=|usr=027}}
| |
| − | {{tp|p=34028132|t=2021. COVID-19 in Patients with Cancer: A Retrospective Study of 212 Cases from a French SARS-CoV-2 Cluster During the First Wave of the COVID-19 Pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34018280|t=2021. Humoral Immune Response of SARS-CoV-2-Infected Patients with Cancer: Influencing Factors and Mechanisms.|pdf=|usr=027}}
| |
| − | {{tp|p=33368829|t=2021. ASH Registry Offers Insights on COVID-19 in Patients with Hematologic Malignancies.|pdf=|usr=027}}
| |
| − | {{tp|p=33856099|t=2021. Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34079393|t=2021. An Experience of Multiple Hematomas in a Coronavirus Disease-19 Patient Administered with ART-123 and Heparin.|pdf=|usr=027}}
| |
| − | {{tp|p=34099979|t=2021. SARS-CoV-2 Viral Persistence Based on Cycle Threshold Value and Liver Injury in Patients With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34099978|t=2021. Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections.|pdf=|usr=027}}
| |
| − | {{tp|p=34095338|t=2021. Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients.|pdf=|usr=027}}
| |
| − | {{tp|p=34095336|t=2021. Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33937433|t=2021. Comparison of All-Cause Mortality Between Individuals With COVID-19 and Propensity Score-Matched Individuals Without COVID-19 in South Korea.|pdf=|usr=027}}
| |
| − | {{tp|p=33875970|t=2021. Persistent Symptoms in Patients Recovering From COVID-19 in Denmark.|pdf=|usr=027}}
| |
| − | {{tp|p=34099529|t=2021. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review.|pdf=|usr=027}}
| |
| − | {{tp|p=33833064|t=2021. Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease.|pdf=|usr=027}}
| |
| − | {{tp|p=34013047|t=2021. Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB.|pdf=|usr=027}}
| |
| − | {{tp|p=33981852|t=2021. COVID-19 cases with delayed absorption of lung lesion.|pdf=|usr=027}}
| |
| − | {{tp|p=33869774|t=2021. Clinical features of hypertensive patients with COVID-19 compared with a normotensive group: Single-center experience in China.|pdf=|usr=027}}
| |
| − | {{tp|p=33973912|t=2021. An Eye on COVID-19: A Meta-analysis of Positive Conjunctival Reverse Transcriptase-Polymerase Chain Reaction and SARS-CoV-2 Conjunctivitis Prevalence.|pdf=|usr=027}}
| |
| − | {{tp|p=33954852|t=2021. Should anosmia and dysgeusia be a concern for oral and maxillofacial surgeons during the COVID-19 pandemic?|pdf=|usr=027}}
| |
| − | {{tp|p=33867304|t=2021. Painful palatal lesion in a patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34022767|t=2021. Reply: Insights and challenges in the management of oral lesions in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34102047|t=2021. Epidemiological, imaging, laboratory, and clinical characteristics and factors related to mortality in patients with COVID-19: a single-center study.|pdf=|usr=027}}
| |
| − | {{tp|p=34036239|t=2021. Severity of Sleep Apnea and COVID-19 Illness.|pdf=|usr=027}}
| |
| − | {{tp|p=33967243|t=2021. Auditory Performance in Recovered SARS-COV-2 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33301283|t=2021. Bilateral Sudden Sensorineural Hearing Loss and Intralabyrinthine Hemorrhage in a Patient With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33968298|t=2021. Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy.|pdf=|usr=027}}
| |
| − | {{tp|p=33997586|t=2021. Pain during and after coronavirus disease 2019: Chinese perspectives.|pdf=|usr=027}}
| |
| − | {{tp|p=34104294|t=2021. Clinical and epidemiological characteristics and outcomes of patients hospitalized for COVID-19 in Douala, Cameroon.|pdf=|usr=027}}
| |
| − | {{tp|p=34046131|t=2021. Late-onset of pulmonary embolism following hospitalization for COVID-19 despite thromboprophylaxis: a report of two cases.|pdf=|usr=027}}
| |
| − | {{tp|p=34046130|t=2021. What would be the impact of COVID-19 on liver function of a patient with chronic hepatitis B? About a case and literature review.|pdf=|usr=027}}
| |
| − | {{tp|p=34046127|t=2021. Central adrenal insufficiency and diabetes insipidus as potential endocrine manifestations of COVID-19 infection: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34046123|t=2021. Clinical characteristics of patients infected with SARS-CoV-2 in North Wollo Zone, North-East Ethiopia.|pdf=|usr=027}}
| |
| − | {{tp|p=33995815|t=2021. Several cases of arterial thrombosis of the limbs revealing asymptomatic and paucisymptomatic COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33995811|t=2021. Predictive factors of mortality in patients with COVID-19 in Guinea: analysis of the first 140 cases admitted to intensive care unit.|pdf=|usr=027}}
| |
| − | {{tp|p=33995798|t=2021. Multiple cardiovascular complications of COVID-19 infection in a young patient: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33995791|t=2021. Late pulmonary embolism in a patient with non-severe COVID-19: case report, value of antithrombotic prophylaxis and literature review.|pdf=|usr=027}}
| |
| − | {{tp|p=33995775|t=2021. Timing of onset of symptom for COVID-19 from publicly reported confirmed cases in Uganda.|pdf=|usr=027}}
| |
| − | {{tp|p=33912312|t=2021. A giant spontaneous subcapsular hematoma of the liver revealing a COVID-19 infection, a coincidence? (A case report).|pdf=|usr=027}}
| |
| − | {{tp|p=33912309|t=2021. Encephalopathy and COVID-19: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33912299|t=2021. A report on the development of COVID-19 guidelines for rehabilitation professionals in African settings.|pdf=|usr=027}}
| |
| − | {{tp|p=33912295|t=2021. Acute pulmonary embolism in a child following SARS-CoV-2 infection: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33912277|t=2021. Clinical and therapeutic outcomes of COVID-19 intensive care units (ICU) patients: a retrospective study in Ghana.|pdf=|usr=027}}
| |
| − | {{tp|p=33889231|t=2021. The occurrence of long COVID: a rapid review.|pdf=|usr=027}}
| |
| − | {{tp|p=33309015|t=2021. Acute pancreatitis in children hospitalized with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34060280|t=2021. Physical and psychological sequelae at three months after acute illness in COVID-19 survivors.|pdf=|usr=027}}
| |
| − | {{tp|p=33860653|t=2021. Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33931304|t=2021. Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression.|pdf=|usr=027}}
| |
| − | {{tp|p=33879549|t=2021. Pholcodine-induced Stevens-Johnson syndrome in a patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33898686|t=2021. Plasma LDH: A specific biomarker for lung affectation in COVID-19?|pdf=|usr=027}}
| |
| − | {{tp|p=34019446|t=2021. Das Long-COVID-Syndrom - ein neues Krankheitsbild nach COVID-19-Infekt.|pdf=|usr=027}}
| |
| − | {{tp|p=33834881|t=2021. Long COVID/PASC (Post Acute Sequelae of SARS-CoV-2 Infection).|pdf=|usr=027}}
| |
| − | {{tp|p=34000110|t=2021. Ptosis and COVID-19: An Unusual Initial Finding.|pdf=|usr=027}}
| |
| − | {{tp|p=34006475|t=2021. The sex-related discrepancy in laboratory parameters of severe COVID-19 patients with diabetes: A retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33849817|t=2021. Insulin resistance in COVID-19 and diabetes.|pdf=|usr=027}}
| |
| − | {{tp|p=33876719|t=2021. Hypothesis: AA amyloidosis is a factor causing systemic complications after coronavirus disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33953461|t=2021. Traumatic jejunal perforation associated with SARS-CoV-2 (COVID-19) infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33373681|t=2021. COVID-19, ferrosenescence and neurodegeneration, a mini-review.|pdf=|usr=027}}
| |
| − | {{tp|p=33940097|t=2021. Post-infection depressive, anxiety and post-traumatic stress symptoms: A prospective cohort study in patients with mild COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34007019|t=2021. Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=33857055|t=2021. How COVID-19 Patient Narratives Concerning Reinfection Mirror Their Mental Health: A Case Series.|pdf=|usr=027}}
| |
| − | {{tp|p=33857054|t=2021. Risk-Taking Behavior in Recovered COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34010256|t=2021. LONG-TERM NEUROPSYCHIATRIC CONSEQUENCES OF SARS-COV INFECTIONS.|pdf=|usr=027}}
| |
| − | {{tp|p=33836472|t=2021. Clinical vulnerability for severity and mortality by COVID-19 among users of alcohol and other substances.|pdf=|usr=027}}
| |
| − | {{tp|p=33902760|t=2021. Clinical features and outcomes of COVID-19 patients hospitalized for psychiatric disorders: a French multi-centered prospective observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=33866067|t=2021. The association between COVID-19 pandemic and maternal isolated hypothyroxinemia in first and second trimesters.|pdf=|usr=027}}
| |
| − | {{tp|p=34089950|t=2021. Survival in adult pneumonia inpatients fulfilling suspected COVID-19 criteria and baseline negative RT-qPCR.|pdf=|usr=027}}
| |
| − | {{tp|p=33316477|t=2021. Survival in adult inpatients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34049831|t=2021. COVID-19 Pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU.|pdf=|usr=027}}
| |
| − | {{tp|p=33539316|t=2021. Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=34099652|t=2021. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care.|pdf=|usr=027}}
| |
| − | {{tp|p=33837219|t=2021. IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals.|pdf=|usr=027}}
| |
| − | {{tp|p=33893295|t=2021. COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system.|pdf=|usr=027}}
| |
| − | {{tp|p=33828252|t=2021. Preventing cardiac damage in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33981029|t=2021. Glucose-lowering treatments and COVID-19 mortality in T2DM.|pdf=|usr=027}}
| |
| − | {{tp|p=34079100|t=2021. The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects.|pdf=|usr=027}}
| |
| − | {{tp|p=33824483|t=2021. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33859371|t=2021. Uncovering SARS-CoV-2 kidney tropism.|pdf=|usr=027}}
| |
| − | {{tp|p=33903743|t=2021. Systemic and organ-specific immune-related manifestations of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34075239|t=2021. NSAIDs not linked to worse COVID-19 outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=33339986|t=2021. Rheumatic disease and COVID-19: epidemiology and outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=34045075|t=2021. COVID-19 reinfection in a kidney transplant recipient, time for rethinking?|pdf=|usr=027}}
| |
| − | {{tp|p=34007095|t=2021. Acute kidney injury in hospitalized patients with COVID-19: a Portuguese cohort.|pdf=|usr=027}}
| |
| − | {{tp|p=33888348|t=2021. Glomeruloesclerosis focal y segmentaria asociada a infeccion por COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33957638|t=2021. Probable Case of Vertical Transmission of SARS-CoV-2 in a Newborn in Mexico.|pdf=|usr=027}}
| |
| − | {{tp|p=33868739|t=2021. COVID-19: Are reinfections a global health threat?|pdf=|usr=027}}
| |
| − | {{tp|p=33340043|t=2021. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA.|pdf=|usr=027}}
| |
| − | {{tp|p=33836957|t=2021. Covid-19 en transplantation renale, lecons du registre francais.|pdf=|usr=027}}
| |
| − | {{tp|p=34044394|t=2021. Endothelial Dysfunction for Acute Kidney Injury in Coronavirus Disease 2019: How Concerned Should We Be?|pdf=|usr=027}}
| |
| − | {{tp|p=33902031|t=2021. COVID-19 Infection: Viral Clearance and Antibody Response in Dialysis Patients and Renal Transplant Recipients.|pdf=|usr=027}}
| |
| − | {{tp|p=33861430|t=2021. Effect of anticoagulant therapy in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33860910|t=2021. The effects of ACE2 expression mediating pharmacotherapy in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33860909|t=2021. Impact of cardiovascular disease and cardiovascular risk factors in hospitalised COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33860908|t=2021. How often and to what extent do admitted COVID-19 patients have signs of cardiac injury?|pdf=|usr=027}}
| |
| − | {{tp|p=33964332|t=2021. Mortality after in-hospital cardiac arrest in patients with COVID-19: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33874649|t=2021. Axial and peripheral spondyloarthritis triggered by sars-cov-2 infection: a report of two cases.|pdf=|usr=027}}
| |
| − | {{tp|p=33985907|t=2021. Caracteristicas de pacientes con enfermedades inflamatorias inmunomediadas hospitalizados por infeccion por SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33895100|t=2021. Hospitalizaciones y mortalidad por COVID-19 en pacientes con enfermedades inflamatorias reumaticas en Andalucia.|pdf=|usr=027}}
| |
| − | {{tp|p=34037165|t=2021. Vertical transmission and COVID-19: a scoping review.|pdf=|usr=027}}
| |
| − | {{tp|p=33860504|t=2021. Transmissao vertical do SARS-CoV-2: Revisao sistematica.|pdf=|usr=027}}
| |
| − | {{tp|p=33860503|t=2021. Comparison of Laboratory and Radiological Findings of Pregnant and Non-Pregnant Women with Covid-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34077991|t=2021. Infeccao por SARS-CoV-2 e patologia placentaria.|pdf=|usr=027}}
| |
| − | {{tp|p=33979895|t=2021. Twelve Months Down the Line: do we know Anything more about the Presence of the SARS-CoV-2 in Human Semen?|pdf=|usr=027}}
| |
| − | {{tp|p=33986784|t=2021. COVID-19: risk of ocular transmission in health care professionals.|pdf=|usr=027}}
| |
| − | {{tp|p=33886866|t=2021. Reabilitacao cardiopulmonar em pacientes pos-COVID-19: serie de casos.|pdf=|usr=027}}
| |
| − | {{tp|p=33886855|t=2021. Caracterizacao do comprometimento pulmonar associado a COVID-19 em pacientes com necessidade de ventilacao mecanica.|pdf=|usr=027}}
| |
| − | {{tp|p=33886854|t=2021. Modificacoes no manejo e desfechos clinicos de pacientes criticos sem COVID-19 durante a pandemia.|pdf=|usr=027}}
| |
| − | {{tp|p=34054133|t=2021. Factores de riesgo de deterioro clinico en pacientes ingresados por COVID-19: estudio caso-control.|pdf=|usr=027}}
| |
| − | {{tp|p=33935292|t=2021. Metaanalisis para evaluar el riesgo de infecciones respiratorias y sindrome de distres respiratorio del adulto con los agonistas del receptor del peptido similar al glucagon tipo 1 en los ensayos de seguridad cardiovascular: consecuencias utiles para la pandemia de COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33998522|t=2021. COVID-19 myopericarditis: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34059237|t=2021. Subacute thyroiditis following COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33998509|t=2021. In search of other respiratory viruses during the COVID-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33843008|t=2021. Thyroid sequelae of COVID-19: a systematic review of reviews.|pdf=|usr=027}}
| |
| − | {{tp|p=33860905|t=2021. Aging versus youth: Endocrine aspects of vulnerability for COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33846867|t=2021. Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications.|pdf=|usr=027}}
| |
| − | {{tp|p=33994585|t=2021. Proteina C reactiva y escala SOFA: una simple escala como factor predictivo temprano de la necesidad de cuidados criticos en los pacientes con neumonia causada por COVID-19 en Espana.|pdf=|usr=027}}
| |
| − | {{tp|p=33994592|t=2021. SARS-CoV-2 infection. Descriptive analysis of a selected case series. Infeccion por SARS-CoV2. Analisis descriptivo de una serie de casos seleccionada.|pdf=|usr=027}}
| |
| − | {{tp|p=33994593|t=2021. ASPERGILOSIS PULMONAR INVASIVA EN PACIENTES CON SINDROME DE DISTRES RESPIRATORIO POR COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33362331|t=2021. Ictus de la arteria cerebral media por embolia paradojica en paciente con neumonia por COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33349587|t=2021. Impact of the first wave of the SARS-CoV-2 pandemic on preferential/emergent pacemaker implantation rate. Spanish study.|pdf=|usr=027}}
| |
| − | {{tp|p=33309674|t=2021. Elevated baseline renin levels as a possible cause of worse prognosis of COVID-19 in patients with heart disease.|pdf=|usr=027}}
| |
| − | {{tp|p=34030947|t=2021. Relationship between patent foramen ovale and COVID-19 in patients admitted to an intensive care unit.|pdf=|usr=027}}
| |
| − | {{tp|p=34055107|t=2021. Neuropatia esporadica de nervio peroneal en la rodilla durante el estado de alarma por pandemia SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33947196|t=2021. Mild ast elevation as an early sign of COVID-19 severity in a multicenter Madrid cohort.|pdf=|usr=027}}
| |
| − | {{tp|p=34015933|t=2021. Autoimmune hepatitis triggered by COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33371692|t=2021. Views of patients with inflammatory bowel disease during the COVID-19 pandemic: ACCU survey results.|pdf=|usr=027}}
| |
| − | {{tp|p=33342216|t=2021. Spontaneous pneumoperitoneum and pneumatosis intestinalis as sole manifestations of a COVID-19 infection. An extremely rare complication.|pdf=|usr=027}}
| |
| − | {{tp|p=34056893|t=2021. Prognostic value of static and dynamic biomarkers in COVID-19 patients: a prospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34008930|t=2021. Clinical characteristics and outcomes of 1,331 patients with COVID-19: HM Spanish Cohort.|pdf=|usr=027}}
| |
| − | {{tp|p=33878844|t=2021. Sindrome post-COVID: Un documento de reflexion y opinion.|pdf=|usr=027}}
| |
| − | {{tp|p=34083670|t=2021. Chronic liver disease not a significant comorbid condition for COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34075155|t=2021. Increased extravascular lung water index (EVLWI) reflects rapid non-cardiogenic oedema and mortality in COVID-19 associated ARDS.|pdf=|usr=027}}
| |
| − | {{tp|p=33833254|t=2021. Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33931692|t=2021. Standard blood laboratory values as a clinical support tool to distinguish between SARS-CoV-2 positive and negative patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33903709|t=2021. SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition.|pdf=|usr=027}}
| |
| − | {{tp|p=33903671|t=2021. Drug-utilisation profiles and COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33888747|t=2021. Clinical features and disease severity in an Iranian population of inpatients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33875764|t=2021. COVID-19 associated mortality and cardiovascular disease outcomes among US women veterans.|pdf=|usr=027}}
| |
| − | {{tp|p=33875742|t=2021. Prevalence and prognostic associations of cardiac abnormalities among hospitalized patients with COVID-19: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33863997|t=2021. The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico.|pdf=|usr=027}}
| |
| − | {{tp|p=33850202|t=2021. Dynamic changes of acquired maternal SARS-CoV-2 IgG in infants.|pdf=|usr=027}}
| |
| − | {{tp|p=33850192|t=2021. A comprehensive evaluation of early potential risk factors for disease aggravation in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33846372|t=2021. Cardiometabolic risks of SARS-CoV-2 hospitalization using Mendelian Randomization.|pdf=|usr=027}}
| |
| − | {{tp|p=33846344|t=2021. Complement C3 identified as a unique risk factor for disease severity among young COVID-19 patients in Wuhan, China.|pdf=|usr=027}}
| |
| − | {{tp|p=33941622|t=2021. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters.|pdf=|usr=027}}
| |
| − | {{tp|p=34044299|t=2021. Cerebrospinal fluid findings in patients with seizure in the setting of COVID-19: A review of the literature.|pdf=|usr=027}}
| |
| − | {{tp|p=34020880|t=2021. Dermografismo blanco como manifestacion cutanea atipica de la COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33832767|t=2021. Incidence of COVID-19 in outpatients with cancer receiving active treatment in the context of a pandemic: An Andalusian cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33989754|t=2021. COVID-19 After Lung Resection in Northern Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=33918646|t=2021. Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population.|pdf=|usr=027}}
| |
| − | {{tp|p=33378321|t=2021. A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy.|pdf=|usr=027}}
| |
| − | {{tp|p=34016949|t=2021. Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza.|pdf=|usr=027}}
| |
| − | {{tp|p=33986253|t=2021. Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34099622|t=2021. Coagulation factors and the incidence of COVID-19 severity: Mendelian randomization analyses and supporting evidence.|pdf=|usr=027}}
| |
| − | {{tp|p=33866749|t=2021. Guidance for the clinical management of infants born to mothers with suspected/confirmed COVID-19 in Singapore.|pdf=|usr=027}}
| |
| − | {{tp|p=33883014|t=2021. Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33907966|t=2021. The association between high risk of sleep apnea, comorbidities, and risk of COVID-19: a population-based international harmonized study.|pdf=|usr=027}}
| |
| − | {{tp|p=33892451|t=2021. Obstructive sleep apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33972929|t=2021. Assessment of Obstructive Sleep Apnea in Association with Severity of COVID-19: A Prospective Observational Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33997622|t=2021. Acute Psychosis in COVID-19: Is It Due to Favipiravir Treatment or Acute Viral Illness?|pdf=|usr=027}}
| |
| − | {{tp|p=34095752|t=2021. Antimicrobial consumption among hospitalized patients with COVID-19 in Pakistan.|pdf=|usr=027}}
| |
| − | {{tp|p=34075351|t=2021. Pemphigus Vulgaris After COVID-19: a Case of Induced Autoimmunity.|pdf=|usr=027}}
| |
| − | {{tp|p=34056546|t=2021. Can COVID-19 Cause Peripheral Facial Nerve Palsy?|pdf=|usr=027}}
| |
| − | {{tp|p=34036244|t=2021. Long-COVID Headache.|pdf=|usr=027}}
| |
| − | {{tp|p=33842842|t=2021. Portal Vein Thrombosis-a Rare Complication of SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33948534|t=2021. Cerebral Venous Thrombosis in Acute Lymphoblastic Leukemia with Severe COVID-19: a Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=33942028|t=2021. The Association of Subacute Thyroiditis with COVID-19: a Systematic Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33937635|t=2021. Pulmonary Embolism and Acute Psychosis, a Case Report of an Outpatient with a Mild Course of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33937632|t=2021. An Unusual Presentation of Pyelonephritis: Is It COVID-19 Related?|pdf=|usr=027}}
| |
| − | {{tp|p=33937631|t=2021. The Complexity of Co-Infections in the Era of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33898924|t=2021. COVID-19 and Pregnancy: Risk, Symptoms, Diagnosis, and Treatment.|pdf=|usr=027}}
| |
| − | {{tp|p=33824942|t=2021. COVID-19 and Pembrolizumab-Induced Secondary Hemophagocytic Lymphohistiocytosis: a Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=33936793|t=2021. Human immunodeficiency virus and mortality from coronavirus disease 2019: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33966492|t=2021. Ischemic Stroke, Inflammation, and Endotheliopathy in COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33851236|t=2021. Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center study.|pdf=|usr=027}}
| |
| − | {{tp|p=33830380|t=2021. Portal vein thrombosis in COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34084615|t=2021. Ruptured cerebral aneurysms in COVID-19 patients: A review of literature with case examples.|pdf=|usr=027}}
| |
| − | {{tp|p=34084609|t=2021. Spontaneous anterior cervicothoracic spinal epidural hematoma extending to clivus in SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34084594|t=2021. Reactivation of COVID-19 in a neurosurgical patient with early neuropsychiatric presentation. Does seroconversion mean immunity?|pdf=|usr=027}}
| |
| − | {{tp|p=33880221|t=2021. Decompressive hemicraniectomy for acute ischemic stroke associated with coronavirus disease 2019 infection: Case report and systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=33966728|t=2021. Clinical and obstetric characteristics of pregnant women with Covid-19: A case series study on 26 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33966721|t=2021. Relationship of COVID-19 with pregnancy.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33875976|t=2021. A Systematic Review and Meta-Analysis of Cancer Patients Affected by a Novel Coronavirus.|pdf=|usr=027}}
| |
| − | {{tp|p=34051388|t=2021. Phenotypic switch from non-active primary Sjogren's syndrome to severe systemic Lupus erythematosus after COVID-19 infection in an elderly man.|pdf=|usr=027}}
| |
| − | {{tp|p=34029372|t=2021. Successful revascularization of total occlusion of the left anterior descending artery in patient with COVID-19 infection and treatment-resistant heart failure.|pdf=|usr=027}}
| |
| − | {{tp|p=33926173|t=2021. Association between cardiovascular disease, cardiovascular drug therapy, and in-hospital outcomes in patients with COVID-19: data from a large single-center registry in Poland.|pdf=|usr=027}}
| |
| − | {{tp|p=33890747|t=2021. Ultrasound-assisted thrombolysis for a giant right atrial thrombus and pulmonary embolism in a COVID-19 patient.|pdf=|usr=027}}
| |
| − | {{tp|p=34098555|t=2021. COVID-19 in CKD Patients: Lessons from 553 CKD Patients with Biopsy-Proven Kidney Disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33352576|t=2021. The Involvement of Chronic Kidney Disease and Acute Kidney Injury in Disease Severity and Mortality in Patients with COVID-19: A Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33930411|t=2021. Use of peritoneal dialysis for acute kidney injury during the COVID-19 pandemic in New York City: a multicenter observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=33363263|t=2021. Systematic Review and Meta-analysis of COVID-19 and Kidney Transplant Recipients, the South West London Kidney Transplant Network Experience.|pdf=|usr=027}}
| |
| − | {{tp|p=33851069|t=2021. Kidney Thrombotic Microangiopathy After COVID-19 Associated With C3 Gene Mutation.|pdf=|usr=027}}
| |
| − | {{tp|p=33898966|t=2021. Acute Kidney Injury and Advanced Kidney Disease in the COVID-19 Pandemic: Proceedings From a National Kidney Foundation Symposium.|pdf=|usr=027}}
| |
| − | {{tp|p=34007963|t=2021. Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion.|pdf=|usr=027}}
| |
| − | {{tp|p=33942030|t=2021. Molecular Analysis of the Kidney From a Patient With COVID-19-Associated Collapsing Glomerulopathy.|pdf=|usr=027}}
| |
| − | {{tp|p=33898967|t=2021. SARS-CoV-2 Seropositivity Rates in Patients and Clinical Staff in New York City Dialysis Facilities: Association With the General Population.|pdf=|usr=027}}
| |
| − | {{tp|p=33319192|t=2021. Thrombotic Microangiopathy in a Kidney Transplant Patient With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33319190|t=2021. The Prevalence of Acute Kidney Injury in Patients Hospitalized With COVID-19 Infection: A Systematic Review and Meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34078024|t=2021. Acute kidney injury and mortality in coronavirus disease 2019: results from a cohort study of 1,280 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33858123|t=2021. Different therapeutic associations of renin-angiotensin system inhibitors with coronavirus disease 2019 compared with usual pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33336243|t=2021. Absolute Lymphocytes, Ferritin, C-Reactive Protein, and Lactate Dehydrogenase Predict Early Invasive Ventilation in Patients With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34022988|t=2021. Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34022973|t=2021. Excess COVID-19 mortality among critically ill patients in Africa.|pdf=|usr=027}}
| |
| − | {{tp|p=33992143|t=2021. Long-term effects of COVID-19 on kidney function.|pdf=|usr=027}}
| |
| − | {{tp|p=33992142|t=2021. Long-term effects of COVID-19 on kidney function - Authors' reply.|pdf=|usr=027}}
| |
| − | {{tp|p=33992141|t=2021. Long-term effects of COVID-19 on kidney function.|pdf=|usr=027}}
| |
| − | {{tp|p=34097856|t=2021. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.|pdf=|usr=027}}
| |
| − | {{tp|p=33347812|t=2021. Infectivity of asymptomatic versus symptomatic COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33357467|t=2021. Long COVID guidelines need to reflect lived experience.|pdf=|usr=027}}
| |
| − | {{tp|p=33864751|t=2021. Were pregnant women more affected by COVID-19 in the second wave of the pandemic?|pdf=|usr=027}}
| |
| − | {{tp|p=33844963|t=2021. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).|pdf=|usr=027}}
| |
| − | {{tp|p=33338439|t=2021. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study.|pdf=|usr=027}}
| |
| − | {{tp|p=33961798|t=2021. SARS-CoV-2 related paediatric acute-onset neuropsychiatric syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33891880|t=2021. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33340468|t=2021. COVID-19 associated arterial ischaemic stroke and multisystem inflammatory syndrome in children: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33932336|t=2021. New insights into the association between body-mass index and severe COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33932335|t=2021. Associations between body-mass index and COVID-19 severity in 6.9 million people in England: a prospective, community-based, cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33989537|t=2021. Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK.|pdf=|usr=027}}
| |
| − | {{tp|p=33357491|t=2021. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland.|pdf=|usr=027}}
| |
| − | {{tp|p=33357490|t=2021. Observational research on severe COVID-19 in diabetes.|pdf=|usr=027}}
| |
| − | {{tp|p=33342754|t=2021. Renin-angiotensin system inhibitors and COVID-19: overwhelming evidence against an association.|pdf=|usr=027}}
| |
| − | {{tp|p=33342753|t=2021. Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34019842|t=2021. Integrated multidisciplinary post-COVID-19 care in Egypt.|pdf=|usr=027}}
| |
| − | {{tp|p=34106656|t=2021. Differences in clinical characteristics and liver injury between suspected and confirmed COVID-19 patients in Jingzhou, Hubei Province of China.|pdf=|usr=027}}
| |
| − | {{tp|p=34106635|t=2021. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34106608|t=2021. Gastrointestinal perforation secondary to COVID-19: Case reports and literature review.|pdf=|usr=027}}
| |
| − | {{tp|p=34106589|t=2021. Comparison of liver biochemical abnormality between COVID-19 patients with liver cirrhosis versus COVID-19 alone and liver cirrhosis alone: A STROBE observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=34087864|t=2021. Serum IL-6 and procalcitonin are two promising novel biomarkers for evaluating the severity of COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33832159|t=2021. COVID-19 infection manifesting as a severe gastroparesis flare: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33832113|t=2021. Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33879741|t=2021. Major determinants of death in patients hospitalized with COVID-19 during the first epidemic wave in Madrid, Spain.|pdf=|usr=027}}
| |
| − | {{tp|p=33847623|t=2021. Improvement in plasma D-dimer level in severe SARS-CoV-2 infection can be an indicator of fibrinolysis suppression: Case reports.|pdf=|usr=027}}
| |
| − | {{tp|p=34007423|t=2021. The Risk of SARS-CoV-2 Reinfection in Duhok city, Kurdistan Region of Iraq.|pdf=|usr=027}}
| |
| − | {{tp|p=33950107|t=2021. Should COVID-19 be branded to viral thrombotic fever?|pdf=|usr=027}}
| |
| − | {{tp|p=34075330|t=2021. A variant in TMPRSS2 is associated with decreased disease severity in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34042167|t=2021. Sindrome post-COVID-19: epidemiologia, criterios diagnosticos y mecanismos patogenicos implicados.|pdf=|usr=027}}
| |
| − | {{tp|p=33378077|t=2021. Hemorragias cerebrales multiples secundarias a coagulacion intravascular diseminada en un paciente con COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33851719|t=2021. Paralisis facial periferica en pacientes con SARS-CoV-2 en decubito prono.|pdf=|usr=027}}
| |
| − | {{tp|p=33936183|t=2021. Defunciones por COVID-19: distribucion por edad y universalidad de la cobertura medica en 22 paises.|pdf=|usr=027}}
| |
| − | {{tp|p=34076204|t=2021. POTENTIAL RISK OF BRAIN DAMAGE AND POOR DEVELOPMENTAL OUTCOMES IN CHILDREN PRENATALLY EXPOSED TO SARS-COV-2: A SYSTEMATIC REVIEW.|pdf=|usr=027}}
| |
| − | {{tp|p=34105606|t=2021. Chronic non-communicable diseases and COVID-19: EPICOVID-19 Brazil results.|pdf=|usr=027}}
| |
| − | {{tp|p=34105633|t=2021. Isolated posterior tibial artery thrombosis after non-severe SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34105631|t=2021. Spontaneous pneumomediastinum associated with Covid-19 pneumonia in a pregnant woman.|pdf=|usr=027}}
| |
| − | {{tp|p=34105629|t=2021. Pulmonary thromboembolism in conjunction with intracavitary thrombus caused by severe acute respiratory syndrome coronavirus-2 infection in a patient living with human immunodeficiency virus.|pdf=|usr=027}}
| |
| − | {{tp|p=33950122|t=2021. Diagnosis and management of coronavirus disease-associated immune thrombocytopenia: a case series.|pdf=|usr=027}}
| |
| − | {{tp|p=33950121|t=2021. Risk factors for critical illness and death among adult Brazilians with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33886821|t=2021. Pathological findings and morphologic correlation of the lungs of autopsied patients with SARS-CoV-2 infection in the Brazilian Amazon using transmission electron microscopy.|pdf=|usr=027}}
| |
| − | {{tp|p=33886817|t=2021. Aquagenic syringeal acrokeratoderma in an adolescent female with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33886816|t=2021. Pneumorrhachis: an uncommon finding in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34095747|t=2021. Clinical and psychosocioeconomic impact of COVID-19 pandemic on patients of the Indian Progressive Systemic Sclerosis Registry (IPSSR).|pdf=|usr=027}}
| |
| − | {{tp|p=33856543|t=2021. Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases.|pdf=|usr=027}}
| |
| − | {{tp|p=33978818|t=2021. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews.|pdf=|usr=027}}
| |
| − | {{tp|p=33954813|t=2021. Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=34100115|t=2021. ANCA-associated vasculitis after COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34091704|t=2021. COVID-19 pneumonia in a patient with granulomatosis with polyangiitis on rituximab: case-based review.|pdf=|usr=027}}
| |
| − | {{tp|p=34032896|t=2021. COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?|pdf=|usr=027}}
| |
| − | {{tp|p=34032894|t=2021. The impact of COVID-19 on familial Mediterranean fever: a nationwide study.|pdf=|usr=027}}
| |
| − | {{tp|p=33903964|t=2021. Sex hormones, autoimmunity and gender disparity in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34040465|t=2021. Comorbidities and Factors Determining Medical Expenses and Length of Stay for Admitted COVID-19 Patients in Korea.|pdf=|usr=027}}
| |
| − | {{tp|p=33958439|t=2021. Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=34053203|t=2021. Healthcare-associated Clostridioides difficile infection during the COVID-19 pandemic in a tertiary care hospital in Romania.|pdf=|usr=027}}
| |
| − | {{tp|p=34104439|t=2021. Hemorrhage and venous thromboembolism in critically ill patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34094558|t=2021. Upper respiratory tract and otolaryngological manifestations of coronavirus disease 2019 (COVID-19): A systemic review.|pdf=|usr=027}}
| |
| − | {{tp|p=34104443|t=2021. Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment.|pdf=|usr=027}}
| |
| − | {{tp|p=34035922|t=2021. A case report of COVID-19 infection and management during pregnancy.|pdf=|usr=027}}
| |
| − | {{tp|p=34035919|t=2021. "Long COVID": A case report of persistent symptoms in a patient with prolonged SARS-CoV-2 shedding for over 110 days.|pdf=|usr=027}}
| |
| − | {{tp|p=34035914|t=2021. Vestibular neuritis caused by severe acute respiratory syndrome coronavirus 2 infection diagnosed by serology: Case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34017591|t=2021. Pneumomediastinum in COVID-19: A series of three cases and review of literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33959284|t=2021. A case of spontaneous pneumomediastinum in a patient with severe SARS-CoV-2 and a review of the literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33889412|t=2021. Post COVID-19 MSSA pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33824641|t=2021. Emergency cesarean section in a COVID-19 patient: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34084102|t=2021. Natural History and Clinical Course of Symptomatic and Asymptomatic COVID-19 Patients in the Kingdom of Saudi Arabia.|pdf=|usr=027}}
| |
| − | {{tp|p=34003706|t=2021. Serum ACE activity and plasma ACE concentration in patients with SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33989101|t=2021. A bimodal pattern of the onset of COVID-19 related acute pancreatitis supports both the cytotoxic and immune-related pathogenesis - a systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=34057188|t=2021. Infection and death by COVID-19 in a cohort of healthcare workers in Mexico.|pdf=|usr=027}}
| |
| − | {{tp|p=33963249|t=2021. Angiotensin converting enzyme 2 is a novel target of the gamma-secretase complex.|pdf=|usr=027}}
| |
| − | {{tp|p=33958604|t=2021. Clinical characteristics of vulnerable populations hospitalized and diagnosed with COVID-19 in Buenos Aires, Argentina.|pdf=|usr=027}}
| |
| − | {{tp|p=34059708|t=2021. Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33941816|t=2021. 8806 Russian patients demonstrate T cell count as better marker of COVID-19 clinical course severity than SARS-CoV-2 viral load.|pdf=|usr=027}}
| |
| − | {{tp|p=34045530|t=2021. Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34045511|t=2021. Androgen regulation of pulmonary AR, TMPRSS2 and ACE2 with implications for sex-discordant COVID-19 outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=34045510|t=2021. Toward understanding COVID-19 pneumonia: a deep-learning-based approach for severity analysis and monitoring the disease.|pdf=|usr=027}}
| |
| − | {{tp|p=34040094|t=2021. Ocular findings among patients surviving COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34035353|t=2021. Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34031519|t=2021. High plasma concentration of non-esterified polyunsaturated fatty acids is a specific feature of severe COVID-19 pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=34012016|t=2021. Effect of COVID-19 on liver abnormalities: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34006973|t=2021. Author Correction: Selforganized wavy infection curve of COVID19.|pdf=|usr=027}}
| |
| − | {{tp|p=34001992|t=2021. Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33986318|t=2021. Elevated transaminases and hypoalbuminemia in Covid-19 are prognostic factors for disease severity.|pdf=|usr=027}}
| |
| − | {{tp|p=33980943|t=2021. The lower respiratory tract microbiome of critically ill patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33980931|t=2021. COVID-19's natural course among ambulatory monitored outpatients.|pdf=|usr=027}}
| |
| − | {{tp|p=33980912|t=2021. Clinical course and risk factors of fatal adverse outcomes in COVID-19 patients in Korea: a nationwide retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33972591|t=2021. Elevated serum SDMA and ADMA at hospital admission predict in-hospital mortality of COVID-19 patients.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33834251|t=2021. SARS-CoV-2 reinfections among hospital staff in the greater Paris area.|pdf=|usr=027}}
| |
| − | {{tp|p=33313926|t=2021. Severe Malnutrition and Anemia Are Associated with Severe COVID in Infants.|pdf=|usr=027}}
| |
| − | {{tp|p=34093678|t=2021. Late mesenteric ischemia after Sars-Cov-2 infection: case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33309903|t=2021. Systematic review and meta-analysis of the prevalence of venous thromboembolic events in novel coronavirus disease-2019 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33836287|t=2021. Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system.|pdf=|usr=027}}
| |
| − | {{tp|p=33907556|t=2021. Persistent interstitial lung abnormalities in post-COVID-19 patients: a case series.|pdf=|usr=027}}
| |
| − | {{tp|p=34044003|t=2021. May viral load detected in saliva in the early stages of infection be a prognostic indicator in COVID-19 patients?|pdf=|usr=027}}
| |
| − | {{tp|p=33835767|t=2021. Effects of angiotensin II receptor blocker usage on viral load, antibody dynamics, and transcriptional characteristics among COVID-19 patients with hypertension.|pdf=|usr=027}}
| |
| − | {{tp|p=34051385|t=2021. Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases.|pdf=|usr=027}}
| |
| − | {{tp|p=33901661|t=2021. Neuralgic amyotrophy and COVID-19 infection: 2 cases of spinal accessory nerve palsy.|pdf=|usr=027}}
| |
| − | {{tp|p=34053958|t=2021. Will Proton Pump Inhibitors Lead to a Higher Risk of COVID-19 Infection and Progression to Severe Disease? A Meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34053956|t=2021. A pilot study of viral load in stools of patients with COVID-19 and diarrhea.|pdf=|usr=027}}
| |
| − | {{tp|p=33952771|t=2021. Frequency of interleukin-6 rs1800795 (-174G/C) and rs1800797 (-597G/A) polymorphisms in COVID-19 patients in Turkey who develop macrophage activation syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33952766|t=2021. How many coinfected patients with influenza and COVID-19 are there in a single Japanese hospital during the first wave?|pdf=|usr=027}}
| |
| − | {{tp|p=34007953|t=2021. Could Daily Monitoring of Fibrin Related Markers Help Suspect a Thrombotic Event in COVID-19 Patients? A Prospective Pilot Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33996075|t=2021. A review on recipients of hematopoietic stem cell transplantation patients with COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33959278|t=2021. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review.|pdf=|usr=027}}
| |
| − | {{tp|p=33995596|t=2021. Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34046087|t=2021. Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies.|pdf=|usr=027}}
| |
| − | {{tp|p=33878961|t=2021. Three-month outcomes of recovered COVID-19 patients: prospective observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=34079269|t=2021. Current Opinion on the use of Direct Oral Anticoagulants for the Prophylaxis of Venous Thromboembolism among Medical Inpatients.|pdf=|usr=027}}
| |
| − | {{tp|p=34104210|t=2021. The role of liver steatosis as measured with transient elastography and transaminases on hard clinical outcomes in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33927016|t=2021. Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length.|pdf=|usr=027}}
| |
| − | {{tp|p=33378787|t=2021. Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33368057|t=2021. Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report.|pdf=|usr=027}}
| |
| − | {{tp|p=34059058|t=2021. Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohort.|pdf=|usr=027}}
| |
| − | {{tp|p=34011381|t=2021. Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33980250|t=2021. Giant intracardiac thrombosis in an infant with leukaemia and prolonged COVID-19 viral RNA shedding: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34078399|t=2021. Point of care ultrasound screening for deep vein thrombosis in critically ill COVID-19 patients, an observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=34078393|t=2021. Point of care diagnostic of hypercoagulability and platelet function in COVID-19 induced acute respiratory distress syndrome: a retrospective observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=33879177|t=2021. An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study.|pdf=|usr=027}}
| |
| − | {{tp|p=33862518|t=2021. D-dimer driven deep vein thrombosis prophylaxis strategy for hospitalized patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33894421|t=2021. COVID-19 and thrombotic microangiopathies.|pdf=|usr=027}}
| |
| − | {{tp|p=33839381|t=2021. Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34020162|t=2021. Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study.|pdf=|usr=027}}
| |
| − | {{tp|p=33989984|t=2021. Incidence and clinical profile of venous thromboembolism in hospitalized COVID-19 patients from Madrid region.|pdf=|usr=027}}
| |
| − | {{tp|p=33975205|t=2021. In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis.|pdf=|usr=027}}
| |
| − | {{tp|p=33964522|t=2021. Therapeutic anticoagulation in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33940309|t=2021. Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33915353|t=2021. Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33894473|t=2021. Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy.|pdf=|usr=027}}
| |
| − | {{tp|p=33338976|t=2021. Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study.|pdf=|usr=027}}
| |
| − | {{tp|p=33310348|t=2021. Association of anticoagulation use with SARS-CoV2 detection.|pdf=|usr=027}}
| |
| − | {{tp|p=33302210|t=2021. Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy.|pdf=|usr=027}}
| |
| − | {{tp|p=34102452|t=2021. Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33433107|t=2021. Rettelse: Lungeembolisme ved covid-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34043219|t=2021. Ervaringen van patienten die COVID-ic-opname overleefden: enquete naar psychische gevolgen.|pdf=|usr=027}}
| |
| − | {{tp|p=34107204|t=2021. CROI 2021: Tuberculosis, Opportunistic Infections, and COVID-19 Among People with HIV.|pdf=|usr=027}}
| |
| − | {{tp|p=34107203|t=2021. CROI 2021: Neurologic Complications of HIV-1 Infection or COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34107202|t=2021. CROI 2021: Metabolic and Other Complications of HIV Infection or COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33319246|t=2021. The first laboratory-confirmed imported infections of SARS-CoV-2 in Sudan.|pdf=|usr=027}}
| |
| − | {{tp|p=34045120|t=2021. Systematic review and meta-analysis of the susceptibility of ABO blood group to COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33850820|t=2021. Clinical analysis of seven pediatric patients with coronavirus disease 2019 (COVID-19) in Jingzhou, Hubei, China: a retrospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=34021116|t=2021. Characteristics of mental health implications and plasma metabolomics in patients recently recovered from COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34001863|t=2021. Understanding the psychiatric symptoms of COVID-19: a meta-analysis of studies assessing psychiatric symptoms in Chinese patients with and survivors of COVID-19 and SARS by using the Symptom Checklist-90-Revised.|pdf=|usr=027}}
| |
| − | {{tp|p=34048985|t=2021. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33352298|t=2021. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33895261|t=2021. A patient with end-stage renal disease who recovered from coronavirus disease 2019 then received a kidney transplant.|pdf=|usr=027}}
| |
| − | {{tp|p=33912658|t=2021. Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33364384|t=2021. COVID-19: A One-center Experience in Paris.|pdf=|usr=027}}
| |
| − | {{tp|p=33892935|t=2021. Acute Biventricular Heart Failure After COVID-19 Infection in an Orthotropic Heart Transplant Patient: A Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=33892930|t=2021. The Course of SARS-CoV-2 in a Patient After a Recent Kidney Transplant: A Literature Review on COVID-19 Therapy.|pdf=|usr=027}}
| |
| − | {{tp|p=33888342|t=2021. Successful Management of COVID-19 Infection in 2 Early Post-Liver Transplant Recipients.|pdf=|usr=027}}
| |
| − | {{tp|p=33846012|t=2021. Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=34053771|t=2021. Successful Salvage Haploidentical Bone Marrow Transplantation in a Child With Hemophagocytic Lymphohistiocytosis, When the Previously Matched Unrelated Donor Tested Positive for SARS-CoV-2 on the Day of Stem Cells Collection.|pdf=|usr=027}}
| |
| − | {{tp|p=34087553|t=2021. The association between severe or death COVID-19 and solid organ transplantation: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33350674|t=2021. Clinical Profile and Outcome of COVID-19 in 250 Kidney Transplant Recipients: A Multicenter Cohort Study From India.|pdf=|usr=027}}
| |
| − | {{tp|p=34091012|t=2021. SARS-CoV-2 and Dengue virus co-infection: A case from North Caribbean Colombia.|pdf=|usr=027}}
| |
| − | {{tp|p=33878449|t=2021. Epidemiological and clinical presentations of hospitalized COVID-19 patients in Libya: An initial report from Africa.|pdf=|usr=027}}
| |
| − | {{tp|p=33852944|t=2021. Clinical characteristics of hospitalized COVID -19 infected patients in Palestine.|pdf=|usr=027}}
| |
| − | {{tp|p=33321195|t=2021. SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: Serosurvey, symptoms and risk factors.|pdf=|usr=027}}
| |
| − | {{tp|p=33307196|t=2021. COVID-19 reinfection? A suspected case in a Peruvian patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33338635|t=2021. COVID-19 and thrombosis: From bench to bedside.|pdf=|usr=027}}
| |
| − | {{tp|p=33966962|t=2021. Sex steroids and COVID-19 mortality in women.|pdf=|usr=027}}
| |
| − | {{tp|p=33934980|t=2021. Bacterial Coinfections in Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33879319|t=2021. The emerging association between COVID-19 and acute stroke.|pdf=|usr=027}}
| |
| − | {{tp|p=33867130|t=2021. Therapeutic Potential of Targeting Plasminogen Activator Inhibitor-1 in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33730776|t=2021. Experience of Treating Critically Ill COVID-19 Patients in Daegu, South Korea.|pdf=|usr=027}}
| |
| − | {{tp|p=33355857|t=2021. The Association between Mortality and the Oxygen Saturation and Fraction of Inhaled Oxygen in Patients Requiring Oxygen Therapy due to COVID-19-Associated Pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33853318|t=2021. COVID-19 pnomonisini taklit eden nitrofurantoine bagli interstisyel akciger hastaligi: Olgu sunumu ve literaturun gozden gecirilmesi.|pdf=|usr=027}}
| |
| − | {{tp|p=33853317|t=2021. COVID-19 yogun bakim hastalarinda invaziv pulmoner aspergillozis gelisimi icin bir risk faktoru mudur?|pdf=|usr=027}}
| |
| − | {{tp|p=33853310|t=2021. COVID-19 hastaliginin bir komplikasyonu olarak pnomomediastinum: Bir olgu sunumu.|pdf=|usr=027}}
| |
| − | {{tp|p=33960938|t=2021. Clinical Characteristics of 195 Cases of COVID-19 with Gastrointestinal Symptoms COVID-19 with Gastrointestinal Symptoms.|pdf=|usr=027}}
| |
| − | {{tp|p=33906331|t=2021. Can Hematological Findings of COVID-19 in Pediatric Patients Guide Physicians Regarding Clinical Severity?|pdf=|usr=027}}
| |
| − | {{tp|p=34022777|t=2021. Malignancy is a risk factor for higher COVID-19 severity:A meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34013703|t=2021. Galectin-3: Can It Be A Diagnostic Tool For Pneumonia In COVID-19 Patients?|pdf=|usr=027}}
| |
| − | {{tp|p=33957728|t=2021. Risk factors associated with mortality in intensive care COVID-19 patients: the importance of chest CT score and intubation timing as risk factors|pdf=|usr=027}}
| |
| − | {{tp|p=33957720|t=2021. COVID-19 clinical course and blood groups: Turkish population-based study|pdf=|usr=027}}
| |
| − | {{tp|p=33929142|t=2021. First known COVID-19 case and contact tracing efforts in Istanbul, Turkey|pdf=|usr=027}}
| |
| − | {{tp|p=33878857|t=2021. The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients|pdf=|usr=027}}
| |
| − | {{tp|p=33315349|t=2021. The predictive and diagnostic accuracy of long pentraxin-3 in COVID-19 pneumonia|pdf=|usr=027}}
| |
| − | {{tp|p=33315348|t=2021. Factors affecting mortality in geriatric patients hospitalized with COVID-19|pdf=|usr=027}}
| |
| − | {{tp|p=33890447|t=2021. Pleural complications of Covid-19 pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33862669|t=2021. A single center survey study of systemic vasculitis and COVID-19 during the first months of pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33948553|t=2021. Role of rehabilitation in a COVID-19 survivor with intensive care unit-acquired weakness: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34106068|t=2021. Spontaneous right coronary artery dissection in a patient with COVID-19 infection: A case report and review of the literature.|pdf=|usr=027}}
| |
| − | {{tp|p=34106063|t=2021. Clinical implications and indicators of mortality among patients hospitalized with concurrent COVID-19 and myocardial infarction.|pdf=|usr=027}}
| |
| − | {{tp|p=34106062|t=2021. Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33847272|t=2021. Aortic floating thrombi with lower limb ischemia and renal infarct in COVID-19: A remote thromboembolic complication.|pdf=|usr=027}}
| |
| − | {{tp|p=33871336|t=2021. Chest-X-ray-Based Scoring, Total Leukocyte Count, and Neutrophil-to-Lymphocyte Ratio for Prediction of COVID-19 in Patients with Severe Acute Respiratory Illness.|pdf=|usr=027}}
| |
| − | {{tp|p=33884595|t=2021. Yeni koronavirus (COVID-19) hastaligi olan yasli ve yuksek komobiditeli hastalarda akut tasli kolesistit tedavisinde perkutan kolesistostomi.|pdf=|usr=027}}
| |
| − | {{tp|p=33850728|t=2021. Is corona virus infection a risk factor for hematuria in secondary bladder amyloidosis? The first case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34066007|t=2021. Post-COVID Syndrome: An Insight on Its Pathogenesis.|pdf=|usr=027}}
| |
| − | {{tp|p=34068473|t=2021. Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33917898|t=2021. Influenza Vaccination and Health Outcomes in COVID-19 Patients: A Retrospective Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33923159|t=2021. Influenza Vaccination and COVID-19 Mortality in the USA: An Ecological Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33926038|t=2021. D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33919284|t=2021. SARS-CoV-2 and Placenta: New Insights and Perspectives.|pdf=|usr=027}}
| |
| − | {{tp|p=33919537|t=2021. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms.|pdf=|usr=027}}
| |
| − | {{tp|p=33921216|t=2021. SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies.|pdf=|usr=027}}
| |
| − | {{tp|p=33363260|t=2021. Pulmonary embolism with Hampton Hump in COVID-19 patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33969233|t=2021. Cerebral venous thrombosis in a young patient with COVID-19.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=34041335|t=2021. Hemorrhagic rash on the legs.|pdf=|usr=027}}
| |
| − | {{tp|p=34056056|t=2021. Dermatomyositis in a COVID-19 positive patient.|pdf=|usr=027}}
| |
| − | {{tp|p=34095870|t=2021. Immunologic skin signatures in SARS-CoV-2-negative patients with chilblain-like lesions.|pdf=|usr=027}}
| |
| − | {{tp|p=33997520|t=2021. The Essential Vulnerability of Human Cardiac Myocytes to SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33975819|t=2021. Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers.|pdf=|usr=027}}
| |
| − | {{tp|p=33865737|t=2021. COVID-19-Positive Patient and Hypoxemia: Are Lungs Always to Be Blamed?|pdf=|usr=027}}
| |
| − | {{tp|p=33933387|t=2021. Thrombosis-Related Honeycomb-Like Structure in Non-Infarct-Related Artery in a COVID-19 Convalescent Patient Presenting With STEMI.|pdf=|usr=027}}
| |
| − | {{tp|p=33895107|t=2021. Atrial Fibrillation in Patients Hospitalized With COVID-19: Incidence, Predictors, Outcomes and Comparison to Influenza.|pdf=|usr=027}}
| |
| − | {{tp|p=33309578|t=2021. COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak.|pdf=|usr=027}}
| |
| − | {{tp|p=34037731|t=2021. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review.|pdf=|usr=027}}
| |
| − | {{tp|p=34032852|t=2021. Association Between Bitter Taste Receptor Phenotype and Clinical Outcomes Among Patients With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34019090|t=2021. Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33974053|t=2021. Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium.|pdf=|usr=027}}
| |
| − | {{tp|p=33938934|t=2021. Clinical Characteristics and Transmission of COVID-19 in Children and Youths During 3 Waves of Outbreaks in Hong Kong.|pdf=|usr=027}}
| |
| − | {{tp|p=33938933|t=2021. Trends in Patient Characteristics and COVID-19 In-Hospital Mortality in the United States During the COVID-19 Pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34100935|t=2021. Risk Factors Associated With COVID-19 Outcomes Among People With Intellectual and Developmental Disabilities Receiving Residential Services.|pdf=|usr=027}}
| |
| − | {{tp|p=33890995|t=2021. COVID-19 Infection and Corrected QT Interval Prolongation-Collateral Damage From Our Newest Enemy.|pdf=|usr=027}}
| |
| − | {{tp|p=33890991|t=2021. Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33890989|t=2021. Association of Maternal Perinatal SARS-CoV-2 Infection With Neonatal Outcomes During the COVID-19 Pandemic in Massachusetts.|pdf=|usr=027}}
| |
| − | {{tp|p=33885771|t=2021. Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men.|pdf=|usr=027}}
| |
| − | {{tp|p=33844002|t=2021. Postoperative In-Hospital Morbidity and Mortality of Patients With COVID-19 Infection Compared With Patients Without COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33830226|t=2021. Mortality Among US Patients Hospitalized With SARS-CoV-2 Infection in 2020.|pdf=|usr=027}}
| |
| − | {{tp|p=33885740|t=2021. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33986193|t=2021. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34061779|t=2021. Cardiovascular complications of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34013064|t=2021. Prevalence and impact of Clostridioides difficile infection among hospitalized patients with coranavirus disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33997748|t=2021. Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis.|pdf=|usr=027}}
| |
| − | {{tp|p=34057620|t=2021. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.|pdf=|usr=027}}
| |
| − | {{tp|p=33930350|t=2021. COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year.|pdf=|usr=027}}
| |
| − | {{tp|p=34104901|t=2021. Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33915101|t=2021. Overview of SARS-CoV-2 infection in adults living with HIV.|pdf=|usr=027}}
| |
| − | {{tp|p=33933190|t=2021. SARS-CoV-2 immunity and HIV infection: total recall?|pdf=|usr=027}}
| |
| − | {{tp|p=33933189|t=2021. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=33316211|t=2021. HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform.|pdf=|usr=027}}
| |
| − | {{tp|p=33316210|t=2021. COVID-19 death in people with HIV: interpret cautiously.|pdf=|usr=027}}
| |
| − | {{tp|p=33984264|t=2021. Post-acute conditions of patients with COVID-19 not requiring hospital admission.|pdf=|usr=027}}
| |
| − | {{tp|p=33984263|t=2021. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33548193|t=2021. Long COVID: tackling a multifaceted condition requires a multidisciplinary approach.|pdf=|usr=027}}
| |
| − | {{tp|p=33333012|t=2021. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.|pdf=|usr=027}}
| |
| − | {{tp|p=33301729|t=2021. Fungal infections should be part of the core outcome set for COVID-19 - Authors' reply.|pdf=|usr=027}}
| |
| − | {{tp|p=33301728|t=2021. Fungal infections should be part of the core outcome set for COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33301725|t=2021. Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33969327|t=2021. Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab.|pdf=|usr=027}}
| |
| − | {{tp|p=34100002|t=2021. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33894836|t=2021. Higher fatality from COVID-19 in patients with cancer in the UK than in Europe.|pdf=|usr=027}}
| |
| − | {{tp|p=33836149|t=2021. A longer look at COVID-19 and neuropsychiatric outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=33836148|t=2021. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.|pdf=|usr=027}}
| |
| − | {{tp|p=33997832|t=2021. Do asymptomatic carriers of SARS-COV-2 transmit the virus?|pdf=|usr=027}}
| |
| − | {{tp|p=33997830|t=2021. SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg.|pdf=|usr=027}}
| |
| − | {{tp|p=33917276|t=2021. Saliva: What Dental Practitioners Should Know about the Role of This Biofluid in the Transmission and Diagnostic of SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33946377|t=2021. The Impact of Increased Fib-4 Score in Patients with Type II Diabetes Mellitus on Covid-19 Disease Prognosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33946186|t=2021. Knowledge, Attitudes, Practices and Some Characteristic Features of People Recovered from COVID-19 in Turkey.|pdf=|usr=027}}
| |
| − | {{tp|p=33924769|t=2021. Successful Treatment of Klebsiella pneumoniae NDM Sepsis and Intestinal Decolonization with Ceftazidime/Avibactam Plus Aztreonam Combination in a Patient with TTP Complicated by SARSCoV-2 Nosocomial Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33923158|t=2021. Herpes Simplex Keratitis in Patients with SARS-CoV-2 Infection: A Series of Five Cases.|pdf=|usr=027}}
| |
| − | {{tp|p=33918326|t=2021. Non-Respiratory Symptoms of Patients Infected with SARS-CoV-2 (Coronavirus Disease 2019): Lessons from Their Initial Presentation at the Hospital.|pdf=|usr=027}}
| |
| − | {{tp|p=33921429|t=2021. Skeletal Muscle Damage in COVID-19: A Call for Action.|pdf=|usr=027}}
| |
| − | {{tp|p=33916210|t=2021. Characteristics, Management, and Outcomes of Elderly Patients with Diabetes in a Covid-19 Unit: Lessons Learned from a Pilot Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33950987|t=2021. Risk factors associated with the need for oxygen therapy in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34032765|t=2021. The impact of recent chemotherapy on immunity in 2 COVID-19 cases with gastrointestinal tumors: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34032692|t=2021. Clinical characteristics, treatment, and prognosis of 74 2019 novel coronavirus disease patients in Hefei: A single-center retrospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=34011023|t=2021. COVID19 infection in a patient with paroxysmal nocturnal hemoglobinuria: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34070672|t=2021. Thromboembolic Complications of SARS-CoV-2 and Metabolic Derangements: Suggestions from Clinical Practice Evidence to Causative Agents.|pdf=|usr=027}}
| |
| − | {{tp|p=34090983|t=2021. Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease.|pdf=|usr=027}}
| |
| − | {{tp|p=34087389|t=2021. Potential association of COVID-19 and ABO blood group: An Indian study.|pdf=|usr=027}}
| |
| − | {{tp|p=33962007|t=2021. Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis.|pdf=|usr=027}}
| |
| − | {{tp|p=33940134|t=2021. Analysis of pathogens and risk factors of secondary pulmonary infection in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34106569|t=2021. Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus.|pdf=|usr=027}}
| |
| − | {{tp|p=33981988|t=2021. SARS-CoV-2-related vascular injury: mechanisms, imaging and models.|pdf=|usr=027}}
| |
| − | {{tp|p=34022205|t=2021. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).|pdf=|usr=027}}
| |
| − | {{tp|p=33836059|t=2021. Prolonged Sars-CoV-2 Viral Culture Detected in a Mild COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33826724|t=2021. Accelerated Progression of Disseminated Coccidioidomycosis Following SARS-CoV-2 Infection: A Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=33881526|t=2021. Guillain-Barre Syndrome Associated With COVID-19 Pneumonia-The First Documented Case in a U.S. Military Intensive Care Unit.|pdf=|usr=027}}
| |
| − | {{tp|p=34036772|t=2021. Reverse trigger in COVID-19 ARDS.|pdf=|usr=027}}
| |
| − | {{tp|p=33960182|t=2021. Early use of fondaparinux at therapeutic dosage in COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33979072|t=2021. COVID-19 and the role of chronic inflammation in patients with type 2 diabetes and depression.|pdf=|usr=027}}
| |
| − | {{tp|p=33971711|t=2021. Acute on chronic liver failure by SARS-CoV-2 in active alcohol use disorder cirrhotic patient: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33913658|t=2021. Role of comorbidities on the mortality in patients with SARS-CoV-2 infection: an Italian cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33970270|t=2021. The Spread of COVID-19 Among 15,000 Physical Therapists in Italy: A Cross-Sectional Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34042296|t=2021. Impact of age to ferritin and neutrophil-lymphocyte ratio as biomarkers for intensive care requirement and mortality risk in COVID-19 patients in Makassar, Indonesia.|pdf=|usr=027}}
| |
| − | {{tp|p=34037158|t=2021. COVID-19 presenting as acute generalized exanthematous pustulosis associated with multiorgan dysfunction in a 44-year-old female patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33909850|t=2021. SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil.|pdf=|usr=027}}
| |
| − | {{tp|p=33919206|t=2021. Association between Influenza Vaccination and Positive SARS-CoV-2 IgG and IgM Tests in the General Population of Katowice Region, Poland.|pdf=|usr=027}}
| |
| − | {{tp|p=33921113|t=2021. COVID-19 and Pregnancy: Vertical Transmission and Inflammation Impact on Newborns.|pdf=|usr=027}}
| |
| − | {{tp|p=33013257|t=2021. Transmission of SARS CoV-2 virus through the ocular mucosa worth taking precautions.|pdf=|usr=027}}
| |
| − | {{tp|p=34103921|t=2021. COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy.|pdf=|usr=027}}
| |
| − | {{tp|p=33907410|t=2021. Cardiovascular Risk Factors Among Patients Infected with COVID-19 in Saudi Arabia.|pdf=|usr=027}}
| |
| − | {{tp|p=34091065|t=2021. Thromboprophylaxis strategies to improve the prognosis of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34087481|t=2021. Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: A systematic review with meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34051372|t=2021. Crosstalk of TLR4, vascular NADPH oxidase, and COVID-19 in diabetes: What are the potential implications?|pdf=|usr=027}}
| |
| − | {{tp|p=33934229|t=2021. Placenta histopathology in SARS-CoV-2 infection: analysis of a consecutive series and comparison with control cohorts.|pdf=|usr=027}}
| |
| − | {{tp|p=34088324|t=2021. Lymphocyte-monocyte-neutrophil index: a predictor of severity of coronavirus disease 2019 patients produced by sparse principal component analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33978940|t=2021. Enriched Opportunistic Pathogens Revealed by Metagenomic Sequencing Hint Potential Linkages between Pharyngeal Microbiota and COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34015620|t=2021. Frequency of HLA alleles among COVID-19 infected patients: Preliminary data from Saudi Arabia.|pdf=|usr=027}}
| |
| − | {{tp|p=33870852|t=2021. High Child-Pugh and CRUB65 scores predict mortality of decompensated cirrhosis patients with COVID-19: A 23-center, retrospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=33836204|t=2021. SARS-CoV-2 presented moderately during two episodes of the infection with lack of antibody responses.|pdf=|usr=027}}
| |
| − | {{tp|p=33842676|t=2021. COVID-19 infection in a HIV positive health care worker: first case report from a tertiary care hospital of North India.|pdf=|usr=027}}
| |
| − | {{tp|p=34067086|t=2021. Pregnancy Outcomes and SARS-CoV-2 Infection: The Spanish Obstetric Emergency Group Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34066524|t=2021. Clinical and Radiological Profiles of COVID-19 Patients with Neurological Symptomatology: A Comparative Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34063160|t=2021. Clinical Characteristics and Outcomes of COVID-19 in West Virginia.|pdf=|usr=027}}
| |
| − | {{tp|p=34072390|t=2021. Insights into SARS-CoV-2 Persistence and Its Relevance.|pdf=|usr=027}}
| |
| − | {{tp|p=34071557|t=2021. COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation.|pdf=|usr=027}}
| |
| − | {{tp|p=34071924|t=2021. Characterization and Outcomes of SARS-CoV-2 Infection in Patients with Sarcoidosis.|pdf=|usr=027}}
| |
| − | {{tp|p=34073492|t=2021. Is the First of the Two Born Saved? A Rare and Dramatic Case of Double Placental Damage from SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=34064104|t=2021. Dysregulation of Pulmonary Responses in Severe COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34067925|t=2021. A Pandemic within Other Pandemics. When a Multiple Infection of a Host Occurs: SARS-CoV-2, HIV and Mycobacterium tuberculosis.|pdf=|usr=027}}
| |
| − | {{tp|p=34063463|t=2021. Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity.|pdf=|usr=027}}
| |
| − | {{tp|p=34066205|t=2021. Symptomatic SARS-CoV-2 Reinfection in a Healthy Healthcare Worker in Italy Confirmed by Whole-Genome Sequencing.|pdf=|usr=027}}
| |
| − | {{tp|p=34065871|t=2021. SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment.|pdf=|usr=027}}
| |
| − | {{tp|p=34064802|t=2021. Cytokines and Leukocytes Subpopulations Profile in SARS-CoV-2 Patients Depending on the CT Score Severity.|pdf=|usr=027}}
| |
| − | {{tp|p=34064763|t=2021. Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33918079|t=2021. Vascular Inflammation Is Associated with Loss of Aquaporin 1 Expression on Endothelial Cells and Increased Fluid Leakage in SARS-CoV-2 Infected Golden Syrian Hamsters.|pdf=|usr=027}}
| |
| − | {{tp|p=33946171|t=2021. Utility of Routine Laboratory Biomarkers to Detect COVID-19: A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33839589|t=2021. Abscopal antitumor effect in a patient with melanoma and coronavirus disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=34016183|t=2021. Genetic susceptibility of COVID-19: a systematic review of current evidence.|pdf=|usr=027}}
| |
| − | {{tp|p=33990223|t=2021. Patient hematology during hospitalization for viral pneumonia caused by SARS-CoV-2 and non-SARS-CoV-2 agents: a retrospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=33310656|t=2021. Maternal, fetal and neonatal outcomes of large series of SARS-CoV-2 positive pregnancies in peripartum period: A single-center prospective comparative study.|pdf=|usr=027}}
| |
| − | {{tp|p=34027625|t=2021. The biologic importance of the vitamin D binding protein polymorphism in pediatric COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33990871|t=2021. Authors' reply: the biologic importance of the vitamin D binding protein polymorphism in pediatric COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33997829|t=2021. Mortality trends among hospitalised COVID-19 patients in Sweden: A nationwide observational cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33969336|t=2021. Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33880458|t=2021. Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34104903|t=2021. Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33969337|t=2021. Changes in COVID-19 in-hospital mortality in hospitalised adults in England over the first seven months of the pandemic: An observational study using administrative data.|pdf=|usr=027}}
| |
| − | {{tp|p=33880459|t=2021. Underlying conditions and risk of hospitalisation, ICU admission and mortality among those with COVID-19 in Ireland: A national surveillance study.|pdf=|usr=027}}
| |
| − | {{tp|p=34027514|t=2021. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33870249|t=2021. Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain.|pdf=|usr=027}}
| |
| − | {{tp|p=33857435|t=2021. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses.|pdf=|usr=027}}
| |
| − | {{tp|p=33675686|t=2021. Young person with long COVID after mild disease.|pdf=|usr=027}}
| |
| − | {{tp|p=34015324|t=2021. Vascular mechanisms and manifestations of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34051176|t=2021. COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion.|pdf=|usr=027}}
| |
| − | {{tp|p=34000238|t=2021. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK.|pdf=|usr=027}}
| |
| − | {{tp|p=33964246|t=2021. An integrated understanding of long-term sequelae after acute COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33964245|t=2021. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=33964243|t=2021. Viable virus shedding during SARS-CoV-2 reinfection.|pdf=|usr=027}}
| |
| − | {{tp|p=33865505|t=2021. SARS-CoV-2 reinfection in a closed setting: lessons for the community.|pdf=|usr=027}}
| |
| − | {{tp|p=33865504|t=2021. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34090607|t=2021. Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?|pdf=|usr=027}}
| |
| − | {{tp|p=34095857|t=2021. Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33907738|t=2021. Patients with gout: an under-recognised group at high risk of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33842894|t=2021. Incident systemic rheumatic disease following COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33942032|t=2021. COVID-19 in patients with rheumatic disease: finally, a denominator.|pdf=|usr=027}}
| |
| − | {{tp|p=33942031|t=2021. SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study.|pdf=|usr=027}}
| |
| − | {{tp|p=34075358|t=2021. Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort.|pdf=|usr=027}}
| |
| − | {{tp|p=34075357|t=2021. Systemic lupus erythematosus does not prevent antibody responses to SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33933714|t=2021. High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies.|pdf=|usr=027}}
| |
| − | {{tp|p=33947938|t=2021. Hairy cell leukemia and COVID-19 adaptation of treatment guidelines.|pdf=|usr=027}}
| |
| − | {{tp|p=33925334|t=2021. Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence.|pdf=|usr=027}}
| |
| − | {{tp|p=33923857|t=2021. Clinical Features of Patients with Home Isolation Sars-Cov-2 Infection: A Multicenter Retrospective Study in Southern Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=34015287|t=2021. Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: A case-control study.|pdf=|usr=027}}
| |
| − | {{tp|p=33865882|t=2021. Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33361110|t=2021. Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression.|pdf=|usr=027}}
| |
| − | {{tp|p=33993321|t=2021. Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34016490|t=2021. Lung cancer patients with COVID-19 in Spain: GRAVID study.|pdf=|usr=027}}
| |
| − | {{tp|p=33985850|t=2021. Higher mortality in lung cancer patients with COVID-19? A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34089082|t=2021. SNPs at 3'UTR of APOL1 and miR-6741-3p target sites associated with kidney diseases more susceptible to SARS-COV-2 infection: in silco and in vitro studies.|pdf=|usr=027}}
| |
| − | {{tp|p=33868964|t=2021. D-Dimer and Serum ferritin as an Independent Risk Factor for Severity in COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34088424|t=2021. Lack of Marked Association Between Gastrointestinal Symptoms and COVID-19 Mortality: An Updated Meta-analysis Based on Adjusted Effect Estimates.|pdf=|usr=027}}
| |
| − | {{tp|p=34088423|t=2021. COVID-19: Precision Medicine and Vascular Endothelium.|pdf=|usr=027}}
| |
| − | {{tp|p=34007956|t=2021. Noninvasive Vocal Biomarker is Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33870099|t=2021. More severe hypercoagulable state in acute COVID-19 pneumonia as compared to other pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33969332|t=2021. Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface.|pdf=|usr=027}}
| |
| − | {{tp|p=33870242|t=2021. SARS-CoV-2 colonization of maternal and fetal cells of the human placenta promotes alteration of local renin-angiotensin system.|pdf=|usr=027}}
| |
| − | {{tp|p=34099241|t=2021. Isquemia arterial aguda secundaria a infeccion por SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=34074480|t=2021. Papel de la ecocardiografia en el diagnostico de la embolia pulmonar durante la infeccion por SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=34083076|t=2021. Neumonia por COVID-19 que afecta solo al pulmon nativo en trasplante unipulmonar.|pdf=|usr=027}}
| |
| − | {{tp|p=34083070|t=2021. Prediccion del desarrollo de tromboembolia pulmonar en pacientes con infeccion por SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=34074471|t=2021. Anemia hemolitica desencadenada por SARS-CoV-2 en una paciente con esferocitosis hereditaria.|pdf=|usr=027}}
| |
| − | {{tp|p=34088524|t=2021. Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34049681|t=2021. Diabetes y tuberculosis: una sindemia complicada por la COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34030861|t=2021. Long-term consequences of SARS-COV2 infection: Long-Covid patterns and possible public health implications.|pdf=|usr=027}}
| |
| − | {{tp|p=33846001|t=2021. Characterization of myocardial injury in a cohort of patients with SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33358436|t=2021. Estado y gestion emocional de los pacientes afectados por la COVID-19 en un centro de salud.|pdf=|usr=027}}
| |
| − | {{tp|p=34016448|t=2021. Lesiones cutaneas en ninos durante la primera ola de la pandemia por SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33975721|t=2021. Abordaje de la aplasia medular en la fase de defervescencia de la pandemia por COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33342556|t=2021. Mortalidad de los pacientes covid-19 con complicaciones tromboticas.|pdf=|usr=027}}
| |
| − | {{tp|p=33958143|t=2021. Myoglobin and troponin as prognostic factors in patients with COVID-19 pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=34074474|t=2021. Encefalitis como manifestacion neurologica del COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33504435|t=2021. Plexo-neuropatia por hematoma en iliopsoas en 4 pacientes COVID.|pdf=|usr=027}}
| |
| − | {{tp|p=33969222|t=2021. Hypoalbuminemia on admission in COVID-19 infection: An early predictor of mortality and adverse events. A retrospective observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=34007878|t=2021. New evidences that discard the possible vertical transmission of SARS-CoV-2 during pregnancy.|pdf=|usr=027}}
| |
| − | {{tp|p=34056110|t=2021. Frequency and predictive validity of olfactory and taste dysfunction in patients with SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33824908|t=2021. Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33910768|t=2021. Early-onset symptomatic radiation necrosis after stereotactic radiosurgery in the setting of COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34080405|t=2021. Early predictors of severity and mortality in COVID-19 hospitalized patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33831722|t=2021. Testicles, adipose organ and heart: A new axis in the management of SARS-CoV-2?|pdf=|usr=027}}
| |
| − | {{tp|p=33836338|t=2021. Could SARS-CoV-2 blocking of ACE2 in endothelial cells result in upregulation of CX3CL1, promoting thrombosis in COVID-19 patients?|pdf=|usr=027}}
| |
| − | {{tp|p=34087613|t=2021. Does COVID 19 generate a milieu for propagation of mucormycosis?|pdf=|usr=027}}
| |
| − | {{tp|p=34048987|t=2021. Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33338955|t=2021. Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33338954|t=2021. Correlation between takotsubo cardiomyopathy and SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33309251|t=2021. Is the oral cavity a reservoir for prolonged SARS-CoV-2 shedding?|pdf=|usr=027}}
| |
| − | {{tp|p=34007094|t=2021. Toxicidad Pulmonar Por Oxigeno Y Covid-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34059221|t=2021. Colonization by multidrug-resistant microorganisms in ICU patients during the COVID-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33985822|t=2021. Tromboembolismo derecho e izquierdo en paciente con infeccion por COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33996668|t=2021. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in Kidney transplant patients: A case series and literature review.|pdf=|usr=027}}
| |
| − | {{tp|p=33996666|t=2021. Cutaneous hemorrhagic bullae in a patient with COVID-19: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33996658|t=2021. Clinical features of 50 cases of 2019 novel coronavirus in Bandar Abbas, Iran.|pdf=|usr=027}}
| |
| − | {{tp|p=34031352|t=2021. Coinfection between SARS-CoV-2 and HIV with a low CD4+ T-cells count.|pdf=|usr=027}}
| |
| − | {{tp|p=33312852|t=2021. COVID-19 associated pulmonary aspergillosis in ICU patients: Report of five cases from Argentina.|pdf=|usr=027}}
| |
| − | {{tp|p=33312851|t=2021. Invasive pulmonary aspergillosis and hyperthermia in an immunocompetent patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33842203|t=2021. Pulmonary aspergillosis and mucormycosis in a patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34016942|t=2021. Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis.|pdf=|usr=027}}
| |
| − | {{tp|p=33854028|t=2021. Persistent Somatic Symptom Burden and Sleep Disturbance in Patients with COVID-19 During Hospitalization and After Discharge: A Prospective Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33844678|t=2021. Epidemiological and Clinical Characteristics of 217 Cases of COVID-19 in Jiangsu Province, China.|pdf=|usr=027}}
| |
| − | {{tp|p=33839733|t=2021. Analysis of Risk Factors for Thromboembolic Events in 88 Patients with COVID-19 Pneumonia in Wuhan, China: A Retrospective Descriptive Report.|pdf=|usr=027}}
| |
| − | {{tp|p=33828892|t=2021. A Rare Cause of ST-Segment Elevation Myocardial Infarction in COVID-19: MINOCA Syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33828883|t=2021. Comparison of D-dimer Level Measured on the Third Day of Hospitalization with Admission D-dimer Level in Predicting In-hospital Mortality in COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34007243|t=2021. Correlation of Low Levels of alpha-1 Antitrypsin and Elevation of Neutrophil to Lymphocyte Ratio with Higher Mortality in Severe COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33974616|t=2021. Neuropsychological & Cognitive Sequelae in COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33974615|t=2021. Potential Heart Problems in Convalescent COVID-19 Children: Alert from a Cuban Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34063699|t=2021. SARS-CoV-2 Reinfection among Healthcare Workers in Mexico: Case Report and Literature Review.|pdf=|usr=027}}
| |
| − | {{tp|p=34067403|t=2021. The Effect of SARS-CoV-2 Virus Infection on the Course of Atopic Dermatitis in Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34069202|t=2021. SARS-CoV-2 Infection Susceptibility of Pregnant Patients at Term Regarding ABO and Rh Blood Groups: A Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34068221|t=2021. Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.|pdf=|usr=027}}
| |
| − | {{tp|p=34021974|t=2021. Outcomes of patients with COVID-19 after inpatient rehabilitation.|pdf=|usr=027}}
| |
| − | {{tp|p=34043803|t=2021. SARS-CoV-2-associated Guillain-Barre syndrome is a para-infectious disease.|pdf=|usr=027}}
| |
| − | {{tp|p=34038563|t=2021. Viral dynamics and clinical courses in long-haulers with SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33910469|t=2021. Challenges in the diagnostic approach of suspected pulmonary embolism in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34103372|t=2021. Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India.|pdf=|usr=027}}
| |
| − | {{tp|p=34083362|t=2021. Association between IL-6 and severe disease and mortality in COVID-19 disease: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33879550|t=2021. Otolaryngology manifestations of COVID-19: a contemporary viewpoint.|pdf=|usr=027}}
| |
| − | {{tp|p=33850011|t=2021. Anticoagulation in COVID-19: current concepts and controversies.|pdf=|usr=027}}
| |
| − | {{tp|p=34019445|t=2021. Intranasale Steroide scheinen bei COVID-19-Kranken mit Anosmie oder Hyposmie keinen positiven Effekt zu haben.|pdf=|usr=027}}
| |
| − | {{tp|p=33939568|t=2021. Prehospital Sinus Node Dysfunction and Asystole in a Previously Healthy Patient with COVID-19.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33871331|t=2021. Respiratory Viral Shedding in Healthcare Workers Reinfected with SARS-CoV-2, Brazil, 2020.|pdf=|usr=027}}
| |
| − | {{tp|p=34037875|t=2021. COVID-19 associated intracranial vasculopathy-MRI vessel wall imaging as adjunct to emergent CT angiography-a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33971617|t=2021. Effect of plasma glucose at admission on COVID-19 mortality: experience from a tertiary hospital.|pdf=|usr=027}}
| |
| − | {{tp|p=34010152|t=2021. Thyroid hormone alterations in critically and non-critically ill patients with SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33361650|t=2021. Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=34102308|t=2021. Predictors of Severe COVID-19 in Patients With Diabetes: A Multicenter Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33887468|t=2021. COVID-19 May Increase the Risk of Insulin Resistance in Adult Patients Without Diabetes: A 6-Month Prospective Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33886062|t=2021. The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism.|pdf=|usr=027}}
| |
| − | {{tp|p=33860882|t=2021. Individuals with isolated congenital GH deficiency due to a GHRH receptor gene mutation appear to cope better with SARS-CoV-2 infection than controls.|pdf=|usr=027}}
| |
| − | {{tp|p=34047879|t=2021. Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=33851033|t=2021. Serum glucose, lactate dehydrogenase and hypertension are mediators of the effect of body mass index on severity of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34010445|t=2021. Endocrine and metabolic aspects of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33313429|t=2021. A first presentation of multiple sclerosis with concurrent COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33937533|t=2021. Stroke in a child with SARS-CoV-2 infection: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33898792|t=2021. Post-COVID seizure: A new feature of "long-COVID".|pdf=|usr=027}}
| |
| − | {{tp|p=33875971|t=2021. Neurological manifestations of patients with mild-to-moderate COVID-19 attending a public hospital in Lima, Peru.|pdf=|usr=027}}
| |
| − | {{tp|p=34025117|t=2021. Manejo del parto, el puerperio y la lactancia en mujeres positivas para SARS-CoV-2. Estudio multicentrico en la Comunidad Valenciana.|pdf=|usr=027}}
| |
| − | {{tp|p=34024968|t=2021. Descripcion de 12 pacientes VIH positivos que han padecido la COVID-19 en nuestra area.|pdf=|usr=027}}
| |
| − | {{tp|p=33008678|t=2021. Conjuntivitis y COVID-19: la importancia de un reconocimiento precoz por el medico.|pdf=|usr=027}}
| |
| − | {{tp|p=33677662|t=2021. Miller Fisher syndrome associated with COVID-19: an up-to-date systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=33954917|t=2021. Causes of respiratory failure in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34021454|t=2021. Uncurtaining the effect of COVID-19 in diabetes mellitus: a complex clinical management approach.|pdf=|usr=027}}
| |
| − | {{tp|p=33838329|t=2021. E-cigarette vape and lung ACE2 expression: Implications for coronavirus vulnerability.|pdf=|usr=027}}
| |
| − | {{tp|p=34015893|t=2021. Clinical outcomes of COVID-19 amongst HIV patients: a systematic literature review.|pdf=|usr=027}}
| |
| − | {{tp|p=33971700|t=2021. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33932726|t=2021. Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.|pdf=|usr=027}}
| |
| − | {{tp|p=33342623|t=2021. SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry.|pdf=|usr=027}}
| |
| − | {{tp|p=33987127|t=2021. What are the Clinical Implications of a Positive RT-PCR Test 6 Months after a Mild SARS-CoV-2 Infection?|pdf=|usr=027}}
| |
| − | {{tp|p=33987125|t=2021. Delayed-onset Necrotizing Myositis following COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33987119|t=2021. Unusual Presentation of COVID-19 Disease Leading to Respiratory Distress and Coma.|pdf=|usr=027}}
| |
| − | {{tp|p=33987115|t=2021. Coronavirus Disease 2019 and Cold Agglutinin Syndrome: An Interesting Case.|pdf=|usr=027}}
| |
| − | {{tp|p=33869101|t=2021. Marantic Endocarditis Associated with COVID-19: A Rare Case Report of a Potentially Deadly Disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33869099|t=2021. Persistent Antiphospholipid Antibodies, Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome and Post-COVID Syndrome: 1 Year On.|pdf=|usr=027}}
| |
| − | {{tp|p=33869094|t=2021. COVID-19-Induced Hyperleucocytosis in Chronic Lymphocytic Leukaemia.|pdf=|usr=027}}
| |
| − | {{tp|p=33869090|t=2021. Acute Epiglottitis Due to COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33956286|t=2021. Sex-specific impact of severe obesity in the outcomes of hospitalized patients with COVID-19: a large retrospective study from the Bronx, New York.|pdf=|usr=027}}
| |
| − | {{tp|p=33939044|t=2021. Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications.|pdf=|usr=027}}
| |
| − | {{tp|p=33893570|t=2021. Prevalence and characteristics of persistent symptoms after non-severe COVID-19: a prospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33904532|t=2021. Mild COVID-19 patients can be safely discharged from emergency department: prospective bicentric pilot study.|pdf=|usr=027}}
| |
| − | {{tp|p=33904528|t=2021. Incidence, risk factors, clinical characteristics and outcomes of deep venous thrombosis in patients with COVID-19 attending the Emergency Department: results of the UMC-19-S8.|pdf=|usr=027}}
| |
| − | {{tp|p=33893922|t=2021. Pre-pandemic cognitive function and COVID-19 mortality: prospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34036466|t=2021. Secondary attack rates of COVID-19 in Norwegian families: a nation-wide register-based study.|pdf=|usr=027}}
| |
| − | {{tp|p=33867526|t=2021. Germline variants in UNC13D and AP3B1 are enriched in COVID-19 patients experiencing severe cytokine storms.|pdf=|usr=027}}
| |
| − | {{tp|p=34023150|t=2021. Incident atrial fibrillation and its risk prediction in patients developing COVID-19: A machine learning based algorithm approach.|pdf=|usr=027}}
| |
| − | {{tp|p=33875336|t=2021. Prevalence of proximal deep vein thrombosis in hospitalized COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33872774|t=2021. Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33957992|t=2021. Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study.|pdf=|usr=027}}
| |
| − | {{tp|p=34030733|t=2021. Clinical features and prognostic factors of intensive and non-intensive 1014 COVID-19 patients: an experience cohort from Alahsa, Saudi Arabia.|pdf=|usr=027}}
| |
| − | {{tp|p=34111831|t=2021. Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19).|pdf=|usr=027}}
| |
| − | {{tp|p=33955183|t=2021. The angiotensin II type 1 receptor blocker valsartan in the battle against COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33975329|t=2021. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination in Pregnancy: Measures of Immunity and Placental Histopathology.|pdf=|usr=027}}
| |
| − | {{tp|p=33910220|t=2021. Maternal Antibody Response, Neutralizing Potency, and Placental Antibody Transfer After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34008016|t=2021. SARS-CoV-2 IgG response in symptomatic and asymptomatic COVID-19-infected healthcare workers.|pdf=|usr=027}}
| |
| − | {{tp|p=34109256|t=2021. Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center.|pdf=|usr=027}}
| |
| − | {{tp|p=34002923|t=2021. Prevalence of anosmia and ageusia symptoms among long-term effects of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34080272|t=2021. The diagnostic accuracy of saliva testing for SARS-CoV-2: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34107478|t=2021. Postinfectious Olfactory Dysfunction: Oral Steroids and Olfactory Training versus Olfactory Training Alone: Is There any Benefit from Steroids?|pdf=|usr=027}}
| |
| − | {{tp|p=33890684|t=2021. Arrhythmias and electrocardiographic findings in Coronavirus disease 2019: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34104187|t=2021. The cardiovascular complications in COVID-19: Focus on acute cardiac injury.|pdf=|usr=027}}
| |
| − | {{tp|p=34104180|t=2021. Is leukopenia and lymphopenia a characteristic feature of COVID-19 in children?|pdf=|usr=027}}
| |
| − | {{tp|p=34104145|t=2021. Aggressive Thromboprophylaxis Improves Clinical Process and Decreases the Need of Intensive Care Unit in Covid-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34016891|t=2021. Patients With Coronavirus Disease 2019 Interstitial Pneumonia Exhibit Pancreatic Hyperenzymemia and Not Acute Pancreatitis.|pdf=|usr=027}}
| |
| − | {{tp|p=33966294|t=2021. Asthma is associated with lower respiratory tract involvement and worse clinical score in children with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34022118|t=2021. Successful ECMO therapy in a child with COVID-19-associated ARDS and acute lymphoblastic leukemia.|pdf=|usr=027}}
| |
| − | {{tp|p=34061445|t=2021. Immune thrombocytopenia secondary to COVID-19 infection: Report of two cases.|pdf=|usr=027}}
| |
| − | {{tp|p=34060701|t=2021. Pediatric coronavirus (COVID-19) death in a child with cyclic neutropenia.|pdf=|usr=027}}
| |
| − | {{tp|p=34061431|t=2021. Sickle cell disease and COVID-19: Susceptibility and severity.|pdf=|usr=027}}
| |
| − | {{tp|p=33991383|t=2021. COVID-19 among children with cancer in Greece (2020): Results from the Nationwide Registry of Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST).|pdf=|usr=027}}
| |
| − | {{tp|p=33965992|t=2021. Neurologic Manifestations of COVID-19 in Children: Emerging Pathophysiologic Insights.|pdf=|usr=027}}
| |
| − | {{tp|p=33856063|t=2021. Acral peeling as the sole skin manifestation of COVID-19 in children.|pdf=|usr=027}}
| |
| − | {{tp|p=34101687|t=2021. Caution of the Etiology of Testicular Swelling in the Context of COVID-19 Pandemic-It May Not Be Testicular Torsion.|pdf=|usr=027}}
| |
| − | {{tp|p=34041810|t=2021. Medical care of newborns born to mothers with confirmed or suspected severe acute respiratory syndrome coronavirus 2 infections in Japan.|pdf=|usr=027}}
| |
| − | {{tp|p=34002470|t=2021. COVID-19 in a child with severe propionic acidemia.|pdf=|usr=027}}
| |
| − | {{tp|p=34101950|t=2021. COVID-19 pneumonia in a child with Sotos syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=34101871|t=2021. Vertical transmission of SARS-CoV2 during pregnancy: A high-risk cohort.|pdf=|usr=027}}
| |
| − | {{tp|p=33972413|t=2021. Reply to Cheng et al.: COVID-19 induces lower extent of cytokines, but damages vascular endothelium by IL-6 signaling.|pdf=|usr=027}}
| |
| − | {{tp|p=34109768|t=2021. Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the US.|pdf=|usr=027}}
| |
| − | {{tp|p=33949922|t=2021. The Presence of SARS-CoV-2 in Conjunctival Secretions of COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33983868|t=2021. The Impact of COVID-19 on Conjunctival Flora.|pdf=|usr=027}}
| |
| − | {{tp|p=33978538|t=2021. COVID-19 Retinal Findings in Patients Admitted to Intensive Care Units and Wards.|pdf=|usr=027}}
| |
| − | {{tp|p=33830840|t=2021. Acute Bilateral Neuroretinitis and Panuveitis in A Patient with Coronavirus Disease 2019: A Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=33826479|t=2021. SARS-CoV-2 Not Detectable in Ocular Specimens of a Patient with a Past Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33826465|t=2021. An Update on COVID-19 Related Ophthalmic Manifestations.|pdf=|usr=027}}
| |
| − | {{tp|p=33856276|t=2021. Coronavirus-19-Associated Retinopathy.|pdf=|usr=027}}
| |
| − | {{tp|p=33856275|t=2021. Simultaneous Bilateral Central Retinal Artery Occlusion following COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33874837|t=2021. Bilateral orbital inflammation in a 6-month old with SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34039215|t=2021. Incidence of COVID-19 After Nonelective Hip and Knee Surgery During the Peak of the Pandemic: The New Jersey Experience.|pdf=|usr=027}}
| |
| − | {{tp|p=34030510|t=2021. Association Between Olfactory Dysfunction and Critical Illness and Mortality in COVID-19: A Meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33845681|t=2021. Risk of COVID-19 Infection Among Chronic Rhinosinusitis Patients Receiving Oral Corticosteroids.|pdf=|usr=027}}
| |
| − | {{tp|p=33863864|t=2021. Myalgia as a symptom at hospital admission by severe acute respiratory syndrome coronavirus 2 infection is associated with persistent musculoskeletal pain as long-term post-COVID sequelae: a case-control study.|pdf=|usr=027}}
| |
| − | {{tp|p=33835971|t=2021. Low Frequency of Acute Pancreatitis in Hospitalized COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34038652|t=2021. Cardiac Sequelae of COVID-19 in Children and Young Adults.|pdf=|usr=027}}
| |
| − | {{tp|p=34048305|t=2021. SARS-CoV-2 Related Ischemic Colitis in an Adolescent With Trisomy 21: Diagnostic Pitfalls and Considerations.|pdf=|usr=027}}
| |
| − | {{tp|p=34082613|t=2021. Massive Perivillous Fibrin Deposition and Chronic Histiocytic Intervillositis a Complication of SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33903294|t=2021. A COVID-19-Positive Infant Presenting With Sudden Cardiac Arrest.|pdf=|usr=027}}
| |
| − | {{tp|p=34032552|t=2021. COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas.|pdf=|usr=027}}
| |
| − | {{tp|p=33970765|t=2021. A case of ischemic colitis in a patient with non transfusion dependent thalassemia (NTDT) infected by SARS-COV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33847301|t=2021. Pulmonary Embolism as the Initial Presentation of Coronavirus Disease 2019 in Adolescents.|pdf=|usr=027}}
| |
| − | {{tp|p=33847300|t=2021. Pericarditis as the Main Clinical Manifestation of COVID-19 in Adolescents.|pdf=|usr=027}}
| |
| − | {{tp|p=33847297|t=2021. Coronavirus Disease 2019 in Pregnancy and Outcomes Among Pregnant Women and Neonates: A Literature Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33847291|t=2021. Differences Between Pediatric Acute Myocarditis Related and Unrelated to SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33956761|t=2021. Pulmonary Artery Thrombosis in a Newborn With Severe Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33956754|t=2021. Clinical Characteristics and Outcomes of a Cohort of Pediatric Oncohematologic Patients With COVID-19 Infection in the City of Bogota, Colombia.|pdf=|usr=027}}
| |
| − | {{tp|p=33902076|t=2021. Concurrent Longitudinally Extensive Transverse Myelitis and Guillain-Barre Syndrome in a Child Secondary to COVID-19 Infection: A Severe Neuroimmunologic Complication of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34016835|t=2021. Neonatal Brain Injury From SARS-CoV-2: Fact or Fiction?|pdf=|usr=027}}
| |
| − | {{tp|p=33990525|t=2021. First Report of SARS-CoV-2 Detection in Cerebrospinal Fluid in a Child With Guillain-Barre Syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33990523|t=2021. The Longest Infectious Virus Shedding in a Child Infected With the G614 Strain of SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33902082|t=2021. COVID-19 as a Cause of Acute Neonatal Encephalitis and Cerebral Cytotoxic Edema.|pdf=|usr=027}}
| |
| − | {{tp|p=33902081|t=2021. COVID-19-Associated Cerebral White Matter Injury in a Newborn Infant With Afebrile Seizure.|pdf=|usr=027}}
| |
| − | {{tp|p=33298761|t=2021. Pediatric COVID-19 and Appendicitis: A Gut Reaction to SARS-CoV-2?|pdf=|usr=027}}
| |
| − | {{tp|p=34089270|t=2021. Successful resuscitation from SARS-CoV-2 infection in a child after Rastelli operation.|pdf=|usr=027}}
| |
| − | {{tp|p=33975949|t=2021. RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33974811|t=2021. Subacute Thyroiditis in COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33881955|t=2021. Olfactory Cleft Opacification in COVID-19 Related Smell Loss: CT Findings and Correlation With Objective Testing.|pdf=|usr=027}}
| |
| − | {{tp|p=33356523|t=2021. Xerostomia and Taste Alterations in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33350319|t=2021. Alteration of Smell and Taste in Asymptomatic and Symptomatic COVID-19 Patients in Sicily, Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=33319584|t=2021. SARS-CoV-2 Presence in Cerumen.|pdf=|usr=027}}
| |
| − | {{tp|p=34051888|t=2021. Post-COVID-19 syndrome: in it for the long haul.|pdf=|usr=027}}
| |
| − | {{tp|p=34000623|t=2021. Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation.|pdf=|usr=027}}
| |
| − | {{tp|p=34000622|t=2021. Clinical features and prognostic factors in Covid-19: A prospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33993053|t=2021. HERV-W envelope expression in blood leukocytes as a marker of disease severity of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33971404|t=2021. Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33910120|t=2021. The Duplicitous Nature of ACE2 in COVID-19 Disease.|pdf=|usr=027}}
| |
| − | {{tp|p=34091416|t=2021. Procoagulant activity of extracellular vesicles in plasma of patients with SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34049243|t=2021. Biomarkers for severe COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33867313|t=2021. Epigenome-wide association study of COVID-19 severity with respiratory failure.|pdf=|usr=027}}
| |
| − | {{tp|p=33857904|t=2021. 'Geno-to-pheno' SARS-CoV-2 genome-COVID-19 association studies.|pdf=|usr=027}}
| |
| − | {{tp|p=33937732|t=2021. Variability in COVID-19 in-hospital mortality rates between national health service trusts and regions in England: A national observational study for the Getting It Right First Time Programme.|pdf=|usr=027}}
| |
| − | {{tp|p=33937730|t=2021. Mumbai mayhem of COVID-19 pandemic reveals important factors that influence susceptibility to infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33907730|t=2021. Psychiatric disorders among hospitalized patients deceased with COVID-19 in Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=34095795|t=2021. Rehabilitation needs and mortality associated with the Covid-19 pandemic: a population-based study of all hospitalised and home-healthcare individuals in a Swedish healthcare region.|pdf=|usr=027}}
| |
| − | {{tp|p=34036253|t=2021. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34036252|t=2021. Clinical frailty scale as a point of care prognostic indicator of mortality in COVID-19: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33969282|t=2021. A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33898952|t=2021. A systematic review and meta-analysis of discharged COVID-19 patients retesting positive for RT-PCR.|pdf=|usr=027}}
| |
| − | {{tp|p=33875978|t=2021. Identifying clinical and biochemical phenotypes in acute respiratory distress syndrome secondary to coronavirus disease-2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33932169|t=2021. A rare presentation of an elderly patient with acute lymphocytic leukemia and platelet count of zero associated with ST-elevation myocardial infarction, pulmonary thromboembolism in the setting of SARS-CoV 2: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34093004|t=2021. Neurological manifestations and neuroimaging findings in patients with SARS-CoV2-a systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=34025115|t=2021. A review on SARS-CoV-2 and stroke pathogenesis and outcome.|pdf=|usr=027}}
| |
| − | {{tp|p=34025113|t=2021. Unexplained worsening of parkinsonian symptoms in a patient with advanced Parkinson's disease as the sole initial presentation of COVID-19 infection: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33967575|t=2021. Guillain-Barre syndrome in 220 patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33942721|t=2021. Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population.|pdf=|usr=027}}
| |
| − | {{tp|p=33720009|t=2021. Genetic association and causal inference converge on hyperglycaemia as a modifiable factor to improve lung function.|pdf=|usr=027}}
| |
| − | {{tp|p=34087089|t=2021. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.|pdf=|usr=027}}
| |
| − | {{tp|p=33900187|t=2021. COVID-19 Co-infection with Legionella pneumophila in 2 Tertiary-Care Hospitals, Germany.|pdf=|usr=027}}
| |
| − | {{tp|p=33900166|t=2021. Symptom Diary-Based Analysis of Disease Course among Patients with Mild Coronavirus Disease, Germany, 2020.|pdf=|usr=027}}
| |
| − | {{tp|p=33292922|t=2021. COVID-19-Associated Fusobacterium nucleatum Bacteremia, Belgium.|pdf=|usr=027}}
| |
| − | {{tp|p=33327991|t=2021. Postmortem Stability of SARS-CoV-2 in Nasopharyngeal Mucosa.|pdf=|usr=027}}
| |
| − | {{tp|p=33347804|t=2021. Characteristics of Patients Co-infected with Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus, Buenos Aires, Argentina, March-June 2020.|pdf=|usr=027}}
| |
| − | {{tp|p=33320080|t=2021. COVID-19 and Fatal Sepsis Caused by Hypervirulent Klebsiella pneumoniae, Japan, 2020.|pdf=|usr=027}}
| |
| − | {{tp|p=34013875|t=2021. Trends in Viral Respiratory Infections During COVID-19 Pandemic, South Korea.|pdf=|usr=027}}
| |
| − | {{tp|p=33913410|t=2021. Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=33957438|t=2021. COVID-19 among patients with epilepsy: Risk factors and course of the disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33309238|t=2021. Neurological features of COVID-19 and epilepsy: Could neuromuscular assessment be a physical and functional marker?|pdf=|usr=027}}
| |
| − | {{tp|p=33342709|t=2021. Meta-analysis of EEG findings in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33341393|t=2021. Evaluating risk to people with epilepsy during the COVID-19 pandemic: Preliminary findings from the COV-E study.|pdf=|usr=027}}
| |
| − | {{tp|p=33993018|t=2021. Acute symptomatic seizures and COVID-19: Hospital-based study.|pdf=|usr=027}}
| |
| − | {{tp|p=34095290|t=2021. Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34084778|t=2021. The benefits of pulmonary rehabilitation in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33889638|t=2021. Effect of ACE1 polymorphism rs1799752 on protein levels of ACE2, the SARS-CoV-2 entry receptor, in alveolar lung epithelium.|pdf=|usr=027}}
| |
| − | {{tp|p=33850935|t=2021. Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes.|pdf=|usr=027}}
| |
| − | {{tp|p=33829055|t=2021. Analysis of pathological changes in the epithelium in COVID-19 patient airways.|pdf=|usr=027}}
| |
| − | {{tp|p=33350605|t=2021. Myocardial injury in severe COVID-19 is similar to pneumonias of other origin: results from a multicentre study.|pdf=|usr=027}}
| |
| − | {{tp|p=33336560|t=2021. Elevated alpha-hydroxybutyrate dehydrogenase as an independent prognostic factor for mortality in hospitalized patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33934560|t=2021. Successful heart transplantation for COVID-19-associated post-infectious fulminant myocarditis.|pdf=|usr=027}}
| |
| − | {{tp|p=33932622|t=2021. The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancer.|pdf=|usr=027}}
| |
| − | {{tp|p=33944543|t=2021. Covid-19: less bronchial airways, more lung alveolar space and blood ways.|pdf=|usr=027}}
| |
| − | {{tp|p=33963433|t=2021. Self-reported smell and taste recovery in coronavirus disease 2019 patients: a one-year prospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=34032909|t=2021. Prevalence and prognosis of otorhinolaryngological symptoms in patients with COVID-19: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33987699|t=2021. Retronasal olfactory testing in early diagnosed and suspected COVID-19 patients: a 7-week follow-up study.|pdf=|usr=027}}
| |
| − | {{tp|p=33983525|t=2021. Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study.|pdf=|usr=027}}
| |
| − | {{tp|p=33932179|t=2021. How does allergic rhinitis impact the severity of COVID-19?: a case-control study.|pdf=|usr=027}}
| |
| − | {{tp|p=33837835|t=2021. The course of subjective and objective chemosensory dysfunction in hospitalized patients with COVID-19: a 6-month follow-up.|pdf=|usr=027}}
| |
| − | {{tp|p=34057701|t=2021. Health status in survivors older than 70 years after hospitalization with COVID-19: observational follow-up study at 3 months.|pdf=|usr=027}}
| |
| − | {{tp|p=34046874|t=2021. Older adults report cancellation or avoidance of medical care during the COVID-19 pandemic: results from the Longitudinal Aging Study Amsterdam.|pdf=|usr=027}}
| |
| − | {{tp|p=34086193|t=2021. Clinical frailty score as an independent predictor of outcome in COVID-19 hospitalised patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33313825|t=2021. A patient with rapid worsening dyspnoea during Covid-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33351891|t=2021. COVID-19 pandemic: complex interactions with the arrhythmic profile and the clinical course of patients with cardiovascular disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33321517|t=2021. Ventricular arrhythmia burden during the coronavirus disease 2019 (COVID-19) pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33889082|t=2021. The Other Side of SARS-CoV-2 Infection: Neurological Sequelae in Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34055940|t=2021. Case Report: Changes of Vascular Reactivity and Arterial Stiffness in a Patient With Covid-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34055939|t=2021. Cardiovascular Impacts on COVID-19 Infected Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34055936|t=2021. Cardiac Involvement in Recovered Patients From COVID-19: A Preliminary 6-Month Follow-Up Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34055928|t=2021. Preexisting Oral Anticoagulant Therapy Ameliorates Prognosis in Hospitalized COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33981736|t=2021. Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort-Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation.|pdf=|usr=027}}
| |
| − | {{tp|p=33981731|t=2021. Associations Between the Use of Renin-Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies.|pdf=|usr=027}}
| |
| − | {{tp|p=33969006|t=2021. Anti-cancer Therapy Leads to Increased Cardiovascular Susceptibility to COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33959645|t=2021. Hospitalized Children With Familial Hypercholesterolemia and COVID-19: A Case for Preventive Anticoagulation.|pdf=|usr=027}}
| |
| − | {{tp|p=33869305|t=2021. Vascular Inflammation as a Therapeutic Target in COVID-19 "Long Haulers": HIITing the Spot?|pdf=|usr=027}}
| |
| − | {{tp|p=33855053|t=2021. Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology.|pdf=|usr=027}}
| |
| − | {{tp|p=33898461|t=2021. COVID-19 During Development: A Matter of Concern.|pdf=|usr=027}}
| |
| − | {{tp|p=33968806|t=2021. SARS CoV-2 Nucleoprotein Enhances the Infectivity of Lentiviral Spike Particles.|pdf=|usr=027}}
| |
| − | {{tp|p=33937096|t=2021. Immune Profile in Patients With COVID-19: Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome.|pdf=|usr=027}}
| |
| − | {{tp|p=34060710|t=2021. Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34111618|t=2021. Expanding the Spectrum of Acute Cerebellitis due to SARS-Cov-2.|pdf=|usr=027}}
| |
| − | {{tp|p=34033702|t=2021. Silent RSV in infants with SARS-CoV-2 infection: A case series.|pdf=|usr=027}}
| |
| − | {{tp|p=33945679|t=2021. A toddler diagnosed with severe postinfectious bronchiolitis obliterans and COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33857338|t=2021. A child with SARS-CoV2-induced croup.|pdf=|usr=027}}
| |
| − | {{tp|p=34062054|t=2021. Asthma and COVID-19: An early inpatient and outpatient experience at a US children's hospital.|pdf=|usr=027}}
| |
| − | {{tp|p=34003595|t=2021. Delayed season's onset and reduction of incidence of bronchiolitis during COVID-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33983678|t=2021. Can laboratory findings predict pulmonary involvement in children with COVID-19 infection?|pdf=|usr=027}}
| |
| − | {{tp|p=33961732|t=2021. Impact of COVID-19 outbreak in acute bronchiolitis: Lesson from a tertiary Italian Emergency Department.|pdf=|usr=027}}
| |
| − | {{tp|p=34076953|t=2021. A single-center report of COVID-19 disease course and management in liver transplanted pediatric patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34001841|t=2021. ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34097572|t=2021. Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets.|pdf=|usr=027}}
| |
| − | {{tp|p=34111211|t=2021. Renal allograft function in kidney transplant recipients infected with SARS-CoV 2: An academic single center experience.|pdf=|usr=027}}
| |
| − | {{tp|p=34109440|t=2021. Morbiditat und Letalitat einer COVID-19-Erkrankung bei Tumorpatienten: eine gematchte Kohortenstudie.|pdf=|usr=027}}
| |
| − | {{tp|p=34082576|t=2021. Intracerebral Hemorrhage in Patients With COVID-19: An Analysis From the COVID-19 Cardiovascular Disease Registry.|pdf=|usr=027}}
| |
| − | {{tp|p=33307546|t=2021. Genetic mechanisms of critical illness in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33887749|t=2021. High-dimensional characterization of post-acute sequelae of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34088860|t=2021. A Case of Vertical Transmission of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33931474|t=2021. Perinatal SARS-CoV-2 Infection and Neonatal COVID-19: A 2021 Update.|pdf=|usr=027}}
| |
| − | {{tp|p=33368892|t=2021. Prolonged SARS-CoV-2 viral shedding in patients with chronic kidney disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33868565|t=2021. Transient Global Amnesia as a Possible First Manifestation of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33842100|t=2021. COVID-19 Associated With Concomitant Varicella Zoster Viral Encephalitis.|pdf=|usr=027}}
| |
| − | {{tp|p=33842098|t=2021. Fatal Necrotizing Encephalitis Associated With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34011636|t=2021. Incidence of COVID-19 and Risk of Diabetic Ketoacidosis in New-Onset Type 1 Diabetes.|pdf=|usr=027}}
| |
| − | {{tp|p=33850028|t=2021. Neonatal SARS-CoV-2 Infections in Breastfeeding Mothers.|pdf=|usr=027}}
| |
| − | {{tp|p=33323493|t=2021. Factors Associated With Severe SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34035074|t=2021. ST-Elevation Myocardial Infarction due to Acute Thrombosis in an Adolescent With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34088867|t=2021. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies.|pdf=|usr=027}}
| |
| − | {{tp|p=33904788|t=2021. Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore.|pdf=|usr=027}}
| |
| − | {{tp|p=33890850|t=2021. A double-edged sword: antibody-mediated procoagulant platelets in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34042772|t=2021. A Knowledge Graph of Mechanistic Associations Between COVID-19, Diabetes Mellitus and Kidney Diseases.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=34016619|t=2021. Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study.|pdf=|usr=027}}
| |
| − | {{tp|p=33926969|t=2021. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors.|pdf=|usr=027}}
| |
| − | {{tp|p=33889551|t=2021. Comorbidities and Age Are Associated With Persistent COVID-19 PCR Positivity.|pdf=|usr=027}}
| |
| − | {{tp|p=33828999|t=2021. Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae.|pdf=|usr=027}}
| |
| − | {{tp|p=33897376|t=2021. Neurotropic Viruses, Astrocytes, and COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33737867|t=2021. Microglia Fighting for Neurological and Mental Health: On the Central Nervous System Frontline of COVID-19 Pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34025575|t=2021. Serum Uric Acid Concentrations and Risk of Adverse Outcomes in Patients With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33995281|t=2021. Review: Obesity and COVID-19: A Detrimental Intersection.|pdf=|usr=027}}
| |
| − | {{tp|p=33995267|t=2021. Severity of COVID-19 and Treatment Strategy for Patient With Diabetes.|pdf=|usr=027}}
| |
| − | {{tp|p=33981284|t=2021. Physiological Role and Use of Thyroid Hormone Metabolites - Potential Utility in COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33868185|t=2021. The Impact of COVID-19 Pandemic Lockdown on the Incidence of New-Onset Type 1 Diabetes and Ketoacidosis Among Saudi Children.|pdf=|usr=027}}
| |
| − | {{tp|p=33868163|t=2021. Type 2 Diabetes Mellitus and COVID-19: A Narrative Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33859620|t=2021. Platelet Protein-Related Abnormalities in Response to Acute Hypoglycemia in Type 2 Diabetes.|pdf=|usr=027}}
| |
| − | {{tp|p=33859617|t=2021. Association Between Longitudinal Change in Abnormal Fasting Blood Glucose Levels and Outcome of COVID-19 Patients Without Previous Diagnosis of Diabetes.|pdf=|usr=027}}
| |
| − | {{tp|p=33841339|t=2021. Poor Metabolic Health Increases COVID-19-Related Mortality in the UK Biobank Sample.|pdf=|usr=027}}
| |
| − | {{tp|p=34093642|t=2021. Machine Learning Assisted Prediction of Prognostic Biomarkers Associated With COVID-19, Using Clinical and Proteomics Data.|pdf=|usr=027}}
| |
| − | {{tp|p=33833673|t=2021. Neuropsychiatric Symptoms of COVID-19 Explained by SARS-CoV-2 Proteins' Mimicry of Human Protein Interactions.|pdf=|usr=027}}
| |
| − | {{tp|p=34054832|t=2021. Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34040615|t=2021. SARS-CoV-2 Infection and Guillain-Barre Syndrome: A Review on Potential Pathogenic Mechanisms.|pdf=|usr=027}}
| |
| − | {{tp|p=34025688|t=2021. Associations of D-Dimer on Admission and Clinical Features of COVID-19 Patients: A Systematic Review, Meta-Analysis, and Meta-Regression.|pdf=|usr=027}}
| |
| − | {{tp|p=34025658|t=2021. Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality.|pdf=|usr=027}}
| |
| − | {{tp|p=34012458|t=2021. Immune Response to COVID-19 During Pregnancy.|pdf=|usr=027}}
| |
| − | {{tp|p=34012444|t=2021. Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34012431|t=2021. CD4(+) T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein.|pdf=|usr=027}}
| |
| − | {{tp|p=33995410|t=2021. Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33981312|t=2021. Neurological Symptoms of COVID-19: The Zonulin Hypothesis.|pdf=|usr=027}}
| |
| − | {{tp|p=33981305|t=2021. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).|pdf=|usr=027}}
| |
| − | {{tp|p=33968060|t=2021. HLA-A11:01:01:01, HLA-C12:02:02:01-HLA-B52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure.|pdf=|usr=027}}
| |
| − | {{tp|p=33968010|t=2021. Increased Serum Levels of Soluble TNF-alpha Receptor Is Associated With ICU Mortality in COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33936104|t=2021. Case Report: Complete and Fast Recovery From Severe COVID-19 in a Pemphigus Patient Treated With Rituximab.|pdf=|usr=027}}
| |
| − | {{tp|p=33936073|t=2021. COVID-19 Among Patients With Inflammatory Rheumatic Diseases.|pdf=|usr=027}}
| |
| − | {{tp|p=33936047|t=2021. SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights.|pdf=|usr=027}}
| |
| − | {{tp|p=33897707|t=2021. Breastfeeding and COVID-19: From Nutrition to Immunity.|pdf=|usr=027}}
| |
| − | {{tp|p=33868239|t=2021. Genetics Insight for COVID-19 Susceptibility and Severity: A Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33859644|t=2021. Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity.|pdf=|usr=027}}
| |
| − | {{tp|p=33841446|t=2021. Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33909258|t=2021. Comparison of the clinical features and therapeutics of COVID-19 in cardio-cerebrovascular disease (CCVD) and non-CCVD patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34055842|t=2021. Clinical and Laboratory Findings of COVID-19 in High-Altitude Inhabitants of Saudi Arabia.|pdf=|usr=027}}
| |
| − | {{tp|p=34055822|t=2021. The Association of Hypertension With the Severity of and Mortality From the COVID-19 in the Early Stage of the Epidemic in Wuhan, China: A Multicenter Retrospective Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34026776|t=2021. Prediction of Re-positivity for Coronavirus Nucleic Acid Among COVID-19 Patients in the Recovery Phase.|pdf=|usr=027}}
| |
| − | {{tp|p=34026775|t=2021. Health Issues and Immunological Assessment Related to Wuhan's COVID-19 Survivors: A Multicenter Follow-Up Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34017846|t=2021. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data.|pdf=|usr=027}}
| |
| − | {{tp|p=34017843|t=2021. ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes.|pdf=|usr=027}}
| |
| − | {{tp|p=34012970|t=2021. Mortality and Life-Sustaining Therapy Decisions in Patients With Cancer and Acute Respiratory Failure Due to COVID-19 or Other Causes: An Observational Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33996867|t=2021. Adolescent and Young Adult ME/CFS After Confirmed or Probable COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33996864|t=2021. Time-to-Death Longitudinal Characterization of Clinical Variables and Longitudinal Prediction of Mortality in COVID-19 Patients: A Two-Center Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33996852|t=2021. Diagnostic Delay of Pulmonary Embolism in COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33996843|t=2021. Prevalence of Venous Thromboembolism in Critically Ill Patients With Coronavirus Disease 2019: A Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33981711|t=2021. Association Between Respiratory Alkalosis and the Prognosis of COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33968961|t=2021. Oral Mucosa, Saliva, and COVID-19 Infection in Oral Health Care.|pdf=|usr=027}}
| |
| − | {{tp|p=33968958|t=2021. Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.|pdf=|usr=027}}
| |
| − | {{tp|p=33968947|t=2021. Single-Cell RNA-seq Reveals Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 Expression in TROP2(+) Liver Progenitor Cells: Implications in Coronavirus Disease 2019-Associated Liver Dysfunction.|pdf=|usr=027}}
| |
| − | {{tp|p=33937300|t=2021. Editorial: Thrombotic Disorders, Prothrombotic Abnormalities and COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33937299|t=2021. Uremia-Associated Immunological Aging and Severity of COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33937281|t=2021. Comparison of Clinical Features and CT Temporal Changes Between Familial Clusters and Non-familial Patients With COVID-19 Pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33898491|t=2021. Frequency and Risk Factors for Spontaneous Pneumomediastinum in COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33898480|t=2021. Advancing Risk Analysis of COVID-19 Clinical Predictors: The Case of Fasting Blood Glucose.|pdf=|usr=027}}
| |
| − | {{tp|p=33869251|t=2021. The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality From COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33855033|t=2021. Hepatic Steatosis, Rather Than Underlying Obesity, Increases the Risk of Infection and Hospitalization for COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33842498|t=2021. Time Till Viral Clearance of Severe Acute Respiratory Syndrome Coronavirus 2 Is Similar for Asymptomatic and Non-critically Symptomatic Individuals.|pdf=|usr=027}}
| |
| − | {{tp|p=33842496|t=2021. High Incidence of Epileptiform Potentials During Continuous EEG Monitoring in Critically Ill COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33842494|t=2021. Clinical Characteristics of Severe COVID-19 Patients Admitted to an Intensive Care Unit in Lombardy During the Italian Pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33829025|t=2021. Evolution of Pathology Patterns in Persons Who Died From COVID-19 in Italy: A National Study Based on Death Certificates.|pdf=|usr=027}}
| |
| − | {{tp|p=33912588|t=2021. The Deadly Duo of COVID-19 and Cancer!|pdf=|usr=027}}
| |
| − | {{tp|p=34093389|t=2021. Case Report: Bilateral Palsy of the Vocal Cords After COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34079511|t=2021. Cognitive and Emotional Disturbances Due to COVID-19: An Exploratory Study in the Rehabilitation Setting.|pdf=|usr=027}}
| |
| − | {{tp|p=33995248|t=2021. Case Report: Behavioral Unresponsiveness in Acute COVID-19 Patients: The Utility of the Motor Behavior Tool-Revised and (18)F-FDG PET/CT.|pdf=|usr=027}}
| |
| − | {{tp|p=33967944|t=2021. Immunological Interfaces: The COVID-19 Pandemic and Depression.|pdf=|usr=027}}
| |
| − | {{tp|p=33927679|t=2021. COVID-19 Dysautonomia.|pdf=|usr=027}}
| |
| − | {{tp|p=33912129|t=2021. Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33897598|t=2021. Prolonged Intubation in Patients With Prior Cerebrovascular Disease and COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33897582|t=2021. Case Report: Cerebrovascular Events Associated With Bacterial and SARS-CoV-2 Infections in an Adolescent.|pdf=|usr=027}}
| |
| − | {{tp|p=33828524|t=2021. The Impact of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorder Beyond Infection Risk.|pdf=|usr=027}}
| |
| − | {{tp|p=33828521|t=2021. Clinical and Radiological Characteristics of Acute Cerebrovascular Diseases Among Egyptian Patients With COVID-19 in Upper Egypt.|pdf=|usr=027}}
| |
| − | {{tp|p=34094950|t=2021. Clinical Characteristics of COVID-19-Infected Cancer Patients in Pakistan: Differences Between Survivors and Non-Survivors.|pdf=|usr=027}}
| |
| − | {{tp|p=34094930|t=2021. High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis.|pdf=|usr=027}}
| |
| − | {{tp|p=34026639|t=2021. More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33842366|t=2021. COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway.|pdf=|usr=027}}
| |
| − | {{tp|p=34084763|t=2021. Can Asymptomatic or Non-Severe SARS-CoV-2 Infection Cause Medium-Term Pulmonary Sequelae in Children?|pdf=|usr=027}}
| |
| − | {{tp|p=33996694|t=2021. An Overview of Asthma and COVID-19: Protective Factors Against SARS-COV-2 in Pediatric Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33996683|t=2021. COVID-19 in Immunosuppressed Children.|pdf=|usr=027}}
| |
| − | {{tp|p=33959568|t=2021. Case Report: Detection of SARS-CoV-2 From Cerebrospinal Fluid in a 34-Month-Old Child With Encephalitis.|pdf=|usr=027}}
| |
| − | {{tp|p=33959029|t=2021. The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33859566|t=2021. Role of Cigarette Smoke on Angiotensin-Converting Enzyme-2 Protein Membrane Expression in Bronchial Epithelial Cells Using an Air-Liquid Interface Model.|pdf=|usr=027}}
| |
| − | {{tp|p=33854432|t=2021. Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials.|pdf=|usr=027}}
| |
| − | {{tp|p=33828483|t=2021. Comparing the Value of Cystatin C and Serum Creatinine for Evaluating the Renal Function and Predicting the Prognosis of COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34093217|t=2021. Alteration of Autonomic Nervous System Is Associated With Severity and Outcomes in Patients With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34028129|t=2021. Oral manifestations of Covid-19-A literature review.|pdf=|usr=027}}
| |
| − | {{tp|p=34091982|t=2021. Role of red blood cell distribution width, as a prognostic indicator in COVID-19: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34077995|t=2021. Epidemiology, prognosis and management of potassium disorders in Covid-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34077600|t=2021. Efficacy and safety of azithromycin in Covid-19 patients: A systematic review and meta-analysis of randomized clinical trials.|pdf=|usr=027}}
| |
| − | {{tp|p=34038014|t=2021. Mucormycosis associated with COVID-19 in two kidney transplant patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33993630|t=2021. Outcomes of COVID-19 in solid organ transplant recipients: A matched cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34097791|t=2021. Kidney transplantation from a SARS-CoV-2-positive donor for the recipients with immunity after COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34092025|t=2021. Heart and liver transplant recipients from donor with positive SARS-CoV-2 RT-PCR at time of transplantation.|pdf=|usr=027}}
| |
| − | {{tp|p=34081817|t=2021. Mucormycosis in post-COVID-19 renal transplant patients: A lethal complication in follow-up.|pdf=|usr=027}}
| |
| − | {{tp|p=33896088|t=2021. Clinical presentation and outcomes of COVID-19 following hematopoietic cell transplantation and cellular therapy.|pdf=|usr=027}}
| |
| − | {{tp|p=34037293|t=2021. Did an effect of kidney transplantation on COVID-19 mortality go unnoticed due to selection bias?|pdf=|usr=027}}
| |
| − | {{tp|p=34037291|t=2021. Response to Invited Commentary "Undoubtedly, kidney transplant recipients have a higher mortality due to COVID-19 disease compared to the general population".|pdf=|usr=027}}
| |
| − | {{tp|p=33862665|t=2021. Is transplantation per se a risk factor for worse outcome of SARS-CoV-2 infection in kidney transplant recipients?|pdf=|usr=027}}
| |
| − | {{tp|p=33960516|t=2021. Incomplete recovery from COVID-19-associated acute kidney injury in kidney transplant recipients: prior graft injury matters the most.|pdf=|usr=027}}
| |
| − | {{tp|p=33884672|t=2021. Recovery of kidney function after AKI because of COVID-19 in kidney transplant recipients.|pdf=|usr=027}}
| |
| − | {{tp|p=34091654|t=2021. The effect of coronaviruses on olfaction: systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=33320115|t=2021. Six month follow-up of self-reported loss of smell during the COVID-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33249429|t=2021. ACE2, TMPRSS2, and Furin expression in the nose and olfactory bulb in mice and humans.|pdf=|usr=027}}
| |
| − | {{tp|p=34085061|t=2021. Sniffin' Sticks Screening 12 test: Presentation of odours on filter paper improves the recognition rate.|pdf=|usr=027}}
| |
| − | {{tp|p=33377890|t=2021. Parosmia is prevalent and persistent amongst those with COVID-19 olfactory dysfunction.|pdf=|usr=027}}
| |
| − | {{tp|p=34037292|t=2021. Undoubtedly, kidney transplant recipients have a higher mortality due to COVID-19 disease compared to the general population.|pdf=|usr=027}}
| |
| − | {{tp|p=34075005|t=2021. Impact of COVID-19 on Lung Allograft and Clinical Outcomes in Lung Transplant Recipients: A Case-control Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33901130|t=2021. Kidney Transplant Surgery in a Recipient With COVID-19 at the Time of Transplantation.|pdf=|usr=027}}
| |
| − | {{tp|p=33988334|t=2021. The Magnitude and Functionality of SARS-CoV-2 Reactive Cellular and Humoral Immunity in Transplant Population Is Similar to the General Population Despite Immunosuppression.|pdf=|usr=027}}
| |
| − | {{tp|p=33988335|t=2021. The Full Spectrum of COVID-19 Development and Recovery Among Kidney Transplant Recipients.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33898655|t=2021. Pulmonary artery pseudoaneurysm secondary to COVID-19 treated with endovascular embolisation.|pdf=|usr=027}}
| |
| − | {{tp|p=34031703|t=2021. COVID-19 in trauma: a propensity-matched analysis of COVID and non-COVID trauma patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33846074|t=2021. Prevalence of COVID-19 Risk Factors and Risks of Severe Acute Respiratory Disease are Markedly Higher in Patients with Symptomatic Peripheral Arterial Occlusive Disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33931300|t=2021. Should We Urgently Modify the Management of SARS-CoV-2 Infected Patients Suffering from Acute Limb Ischaemia?|pdf=|usr=027}}
| |
| − | {{tp|p=33824066|t=2021. How Does SARS-CoV-2 Infection Affect Survival of Emergency Cardiovascular Patients? A Cohort Study From a German Insurance Claims Database.|pdf=|usr=027}}
| |
| − | {{tp|p=32807675|t=2021. COVID Fingers: Another Severe Vascular Manifestation.|pdf=|usr=027}}
| |
| − | {{tp|p=33992951|t=2021. Mind long COVID: Psychiatric sequelae of SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33966132|t=2021. Pulmonary embolism in patients with COVID-19 and value of D-dimer assessment: a meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33958433|t=2021. Between inflammation and thrombosis: endothelial cells in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34083401|t=2021. COVID-19 Pneumothorax in the United Kingdom: a prospective observational study using the ISARIC WHO clinical characterisation protocol.|pdf=|usr=027}}
| |
| − | {{tp|p=33361097|t=2021. Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33986033|t=2021. Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment.|pdf=|usr=027}}
| |
| − | {{tp|p=33863743|t=2021. Intrapulmonary bronchopulmonary anastomoses in COVID-19 respiratory failure.|pdf=|usr=027}}
| |
| − | {{tp|p=33833035|t=2021. Prevalence of pulmonary embolism on hospital admission in COVID-19 patients: is there a role for pre-test probability scores and home treatment?|pdf=|usr=027}}
| |
| − | {{tp|p=33833032|t=2021. SARS-CoV-2 infections in people with primary ciliary dyskinesia: neither frequent, nor particularly severe.|pdf=|usr=027}}
| |
| − | {{tp|p=33888524|t=2021. Interstitial lung disease increases susceptibility to and severity of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33863736|t=2021. COVID-19 pneumonia and the pulmonary vasculature - a marriage made in hell.|pdf=|usr=027}}
| |
| − | {{tp|p=33303546|t=2021. Intrapulmonary shunt measured by bedside pulse oximetry predicts worse outcomes in severe COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33303539|t=2021. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial.|pdf=|usr=027}}
| |
| − | {{tp|p=34002835|t=2021. Prevalence and significance of mediastinal lymphadenopathy in patients with Severe Acute Respiratory Syndrome Corona Virus-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34002834|t=2021. Heparins and 2019-nCoV infection: a narrative review.|pdf=|usr=027}}
| |
| − | {{tp|p=33829466|t=2021. Effects of increasing aerobic capacity on improving psychological problems seen in patients with COVID-19: a review.|pdf=|usr=027}}
| |
| − | {{tp|p=33829461|t=2021. Post-COVID pulmonary fibrosis: therapeutic efficacy using with mesenchymal stem cells - How the lung heals.|pdf=|usr=027}}
| |
| − | {{tp|p=33829460|t=2021. Worse impact of second wave COVID-19 pandemic in adults but not in children with inflammatory bowel disease: an Italian single tertiary center experience.|pdf=|usr=027}}
| |
| − | {{tp|p=33829459|t=2021. Ventilatory therapies and Intensive Care admissions for patients with COVID-19: a systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=33928614|t=2021. Prognostic significance of Tp-e interval and Tp-e/QTc ratio in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33883981|t=2021. COVID-19: Is reinfection possible?|pdf=|usr=027}}
| |
| − | {{tp|p=34053422|t=2021. Clinical Effects of COVID-19 on Hematopoietic Stem Cell Transplant Outcomes in Pediatric Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34085915|t=2021. Management of COVID-19 in Liver Transplant Recipients With Immunosuppressant Therapy: Experiences of an Iranian Transplant Registry.|pdf=|usr=027}}
| |
| − | {{tp|p=34085913|t=2021. COVID-19 in Lung Transplant Recipients: 2 Cases With Acute Respiratory Distress Syndrome Successfully Treated With High-Dose Corticosteroids.|pdf=|usr=027}}
| |
| − | {{tp|p=33928873|t=2021. COVID-19 in a Lung Transplant Patient: Rapid Progressive Chronic Lung Allograft Dysfunction.|pdf=|usr=027}}
| |
| − | {{tp|p=34048906|t=2021. Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?|pdf=|usr=027}}
| |
| − | {{tp|p=34059141|t=2021. Platelet-driven coagulopathy in COVID-19 patients: in comparison to seasonal influenza cases.|pdf=|usr=027}}
| |
| − | {{tp|p=33968172|t=2021. Clinical and diagnostic value of the combination of lymphocyte count and creatine kinase in the detection of coronavirus 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=34035853|t=2021. COVID-19-related thyroid conditions (Review).|pdf=|usr=027}}
| |
| − | {{tp|p=33363603|t=2021. SARS-CoV-2, multiple sclerosis, and focal deficit in a postpartum woman: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33335578|t=2021. Clinical characteristics and infectivity of asymptomatic carriers of SARS-CoV-2 (Review).|pdf=|usr=027}}
| |
| − | {{tp|p=33832398|t=2021. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management.|pdf=|usr=027}}
| |
| − | {{tp|p=34015983|t=2021. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives.|pdf=|usr=027}}
| |
| − | {{tp|p=33840351|t=2021. The diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33882768|t=2021. Outcomes of acute respiratory distress syndrome in COVID-19 patients compared to the general population: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33944643|t=2021. Clinical characteristics and outcomes of hospitalized COVID-19 patients with COPD.|pdf=|usr=027}}
| |
| − | {{tp|p=33905286|t=2021. The Glasgow Prognostic Score and fibrinogen to albumin ratio as prognostic factors in hospitalized patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33994333|t=2021. Most severe Covid-19 due to four cardiometabolic conditions.|pdf=|usr=027}}
| |
| − | {{tp|p=33868645|t=2021. The clinical impact of bacterial co-infection among moderate, severe and critically ill COVID-19 patients in the second referral hospital in Surabaya.|pdf=|usr=027}}
| |
| − | {{tp|p=33824716|t=2021. Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33889861|t=2021. Retrospective observational RT-PCR analyses on 688 babies born to 843 SARS-CoV-2 positive mothers, placental analyses and diagnostic analyses limitations suggest vertical transmission is possible.|pdf=|usr=027}}
| |
| − | {{tp|p=33859466|t=2021. Postoperative Neurologic Deficits in a Veteran With Recent COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34060640|t=2021. Unusual echocardiographic evidence of hypercoagulation in usual left atrial appendage as the first and only sign of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33969672|t=2021. COVID-19 - neuropathological point of view, pathobiology, and dilemmas after the first year of the pandemic struggle.|pdf=|usr=027}}
| |
| − | {{tp|p=33890243|t=2021. Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=33851328|t=2021. Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease.|pdf=|usr=027}}
| |
| − | {{tp|p=34061792|t=2021. Severe systemic thrombosis in a young COVID-19 patient with a rare homozygous prothrombin G20210A mutation.|pdf=|usr=027}}
| |
| − | {{tp|p=34061785|t=2021. Use of renin-angiotensin system inhibitors and clinical predictors of COVID-19 severity in a tertiary hospital in the city of Buenos Aires.|pdf=|usr=027}}
| |
| − | {{tp|p=33962695|t=2021. Neurological pathogenesis of SARS-CoV-2 (COVID-19): from virological features to clinical symptoms.|pdf=|usr=027}}
| |
| − | {{tp|p=33881684|t=2021. The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33942510|t=2021. Factors associated with COVID-19 related hospitalisation, critical care admission and mortality using linked primary and secondary care data.|pdf=|usr=027}}
| |
| − | {{tp|p=34085762|t=2021. SARS-CoV-2 re-infection versus prolonged shedding: A case series.|pdf=|usr=027}}
| |
| − | {{tp|p=34007667|t=2021. Post-COVID Recovery Assessment Clinics: A Real Need of Time.|pdf=|usr=027}}
| |
| − | {{tp|p=33942034|t=2021. Genetic correlations between COVID-19 and a variety of traits and diseases.|pdf=|usr=027}}
| |
| − | {{tp|p=34034832|t=2021. Unilateral acute posterior multifocal placoid pigment epitheliopathy in a convalescent COVID-19 patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33968603|t=2021. Hyperbilirubinemia with mild COVID-19 patient: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33964720|t=2021. Sino-orbital mucormycosis in a COVID-19 patient: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33936934|t=2021. A rare case of heterotopic pancreatitis and intestinal malrotation in a COVID-19 positive patient. COVID-19, causative or coincidence?|pdf=|usr=027}}
| |
| − | {{tp|p=34109406|t=2021. COVID-19 associated Mucormycosis: An epidemic within a pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34107295|t=2021. Association of prior radiation dose to the cardiopulmonary system with COVID-19 outcomes in patients with cancer.|pdf=|usr=027}}
| |
| − | {{tp|p=33307933|t=2021. Clinical features and outcome of maintenance hemodialysis patients with COVID-19 from a tertiary nephrology care center in Romania.|pdf=|usr=027}}
| |
| − | {{tp|p=34108126|t=2021. Incidence of pneumomediastinum in COVID-19: A single-center comparison between 1st and 2nd wave.|pdf=|usr=027}}
| |
| − | {{tp|p=34043841|t=2021. Quantifying the risk of SARS-CoV-2 reinfection over time.|pdf=|usr=027}}
| |
| − | {{tp|p=33969909|t=2021. Extracorporeal CO2 removal and renal replacement therapy in acute severe respiratory failure in COVID-19 pneumonia: Case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34002238|t=2021. Post-COVID-19 pulmonary fibrosis.|pdf=|usr=027}}
| |
| − | {{tp|p=34048378|t=2021. A Rapid Guidance Process for the Development of an Anticoagulation Protocol in the COVID-19 Pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34076373|t=2021. Prevalence of candidiasis and oral candidiasis in COVID-19 patients: a cross-sectional pilot study from the patients' registry in a large health center.|pdf=|usr=027}}
| |
| − | {{tp|p=33347399|t=2021. d-Dimer and COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34035148|t=2021. COVID-19 ARDS Is Characterized by Increased Dead Space Ventilation Compared With Non-COVID ARDS.|pdf=|usr=027}}
| |
| − | {{tp|p=33514664|t=2021. Diaphragmatic Mobility Loss in Subjects With Moderate to Very Severe COPD May Improve After In-Patient Pulmonary Rehabilitation.|pdf=|usr=027}}
| |
| − | {{tp|p=34001764|t=2021. Acute macular neuroretinopathy as the presenting manifestation of COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34024584|t=2021. Accueil des patients insuffisants renaux chroniques et Covid-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33682382|t=2021. Face a la COVID-19. Maintenir ou stopper la metformine chez le patient diabetique de type 2 infecte par le SARS-CoV-2 ?|pdf=|usr=027}}
| |
| − | {{tp|p=34106540|t=2021. Covid-19 : consequences sur le larynx, la respiration et la voix.|pdf=|usr=027}}
| |
| − | {{tp|p=34077043|t=2021. Anticoagulation prophylactique des patients Covid-19 : pas d'interet a augmenter la dose ?|pdf=|usr=027}}
| |
| − | {{tp|p=33908722|t=2021. Prise en charge diagnostique et therapeutique des sequelles a moyen et long termes liees a l'infection a SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33908720|t=2021. Physiopathologie de l'hypoxemie silencieuse dans le Covid-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33908719|t=2021. Neuropathies aigues severes induites par l'infection a SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33908718|t=2021. Covid long neuropsychologique : origine neurologique ou psychiatrique ?|pdf=|usr=027}}
| |
| − | {{tp|p=33908716|t=2021. Encephalopathie aigue et Covid-19: hypotheses physiopathologiques.|pdf=|usr=027}}
| |
| − | {{tp|p=33908715|t=2021. Complications neurologiques du virus SARS-CoV-2: une controverse de plus ?|pdf=|usr=027}}
| |
| − | {{tp|p=33899829|t=2021. Il delirium nel paziente covid-19 "giovane" (<65 anni): indicazioni cliniche preliminari.|pdf=|usr=027}}
| |
| − | {{tp|p=33989483|t=2021. Marcadores de funcionamiento renal en pacientes infectados por SARS-CoV-2. Revision rapida de la literatura.|pdf=|usr=027}}
| |
| − | {{tp|p=33989485|t=2021. Associated risks of smoking and possible benefits of cessation in Covid-19: a rapid narrative review.|pdf=|usr=027}}
| |
| − | {{tp|p=33896791|t=2021. Community-based study links skin rashes to COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34106799|t=2021. Leukocyte differential and reactive lymphocyte counts from Sysmex XN analyzer in the evaluation of SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33342313|t=2021. How do routine laboratory tests change in coronavirus disease 2019?|pdf=|usr=027}}
| |
| − | {{tp|p=33985372|t=2021. Sex-specific deaths in Norway and Sweden during the COVID-19 pandemic: Did mandates make a difference?|pdf=|usr=027}}
| |
| − | {{tp|p=34035154|t=2021. Estimating infectiousness throughout SARS-CoV-2 infection course.|pdf=|usr=027}}
| |
| − | {{tp|p=34058768|t=2021. Venous Thromboembolism among Critically Ill Children: A Narrative Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33962474|t=2021. Venous Thromboembolism among Noncritically Ill Hospitalized Children: Key Considerations for the Pediatric Hospital Medicine Specialist.|pdf=|usr=027}}
| |
| − | {{tp|p=33962473|t=2021. Sustained High D-Dimer in Outpatients Who Have Recovered from Mild to Moderate Coronavirus Disease 2019 (COVID-19).|pdf=|usr=027}}
| |
| − | {{tp|p=34062596|t=2021. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II.|pdf=|usr=027}}
| |
| − | {{tp|p=33893632|t=2021. Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33893631|t=2021. Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization.|pdf=|usr=027}}
| |
| − | {{tp|p=33893630|t=2021. Mean Platelet Volume Predicts Severe COVID-19 Illness.|pdf=|usr=027}}
| |
| − | {{tp|p=33851386|t=2021. Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33851385|t=2021. Platelet Function in Viral Immunity and SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33378783|t=2021. Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness.|pdf=|usr=027}}
| |
| − | {{tp|p=33378782|t=2021. Pulmonary Thrombosis in COVID-19 Treated by Thrombolysis: A Small Case Series Using Streptokinase.|pdf=|usr=027}}
| |
| − | {{tp|p=33336328|t=2021. Fatal Disseminated Intravascular Coagulopathy in Covid-19: A Small Case Series.|pdf=|usr=027}}
| |
| − | {{tp|p=33860515|t=2021. Post COVID-19 Arterial Thromboembolism: A Clear and Present Danger.|pdf=|usr=027}}
| |
| − | {{tp|p=33958544|t=2021. Microvascular Dysfunction in Patients with Critical COVID-19, A Pilot Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33989265|t=2021. Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU.|pdf=|usr=027}}
| |
| − | {{tp|p=33989264|t=2021. Fibrinolytic Shutdown in COVID-19 Is Likely a Misnomer.|pdf=|usr=027}}
| |
| − | {{tp|p=33942118|t=2021. Ulysses Syndrome and the COVID-19 Pandemic.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=34025446|t=2021. Intermuscular Adipose Tissue as a Risk Factor for Mortality and Muscle Injury in Critically Ill Patients Affected by COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34012410|t=2021. COVID-19 and Hypertension: The What, the Why, and the How.|pdf=|usr=027}}
| |
| − | {{tp|p=33935803|t=2021. Severe Acute Respiratory Syndrome Coronavirus 2 and Male Reproduction: Relationship, Explanations, and Clinical Remedies.|pdf=|usr=027}}
| |
| − | {{tp|p=33868029|t=2021. Plasma Linoleate Diols Are Potential Biomarkers for Severe COVID-19 Infections.|pdf=|usr=027}}
| |
| − | {{tp|p=33841169|t=2021. Alteration of Diffusion Capacity After SARS-CoV-2 Infection: A Pathophysiological Approach.|pdf=|usr=027}}
| |
| − | {{tp|p=34093286|t=2021. Long Haulers-What Is the Evidence for Post-COVID Fatigue?|pdf=|usr=027}}
| |
| − | {{tp|p=34093279|t=2021. Prevalence of Post-traumatic Stress Symptoms and Its Associations With Quality of Life, Demographic and Clinical Characteristics in COVID-19 Survivors During the Post-COVID-19 Era.|pdf=|usr=027}}
| |
| − | {{tp|p=34079487|t=2021. COVID-19 in People With Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33942104|t=2021. Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design.|pdf=|usr=027}}
| |
| − | {{tp|p=33349849|t=2021. The effect of angiotensin-converting enzyme levels on COVID-19 susceptibility and severity: a Mendelian randomization study.|pdf=|usr=027}}
| |
| − | {{tp|p=33349845|t=2021. Development and validation of a prognostic model based on comorbidities to predict COVID-19 severity: a population-based study.|pdf=|usr=027}}
| |
| − | {{tp|p=33953603|t=2021. Epidemiology, Clinical Characteristics, and Outcomes of a Large Cohort of COVID-19 Outpatients in Michigan.|pdf=|usr=027}}
| |
| − | {{tp|p=33824762|t=2021. The Effect of Chronic and Inhospital Exposure to Renin-Angiotensin System Inhibitors on the Outcome and Inflammatory State of Coronavirus Disease 2019 Adult Inpatients.|pdf=|usr=027}}
| |
| − | {{tp|p=33862207|t=2021. A case of rapidly progressive upper limb ischemic necrosis in a patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33965598|t=2021. Potential value of circulating endothelial cells for the diagnosis and treatment of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33962081|t=2021. Clinical course of alopecia after COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34038766|t=2021. Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study.|pdf=|usr=027}}
| |
| − | {{tp|p=34023492|t=2021. Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=34022336|t=2021. Day-by-day symptoms following positive and negative PCR tests for SARS-CoV-2 in non-hospitalized healthcare workers: A 90-day follow-up study.|pdf=|usr=027}}
| |
| − | {{tp|p=34022334|t=2021. Non-ABO red cell antibodies and risk of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34004328|t=2021. Association of hypothermia with increased mortality rate in SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34000422|t=2021. Transient perivascular inflammation of the carotid artery (TIPIC) syndrome in a patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34000419|t=2021. Clinical presentation, outcomes and factors associated with mortality: A prospective study from three COVID-19 referral care centres in West Africa.|pdf=|usr=027}}
| |
| − | {{tp|p=34000418|t=2021. Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: A systematic review and meta-analysis of adjusted effect estimates.|pdf=|usr=027}}
| |
| − | {{tp|p=33842198|t=2021. Post covid-19 invasive pulmonary Aspergillosis: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33977912|t=2021. A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34035963|t=2021. Getting to the Heart of the Matter: Myocardial Injury, Coagulopathy, and Other Potential Cardiovascular Implications of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33907474|t=2021. Novel Coronavirus (COVID-19)-Associated Guillain-Barre' Syndrome: Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=34100972|t=2021. Intracerebral Aspergillus fumigatus abscess and SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=34097083|t=2021. Neurological complications of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33974106|t=2021. Natural history, trajectory, and management of mechanically ventilated COVID-19 patients in the United Kingdom.|pdf=|usr=027}}
| |
| − | {{tp|p=33852032|t=2021. Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months.|pdf=|usr=027}}
| |
| − | {{tp|p=33844045|t=2021. Long-term mortality of elderly patients after intensive care unit admission for COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34052905|t=2021. Pulmonary immuno-thrombosis in COVID-19 ARDS pathogenesis.|pdf=|usr=027}}
| |
| − | {{tp|p=33527154|t=2021. Anatomical, physiological and clinical similarities and differences in ARDS physiological subtypes.|pdf=|usr=027}}
| |
| − | {{tp|p=33332525|t=2021. Cavitary lung lesions and pneumothorax in a healthy patient with active coronavirus-19 (COVID-19) viral pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33968148|t=2021. C-Reactive Protein as a Prognostic Indicator in COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33963517|t=2021. Pooled analysis of mid-regional pro-adrenomedullin values in COVID-19 patients with critical illness.|pdf=|usr=027}}
| |
| − | {{tp|p=34046852|t=2021. Cardiac complications during the active phase of COVID-19: review of the current evidence.|pdf=|usr=027}}
| |
| − | {{tp|p=34043116|t=2021. COVID-19-related symptom clustering in a primary care vs internal medicine setting.|pdf=|usr=027}}
| |
| − | {{tp|p=33368021|t=2021. COVID-19 coagulopathy: is it disseminated intravascular coagulation?|pdf=|usr=027}}
| |
| − | {{tp|p=33893976|t=2021. Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI).|pdf=|usr=027}}
| |
| − | {{tp|p=33830418|t=2021. Delirium is common in patients hospitalized with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33893977|t=2021. SIADH and severe COVID-19 pneumonia in elderly patients: a therapeutic challenge in developing countries.|pdf=|usr=027}}
| |
| − | {{tp|p=33864203|t=2021. The clinical course of COVID-19 in systemic sclerosis patients, report from 150 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34053992|t=2021. Post-COVID-19 Postural Orthostatic Tachycardia Syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=34053986|t=2021. A Kidney Transplant Patient Who Died of COVID-19-associated Severe Acute Respiratory Distress Syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33994442|t=2021. Acute Pancreatitis Related to COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33994439|t=2021. Radiologically Undetectable Latent Pulmonary Lymphocyte Infiltration Suggesting the Need for Early Glucocorticoid Therapy: An Autopsy Case of Rapidly Progressive COVID-19 Pneumonia with Lymphopenia.|pdf=|usr=027}}
| |
| − | {{tp|p=33963513|t=2021. Postmortem pathological changes in extrapulmonary organs in SARS-CoV-2 rt-PCR-positive cases: a single-center experience.|pdf=|usr=027}}
| |
| − | {{tp|p=34075529|t=2021. Infants infected with SARS-CoV-2 and newborns born to mother diagnosed with COVID-19: clinical experience.|pdf=|usr=027}}
| |
| − | {{tp|p=33904672|t=2021. Clinical Presentation of Iranian Patients Affected with COVID-19: A Thousand Faces Disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33904671|t=2021. The Association of Age, Sex, and RT-PCR Results with the Lymphocyte and Neutrophil Counts in SARS-CoV-2 Infection: A Cross-sectional Analysis of 1450 Iranian Patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33889357|t=2021. Differential alteration trend of white blood cells (WBCs) and monocytes count in severe and non-severe COVID-19 patients within a 7-day follow-up.|pdf=|usr=027}}
| |
| − | {{tp|p=33954104|t=2021. Time of Delivery in Women with Coronavirus Disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33936225|t=2021. Hypocalcemia in Covid-19: A Prognostic Marker for Severe Disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33936224|t=2021. Radiological and Laboratory Findings of Patients with COVID-19 Infection at the Time of Admission.|pdf=|usr=027}}
| |
| − | {{tp|p=34027315|t=2021. Phenome-wide and expression quantitative trait locus associations of coronavirus disease 2019 genetic risk loci.|pdf=|usr=027}}
| |
| − | {{tp|p=33941228|t=2021. What are the risk factors for admission to the pediatric intensive unit among pediatric patients with COVID-19?|pdf=|usr=027}}
| |
| − | {{tp|p=34078441|t=2021. Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature.|pdf=|usr=027}}
| |
| − | {{tp|p=34078429|t=2021. A fatal toxic shock-like syndrome post COVID-19 infection in a child.|pdf=|usr=027}}
| |
| − | {{tp|p=33965589|t=2021. Orbital inflammatory disease associated with COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33992595|t=2021. COVID-19 and Catatonia: A Case Series and Systematic Review of Existing Literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33999015|t=2021. COVID-19 Burden and Risk Among People With HIV.|pdf=|usr=027}}
| |
| − | {{tp|p=33338534|t=2021. COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience.|pdf=|usr=027}}
| |
| − | {{tp|p=33892926|t=2021. Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis.|pdf=|usr=027}}
| |
| − | {{tp|p=33931377|t=2021. Estimating COVID-19 Infection and Severity Risks in Patients with Chronic Rhinosinusitis: A Korean Nationwide Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33852880|t=2021. Asthma may not be a risk factor for severe COVID-19 in children.|pdf=|usr=027}}
| |
| − | {{tp|p=33965591|t=2021. COVID-19 in a series of patients with aspirin-exacerbated respiratory disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33940216|t=2021. Effect of COVID-19 on asthma exacerbation.|pdf=|usr=027}}
| |
| − | {{tp|p=33915310|t=2021. More Data on Risks and Outcomes of COVID-19 in Asthma, COPD, and Bronchiectasis.|pdf=|usr=027}}
| |
| − | {{tp|p=33894392|t=2021. Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity.|pdf=|usr=027}}
| |
| − | {{tp|p=33309934|t=2021. Prevalence of Comorbid Asthma and Related Outcomes in COVID-19: A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33359593|t=2021. Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33359476|t=2021. Eruptions and related clinical course among 296 hospitalized adults with confirmed COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33926664|t=2021. New Heart Failure Diagnoses Among Patients Hospitalized for COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33888250|t=2021. The Clinical Challenge of ST-Segment Elevation Myocardial Infarction and COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33839011|t=2021. Fibrinolysis Shutdown in COVID-19-Associated Coagulopathy: A Crosstalk among Immunity, Coagulation, and Specialists in Medicine and Surgery.|pdf=|usr=027}}
| |
| − | {{tp|p=33839010|t=2021. Thromboelastography MightBe More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34020214|t=2021. Systemic review of CNS involvement and its manifestations in SARS-CoV2 positive patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33990155|t=2021. Evaluation of urine SARS-COV-2 RT-PCR as a predictor of acute kidney injury and disease severity in patients with critical COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33317374|t=2021. Fever in the ICU: A Predictor of Mortality in Mechanically Ventilated COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33855639|t=2021. Pre-existing atrial fibrillation is associated with increased mortality in COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33849952|t=2021. Hemogram as marker of in-hospital mortality in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34050001|t=2021. Correlation of rate of serum albumin decline with other acute phase reactants and effect of current treatment options on serum albumin level in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34050000|t=2021. Dynamic albumin values as clinical surrogate for COVID-19 therapeutics.|pdf=|usr=027}}
| |
| − | {{tp|p=34088220|t=2021. COVID-19 and Combined Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Nonketotic Coma: Report of 11 Cases.|pdf=|usr=027}}
| |
| − | {{tp|p=34036814|t=2021. Distinct Coagulopathy With Myocardial Injury and Pulmonary Embolism in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33978499|t=2021. A Unique Case of Spontaneous Pneumomediastinum in a Patient With COVID-19 and Influenza Coinfection.|pdf=|usr=027}}
| |
| − | {{tp|p=33969726|t=2021. Severe Sinus Bradycardia: An Unusual Cardiac Manifestation of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33928804|t=2021. Bronchopleural Fistula as a Complication in a COVID-19 Patient Managed With Endobronchial Valves.|pdf=|usr=027}}
| |
| − | {{tp|p=33853424|t=2021. Subacute Thyroiditis and Heart Failure in a Patient Presenting With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33847153|t=2021. COVID-19 Presenting as Acute Necrotizing Pancreatitis.|pdf=|usr=027}}
| |
| − | {{tp|p=34002553|t=2021. Clinical Characteristics of COVID-19: Risk Factors for Early Oxygen Requirement after Hospitalization.|pdf=|usr=027}}
| |
| − | {{tp|p=33975399|t=2021. Risk Factors of Outcomes of COVID-19 Patients in Korea: Focus on Early Symptoms.|pdf=|usr=027}}
| |
| − | {{tp|p=34100564|t=2021. Clinical Features of Olfactory Dysfunction in COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33876590|t=2021. Letter to the Editor: Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.|pdf=|usr=027}}
| |
| − | {{tp|p=33888166|t=2021. Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study.|pdf=|usr=027}}
| |
| − | {{tp|p=33883051|t=2021. The outcome of olfactory impairment in patients with otherwise paucisymptomatic coronavirus disease 2019 during the pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33827722|t=2021. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum.|pdf=|usr=027}}
| |
| − | {{tp|p=33941249|t=2021. Severe COVID-19 in the intensive care unit: a case series.|pdf=|usr=027}}
| |
| − | {{tp|p=34049584|t=2021. Ventricular tachycardia with epicardial and pericardial fibrosis 6 months after resolution of subclinical COVID-19: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34049573|t=2021. Neonates with coronavirus disease 2019 acquired from infected mothers: the incompatibility of maternal intensity and infant lung involvement: two case reports.|pdf=|usr=027}}
| |
| − | {{tp|p=34006322|t=2021. Elective laparoscopic colectomy in a patient 3 weeks after coronavirus disease 2019 infection: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33980269|t=2021. Unilateral frosted branch angiitis in an human immunodeficiency virus-infected patient with concurrent COVID-19 infection: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33910640|t=2021. Acute inflammatory demyelinating polyneuropathy or Guillain-Barre syndrome associated with COVID-19: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33910621|t=2021. Presentation of COVID-19 infection with bizarre behavior and encephalopathy: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33910620|t=2021. Simultaneous development of COVID-19 pneumonia and pulmonary metastasis in a known case of chondrosarcoma: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33892788|t=2021. Clinical course, radiological findings and late outcome in preterm infant with suspected vertical transmission born to a mother with severe COVID-19 pneumonia: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33888154|t=2021. Newly detected rapid eye movement associated sleep apnea after coronavirus disease 2019 as a possible cause for chronic fatigue: two case reports.|pdf=|usr=027}}
| |
| − | {{tp|p=33984098|t=2021. Brugada Pattern: Unraveling Possible Cardiac Manifestation of SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33856347|t=2021. Prevalence and Influence of COVID-19 in Asthma Control and Lung Function in Severe Asthma Patients Receiving Biological Treatment.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=34007357|t=2021. Do Certain Biomarkers Predict Adverse Outcomes in Coronavirus Disease 2019?|pdf=|usr=027}}
| |
| − | {{tp|p=33361342|t=2021. The Importance and Challenges of Identifying SARS-CoV-2 Reinfections.|pdf=|usr=027}}
| |
| − | {{tp|p=33897205|t=2021. Mortality escalates in patients of proximal femoral fractures with COVID-19: A systematic review and meta-analysis of 35 studies on 4255 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34007807|t=2021. Coronavirus Disease-2019 (COVID-19) and the Liver.|pdf=|usr=027}}
| |
| − | {{tp|p=34007806|t=2021. Progress in the Clinical Features and Pathogenesis of Abnormal Liver Enzymes in Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=34099984|t=2021. SARS-CoV-2 and Mycobacterium tuberculosis coinfection: A case of unusual bronchoesophageal fistula.|pdf=|usr=027}}
| |
| − | {{tp|p=33862544|t=2021. Clinical features and outcomes of neonatal COVID-19: A systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=34022753|t=2021. Cancer, transplant, and immunocompromising conditions were not significantly associated with severe illness or death in hospitalized COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33855649|t=2021. Effect of SARS-CoV-2 Infection on Pregnancy Outcomes in an Inner-City Black Patient Population.|pdf=|usr=027}}
| |
| − | {{tp|p=33889341|t=2021. Acute viral myositis complicated by rhabdomyolysis: a sole manifestation of COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33889317|t=2021. The use of direct acting oral anticoagulants in patients with COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33618282|t=2021. Oldest-old Covid-19 patients: Lessons learnt in a geriatric intermediate care unit.|pdf=|usr=027}}
| |
| − | {{tp|p=33611151|t=2021. Sustained low-efficiency dialysis with regional citrate anticoagulation in critically ill patients with COVID-19 associated AKI: A pilot study.|pdf=|usr=027}}
| |
| − | {{tp|p=33957578|t=2021. COVID-19 influences lung microbiota dynamics and favors the emergence of rare infectious diseases: A case report of Hafnia Alvei pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33878517|t=2021. Continuous renal replacement therapy in intensive care patients with COVID-19; survival and renal recovery.|pdf=|usr=027}}
| |
| − | {{tp|p=33770571|t=2021. The value of D-dimer to predict pulmonary embolism in critically ill COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33721609|t=2021. Late augmented renal clearance in patients with COVID-19 in the intensive care unit. A prospective observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=33849305|t=2021. Chilblain-Like Lesions (CLL) Associated With COVID-19 ("COVID Toes"): A Systematic Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33883098|t=2021. SARS-CoV-2 and Burkholderia cenocepacia infection in a patient with Cystic Fibrosis: An unfavourable conjunction?|pdf=|usr=027}}
| |
| − | {{tp|p=33549520|t=2021. First and second wave of SARS-CoV2 in Italian Cystic Fibrosis patients: Data from Italian Cystic Fibrosis Registry.|pdf=|usr=027}}
| |
| − | {{tp|p=34016559|t=2021. Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.|pdf=|usr=027}}
| |
| − | {{tp|p=33309057|t=2021. Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=33655804|t=2021. Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33624293|t=2021. Dermatological manifestations during COVID-19 and histological picture: Description of two clinical cases.|pdf=|usr=027}}
| |
| − | {{tp|p=33660918|t=2021. SARS-CoV-2 infection-related diabetes mellitus.|pdf=|usr=027}}
| |
| − | {{tp|p=33559395|t=2021. Is prediabetes a risk factor for severe COVID-19?|pdf=|usr=027}}
| |
| − | {{tp|p=33655669|t=2021. Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia).|pdf=|usr=027}}
| |
| − | {{tp|p=33358523|t=2021. Impact of obesity on COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34099384|t=2021. Preadmission predictors of severe COVID-19 in patients with diabetes mellitus.|pdf=|usr=027}}
| |
| − | {{tp|p=33654683|t=2021. Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33553435|t=2021. Risk Factors in Patients with Diabetes Hospitalized for COVID-19: Findings from a Multicenter Retrospective Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33982248|t=2021. Biventricular apical ballooning in patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33599906|t=2021. Echocardiographic signs of successful thrombolysis in a pulmonary embolism and COVID-19 pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33906056|t=2021. Cardiac arrhythmias in patients with COVID-19: Lessons from 2300 telemetric monitoring days on the intensive care unit.|pdf=|usr=027}}
| |
| − | {{tp|p=34092446|t=2021. Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department.|pdf=|usr=027}}
| |
| − | {{tp|p=33863570|t=2021. Large Cerebellar Stroke in a Young COVID-19-Positive Patient: Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=34056499|t=2021. Activation of Vasopressin System During COVID-19 is Associated With Adverse Clinical Outcomes: An Observational Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33964007|t=2021. Graves' disease and Graves' orbitopathy following COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34101132|t=2021. Thyroid dysfunction in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33929709|t=2021. Molecular diagnosis of SARS-CoV-2 in seminal fluid.|pdf=|usr=027}}
| |
| − | {{tp|p=34053961|t=2021. Clinical Characteristics and Risk Factors for Severe Outcomes of Novel Coronavirus Infection, January-March 2020, Japan.|pdf=|usr=027}}
| |
| − | {{tp|p=33876594|t=2021. COVID-19 and Comorbidities: Audit of 2,000 COVID-19 Deaths in India.|pdf=|usr=027}}
| |
| − | {{tp|p=34041202|t=2021. Viral genome sequencing for Defining Re-infection with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34041201|t=2021. Symptomatic reinfection with COVID-19: A first from Western India.|pdf=|usr=027}}
| |
| − | {{tp|p=34041137|t=2021. Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34017797|t=2021. Hyperglycemia: An independent accompaniment of COVID -19.|pdf=|usr=027}}
| |
| − | {{tp|p=34017770|t=2021. Clinical spectrum and outcome of patients visiting coronavirus screening centre in North India and clinical predictors for COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34017730|t=2021. MuLBSTA score in COVID-19 pneumonia and prediction of 14-day mortality risk: A study in an Indian cohort.|pdf=|usr=027}}
| |
| − | {{tp|p=34017710|t=2021. Oral manifestations and dental practice recommendations during COVID-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34017709|t=2021. Cutaneous manifestations associated with COVID-19 in children: A systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=34017708|t=2021. Severe COVID-19: A distinct entity.|pdf=|usr=027}}
| |
| − | {{tp|p=34041119|t=2021. Hiccups and hyponatremia: Unusual co-presentation in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34041103|t=2021. Clinical and demographic characteristics of patients with coronavirus disease 2019 in Security Forces Hospital, Riyadh, Saudi Arabia.|pdf=|usr=027}}
| |
| − | {{tp|p=34041093|t=2021. COVID-19 in pregnancy: A preliminary 50-day review from India.|pdf=|usr=027}}
| |
| − | {{tp|p=33840544|t=2021. Nowcasting the prevalence of asymptomatic, preclinical, and clinical COVID-19 infections.|pdf=|usr=027}}
| |
| − | {{tp|p=33341350|t=2021. Corticosteroids and rehabilitation in COVID-19 survivors.|pdf=|usr=027}}
| |
| − | {{tp|p=33934948|t=2021. Motor demyelinating tibial neuropathy in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33933336|t=2021. Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33840494|t=2021. Bilateral cystoid maculopathy as first manifestation of SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33838944|t=2021. Les injections intravitrennes au CHU de Caen durant l'epidemie de SARS-COV2.|pdf=|usr=027}}
| |
| − | {{tp|p=34072876|t=2021. Impact of the SARS-CoV-2 Pandemic in Candidaemia, Invasive Aspergillosis and Antifungal Consumption in a Tertiary Hospital.|pdf=|usr=027}}
| |
| − | {{tp|p=34063556|t=2021. Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different?|pdf=|usr=027}}
| |
| − | {{tp|p=33917967|t=2021. Candidemia among Iranian Patients with Severe COVID-19 Admitted to ICUs.|pdf=|usr=027}}
| |
| − | {{tp|p=33925084|t=2021. Acute Pulmonary Histoplasmosis Following COVID-19: Novel Laboratorial Methods Aiding Diagnosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33920755|t=2021. When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33905039|t=2021. Acute Gastrointestinal Injury and Feeding Intolerance as Prognostic Factors in Critically Ill COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33977014|t=2021. Transient global amnesia with bilateral hippocampal lesions during the COVID-19 global outbreak.|pdf=|usr=027}}
| |
| − | {{tp|p=33948800|t=2021. Spontaneous Pneumomediastinum in a Patient with COVID-19 Pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=34100231|t=2021. Thirty-Day Post-Discharge Outcomes Following COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33987793|t=2021. Psychological Distress, Persistent Physical Symptoms, and Perceived Recovery After COVID-19 Illness.|pdf=|usr=027}}
| |
| − | {{tp|p=33945610|t=2021. Cardiometabolic Therapy and Mortality in Very Old Patients With Diabetes Hospitalized due to COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33355656|t=2021. Association of Paraspinal Muscle Measurements on Chest Computed Tomography With Clinical Outcomes in Patients With Severe Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33828847|t=2021. Sudden death of COVID-19 patients in Wuhan, China: A retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33911453|t=2021. Positive SARS-CoV-2 RNA with Significant Inflammatory State and Thrombophilia after 12 Weeks of Initial Diagnosis of COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33911452|t=2021. Persistent Hypercoagulable State in COVID-19: A Case Series of COVID-19 Associated Pulmonary Embolism.|pdf=|usr=027}}
| |
| − | {{tp|p=33911447|t=2021. Clinical Determinants of Severe COVID-19 Disease - A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33983062|t=2021. Critical ischaemia of the hand and upper limb in a patient with long COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34088273|t=2021. Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34059432|t=2021. First lung and kidney multi-organ transplant following COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34007371|t=2021. Thrombotic Microangiopathy in a Patient With COVID-19 Infection and Metastatic Cholangiocarcinoma.|pdf=|usr=027}}
| |
| − | {{tp|p=34007369|t=2021. An Unusual Cause of Gastrointestinal Perforation in an Adolescent Patient With Beta-Thalassemia on Deferasirox and SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34007367|t=2021. ABO in Correlation to the Requirement of Mechanical Ventilation and Mortality in Critically Ill Patients With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33897909|t=2021. Hemophagocytic lymphohistiocytosis, a new cause of death during 'post-acute COVID-19 syndrome?' A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34090927|t=2021. Reply to: Comments on "Association of liver abnormalities with in-hospital mortality in patients with COVID-19".|pdf=|usr=027}}
| |
| − | {{tp|p=33338513|t=2021. Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD.|pdf=|usr=027}}
| |
| − | {{tp|p=33347952|t=2021. Association of liver abnormalities with in-hospital mortality in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33862041|t=2021. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?|pdf=|usr=027}}
| |
| − | {{tp|p=33862040|t=2021. Reply to: "Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients".|pdf=|usr=027}}
| |
| − | {{tp|p=33352246|t=2021. Non-COVID co-morbidity: potential indirect consequences of the SARS-CoV-2 pandemic in a neonatal intensive care unit.|pdf=|usr=027}}
| |
| − | {{tp|p=33891985|t=2021. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=33891983|t=2021. Outcomes of asymptomatic hospital employees in COVID-19 post-exposure quarantine during the second pandemic wave in Zurich.|pdf=|usr=027}}
| |
| − | {{tp|p=33852950|t=2021. Fungal and bacterial coinfections increase mortality of severely ill COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34062186|t=2021. Follow-up study of pulmonary function among COVID-19 survivors 1 year after recovery.|pdf=|usr=027}}
| |
| − | {{tp|p=33992686|t=2021. Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review.|pdf=|usr=027}}
| |
| − | {{tp|p=34051225|t=2021. Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34029629|t=2021. Mucormycosis-A serious threat in the COVID-19 pandemic?|pdf=|usr=027}}
| |
| − | {{tp|p=34029627|t=2021. Genomic evidence of SARS-CoV-2 reinfection case with the emerging B.1.2 variant in Brazil.|pdf=|usr=027}}
| |
| − | {{tp|p=34020213|t=2021. Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34020212|t=2021. The effect of COVID-19 on parathyroid glands.|pdf=|usr=027}}
| |
| − | {{tp|p=34020210|t=2021. Clinical and hematologic presentations of adults with COVID-19 patients in Jeddah: A case control study.|pdf=|usr=027}}
| |
| − | {{tp|p=34020209|t=2021. Clinical outcomes of maternal and neonate with COVID-19 infection - Multicenter study in Saudi Arabia.|pdf=|usr=027}}
| |
| − | {{tp|p=34020208|t=2021. Clinical outcomes of patients hospitalized for COVID-19 and evidence-based on the pharmacological management reduce mortality in a region of the Colombian Caribbean.|pdf=|usr=027}}
| |
| − | {{tp|p=33984658|t=2021. A prediction model of risk factors for complications among SARS-CoV2 positive patients: Cases from Jordan.|pdf=|usr=027}}
| |
| − | {{tp|p=33971576|t=2021. Re-infection of SARS-CoV-2: A case in a young dental healthcare worker.|pdf=|usr=027}}
| |
| − | {{tp|p=33341486|t=2021. Clinical characteristics of asymptomatic and symptomatic COVID-19 patients in the Eastern Province of Saudi Arabia.|pdf=|usr=027}}
| |
| − | {{tp|p=33341484|t=2021. Spread of OXA-48-producing Klebsiella pneumoniae among COVID-19-infected patients: The storm after the storm.|pdf=|usr=027}}
| |
| − | {{tp|p=33743372|t=2021. Progression from Pneumonia to ARDS as a Predictor for Fatal COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34079332|t=2021. Obesity-Related Inflammation and Endothelial Dysfunction in COVID-19: Impact on Disease Severity.|pdf=|usr=027}}
| |
| − | {{tp|p=33953595|t=2021. Factors Associated with the Expression of ACE2 in Human Lung Tissue: Pathological Evidence from Patients with Normal FEV1 and FEV1/FVC.|pdf=|usr=027}}
| |
| − | {{tp|p=33880442|t=2021. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms.|pdf=|usr=027}}
| |
| − | {{tp|p=33850804|t=2021. SARS-CoV-2 and Acute Diverticulitis: the Expanding Gastrointestinal Manifestations of COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33850795|t=2021. ACEI/ARB Drug Therapy in COVID-19 Patients: Yes Or No?|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33868085|t=2021. A Translational Perspective of Maternal Immune Activation by SARS-CoV-2 on the Potential Prenatal Origin of Neurodevelopmental Disorders: The Role of the Cholinergic Anti-inflammatory Pathway.|pdf=|usr=027}}
| |
| − | {{tp|p=33348293|t=2021. Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33933851|t=2021. The role of IL-6/lymphocyte ratio in the peripheral blood of severe patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33933847|t=2021. Hematological characteristics of patients with novel coronavirus pneumonia in intensive care unit.|pdf=|usr=027}}
| |
| − | {{tp|p=33930704|t=2021. Evaluation of hepatic enzymes activities in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33309765|t=2021. Vertical transmission and kidney damage in newborns whose mothers had coronavirus disease 2019 during pregnancy.|pdf=|usr=027}}
| |
| − | {{tp|p=33912436|t=2021. COVID-19: Asymptomatic Carrier: An Autopsy Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=33907520|t=2021. Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33907513|t=2021. Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury.|pdf=|usr=027}}
| |
| − | {{tp|p=33867834|t=2021. Assessment of global asymptomatic SARS-CoV-2 infection and management practices from China.|pdf=|usr=027}}
| |
| − | {{tp|p=34086142|t=2021. Post COVID-19 persistent fatigue: a proposal for rehabilitative interventions in the spa setting.|pdf=|usr=027}}
| |
| − | {{tp|p=33974962|t=2021. The role of sex and inflammation in cardiovascular outcomes and mortality in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34000358|t=2021. Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33309764|t=2021. Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: A population-based propensity score matched study.|pdf=|usr=027}}
| |
| − | {{tp|p=34096317|t=2021. Chronic Cardio-Metabolic Disease Increases the Risk of Worse Outcomes Among Hospitalized Patients With COVID-19: A Multicenter, Retrospective, and Real-World Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34058857|t=2021. Death by COVID-19: An Open Investigation.|pdf=|usr=027}}
| |
| − | {{tp|p=33307964|t=2021. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System.|pdf=|usr=027}}
| |
| − | {{tp|p=33989538|t=2021. Variation in Care of Community and Nursing Home Residents Who Died of COVID-19 in Ontario, Canada.|pdf=|usr=027}}
| |
| − | {{tp|p=33894176|t=2021. Recovery from Coronavirus Disease 2019 among Older Adults in Post-Acute Skilled Nursing Facilities.|pdf=|usr=027}}
| |
| − | {{tp|p=33865795|t=2021. Coronavirus Disease 2019 in French Residential Care Facilities: A Nationwide Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34082022|t=2021. Left Atrial Function in Patients with Coronavirus Disease 2019 and Its Association with Incident Atrial Fibrillation/Flutter.|pdf=|usr=027}}
| |
| − | {{tp|p=33374002|t=2021. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=33930144|t=2021. Role of von Willebrand Factor in COVID-19 Associated Coagulopathy.|pdf=|usr=027}}
| |
| − | {{tp|p=34002634|t=2021. Impact of presymptomatic COVID-19 on vascular and skeletal muscle function: a case study.|pdf=|usr=027}}
| |
| − | {{tp|p=33977466|t=2021. The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility.|pdf=|usr=027}}
| |
| − | {{tp|p=33863266|t=2021. Asthma does not influence the severity of COVID-19: a meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33838341|t=2021. Phenotyping coronavirus disease 2019 during a global health pandemic: Lessons learned from the characterization of an early cohort.|pdf=|usr=027}}
| |
| − | {{tp|p=34047290|t=2021. COVID-19 and central nervous system interplay: A big picture beyond clinical manifestation.|pdf=|usr=027}}
| |
| − | {{tp|p=34057983|t=2021. A review of Covid-19 and acute kidney injury: from pathophysiology to clinical results.|pdf=|usr=027}}
| |
| − | {{tp|p=33836039|t=2021. COVID-19 and chronic kidney disease: a comprehensive review.|pdf=|usr=027}}
| |
| − | {{tp|p=33939338|t=2021. Intramuscular adipose tissue at level Th12 is associated with survival in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34102017|t=2021. Severe loss of mechanical efficiency in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33995633|t=2021. Severity of COVID-19 in Cancer patients versus patients without Cancer: A Propensity Score Matching Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34007346|t=2021. Suspected subclinical myocarditis detected by cardiac magnetic resonance imaging late post COVID-19 recovery.|pdf=|usr=027}}
| |
| − | {{tp|p=33897917|t=2021. Systolic dysfunction and complete heart block as complications of fulminant myocarditis in a recovered COVID-19 patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33902671|t=2021. COVID-19 related mortality in post-operative cardiac surgical patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33865683|t=2021. Massive Spontaneous Subcutaneous Emphysema and Pneumomediastinum as Rare Complications of COVID-19 Pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33867235|t=2021. Outcomes and Risk Factors for Cardiovascular Events in Hospitalized COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33358106|t=2021. COVID-Associated Myocardial Injury: Crossing the Threshold for Mechanical Circulatory Support.|pdf=|usr=027}}
| |
| − | {{tp|p=33980426|t=2021. Right Ventricular Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33966995|t=2021. The 5 Reasons Why People Die of Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=34076828|t=2021. Is the mechanism of COVID-19 coagulopathy still a rabbit's hole?|pdf=|usr=027}}
| |
| − | {{tp|p=33959727|t=2021. Review of the COVID-19 Risk in Multiple Sclerosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33989761|t=2021. COVID-19 and Parkinson's disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia.|pdf=|usr=027}}
| |
| − | {{tp|p=33857843|t=2021. Anesthesia and the "post-COVID syndrome": Perioperative considerations for patients with prior SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34025027|t=2021. Exacerbation of liver dysfunction in non-alcoholic steatohepatitis patients during the coronavirus disease 2019 (COVID-19) pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34092967|t=2021. COVID-19 and short and medium-term outcomes in liver transplant patients: A spanish single-center case series.|pdf=|usr=027}}
| |
| − | {{tp|p=33994708|t=2021. Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation.|pdf=|usr=027}}
| |
| − | {{tp|p=33951308|t=2021. Arterial stiffness and COVID-19: A bidirectional cause-effect relationship.|pdf=|usr=027}}
| |
| − | {{tp|p=33880241|t=2021. Thromboembolic Disease in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34089457|t=2021. Atypical Inflammatory Syndrome Triggered by SARS-CoV-2 in Infants with Down Syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=34050837|t=2021. MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population.|pdf=|usr=027}}
| |
| − | {{tp|p=33942228|t=2021. SARS-CoV-2 Infection in a Child with Severe Congenital Neutropenia.|pdf=|usr=027}}
| |
| − | {{tp|p=33945513|t=2021. Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection.|pdf=|usr=027}}
| |
| − | {{tp|p=34061776|t=2021. Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1.|pdf=|usr=027}}
| |
| − | {{tp|p=34061775|t=2021. Do monogenic inborn errors of immunity cause susceptibility to severe COVID-19?|pdf=|usr=027}}
| |
| − | {{tp|p=34043590|t=2021. Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34014840|t=2021. Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine.|pdf=|usr=027}}
| |
| − | {{tp|p=33951237|t=2021. Cautions on the laboratory indicators of COVID-19 patients on and during admission.|pdf=|usr=027}}
| |
| − | {{tp|p=33372716|t=2021. Features of alpha-HBDH in COVID-19 patients: A cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33314316|t=2021. The prognostic value of general laboratory testing in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34065057|t=2021. The Relationship between Inflammatory Cytokines and Coagulopathy in Patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34066892|t=2021. HGF, IL-1alpha, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34064463|t=2021. The Spectrum of COVID-19-Associated Myocarditis: A Patient-Tailored Multidisciplinary Approach.|pdf=|usr=027}}
| |
| − | {{tp|p=34063729|t=2021. Short-Stay Hospitalizations for Patients with COVID-19: A Retrospective Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34071452|t=2021. Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34070339|t=2021. Comparison of Acute Kidney Injury in Patients with COVID-19 and Other Respiratory Infections: A Prospective Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34070236|t=2021. Clinical Implications of Neurological Comorbidities and Complications in ICU Patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34073928|t=2021. Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020.|pdf=|usr=027}}
| |
| − | {{tp|p=34063243|t=2021. Individual Characteristics as Prognostic Factors of the Evolution of Hospitalized COVID-19 Romanian Patients: A Comparative Observational Study between the First and Second Waves Based on Gaussian Graphical Models and Structural Equation Modeling.|pdf=|usr=027}}
| |
| − | {{tp|p=34069751|t=2021. Clinical Manifestations of COVID-19 in the Feet: A Review of Reviews.|pdf=|usr=027}}
| |
| − | {{tp|p=34069530|t=2021. Characteristics and Risk Factors for Intensive Care Unit Cardiac Arrest in Critically Ill Patients with COVID-19-A Retrospective Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34067606|t=2021. Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity.|pdf=|usr=027}}
| |
| − | {{tp|p=34065646|t=2021. Fetal and Perinatal Outcome Following First and Second Trimester COVID-19 Infection: Evidence from a Prospective Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34069041|t=2021. Stay Home! Stay Safe! First Post-Discharge Cardiologic Evaluation of Low-Risk-Low-BNP Heart Failure Patients in COVID-19 Era.|pdf=|usr=027}}
| |
| − | {{tp|p=34068867|t=2021. Alterations in Respiratory Function Test Three Months after Hospitalisation for COVID-19 Pneumonia: Value of Determining Nitric Oxide Diffusion.|pdf=|usr=027}}
| |
| − | {{tp|p=34068127|t=2021. Myocardial Injury in COVID-19 Patients: Association with Inflammation, Coagulopathy and In-Hospital Prognosis.|pdf=|usr=027}}
| |
| − | {{tp|p=34068023|t=2021. Assessment of the Association of COPD and Asthma with In-Hospital Mortality in Patients with COVID-19. A Systematic Review, Meta-Analysis, and Meta-Regression Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34066031|t=2021. Carbapenem-Resistant Klebsiella pneumoniae Infections in ICU COVID-19 Patients-A Scoping Review.|pdf=|usr=027}}
| |
| − | {{tp|p=34065902|t=2021. Combined Cardiac Risk Factors Predict COVID-19 Related Mortality and the Need for Mechanical Ventilation in Coptic Clergy.|pdf=|usr=027}}
| |
| − | {{tp|p=34064556|t=2021. Acute Pulmonary Embolism in Patients with and without COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34068725|t=2021. Impact of Kidney Failure on the Severity of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34062864|t=2021. Risk Factors for Mortality in COVID-19 Hospitalized Patients in Piedmont, Italy: Results from the Multicenter, Regional, CORACLE Registry.|pdf=|usr=027}}
| |
| − | {{tp|p=34062770|t=2021. Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge.|pdf=|usr=027}}
| |
| − | {{tp|p=33917886|t=2021. SARS-CoV-2 Renal Impairment in Critical Care: An Observational Study of 42 Cases (Kidney COVID).|pdf=|usr=027}}
| |
| − | {{tp|p=33917774|t=2021. Skin Manifestation of SARS-CoV-2: The Italian Experience.|pdf=|usr=027}}
| |
| − | {{tp|p=33916917|t=2021. Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity.|pdf=|usr=027}}
| |
| − | {{tp|p=33917558|t=2021. Physical Activity and the Risk of COVID-19 Infection and Mortality: A Nationwide Population-Based Case-Control Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33916569|t=2021. Seroprevalence of SARS-CoV-2-Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=33925423|t=2021. SARS-CoV-2 Infection in Hereditary Hemorrhagic Telangiectasia Patients Suggests Less Clinical Impact Than in the General Population.|pdf=|usr=027}}
| |
| − | {{tp|p=33922777|t=2021. Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 Registry.|pdf=|usr=027}}
| |
| − | {{tp|p=33921679|t=2021. Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33920701|t=2021. Risk Factors for Mortality in Adult COVID-19 Patients Who Develop Bloodstream Infections Mostly Caused by Antimicrobial-Resistant Organisms: Analysis at a Large Teaching Hospital in Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=33923851|t=2021. Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33923719|t=2021. Increased Creatine Kinase May Predict A Worse COVID-19 Outcome.|pdf=|usr=027}}
| |
| − | {{tp|p=33924637|t=2021. Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33924631|t=2021. Comorbidities and Susceptibility to COVID-19: A Generalized Gene Set Data Mining Approach.|pdf=|usr=027}}
| |
| − | {{tp|p=33924475|t=2021. Admission High-Sensitive Cardiac Troponin T Level Increase Is Independently Associated with Higher Mortality in Critically Ill Patients with COVID-19: A Multicenter Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33920093|t=2021. Dexamethasone in Patients Hospitalized with COVID-19: Whether, When and to Whom.|pdf=|usr=027}}
| |
| − | {{tp|p=33854659|t=2021. Declining Intensive Care Unit Mortality of COVID-19: A Multi-Center Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34007362|t=2021. A Simplified Comorbidity Evaluation Predicting Clinical Outcomes Among Patients With Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=34007361|t=2021. Impact of Body Mass Index on COVID-19-Related In-Hospital Outcomes and Mortality.|pdf=|usr=027}}
| |
| − | {{tp|p=33970387|t=2021. The effect of COVID-19 epidemic on vital signs in hospitalized patients: a pre-post heat-map study from a large teaching hospital.|pdf=|usr=027}}
| |
| − | {{tp|p=33835735|t=2021. Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2.|pdf=|usr=027}}
| |
| − | {{tp|p=34030942|t=2021. Letter to the Editor regarding "Missed cerebrovascular events during prolonged sedation for COVID-19 pneumonia".|pdf=|usr=027}}
| |
| − | {{tp|p=33863542|t=2021. Cervical spinal cord infarction associated with coronavirus infectious disease (COVID)-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33863533|t=2021. The impact of COVID-19 on neurosurgical head trauma referrals and admission at a tertiary neurosurgical centre.|pdf=|usr=027}}
| |
| − | {{tp|p=33863529|t=2021. SARS-CoV-2-associated first episode of acute mania with psychotic features.|pdf=|usr=027}}
| |
| − | {{tp|p=33863528|t=2021. Unilateral common carotid artery dissection in a patient with recent COVID-19: An association or a coincidence?|pdf=|usr=027}}
| |
| − | {{tp|p=33863524|t=2021. COVID-19-related cognitive dysfunction may be associated with transient disruption in the DLPFC glutamatergic pathway.|pdf=|usr=027}}
| |
| − | {{tp|p=33992187|t=2021. Post-COVID 19 neurological syndrome: Implications for sequelae's treatment.|pdf=|usr=027}}
| |
| − | {{tp|p=33992168|t=2021. Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=34055717|t=2021. Clinical Characteristics of Patients With Re-admitted of Novel Coronavirus 2019 (nCOVID-19) in Wenzhou, China.|pdf=|usr=027}}
| |
| − | {{tp|p=34055716|t=2021. SARS-CoV-2 Infection in Healthcare Professionals and General Population During "First Wave" of COVID-19 Pandemic: A Cross-Sectional Study Conducted in Sicily, Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=33987158|t=2021. A Retrospective Cohort Study on the Clinical Course of Patients With Moderate-Type COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33968885|t=2021. Clinical Factors and Quantitative CT Parameters Associated With ICU Admission in Patients of COVID-19 Pneumonia: A Multicenter Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33937174|t=2021. Epidemiological and Clinical Characteristics of COVID-19: A Retrospective Multi-Center Study in Pakistan.|pdf=|usr=027}}
| |
| − | {{tp|p=33912531|t=2021. A Follow-Up Investigation of Mental Health Among Discharged COVID-19 Patients in Wuhan, China.|pdf=|usr=027}}
| |
| − | {{tp|p=33903850|t=2021. Title of the Article: Paranasal Mucormycosis in COVID-19 Patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33868972|t=2021. Prevalence and Recovery from Newly Onset Anosmia and Ageusia in Covid 19 Patients at our Teritary Care Centre.|pdf=|usr=027}}
| |
| − | {{tp|p=33447927|t=2021. Corona Virus Disease-19 Presented with Acute Pancreatitis.|pdf=|usr=027}}
| |
| − | {{tp|p=33825132|t=2021. COVID with Diabetic Ketoacidosis: Intriguer or Consequence.|pdf=|usr=027}}
| |
| − | {{tp|p=34036546|t=2021. Coagulation Abnormalities Due to COVID-19 in a Child with Thalassemia: Correspondence.|pdf=|usr=027}}
| |
| − | {{tp|p=34036543|t=2021. Guillain-Barre Syndrome with Preserved Reflexes in a Child after COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34083839|t=2021. Angioedema in a patient with COVID-19 who received depot olanzapine pamoate: Diagnostic dilemma posed.|pdf=|usr=027}}
| |
| − | {{tp|p=34083837|t=2021. Susceptibility of clinically depressed patients to COVID-19: Is there a link?|pdf=|usr=027}}
| |
| − | {{tp|p=33994698|t=2021. A Case Series of Life-Threatening Hemorrhagic Events in Patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34035609|t=2021. Detection of SARS-CoV-2 RNA in the Pleural Swab of a COVID-19 Patient with a Pneumothorax.|pdf=|usr=027}}
| |
| − | {{tp|p=33935396|t=2021. Acute Kidney Injury in COVID-19: a Brief Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33867749|t=2021. Early Detection and Successful Management of Acute Mesenteric Ischaemia in Symptomatic COVID-19 Patient.|pdf=|usr=027}}
| |
| − | {{tp|p=34099197|t=2021. Post covid 19 pulmonary fibrosis. Is it real threat?|pdf=|usr=027}}
| |
| − | {{tp|p=34001199|t=2021. Lung histopathological findings in COVID-19 disease - a systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=34078415|t=2021. Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab.|pdf=|usr=027}}
| |
| − | {{tp|p=33947485|t=2021. Incidence of postprocedural coronavirus disease 2019 (COVID-19) at an urban academic medical center.|pdf=|usr=027}}
| |
| − | {{tp|p=33934744|t=2021. Reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.7 variant in an immunocompromised adolescent.|pdf=|usr=027}}
| |
| − | {{tp|p=33966675|t=2021. Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19).|pdf=|usr=027}}
| |
| − | {{tp|p=33323138|t=2021. Predictors for in-hospital mortality from coronavirus disease 2019 (COVID-19) infection among adults aged 18-65 years.|pdf=|usr=027}}
| |
| − | {{tp|p=33867000|t=2021. Clinical characteristics of hospitalized patients with false-negative severe acute respiratory coronavirus virus 2 (SARS-CoV-2) test results.|pdf=|usr=027}}
| |
| − | {{tp|p=33845927|t=2021. Hospital-acquired infections among adult patients admitted for coronavirus disease 2019 (COVID-19).|pdf=|usr=027}}
| |
| − | {{tp|p=33911876|t=2021. Prolonged Viral Shedding in Patients with Mild to Moderate COVID-19 Disease: A Regional Perspective.|pdf=|usr=027}}
| |
| − | {{tp|p=34024217|t=2021. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments.|pdf=|usr=027}}
| |
| − | {{tp|p=33849385|t=2021. Reinfection of SARS-CoV-2 - analysis of 23 cases from the literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33845915|t=2021. Risk factors for developing severe COVID-19 in China: an analysis of disease surveillance data.|pdf=|usr=027}}
| |
| − | {{tp|p=33977506|t=2021. Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia.|pdf=|usr=027}}
| |
| − | {{tp|p=33939121|t=2021. Prevalence and Mortality due to COVID-19 in HIV Co-Infected Population: A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34079300|t=2021. Secondary Infections in Hospitalized COVID-19 Patients: Indian Experience.|pdf=|usr=027}}
| |
| − | {{tp|p=33953575|t=2021. Outcomes in Patients with SARS-CoV-2 and Clostridioides difficile Coinfection.|pdf=|usr=027}}
| |
| − | {{tp|p=33933633|t=2021. Genetic polymorphisms as multi-biomarkers in severe acute respiratory syndrome (SARS) by coronavirus infection: A systematic review of candidate gene association studies.|pdf=|usr=027}}
| |
| − | {{tp|p=33352320|t=2021. Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months.|pdf=|usr=027}}
| |
| − | {{tp|p=33338639|t=2021. Ethnic and age-specific acute lung injury/acute respiratory distress syndrome risk associated with angiotensin-converting enzyme insertion/deletion polymorphisms, implications for COVID-19: A meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33933634|t=2021. Disparities in COVID-19 severities and casualties across ethnic groups around the globe and patterns of ACE2 and PIR variants.|pdf=|usr=027}}
| |
| − | {{tp|p=33905884|t=2021. Dyslipidemia in breast cancer patients increases the risk of SAR-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34059997|t=2021. Narrative review of the relationship between COVID-19 and PJP: does it represent coinfection or colonization?|pdf=|usr=027}}
| |
| − | {{tp|p=34091869|t=2021. COVID-19: persistence of symptoms and lung alterations after 3-6 months from hospital discharge.|pdf=|usr=027}}
| |
| − | {{tp|p=33978937|t=2021. Coronary artery calcification and epicardial adipose tissue as independent predictors of mortality in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33332691|t=2021. Role of serum albumin and proteinuria in patients with SARS-CoV-2 pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=34054961|t=2021. Is SARS-CoV-2 an Etiologic Agent or Predisposing Factor for Oral Lesions in COVID-19 Patients? A Concise Review of Reported Cases in the Literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33882839|t=2021. Fulminant hepatic failure in a patient testing re-positive for SARS-CoV-2: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34040642|t=2021. COVID-19 and Obesity: An Epidemiologic Analysis of the Brazilian Data.|pdf=|usr=027}}
| |
| − | {{tp|p=33859687|t=2021. Diabetes Mellitus and COVID-19: Associations and Possible Mechanisms.|pdf=|usr=027}}
| |
| − | {{tp|p=33833797|t=2021. Subacute Thyroiditis during the COVID-19 Pandemic: Searching for a Clinical Association with SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=34072951|t=2021. Neuropsychological Pattern in a Series of Post-Acute COVID-19 Patients in a Rehabilitation Unit: Retrospective Analysis and Correlation with Functional Outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=34072815|t=2021. Consequences of Early Separation of Maternal-Newborn Dyad in Neonates Born to SARS-CoV-2 Positive Mothers: An Observational Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34072557|t=2021. Six Months Follow-Up of Patients with Invasive Mechanical Ventilation due to COVID-19 Related ARDS.|pdf=|usr=027}}
| |
| − | {{tp|p=34073422|t=2021. Pregnancy Outcome, Antibodies, and Placental Pathology in SARS-CoV-2 Infection during Early Pregnancy.|pdf=|usr=027}}
| |
| − | {{tp|p=34070662|t=2021. Breast Milk and COVID-19: From Conventional Data to "Omics" Technologies to Investigate Changes Occurring in SARS-CoV-2 Positive Mothers.|pdf=|usr=027}}
| |
| − | {{tp|p=34074005|t=2021. The Differences in Clinical Presentation, Management, and Prognosis of Laboratory-Confirmed COVID-19 between Pregnant and Non-Pregnant Women: A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34073925|t=2021. COVID-19 among Healthcare Workers in the University Clinical Hospital in Wroclaw, Poland.|pdf=|usr=027}}
| |
| − | {{tp|p=34067850|t=2021. Evaluation of the Prognosis of COVID-19 Patients According to the Presence of Underlying Diseases and Drug Treatment.|pdf=|usr=027}}
| |
| − | {{tp|p=34067776|t=2021. Post-COVID-19 Syndrome and the Potential Benefits of Exercise.|pdf=|usr=027}}
| |
| − | {{tp|p=34068405|t=2021. Higher 90-Day Mortality after Surgery for Hip Fractures in Patients with COVID-19: A Case-Control Study from a Single Center in Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=34066174|t=2021. A Review of Prolonged Post-COVID-19 Symptoms and Their Implications on Dental Management.|pdf=|usr=027}}
| |
| − | {{tp|p=33916365|t=2021. Pregnancy Outcome during the First COVID 19 Lockdown in Vienna, Austria.|pdf=|usr=027}}
| |
| − | {{tp|p=33923992|t=2021. Co-Infections in Critically Ill Patients with or without COVID-19: A Comparison of Clinical Microbial Culture Findings.|pdf=|usr=027}}
| |
| − | {{tp|p=33923972|t=2021. Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management.|pdf=|usr=027}}
| |
| − | {{tp|p=33923642|t=2021. Childbirth Care among SARS-CoV-2 Positive Women in Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=33921458|t=2021. Cardiorespiratory Fitness in Volleyball Athletes Following a COVID-19 Infection: A Cross-Sectional Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33915937|t=2021. Mild to Severe Neurological Manifestations of COVID-19: Cases Reports.|pdf=|usr=027}}
| |
| − | {{tp|p=33359065|t=2021. Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir.|pdf=|usr=027}}
| |
| − | {{tp|p=33359064|t=2021. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count.|pdf=|usr=027}}
| |
| − | {{tp|p=33352326|t=2021. Association of prescribed medications with the risk of COVID-19 infection and severity among adults in South Korea.|pdf=|usr=027}}
| |
| − | {{tp|p=33352324|t=2021. High prevalence of occult thrombosis in cases of mild/moderate COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33352323|t=2021. Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale.|pdf=|usr=027}}
| |
| − | {{tp|p=33326874|t=2021. Covid-19 and blood groups: ABO antibody levels may also matter.|pdf=|usr=027}}
| |
| − | {{tp|p=33326871|t=2021. The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease-A report from Central and Eastern Europe.|pdf=|usr=027}}
| |
| − | {{tp|p=33901654|t=2021. Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: A tailored approach.|pdf=|usr=027}}
| |
| − | {{tp|p=33887455|t=2021. Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - A possible pattern? Observational study and review of the literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33862215|t=2021. COVID-19-related myocarditis post-heart transplantation.|pdf=|usr=027}}
| |
| − | {{tp|p=33862208|t=2021. Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) are Associated with the Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33857606|t=2021. A follow-up study of respiratory and physical function after discharge in patients with redetectable positive SARS-CoV-2 nucleic acid results following recovery from COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34089886|t=2021. Inverse association between hypertension treatment and COVID-19 prevalence in Japan.|pdf=|usr=027}}
| |
| − | {{tp|p=34089883|t=2021. COVID-19: Autopsy findings in six patients between 26 and 46 years of age.|pdf=|usr=027}}
| |
| − | {{tp|p=34087488|t=2021. Rapid identification of bacteria from respiratory samples of patients hospitalized in intensive care units, with FilmArray Pneumonia Panel Plus.|pdf=|usr=027}}
| |
| − | {{tp|p=33930542|t=2021. Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study.|pdf=|usr=027}}
| |
| − | {{tp|p=33326870|t=2021. Severe type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences.|pdf=|usr=027}}
| |
| − | {{tp|p=33310024|t=2021. Oxygen metabolism markers as predictors of mortality in severe COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33895407|t=2021. First COVID-19 cases with high secondary infection among health workers, Sana'a capital, April 2020: Lessons learned and future opportunities.|pdf=|usr=027}}
| |
| − | {{tp|p=33891517|t=2021. COVID-19 Toes and Other Skin Lesions During the Pandemic: Emerging Entities?|pdf=|usr=027}}
| |
| − | {{tp|p=34104085|t=2021. Repositive RT-PCR test in discharged COVID-19 patients during medical isolation observation.|pdf=|usr=027}}
| |
| − | {{tp|p=33967613|t=2021. Clinical course of patients on maintenance hemodialysis and COVID-19: a retrospective longitudinal study.|pdf=|usr=027}}
| |
| − | {{tp|p=33967608|t=2021. Completed absorption of coronavirus disease 2019 (COVID-19) pneumonia lesions: a preliminary study.|pdf=|usr=027}}
| |
| − | {{tp|p=33859516|t=2021. Through The Back Door: Expiratory Accumulation of SARS-Cov-2 in the Olfactory Mucosa as Mechanism for CNS Penetration.|pdf=|usr=027}}
| |
| − | {{tp|p=34067072|t=2021. High Levels of the Cleaved Form of Galectin-9 and Osteopontin in the Plasma Are Associated with Inflammatory Markers That Reflect the Severity of COVID-19 Pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=34072715|t=2021. The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis-A Literature Review.|pdf=|usr=027}}
| |
| − | {{tp|p=34071527|t=2021. The Immunological Role of the Placenta in SARS-CoV-2 Infection-Viral Transmission, Immune Regulation, and Lactoferrin Activity.|pdf=|usr=027}}
| |
| − | {{tp|p=34065289|t=2021. Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34065210|t=2021. The Emerging Role of Neutrophils in the Pathogenesis of Thrombosis in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34063231|t=2021. The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer.|pdf=|usr=027}}
| |
| − | {{tp|p=34067683|t=2021. Circulating Soluble ACE2 and Upstream microRNA Expressions in Serum of Type 2 Diabetes Mellitus Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34066226|t=2021. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33525440|t=2021. The Central Role of Fibrinolytic Response in COVID-19-A Hematologist's Perspective.|pdf=|usr=027}}
| |
| − | {{tp|p=33917718|t=2021. Influence of Previous COVID-19 and Mastitis Infections on the Secretion of Brain-Derived Neurotrophic Factor and Nerve Growth Factor in Human Milk.|pdf=|usr=027}}
| |
| − | {{tp|p=33946479|t=2021. Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33946649|t=2021. ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis.|pdf=|usr=027}}
| |
| − | {{tp|p=33926110|t=2021. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33925881|t=2021. Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences.|pdf=|usr=027}}
| |
| − | {{tp|p=33920904|t=2021. Neurological Complications of COVID-19: Underlying Mechanisms and Management.|pdf=|usr=027}}
| |
| − | {{tp|p=33920790|t=2021. Cardiovascular Outcomes in the Acute Phase of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34059786|t=2021. Are adipokines the missing link between obesity, immune response, and outcomes in severe COVID-19?|pdf=|usr=027}}
| |
| − | {{tp|p=34002039|t=2021. Weight trajectories and abdominal adiposity in COVID-19 survivors with overweight/obesity.|pdf=|usr=027}}
| |
| − | {{tp|p=33994275|t=2021. Guillain-Barre syndrome in the early post-partum period following COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33845420|t=2021. Otolaryngology manifestations of COVID-19 in pediatric patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33894522|t=2021. COVID-19 and severe ENT infections in pediatric patients. IS there a relationship?|pdf=|usr=027}}
| |
| − | {{tp|p=33964672|t=2021. Hearing screening outcomes in neonates of SARS-CoV-2 positive pregnant women.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=34046379|t=2021. Outcomes of COVID-19 Admissions in the New York City Public Health System and Variations by Hospitals and Boroughs During the Initial Pandemic Response.|pdf=|usr=027}}
| |
| − | {{tp|p=33932157|t=2021. Neurological and cognitive sequelae of Covid-19: a four month follow-up.|pdf=|usr=027}}
| |
| − | {{tp|p=34085094|t=2021. Altered mental status in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=32712866|t=2021. Comment on "Stroke in patients with SARSCoV2 infection: case series" from a London hospital experience.|pdf=|usr=027}}
| |
| − | {{tp|p=33830334|t=2021. Palilalia as a prominent feature of anti-NMDA receptor encephalitis in a woman with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33929617|t=2021. Neurological update: COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33914141|t=2021. Intraluminal carotid thrombosis and acute ischemic stroke associated with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33909158|t=2021. Spontaneous spinal cord ischemia during COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33904965|t=2021. COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica.|pdf=|usr=027}}
| |
| − | {{tp|p=33893540|t=2021. Serum neurofilament light chain (sNfL) values in a large cross-sectional population of children with asymptomatic to moderate COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33884450|t=2021. SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33876325|t=2021. Neurosensory dysphagia in a COVID-19 patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33852086|t=2021. Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19?|pdf=|usr=027}}
| |
| − | {{tp|p=33930693|t=2021. COVID-19 and fatigue: Where do we go from here? Response to Ortelli et al.|pdf=|usr=027}}
| |
| − | {{tp|p=33321326|t=2021. Guillain Barre Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series.|pdf=|usr=027}}
| |
| − | {{tp|p=33355335|t=2021. Muscle Biopsy Findings in a Case of SARS-CoV-2-Associated Muscle Injury.|pdf=|usr=027}}
| |
| − | {{tp|p=33871008|t=2021. COVID-19 Patients With CNS Complications and Neuropathologic Features of Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalopathy.|pdf=|usr=027}}
| |
| − | {{tp|p=33340640|t=2021. Cerebral vasculitis of medium-sized vessels as a possible mechanism of brain damage in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34087330|t=2021. Imaging spectrum of acute invasive fungal rhino-orbital-cerebral sinusitis in COVID-19 patients: A case series and a review of literature.|pdf=|usr=027}}
| |
| − | {{tp|p=34046865|t=2021. Guillain-Barre syndrome associated with COVID-19: a case report study.|pdf=|usr=027}}
| |
| − | {{tp|p=34101087|t=2021. COVID-19 leukoencephalopathy with subacute magnetic resonance imaging findings of vasculitis and demyelination.|pdf=|usr=027}}
| |
| − | {{tp|p=34101085|t=2021. MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or inflammatory myelitis?|pdf=|usr=027}}
| |
| − | {{tp|p=33983506|t=2021. Neuropathies and neurological dysfunction induced by coronaviruses.|pdf=|usr=027}}
| |
| − | {{tp|p=33977501|t=2021. Delayed post-hypoxic leukoencephalopathy in an adult with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33904138|t=2021. A case report of simultaneous autoimmune and COVID-19 encephalitis.|pdf=|usr=027}}
| |
| − | {{tp|p=33876412|t=2021. Unexpected worsening of progressive multifocal leucoencephalopathy following COVID-19 pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33876411|t=2021. Central nervous system vasculopathy associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a novel case report from Iran.|pdf=|usr=027}}
| |
| − | {{tp|p=33825173|t=2021. Limbic encephalitis in a COVID-19 patient?|pdf=|usr=027}}
| |
| − | {{tp|p=33367960|t=2021. Meningoencephalitis associated with COVID-19: a systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=33904148|t=2021. Stress testing and myocardial perfusion imaging for patients after recovery from severe COVID-19 infection requiring hospitalization: A single-center experience.|pdf=|usr=027}}
| |
| − | {{tp|p=33976591|t=2021. Recognizing the Clinical Sequelae of COVID-19 in Adults: COVID-19 Long-Haulers.|pdf=|usr=027}}
| |
| − | {{tp|p=33949641|t=2021. The Impact of Frailty on COVID-19 Outcomes: A Systematic Review and Meta-analysis of 16 Cohort Studies.|pdf=|usr=027}}
| |
| − | {{tp|p=33367458|t=2021. Effects of Comorbidities on the Elderly Patients with COVID-19: Clinical Characteristics of Elderly Patients Infected with COVID-19 from Sichuan, China.|pdf=|usr=027}}
| |
| − | {{tp|p=33927066|t=2021. Diabesity Associates with Poor COVID-19 Outcomes among Hospitalized Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33349556|t=2021. Clinical Profile, Viral Load, Maternal-Fetal Outcomes of Pregnancy With COVID-19: 4-Week Retrospective, Tertiary Care Single-Centre Descriptive Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33961521|t=2021. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?|pdf=|usr=027}}
| |
| − | {{tp|p=33987731|t=2021. "Old wine in a new bottle" - post COVID-19 infection, central serous chorioretinopathy and the steroids.|pdf=|usr=027}}
| |
| − | {{tp|p=34055261|t=2021. Ocular Manifestations of Patients with Coronavirus Disease 2019: A Comprehensive Review.|pdf=|usr=027}}
| |
| − | {{tp|p=34043293|t=2021. Multiple thrombotic events in a patient with coronavirus 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33368245|t=2021. Effects of cigarette smoking on SARS-CoV-2 receptor ACE2 expression in the respiratory epithelium(dagger).|pdf=|usr=027}}
| |
| − | {{tp|p=33978304|t=2021. Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.|pdf=|usr=027}}
| |
| − | {{tp|p=33960723|t=2021. A series of COVID-19 autopsies with clinical and pathologic comparisons to both seasonal and pandemic influenza.|pdf=|usr=027}}
| |
| − | {{tp|p=33837673|t=2021. Characterisation of cardiac pathology in 23 autopsies of lethal COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33306581|t=2021. The Effect of Helicobacter pylori on the Presentation and Clinical Course of Coronavirus Disease 2019 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33828949|t=2021. Spontaneous hemopneumothorax in an adolescent with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33367801|t=2021. Severe Acute Respiratory Syndrome Coronavirus 2 Placental Infection and Inflammation Leading to Fetal Distress and Neonatal Multi-Organ Failure in an Asymptomatic Woman.|pdf=|usr=027}}
| |
| − | {{tp|p=34071251|t=2021. COVID-19 Infection during Pregnancy: Risk of Vertical Transmission, Fetal, and Neonatal Outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=34063824|t=2021. Personalized Approach to Patient with MRI Brain Changes after SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34069451|t=2021. Biomarkers Linked with Dynamic Changes of Renal Function in Asymptomatic and Mildly Symptomatic COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34069409|t=2021. SARS-CoV-2-Laden Respiratory Aerosol Deposition in the Lung Alveolar-Interstitial Region Is a Potential Risk Factor for Severe Disease: A Modeling Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33347610|t=2021. Silent hypoxaemia in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33942774|t=2021. Convalescent plasma, cytomegalovirus infection, and persistent leukopenia in COVID-19 recovery phase: What is the link?|pdf=|usr=027}}
| |
| − | {{tp|p=33942769|t=2021. COVID-19 pneumonia, immunosuppression, and cytomegalovirus activation: A perspective.|pdf=|usr=027}}
| |
| − | {{tp|p=33835059|t=2021. Eschar: An indispensable clue for the diagnosis of scrub typhus and COVID-19 co-infection during the ongoing pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34096390|t=2021. Cardio-Pulmonary Sequelae in Recovered COVID-19 Patients: Considerations for Primary Care.|pdf=|usr=027}}
| |
| − | {{tp|p=34024181|t=2021. Body Mass Index, Multi-Morbidity, and COVID-19 Risk Factors as Predictors of Severe COVID-19 Outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=33985374|t=2021. Characteristics and Outcomes of COVID-19 Infection from an Urban Ambulatory COVID-19 Clinic-Guidance for Outpatient Clinicians in Triaging Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33880955|t=2021. A Multidisciplinary NHS COVID-19 Service to Manage Post-COVID-19 Syndrome in the Community.|pdf=|usr=027}}
| |
| − | {{tp|p=33855875|t=2021. A Midwest COVID-19 Cohort for the Evaluation of Multimorbidity and Adverse Outcomes from COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33829916|t=2021. Analysis of Risk Factors in COVID-19 Adult Mortality in Russia.|pdf=|usr=027}}
| |
| − | {{tp|p=34009992|t=2021. Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33301685|t=2021. COVID-19: The Effect of Host Genetic Variations on Host-Virus Interactions.|pdf=|usr=027}}
| |
| − | {{tp|p=34091347|t=2021. Impact of peritraumatic dissociation in hospitalized patients with COVID-19 pneumonia: A longitudinal study.|pdf=|usr=027}}
| |
| − | {{tp|p=34051516|t=2021. Physical and mental health complications post-COVID-19: Scoping review.|pdf=|usr=027}}
| |
| − | {{tp|p=34051515|t=2021. Psychological burden in patients with COVID-19 and their relatives 90 days after hospitalization: A prospective observational cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34023580|t=2021. Prevalence of depression, anxiety, and insomnia symptoms among patients with COVID-19: A meta-analysis of quality effects model.|pdf=|usr=027}}
| |
| − | {{tp|p=33963399|t=2021. The extent of infectious SARS-CoV-2 shedding in an Argentinean cohort.|pdf=|usr=027}}
| |
| − | {{tp|p=34041012|t=2021. Pregnancy Consequences and Vertical Transmission Potential of SARS-CoV-2 Infection: Seeking Answers From a Preliminary Observation.|pdf=|usr=027}}
| |
| − | {{tp|p=33936940|t=2021. Cardiac Tamponade, Sever Hypothyroidism and Acute Respiratory Distress Syndrome (ARDS) with COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34090826|t=2021. Association of physical activity levels and the prevalence of COVID-19-associated hospitalization.|pdf=|usr=027}}
| |
| − | {{tp|p=33903045|t=2021. Testosterone's Role in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33962880|t=2021. Letter to the Editor on "COVID-19 Infection in Men on Testosterone Replacement Therapy".|pdf=|usr=027}}
| |
| − | {{tp|p=33964424|t=2021. Can adhesive capsulitis of the shoulder be a consequence of COVID-19? Case series of 12 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34059440|t=2021. Comments on Stroke as a Neurological Complication of COVID-19: A Systematic Review and Meta-Analysis of Incidence, Outcomes and Predictors.|pdf=|usr=027}}
| |
| − | {{tp|p=34045111|t=2021. Cerebral venous thrombosis following COVID-19 vaccination.|pdf=|usr=027}}
| |
| − | {{tp|p=34039523|t=2021. Elevated Lipoprotein(a) and Cerebral Venous Sinus Thrombosis in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33360509|t=2021. The Incidence and Mortality Ratio of Ischemic Cerebrovascular Accidents in COVID-19 Cases: A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33341565|t=2021. Stroke as a Neurological Complication of COVID-19: A Systematic Review and Meta-Analysis of Incidence, Outcomes and Predictors.|pdf=|usr=027}}
| |
| − | {{tp|p=33341023|t=2021. Transcranial Doppler Ultrasound Evidence of Active Cerebral Embolization in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33933349|t=2021. Failure of Anticoagulation to Prevent Stroke in Context of Lupus-Associated Anti-Phospholipid Syndrome and Mild COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33895426|t=2021. COVID-19 Associated Reversible Cerebral Vasoconstriction Syndrome Successfully Treated with Nimodipine and Aspirin.|pdf=|usr=027}}
| |
| − | {{tp|p=33892314|t=2021. Outcomes of COVID-19 Complications and their Possibilities as Potential Triggers of Stroke.|pdf=|usr=027}}
| |
| − | {{tp|p=33863617|t=2021. Consideration Needed for early Anticoagulation Following Intravenous tPA in Patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33840594|t=2021. Response to the Letter to the Editor: Consideration Needed for Early Anticoagulation Following Intravenous tPA in Patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34084447|t=2021. Acute abdomen in a 54-year-old COVID-19 patient: a case teport.|pdf=|usr=027}}
| |
| − | {{tp|p=33859814|t=2021. SARS-CoV-2 in peritoneal swabs from asymptomatic patients undergoing emergency abdominal surgery.|pdf=|usr=027}}
| |
| − | {{tp|p=33975028|t=2021. Rhabdomyolysis in Severe COVID-19: Male Sex, High Body Mass Index, and Prone Positioning Confer High Risk.|pdf=|usr=027}}
| |
| − | {{tp|p=33867909|t=2021. An unusual and atypical presentation of the novel coronavirus: A case report and brief review of the literature.|pdf=|usr=027}}
| |
| − | {{tp|p=34020800|t=2021. Commentary: To operate or wait? Contextualizing early outcomes of cardiac surgery in COVID-19-positive patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33933259|t=2021. Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33841931|t=2021. Early identification of patients with severe COVID-19 at increased risk of in-hospital death: a multicenter case-control study in Wuhan.|pdf=|usr=027}}
| |
| − | {{tp|p=33966157|t=2021. The characteristics and outcomes of critically Ill patients with COVID-19 who received systemic thrombolysis for presumed pulmonary embolism: an observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=33939101|t=2021. Prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for COVID-19: a cautionary tale.|pdf=|usr=027}}
| |
| − | {{tp|p=34047938|t=2021. Incidence of thrombotic complications in COVID-19 : On behalf of ICODE: The International COVID-19 Thrombosis Biomarkers Colloquium.|pdf=|usr=027}}
| |
| − | {{tp|p=34047937|t=2021. Transient endothelial injury and release of lupus anticoagulant in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34047936|t=2021. Increased incidence of massive hemorrhage at uncommon sites after initiation of systemic anticoagulation in critically ill patients with coronavirus disease 2019 (COVID-19) infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34021852|t=2021. International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests.|pdf=|usr=027}}
| |
| − | {{tp|p=34019231|t=2021. Screening for venous thromboembolism in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33982161|t=2021. ICODE: the international COVID-19 thrombosis biomarkers colloquium-novel soluble biomarkers: circulating cell-free nucleic acids and other molecules.|pdf=|usr=027}}
| |
| − | {{tp|p=33973157|t=2021. Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon?|pdf=|usr=027}}
| |
| − | {{tp|p=33826054|t=2021. Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population.|pdf=|usr=027}}
| |
| − | {{tp|p=34080103|t=2021. Association between previous anticoagulant use and mortality among hospitalized patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34061283|t=2021. Prior use of anticoagulation is associated with a better survival in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33909261|t=2021. Massive intraperitoneal hemorrhage in patients with COVID-19: a case series.|pdf=|usr=027}}
| |
| − | {{tp|p=33829396|t=2021. COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography.|pdf=|usr=027}}
| |
| − | {{tp|p=33904053|t=2021. COVID 19 infection associated with thrombotic thrombocytopenic purpura.|pdf=|usr=027}}
| |
| − | {{tp|p=33890200|t=2021. Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid.|pdf=|usr=027}}
| |
| − | {{tp|p=33886038|t=2021. Second wave of the COVID-19 pandemic: D-dimer levels are not so high anymore.|pdf=|usr=027}}
| |
| − | {{tp|p=33866481|t=2021. Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33844151|t=2021. Abnormal immunothrombosis and lupus anticoagulant in a catastrophic COVID-19 recalling Asherson's syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33844150|t=2021. Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation.|pdf=|usr=027}}
| |
| − | {{tp|p=33850800|t=2021. Analysis of Digestive Endoscopic Results During COVID-19.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=34045814|t=2021. Acute Peripheral Arterial Thrombosis in COVID-19 Patients on Therapeutic Anticoagulation.|pdf=|usr=027}}
| |
| − | {{tp|p=34045801|t=2021. Prevalence of Bloodstream Infections and their Etiology in COVID-19 Patients Admitted in a Tertiary Care Hospital in Jaipur.|pdf=|usr=027}}
| |
| − | {{tp|p=34045800|t=2021. Comparison of Severity of COVID-19 Infection among Patients Using RAAS Inhibitors and Non-RAAS Inhibitors.|pdf=|usr=027}}
| |
| − | {{tp|p=34045795|t=2021. Prevalence of Bloodstream Infections and their Etiology in COVID-19 Patients: A Tale of Two Cities.|pdf=|usr=027}}
| |
| − | {{tp|p=34045794|t=2021. A Shot in the Dark! RAAS Inhibitors Cause Severe COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33991309|t=2021. Prevalence of liver injury in 445 patients with Corona Virus Disease-19-Single-centre experience from southern India.|pdf=|usr=027}}
| |
| − | {{tp|p=34007125|t=2021. SARS-CoV2 Infection in Hematopoietic Stem Cell Transplant recipients: A Case Series from a Tertiary Cancer Centre in India.|pdf=|usr=027}}
| |
| − | {{tp|p=34052046|t=2021. Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: Case series from the north-western part of India.|pdf=|usr=027}}
| |
| − | {{tp|p=33902980|t=2021. Clinical presentation & laboratory diagnosis of SARS-CoV-2: An observational study from a tertiary care centre in New Delhi, India.|pdf=|usr=027}}
| |
| − | {{tp|p=33933319|t=2021. Response to the comments received on a case report SARS-CoV-2 viral sepsis with meningoencephalitis.|pdf=|usr=027}}
| |
| − | {{tp|p=33966856|t=2021. Profile of co-infections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: Implication on antimicrobial resistance.|pdf=|usr=027}}
| |
| − | {{tp|p=33913913|t=2021. Prevalence of SARS-CoV-2 among central retinal vein occlusion patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33913893|t=2021. Cavernous sinus thrombosis with central retinal artey occlusion in COVID-19: A case report and review of literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33913892|t=2021. Acute monocular vision loss as presenting symptom of delayed stroke from internal carotid occlusion in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33913891|t=2021. A case series of presumed fungal endogenous endophthalmitis in post COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33913890|t=2021. Commentary: COVID-19 and ocular inflammation: Where do we stand and where are we headed?|pdf=|usr=027}}
| |
| − | {{tp|p=33913877|t=2021. Commentary: Retinal manifestations in patients following COVID-19 infection: A consecutive case series.|pdf=|usr=027}}
| |
| − | {{tp|p=33913876|t=2021. Retinal manifestations in patients following COVID-19 infection: A consecutive case series.|pdf=|usr=027}}
| |
| − | {{tp|p=33913875|t=2021. Fundus evaluation in COVID-19 positives with non-severe disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33913833|t=2021. Commentary: Impact of COVID-19 on ocular surface health.|pdf=|usr=027}}
| |
| − | {{tp|p=33323643|t=2021. Response to comments on: Retinal vein occlusion in COVID-19: A novel entity.|pdf=|usr=027}}
| |
| − | {{tp|p=33323642|t=2021. Comments on: Retinal vein occlusion in COVID-19: A novel entity.|pdf=|usr=027}}
| |
| − | {{tp|p=33323641|t=2021. Response to comments on: Retinal vein occlusion in COVID 19: A novel entity.|pdf=|usr=027}}
| |
| − | {{tp|p=33323640|t=2021. Comments on: Retinal vein occlusion in COVID-19: A novel entity.|pdf=|usr=027}}
| |
| − | {{tp|p=33323613|t=2021. Response to comments on: Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study.|pdf=|usr=027}}
| |
| − | {{tp|p=33323612|t=2021. Comments on: Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study.|pdf=|usr=027}}
| |
| − | {{tp|p=33967302|t=2021. Usual and Unusual Musculoskeletal Sequalae of COVID 19!|pdf=|usr=027}}
| |
| − | {{tp|p=34075336|t=2021. Vocal Disorders in Patients with COVID 19 in Egypt.|pdf=|usr=027}}
| |
| − | {{tp|p=34075334|t=2021. Smell and Taste Disturbance in COVID-19 Patients: A Prospective Multicenteric Review.|pdf=|usr=027}}
| |
| − | {{tp|p=34055592|t=2021. Parosmia Due to COVID-19 Disease: A 268 Case Series.|pdf=|usr=027}}
| |
| − | {{tp|p=33996529|t=2021. Hearing Loss-a Camouflaged Manifestation of COVID 19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34099977|t=2021. Incidence of Anosmia among Covid 19 patients in India.|pdf=|usr=027}}
| |
| − | {{tp|p=33937010|t=2021. Incidence of Sino-Nasal Symptoms in COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33937009|t=2021. Olfactory and Gustatory Dysfunction in Covid-19: An Observational Study in a Tertiary Care Institute of Western Rajasthan.|pdf=|usr=027}}
| |
| − | {{tp|p=33937008|t=2021. A Study on Otorhinolaryngological Presentations in Covid 19 Patients in a Tertiary Health Care Center.|pdf=|usr=027}}
| |
| − | {{tp|p=33907681|t=2021. Prospective Analysis of the Chronology of Smell and Taste Dysfunction in COVID-19 Positive ENT Doctors.|pdf=|usr=027}}
| |
| − | {{tp|p=34087349|t=2021. Lower respiratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: Relationship with biomarkers of disease severity.|pdf=|usr=027}}
| |
| − | {{tp|p=33358763|t=2021. Use of rapid ferritin test to predict clinical deterioration in at home COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33839184|t=2021. COVID-19 reinfection in healthcare workers: A case series.|pdf=|usr=027}}
| |
| − | {{tp|p=33831458|t=2021. Clinical characteristics and outcome of SARS-CoV-2 infection during pregnancy.|pdf=|usr=027}}
| |
| − | {{tp|p=33826926|t=2021. Patterns and prediction of liver injury with persistent cholestasis in survivors of severe SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33940088|t=2021. Gastrointestinal manifestations are associated with severe pediatric COVID-19: A study in tertiary hospital.|pdf=|usr=027}}
| |
| − | {{tp|p=33932448|t=2021. Differences between the waves in Northern Italy: How the characteristics and the outcome of COVID-19 infected patients admitted to the emergency room have changed.|pdf=|usr=027}}
| |
| − | {{tp|p=33887285|t=2021. Risk stratification of cardiac sequelae detected using cardiac magnetic resonance in late convalescence at the six-month follow-up of recovered COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33340595|t=2021. Fatal relapse of COVID-19 after recovery? A case report of an older Italian patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33373652|t=2021. Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection.|pdf=|usr=027}}
| |
| − | {{tp|p=33373650|t=2021. Post-COVID-19 functional status six-months after hospitalization.|pdf=|usr=027}}
| |
| − | {{tp|p=33962861|t=2021. Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies.|pdf=|usr=027}}
| |
| − | {{tp|p=33893036|t=2021. Successful deceased donor kidney transplantation to a recipient with a history of COVID-19 treatment.|pdf=|usr=027}}
| |
| − | {{tp|p=33867266|t=2021. A fatal case of COVID-19-associated invasive pulmonary aspergillosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33865698|t=2021. Invasive pneumococcal disease affected the fatal outcome in a COVID-19 patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33342681|t=2021. Experience of 101 patients with coronavirus infectious disease 2019 (COVID-19) at a tertiary care center in Japan.|pdf=|usr=027}}
| |
| − | {{tp|p=33328135|t=2021. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.|pdf=|usr=027}}
| |
| − | {{tp|p=34106886|t=2021. Is venous thromboembolism a predictable marker in older patients with COVID-19 infection? A single-center observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=34106884|t=2021. Co-infection of COVID-19 and recurrent malaria.|pdf=|usr=027}}
| |
| − | {{tp|p=33839715|t=2021. Does Macrophage Migration Inhibitory Factor predict the prognosis of COVID-19 disease?|pdf=|usr=027}}
| |
| − | {{tp|p=33839710|t=2021. Lung Fibrosis Sequelae After Recovery from COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33839709|t=2021. The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33956649|t=2021. Use of antibiotics in COVID-19 ICU patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33956647|t=2021. Clinical characteristics and outcomes of COVID-19: Experience at a major tertiary care center in Pakistan.|pdf=|usr=027}}
| |
| − | {{tp|p=33956644|t=2021. Characteristics and Pregnancy Outcomes of Asymptomatic and Symptomatic Women with COVID-19: Lessons from Hospitals in Wuhan.|pdf=|usr=027}}
| |
| − | {{tp|p=33325510|t=2021. Natural History of Coronavirus Disease 2019: Risk Factors for Hospitalizations and Deaths Among >26 Million US Medicare Beneficiaries.|pdf=|usr=027}}
| |
| − | {{tp|p=33837392|t=2021. Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33949651|t=2021. Association of Granulin rs5848 (C>T) Polymorphism With Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Mortality Rate.|pdf=|usr=027}}
| |
| − | {{tp|p=33928374|t=2021. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33964153|t=2021. Prolonged Coronavirus Disease 2019 in a Patient With Rheumatoid Arthritis on Rituximab Therapy.|pdf=|usr=027}}
| |
| − | {{tp|p=33880537|t=2021. ACE2, TMPRSS2 and L-SIGN expression in placentae from HIV-positive pregnancies exposed to antiretroviral therapy-implications for SARS-CoV-2 placental infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33880519|t=2021. SARS-CoV-2 ACE2 and TMPRSS2 Receptor Protein Expression Patterns Throughout Gestation.|pdf=|usr=027}}
| |
| − | {{tp|p=33862328|t=2021. Central line-associated blood stream infection during COVID-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33857723|t=2021. Dual catastrophe of COVID-19: Massive pulmonary embolism and stroke in a previously healthy young patient: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33848891|t=2021. Reactivation of SARS-CoV-2 infection following recovery from COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33848886|t=2021. Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy.|pdf=|usr=027}}
| |
| − | {{tp|p=33848885|t=2021. Early prediction keys for COVID-19 cases progression: A meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34022735|t=2021. Susceptibility to SARS-CoV-2 infection in patients undergoing chemotherapy and radiation therapy.|pdf=|usr=027}}
| |
| − | {{tp|p=34022734|t=2021. Prevalence and predictors of in-hospital mortality of patients hospitalized with COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33984095|t=2021. Rhinocerebral Mucormycosis and COVID-19 Pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33984087|t=2021. Anesthetic Management of a Child With Propionic Acidemia Complicated by Bacteremia and Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=027}}
| |
| − | {{tp|p=34003765|t=2021. Olfactory Training and Visual Stimulation Assisted by a Web Application for Patients With Persistent Olfactory Dysfunction After SARS-CoV-2 Infection: Observational Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33994470|t=2021. A case report of super responder of critical COVID-19 pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=34062210|t=2021. Respiratory bacterial co-infections in intensive care unit-hospitalized COVID-19 patients: Conventional culture vs BioFire FilmArray pneumonia Plus panel.|pdf=|usr=027}}
| |
| − | {{tp|p=33871721|t=2021. Pregnant women with COVID-19: the placental involvement and consequences.|pdf=|usr=027}}
| |
| − | {{tp|p=33824998|t=2021. Obesity and its impact on COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33819422|t=2021. Myoclonus-Ataxia Syndrome Associated with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33883900|t=2021. Predictors of Length of Hospital Stay, Mortality, and Outcomes Among Hospitalised COVID-19 Patients in Saudi Arabia: A Cross-Sectional Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33857916|t=2021. Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient - Case report and review of literature.|pdf=|usr=027}}
| |
| − | {{tp|p=34097293|t=2021. Fatal SARS-CoV-2 reinfection in an immunosuppressed patient on hemodialysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34089518|t=2021. Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge.|pdf=|usr=027}}
| |
| − | {{tp|p=34050905|t=2021. A clinical study on the changing dynamics of disease severity, management strategies and outcomes of COVID-19 in patients requiring haemodialysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33999392|t=2021. COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33826113|t=2021. Hyponatremia is associated with poor outcome in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33811605|t=2021. Correction to: COVID-19-related collapsing glomerulopathy revealing a rare risk variant of APOL1: lessons for the clinical nephrologist.|pdf=|usr=027}}
| |
| − | {{tp|p=33895700|t=2021. Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=33845283|t=2021. Steroid-responsive, transverse myelitis is a known complication of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33957540|t=2021. Guillain-Barre syndrome associated with SARS-CoV-2 infection: A case report with long term follow up.|pdf=|usr=027}}
| |
| − | {{tp|p=33933818|t=2021. Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities.|pdf=|usr=027}}
| |
| − | {{tp|p=34082192|t=2021. Post-infectious rhombencephalitis after coronavirus-19 infection: A case report and literature review.|pdf=|usr=027}}
| |
| − | {{tp|p=34023795|t=2021. Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome requires cerebro-spinal-fluid studies.|pdf=|usr=027}}
| |
| − | {{tp|p=34078648|t=2021. Three-month functional outcomes following endovascular thrombectomy during the first wave of the COVID-19 pandemic: a Canadian single-center cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34031747|t=2021. SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=34009454|t=2021. COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2.|pdf=|usr=027}}
| |
| − | {{tp|p=34003372|t=2021. Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung.|pdf=|usr=027}}
| |
| − | {{tp|p=34003371|t=2021. Pediatric LGI1 and CASPR2 autoimmunity associated with COVID 19: Morvan syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33973106|t=2021. Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33796896|t=2021. Management considerations for stroke-like episodes in MELAS with concurrent COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33866114|t=2021. Impact of cerebral venous sinus thrombosis associated with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33857734|t=2021. Covid-19: Involvement of the nervous system. Identifying neurological predictors defining the course of the disease.|pdf=|usr=027}}
| |
| − | {{tp|p=34004463|t=2021. Impact of SARS-CoV-2 infection on acute intracerebral haemorrhage in northern Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=34000678|t=2021. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications.|pdf=|usr=027}}
| |
| − | {{tp|p=33989852|t=2021. Ischemic stroke associated with aneurysmal lenticulostriate vasculopathy and symmetric reversible basal ganglia lesions in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33360484|t=2021. Neuropathological explanation of minimal COVID-19 infection rate in newborns, infants and children - a mystery so far. New insight into the role of Substance P.|pdf=|usr=027}}
| |
| − | {{tp|p=33359928|t=2021. Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom.|pdf=|usr=027}}
| |
| − | {{tp|p=34090021|t=2021. Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=34033370|t=2021. Post Acute Coronavirus (COVID-19) Syndrome|pdf=|usr=027}}
| |
| − | {{tp|p=34033324|t=2021. Gastrointestinal And Hepatic Manifestations Of Coronavirus (COVID-19)|pdf=|usr=027}}
| |
| − | {{tp|p=33351420|t=2021. Olfactory Testing|pdf=|usr=027}}
| |
| − | {{tp|p=33877759|t=2021. In the wake of the pandemic: Preparing for Long COVID|pdf=|usr=027}}
| |
| − | {{tp|p=34009770|t=2020. Science Brief: Evidence used to update the list of underlying medical conditions that increase a person's risk of severe illness from COVID-19|pdf=|usr=027}}
| |
| − | {{tp|p=33997278|t=2021. Persistence of Elevated Procalcitonin in a Patient with Coronavirus Disease 2019 Uncovered a Diagnosis of Medullary Thyroid Carcinoma.|pdf=|usr=027}}
| |
| − | {{tp|p=33738273|t=2020. Anti-Infective, Anti-Inflammatory, and Immunomodulatory Properties of Breast Milk Factors for the Protection of Infants in the Pandemic From COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34095211|t=2021. Case Report: COVID-19 Pneumonia Following Left Pneumonectomy for Lung Cancer Complicated by Empyema and Bronchopleural Fistula.|pdf=|usr=027}}
| |
| − | {{tp|p=33876965|t=2021. Characteristics of the 24-hour ambulatory blood pressure monitoring in a COVID-19 survivor.|pdf=|usr=027}}
| |
| − | {{tp|p=33973485|t=2021. Metabolite reanalysis revealed potential biomarkers for COVID-19: a potential link with immune response.|pdf=|usr=027}}
| |
| − | {{tp|p=33847139|t=2021. The interplay of SARS-CoV-2 and Clostridioides difficile infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34035804|t=2021. Clinical Evaluation of Acute Pancreatitis Caused by SARS-CoV-2 Virus Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34015338|t=2021. Letter to the Editor: Characteristics of Liver Transplant Patients Admitted with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33875144|t=2021. A "double-hit" damage mechanism can explain self-limited GI bleeding in COVID-19 pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33837476|t=2021. Lobectomy with pathological examination in lung cancer patients who recovered from COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33977168|t=2021. Diversity and genomic determinants of the microbiomes associated with COVID-19 and non-COVID respiratory diseases.|pdf=|usr=027}}
| |
| − | {{tp|p=34071309|t=2021. Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33921689|t=2021. Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women.|pdf=|usr=027}}
| |
| − | {{tp|p=33838280|t=2021. Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality.|pdf=|usr=027}}
| |
| − | {{tp|p=33824009|t=2021. Dementia as a mortality predictor among older adults with COVID-19: A systematic review and meta-analysis of observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=34088523|t=2021. The COVID-19 conundrum: Where both the virus and treatment contribute to delirium.|pdf=|usr=027}}
| |
| − | {{tp|p=33898348|t=2021. Post-infectious focal encephalitis due to COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34046516|t=2021. Pulmonary Embolism Associated with COVID-19 Occurs in Predominantly Elderly Patients with Comorbidities: A Single Center Retrospective Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33853067|t=2021. COVID-19: Clinical Presentation and Prognostic Factors of Severe Disease and Mortality in the Oldest-Old Population: A Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33853063|t=2021. Oral Candidiasis and COVID-19 in Users of Removable Dentures: Is Special Oral Care Needed?|pdf=|usr=027}}
| |
| − | {{tp|p=33965962|t=2021. Apolipoprotein E4 Allele in Subjects with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34019232|t=2021. Acute-care hospital reencounters in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33914310|t=2021. COVID-19 during pregnancy one year on - what lessons did we learn?|pdf=|usr=027}}
| |
| − | {{tp|p=33937572|t=2021. Elevated high-sensitivity troponin is associated with subclinical cardiac dysfunction in patients recovered from coronavirus disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33937570|t=2021. Characteristics of patients with novel coronavirus disease (COVID-19) during the first surge versus the second surge of infections in Osaka Prefecture, Japan.|pdf=|usr=027}}
| |
| − | {{tp|p=33937569|t=2021. Epidemiological correlation between COVID-19 epidemic and prevalence of alpha-1 antitrypsin deficiency in the world.|pdf=|usr=027}}
| |
| − | {{tp|p=33937568|t=2021. COVID-19 and bronchial asthma: current perspectives.|pdf=|usr=027}}
| |
| − | {{tp|p=33937566|t=2021. SARS-CoV-2 surreptitiously injures the heart of Japanese: echocardiography is useful in evaluating cardiac damage.|pdf=|usr=027}}
| |
| − | {{tp|p=34040935|t=2021. The World Heart Federation Global Study on COVID-19 and Cardiovascular Disease.|pdf=|usr=027}}
| |
| − | {{tp|p=34017904|t=2021. Novel Coronavirus Infection in an Infant with Intussusception.|pdf=|usr=027}}
| |
| − | {{tp|p=33832489|t=2021. Prevalence of psychiatric diagnosis and related psychopathological symptoms among patients with COVID-19 during the second wave of the pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34003362|t=2021. No secret hiding place on the ocular surface: what about after systemic SARS-CoV-2 infection?|pdf=|usr=027}}
| |
| − | {{tp|p=34097111|t=2021. Examination of the effects of COVID 19 on corneal endothelium.|pdf=|usr=027}}
| |
| − | {{tp|p=33961108|t=2021. Reduced macular vessel density in COVID-19 patients with and without associated thrombotic events using optical coherence tomography angiography.|pdf=|usr=027}}
| |
| − | {{tp|p=33947467|t=2021. Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections.|pdf=|usr=027}}
| |
| − | {{tp|p=33832219|t=2021. Circulating histones play a central role in COVID-19-associated coagulopathy and mortality.|pdf=|usr=027}}
| |
| − | {{tp|p=33979992|t=2021. Low incidence of COVID-19 severe complications in a large cohort of children with sickle cell disease: a protective role for basal interferon-1 activation?|pdf=|usr=027}}
| |
| − | {{tp|p=33975613|t=2021. COVID-19 and periodontitis: reflecting on a possible association.|pdf=|usr=027}}
| |
| − | {{tp|p=34068009|t=2021. Long-COVID Syndrome? A Study on the Persistence of Neurological, Psychological and Physiological Symptoms.|pdf=|usr=027}}
| |
| − | {{tp|p=33334865|t=2021. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34098237|t=2021. Does COVID-19 pneumonia signify secondary organizing pneumonia?: A narrative review comparing the similarities between these two distinct entities.|pdf=|usr=027}}
| |
| − | {{tp|p=34090177|t=2021. Pre-hospital antiplatelet medication use on COVID-19 disease severity.|pdf=|usr=027}}
| |
| − | {{tp|p=34087677|t=2021. The incidence, clinical characteristics, and outcomes of pneumothorax in hospitalized COVID-19 patients: A systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=33340827|t=2021. Heparan sulfate consumption as a potential mechanism of intra-cardiac thrombosis in SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33310504|t=2021. Clinical outcomes of pleural drainage on pneumothorax and hydrothorax in critically ill patients with COVID-19: A case series with literature review.|pdf=|usr=027}}
| |
| − | {{tp|p=33302147|t=2021. COVID-19 and Spontaneous Pneumomediastinum: A case series.|pdf=|usr=027}}
| |
| − | {{tp|p=33831700|t=2021. The incidence of pleural effusion in COVID-19 pneumonia: State-of-the-art review.|pdf=|usr=027}}
| |
| − | {{tp|p=33827763|t=2021. Comment on: Myocarditis, paraparesia and ARDS associated to COVID-19 infection".|pdf=|usr=027}}
| |
| − | {{tp|p=33827762|t=2021. Comment on: "Pattern of anticoagulation prescription for patients with Covid-19 acute respiratory distress syndrome admitted to ICU. Does it impact outcome?"|pdf=|usr=027}}
| |
| − | {{tp|p=34049806|t=2021. Pulmonary Embolism Prophylaxis in Patients With COVID-19: An Emerging Issue.|pdf=|usr=027}}
| |
| − | {{tp|p=33316414|t=2021. The possible association between COVID-19 and postural tachycardia syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33743048|t=2021. Impact of the COVID-19 outbreak on hospitalizations and outcomes in patients with acute myocardial infarction in a Japanese Single Center.|pdf=|usr=027}}
| |
| − | {{tp|p=34056141|t=2021. Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of COVID-19 death.|pdf=|usr=027}}
| |
| − | {{tp|p=34036187|t=2021. Remarkable vessel enlargement within lung consolidation in COVID-19 compared to AH1N1 pneumonia: A retrospective study in Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=33842709|t=2021. Clinical characteristics and outcomes of COVID-19 patients with diabetes mellitus in Kuwait.|pdf=|usr=027}}
| |
| − | {{tp|p=34095755|t=2021. Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34056547|t=2021. Cold Agglutinin Associated With COVID-19 Infection in a Thalassemia Patient with Multiple Alloantibodies: A Case of Cold Hemagglutinin Disease (CAD) with Complex Antibody Detection.|pdf=|usr=027}}
| |
| − | {{tp|p=34027307|t=2021. Hemoglobinopathy and COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34027306|t=2021. Renal infarction associated with asymptomatic Covid-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33363267|t=2021. Acute chest syndrome and COVID-19 in sickle cell disease pediatric patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33846700|t=2021. Thrombotic thrombocytopenic purpura associated with COVID-19 in a pediatric patient: case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33969271|t=2021. Peripheral smear in COVID 19: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33826042|t=2021. Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33909284|t=2021. Short-Term Consequences of SARS-CoV-2-Related Pneumonia: A Follow Up Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33881750|t=2021. Novel Indices of Home Blood Pressure Variability and Hypertension-Mediated Organ Damage in Treated Hypertensive Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33833585|t=2021. SARS-CoV-2 and Human Immunodeficiency Virus: Pathogen Pincer Attack.|pdf=|usr=027}}
| |
| − | {{tp|p=34019138|t=2021. Ertaubung nach COVID-19?|pdf=|usr=027}}
| |
| − | {{tp|p=33988723|t=2021. Zukunftsweisende Therapieansatze bei Riechstorungen: elektrische Stimulation, Stammzelltherapie und Transplantation von Riechepithel - eine Ubersicht.|pdf=|usr=027}}
| |
| − | {{tp|p=33837445|t=2021. Ertaubung nach COVID-19?|pdf=|usr=027}}
| |
| − | {{tp|p=33847870|t=2021. Neuropilin-1 may be responsible for retinal findings in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33844172|t=2021. TLR3 (rs3775291) variant is not associated with SARS-CoV-2 infection and related mortality: a population-based correlation analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34001248|t=2021. Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33972137|t=2021. Risk HLA alleles in South America and potential new epitopes for SARS-CoV2.|pdf=|usr=027}}
| |
| − | {{tp|p=33949668|t=2021. Integrative genomics analysis reveals a 21q22.11 locus contributing risk to COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33321162|t=2021. Trophoblast damage with acute and chronic intervillositis: disruption of the placental barrier by severe acute respiratory syndrome coronavirus 2.|pdf=|usr=027}}
| |
| − | {{tp|p=33905777|t=2021. Comprehensive evaluation of bronchoalveolar lavage from patients with severe COVID-19 and correlation with clinical outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=33961839|t=2021. Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression.|pdf=|usr=027}}
| |
| − | {{tp|p=34026549|t=2021. Full autopsy in a confirmed COVID-19 patient in Lagos, Nigeria - A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33346816|t=2021. Persistence of SARS-CoV-2 in the first trimester placenta leading to transplacental transmission and fetal demise from an asymptomatic mother.|pdf=|usr=027}}
| |
| − | {{tp|p=34047686|t=2021. Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs.|pdf=|usr=027}}
| |
| − | {{tp|p=34017093|t=2021. Renin-angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials.|pdf=|usr=027}}
| |
| − | {{tp|p=33377393|t=2021. Impact of Arterial Stiffness on All-Cause Mortality in Patients Hospitalized With COVID-19 in Spain.|pdf=|usr=027}}
| |
| − | {{tp|p=33325240|t=2021. Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension: An Observational Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33840201|t=2021. Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling.|pdf=|usr=027}}
| |
| − | {{tp|p=34075329|t=2021. Autoptic identification of disseminated mucormycosis in a young male presenting with cerebrovascular event, multi-organ dysfunction and COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34026548|t=2021. Myonecrosis secondary to COVID-19-related deep vein thrombosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33977081|t=2021. Co-infection with coronavirus disease 2019, previously undiagnosed human immunodeficiency virus, Pneumocystis jirovecii pneumonia and cytomegalovirus pneumonitis, with possible immune reconstitution inflammatory syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33936950|t=2021. Acute psychosis associated with recent SARS-CoV-2 infection: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33898261|t=2021. COVID-19 associated parotitis.|pdf=|usr=027}}
| |
| − | {{tp|p=33898251|t=2021. Neuro-imaging manifestations of COVID-19: Predilection for PICA infarcts.|pdf=|usr=027}}
| |
| − | {{tp|p=33842208|t=2021. COVID-19-associated leukocytoclastic vasculitis leading to gangrene and amputation.|pdf=|usr=027}}
| |
| − | {{tp|p=33842207|t=2021. Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.|pdf=|usr=027}}
| |
| − | {{tp|p=33842206|t=2021. Case report: Epiglottitis in the setting of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34074305|t=2021. A potential association between immunosenescence and high COVID-19 related mortality among elderly patients with cardiovascular diseases.|pdf=|usr=027}}
| |
| − | {{tp|p=34078004|t=2021. Long-coronavirus disease among people living with HIV in western India: An observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=33979068|t=2021. COVID-19 infection in CVID patients: What we know so far.|pdf=|usr=027}}
| |
| − | {{tp|p=33979033|t=2021. The first non-radiographic axial spondyloarthrits with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33960733|t=2021. Parameters associated with diagnosis of COVID-19 in emergency department.|pdf=|usr=027}}
| |
| − | {{tp|p=33942541|t=2021. Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33332737|t=2021. Does COVID-19 contribute to development of neurological disease?|pdf=|usr=027}}
| |
| − | {{tp|p=34051147|t=2021. Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33905752|t=2021. HLA-C17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk.|pdf=|usr=027}}
| |
| − | {{tp|p=33901540|t=2021. Will a little change do you good? A putative role of polymorphisms in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34061330|t=2021. Management of COVID-19 pneumonia in a child with NEMO deficiency.|pdf=|usr=027}}
| |
| − | {{tp|p=33907355|t=2021. Evaluation of the Role of Routine Laboratory Biomarkers in COVID-19 Patients: Perspective from a Tertiary Care Hospital in India.|pdf=|usr=027}}
| |
| − | {{tp|p=33875909|t=2021. An Integrated Approach of the Potential Underlying Molecular Mechanistic Paradigms of SARS-CoV-2-Mediated Coagulopathy.|pdf=|usr=027}}
| |
| − | {{tp|p=34045816|t=2021. Severe Thrombocytopenia in COVID-19: A Conundrum in Dengue-endemic Areas.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33856739|t=2021. Gout, Rheumatoid Arthritis, and the Risk of Death Related to Coronavirus Disease 2019: An Analysis of the UK Biobank.|pdf=|usr=027}}
| |
| − | {{tp|p=33320278|t=2021. Cutaneous Hyperaesthesia in SARS-CoV-2 Infection: Rare but not Unique Clinical Manifestation.|pdf=|usr=027}}
| |
| − | {{tp|p=34089096|t=2021. Dysglycemia after COVID-19 pneumonia: a six-month cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33873184|t=2021. Systematic Review of Microthrombi in COVID-19 Autopsies.|pdf=|usr=027}}
| |
| − | {{tp|p=34012213|t=2021. Predictive Value of C-reactive Protein, Lactate Dehydrogenase, Ferritin and D-dimer Levels in Diagnosing COVID-19 Patients: a Retrospective Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33870093|t=2021. Muscle manifestations and CK levels in COVID infection: results of a large cohort of patients inside a Pandemic COVID-19 Area.|pdf=|usr=027}}
| |
| − | {{tp|p=33959390|t=2021. COVID-19 in Russia: Clinical and Immunological Features of the First-Wave Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33954931|t=2021. Neurological diseases and COVID-19: prospective analyses using the UK Biobank.|pdf=|usr=027}}
| |
| − | {{tp|p=34080170|t=2021. A case report of Guillain-Barre syndrome in a pregnant woman infected by COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33934300|t=2021. Demyelination as a result of an immune response in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33881754|t=2021. Investigating the effects of the COVID-19 pandemic on the reasons for application to the emergency department in patients with neurological symptoms.|pdf=|usr=027}}
| |
| − | {{tp|p=34028810|t=2021. Multiple sclerosis and COVID-19: The Swedish experience.|pdf=|usr=027}}
| |
| − | {{tp|p=34028792|t=2021. Association of consciousness impairment and mortality in people with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33914898|t=2021. Myasthenia gravis and COVID-19: A case series and comparison with literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33890282|t=2021. Electrodiagnostic findings in patients with non-COVID-19- and COVID-19-related acute respiratory distress syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33903954|t=2021. The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models.|pdf=|usr=027}}
| |
| − | {{tp|p=33885150|t=2021. COVID-19 in pregnancy-characteristics and outcomes of pregnant women admitted to hospital because of SARS-CoV-2 infection in the Nordic countries.|pdf=|usr=027}}
| |
| − | {{tp|p=34096034|t=2021. COVID-19 pandemic and population-level pregnancy and neonatal outcomes: a living systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34041854|t=2021. Bilateral acute macular neuroretinopathy following COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33970896|t=2021. COVID-19 in the tonsillectomised population.|pdf=|usr=027}}
| |
| − | {{tp|p=34028454|t=2021. The importance of early detection of ENT symptoms in mild-to-moderate COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34054131|t=2021. inverted question markTienen las mujeres jovenes con COVID-19, mayor riesgo de presentar disfuncion olfatoria?|pdf=|usr=027}}
| |
| − | {{tp|p=34043855|t=2021. Iatrogenic immunosuppression can lead to prolonged viral shedding and absent immune response to COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34053113|t=2021. Unravelling the epidemiology and clinical impact of SARS-CoV-2 infection in neonates.|pdf=|usr=027}}
| |
| − | {{tp|p=33459404|t=2021. Reporting suspicions of long COVID in children is justified during this global emergency.|pdf=|usr=027}}
| |
| − | {{tp|p=33894064|t=2021. Severe mental illness is associated with increased mortality and severe course of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34004156|t=2021. Pitiriasis rosada en un paciente pediatrico con diagnostico confirmado de COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34012164|t=2021. Immunoglobulin A Antiphospholipid Antibodies in Patients With Chilblain-like Lesions During the COVID-19 Pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33994549|t=2021. Are Oral Mucosal Changes a Sign of COVID-19? A Cross-Sectional Study at a Field Hospital.|pdf=|usr=027}}
| |
| − | {{tp|p=34012165|t=2021. Cutaneous Manifestations in Patients With COVID-19: Clinical Characteristics and Possible Pathophysiologic Mechanisms.|pdf=|usr=027}}
| |
| − | {{tp|p=33342201|t=2021. Pneumothorax rate in intubated patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33952873|t=2021. A New Rash Differential: CoVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34059884|t=2021. Comment on "Western Dietary Pattern Antioxidant Intakes and Oxidative Stress: Importance during the SARS-CoV-2/COVID-19 Pandemic".|pdf=|usr=027}}
| |
| − | {{tp|p=34059883|t=2021. Comment on "Western Dietary Pattern Antioxidant Intakes and Oxidative Stress: Importance during the SARS-CoV-2/COVID-19 Pandemic".|pdf=|usr=027}}
| |
| − | {{tp|p=33937586|t=2021. Neuro-Ophthalmologic Manifestations of Novel Coronavirus.|pdf=|usr=027}}
| |
| − | {{tp|p=33937585|t=2021. Retina in the Age of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33966266|t=2021. Long COVID-19: an emerging pandemic in itself.|pdf=|usr=027}}
| |
| − | {{tp|p=33966261|t=2021. Predictors of mortality in patients with severe COVID-19 pneumonia - a retrospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=33881162|t=2021. Ambient temperature and COVID-19 outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=33961213|t=2021. A Retrospective Study of COVID-19-Related Urgent Medical Visits and Hospitalizations After Outpatient COVID-19 Diagnosis in the US.|pdf=|usr=027}}
| |
| − | {{tp|p=34086266|t=2021. Platelet Reactivity and Coagulation Markers in Patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33984129|t=2021. Prevalence, incidence and mortality of delirium in patients with COVID-19: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33951153|t=2021. Follow-up services for delirium after COVID-19-where now?|pdf=|usr=027}}
| |
| − | {{tp|p=33951151|t=2021. What is the relationship between validated frailty scores and mortality for adults with COVID-19 in acute hospital care? A systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=33842905|t=2021. Severe acute respiratory syndrome coronavirus 2 detected in placentas of 2 coronavirus disease 2019-positive asymptomatic pregnant women-case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33961708|t=2021. Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33987850|t=2021. ACE2 downregulation in olfactory mucosa: Eosinophilic rhinosinusitis as COVID-19 protective factor?|pdf=|usr=027}}
| |
| − | {{tp|p=33319360|t=2021. The role of circulating eosinophils on COVID-19 mortality varies by race/ethnicity.|pdf=|usr=027}}
| |
| − | {{tp|p=34080210|t=2021. Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33559975|t=2021. COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US.|pdf=|usr=027}}
| |
| − | {{tp|p=33881211|t=2021. Dementia is an age-independent risk factor for severity and death in COVID-19 inpatients.|pdf=|usr=027}}
| |
| − | {{tp|p=33838684|t=2021. COVID-19 in adults with dementia: clinical features and risk factors of mortality-a clinical cohort study on 125 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33845032|t=2021. Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry.|pdf=|usr=027}}
| |
| − | {{tp|p=33891907|t=2021. Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV trial.|pdf=|usr=027}}
| |
| − | {{tp|p=34079633|t=2021. Association of Hematologic biomarkers and their combinations with disease severity and mortality in COVID-19- an Indian perspective.|pdf=|usr=027}}
| |
| − | {{tp|p=34001336|t=2021. Effect SARS-COV-2 on Cases of Transcatheter Aortic Valve Implantation.|pdf=|usr=027}}
| |
| − | {{tp|p=34084661|t=2021. Cardiac involvement in critically ill and mechanically ventilated patients with COVID-19 - a prospective, observational echocardiographic study.|pdf=|usr=027}}
| |
| − | {{tp|p=34084656|t=2021. Pre-existing cardiovascular disease, acute kidney injury, and cardiovascular outcomes in hospitalized blacks with COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33963170|t=2021. Rhabdomyolysis Following Recovery from Severe COVID-19: A Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=33941758|t=2021. COVID-19 Presentation in Patients with Sickle Cell Disease: A Case Series.|pdf=|usr=027}}
| |
| − | {{tp|p=34074832|t=2021. Pay Attention to Distinguish Hepatitis from Novel Coronavirus Hepatitis in the Context of COVID-19 Pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34028864|t=2021. Clonal hematopoiesis in patients with Covid-19 is stable and not linked to an aggravated clinical course.|pdf=|usr=027}}
| |
| − | {{tp|p=33914955|t=2021. SARS-CoV-2 infection in patients with beta-thalassemia: Experience from Lebanon.|pdf=|usr=027}}
| |
| − | {{tp|p=33909916|t=2021. Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy.|pdf=|usr=027}}
| |
| − | {{tp|p=33942071|t=2021. Post-COVID-19 Syndrome: Theoretical Basis, Identification, and Management.|pdf=|usr=027}}
| |
| − | {{tp|p=33836538|t=2021. Comprehensive Review of Cardiovascular Involvement in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33877962|t=2021. Obesidade e COVID-19: Presente e Futuro.|pdf=|usr=027}}
| |
| − | {{tp|p=33315008|t=2021. Manifestacoes Cutaneas Associadas a COVID-19: Uma Revisao Narrativa.|pdf=|usr=027}}
| |
| − | {{tp|p=33949163|t=2021. Putative mechanism of neurological damage in COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33926589|t=2021. Inflammatory neuropsychiatric disorders and COVID-19 neuroinflammation.|pdf=|usr=027}}
| |
| − | {{tp|p=33345664|t=2021. Covid-19 intensive care admissions and mortality among swedish patients with cancer.|pdf=|usr=027}}
| |
| − | {{tp|p=33346687|t=2021. Olfactory function and findings on chest computed tomography in COVID-19: is there any correlation?|pdf=|usr=027}}
| |
| − | {{tp|p=33307905|t=2021. Smell and taste loss in COVID-19 patients: assessment outcomes in a Victorian population.|pdf=|usr=027}}
| |
| − | {{tp|p=33823752|t=2021. Persisting olfactory dysfunction improves in patients 6 months after COVID-19 disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33993529|t=2021. Early-onset SARS-CoV-2 infection in neonates born to COVID positive mothers.|pdf=|usr=027}}
| |
| − | {{tp|p=33351207|t=2021. Clinical course of COVID-19 in children with pre-existing medical conditions.|pdf=|usr=027}}
| |
| − | {{tp|p=33368844|t=2021. Commentary on Simons et al. Public health implications of the suggested association between nicotine, smoking and infection with SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33952874|t=2021. INSTRUCTIONS: A New Rash Differential: CoVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33973188|t=2021. Neurologic Manifestations of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33973186|t=2021. COVID-19 in Patients with Cancer.|pdf=|usr=027}}
| |
| − | {{tp|p=33973185|t=2021. How Prevalent Is Cancer in Confirmed Cases with Coronaviruses and Severe Acute Respiratory Syndromes?|pdf=|usr=027}}
| |
| − | {{tp|p=33973184|t=2021. COVID-19 and Cardiovascular Diseases.|pdf=|usr=027}}
| |
| − | {{tp|p=33973183|t=2021. COVID-19 in Patients with Hypertension.|pdf=|usr=027}}
| |
| − | {{tp|p=33973182|t=2021. Coronavirus Diseases in Pregnant Women, the Placenta, Fetus, and Neonate.|pdf=|usr=027}}
| |
| − | {{tp|p=33973175|t=2021. Genetic Polymorphisms in the Host and COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33973174|t=2021. Coronavirus: Pure Infectious Disease or Genetic Predisposition.|pdf=|usr=027}}
| |
| − | {{tp|p=33656725|t=2021. The Primary Outcomes and Epidemiological and Clinical Features of Coronavirus Disease 2019 (COVID-19) in Iran.|pdf=|usr=027}}
| |
| − | {{tp|p=33323800|t=2021. Gene Expression of Angiotensin-Converting Enzyme 2 Receptor in Skin and the Implications for COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33871408|t=2021. Case Report of Two Patients With COVID-19 and Sacral Pressure Injuries Associated with Pyoderma Gangrenosum.|pdf=|usr=027}}
| |
| − | {{tp|p=33946091|t=2021. Severe coronavirus disease 2019 in a patient with HIV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34082616|t=2021. COVID-19 and HIV/AIDS in a cohort study in Sao Paulo, Brazil: outcomes and disparities by race and schooling.|pdf=|usr=027}}
| |
| − | {{tp|p=33347338|t=2021. What Might Surviving Coronavirus Disease 2019 Look Like for People Living with HIV?|pdf=|usr=027}}
| |
| − | {{tp|p=33966477|t=2021. Short Communication: HIV Viral Load Trends During the Coronavirus Disease 2019 Pandemic in a Reference Center for HIV in Rome, Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=33913751|t=2021. Short Communication: Coronavirus Disease 19 Among People Living with HIV in Western India: An Observational Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33913732|t=2021. Progression Risk in People with HIV and COVID-19: Predictive Performance of Current Risk Scores.|pdf=|usr=027}}
| |
| − | {{tp|p=34082440|t=2021. Differentials of SARS-CoV-2 Viral RNA Re-positivity in Discharged COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33985953|t=2021. Leptomeningeal Enhancement Due to COVID-19 on 3D-FLAIR and T1 Black-Blood MR Imaging Sequences.|pdf=|usr=027}}
| |
| − | {{tp|p=33888458|t=2021. Modelling the Anatomic Distribution of Neurologic Events in Patients with COVID-19: A Systematic Review of MRI Findings.|pdf=|usr=027}}
| |
| − | {{tp|p=33888450|t=2021. Cerebral Venous Thrombosis in COVID-19: A New York Metropolitan Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34016586|t=2021. Collicular Hyperactivation in Patients with COVID-19: A New Finding on Brain MRI and PET/CT.|pdf=|usr=027}}
| |
| − | {{tp|p=33355486|t=2021. Beyond the AJR: "Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)".|pdf=|usr=027}}
| |
| − | {{tp|p=34006736|t=2021. Disseminated Inflammatory Lesions in 2 COVID-19 Patients: Challenge.|pdf=|usr=027}}
| |
| − | {{tp|p=34006732|t=2021. Disseminated Inflammatory Lesions in 2 Patients With COVID-19: Answer.|pdf=|usr=027}}
| |
| − | {{tp|p=34047305|t=2021. Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy.|pdf=|usr=027}}
| |
| − | {{tp|p=34074814|t=2021. Clinical Characteristics of COVID-19 Patients With Gastrointestinal Symptoms in Northern Italy: Few Issues.|pdf=|usr=027}}
| |
| − | {{tp|p=33298699|t=2021. A Tip of the Iceberg on the Mechanism of SARS-CoV-2-Induced Liver Injury.|pdf=|usr=027}}
| |
| − | {{tp|p=33993134|t=2021. Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.|pdf=|usr=027}}
| |
| − | {{tp|p=33982972|t=2021. SARS-COV-2 Infection in Patients With Alcohol-Associated Hepatitis: Metabolic Similarities and Treatment Challenges.|pdf=|usr=027}}
| |
| − | {{tp|p=33982951|t=2021. Are Patients With Inflammatory Bowel Disease at an Increased Risk of Developing SARS-CoV-2 than Patients Without Inflammatory Bowel Disease? Results From a Nationwide Veterans' Affairs Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33991361|t=2021. Laboratory testing for ADAMTS13: Utility for TTP diagnosis/exclusion and beyond.|pdf=|usr=027}}
| |
| − | {{tp|p=33387457|t=2021. Integrative Medicine and the Long Hauler Syndrome-We Meet Again.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33967265|t=2021. Progressive COVID-19-Associated Coagulopathy Despite Treatment with Therapeutic Anticoagulation and Thrombolysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33930011|t=2021. Low Visual Acuity Due to Acute Macular Neuroretinopathy Associated with COVID-19: A Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=33883541|t=2021. Thromboelastography-Guided Anticoagulant Therapy for the Double Hazard of Thrombohemorrhagic Events in COVID-19: A Report of 3 Cases.|pdf=|usr=027}}
| |
| − | {{tp|p=34060006|t=2021. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization and Mortality in Patients with Psoriasis: A Population-Based Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33914058|t=2021. Liver Pathology and SARS-CoV-2 Detection in Formalin-Fixed Tissue of Patients With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33300981|t=2021. Retrospective Analyses Associate Hemostasis Activation Biomarkers With Poor Outcomes in Patients With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33992488|t=2021. Can on-admission anemia predict severe COVID-19 cases? A discussion about statistical and clinical significance.|pdf=|usr=027}}
| |
| − | {{tp|p=33965276|t=2021. An unusual cause of spontaneous pneumothorax: Post-COVID-19 pulmonary fibrosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33895645|t=2021. On-admission anemia predicts mortality in COVID-19 patients: A single center, retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33958246|t=2021. Deriving cut-off values for continuous predictors of severe outcomes in COVID-19 through meta-analysis of individual studies: A comment on the article by Hariyanto et al.|pdf=|usr=027}}
| |
| − | {{tp|p=33992487|t=2021. On-admission parameters based prognostication in COVID-19: an important missing link....|pdf=|usr=027}}
| |
| − | {{tp|p=33348224|t=2021. D-Dimer as a potential biomarker for disease severity in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33333477|t=2021. Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality.|pdf=|usr=027}}
| |
| − | {{tp|p=33309506|t=2021. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33838471|t=2021. The role of the BUN/albumin ratio in predicting mortality in COVID-19 patients in the emergency department.|pdf=|usr=027}}
| |
| − | {{tp|p=34015609|t=2021. Demographic and clinical correlates of acute and convalescent SARS-CoV-2 infection among patients of a U.S. emergency department.|pdf=|usr=027}}
| |
| − | {{tp|p=33895644|t=2021. The effect of cardiovascular disease and acute cardiac injury on fatal COVID-19: a meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33895040|t=2021. Triple threat: New presentation with diabetic ketoacidosis, COVID-19, and cardiac arrhythmias.|pdf=|usr=027}}
| |
| − | {{tp|p=33958247|t=2021. Saddle pulmonary embolism in a pediatric patient with nephrotic syndrome and recent COVID-19 pneumonia: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33982973|t=2021. Association Between Famotidine Use and Clinical Outcomes in Patients With COVID-19: Assessment of Available Evidence.|pdf=|usr=027}}
| |
| − | {{tp|p=33357513|t=2021. Host genetic effects in pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33320177|t=2021. Response to "ACE-2 Downregulation and Incidence of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Infection".|pdf=|usr=027}}
| |
| − | {{tp|p=33891988|t=2021. Association between Influenza Vaccination and severe COVID-19 outcomes at a designated COVID-only hospital in Brooklyn.|pdf=|usr=027}}
| |
| − | {{tp|p=33342610|t=2021. COVID-19: The Kidneys Tell a Tale.|pdf=|usr=027}}
| |
| − | {{tp|p=34062151|t=2021. COVID-19 Associated Dysautonomia: Not Limited to Critically Ill! Response to: Dysautonomia: An Overlooked Neurological Manifestation in a Critically Ill COVID-19 Patient.|pdf=|usr=027}}
| |
| − | {{tp|p=34033806|t=2021. Avascular Necrosis in Patients Recovering from COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34023311|t=2021. COVID-19: A Potential Trigger for Thyroid Dysfunction.|pdf=|usr=027}}
| |
| − | {{tp|p=34024356|t=2021. Diabetic Ketoacidosis in Patients With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34024354|t=2021. Resurgence of Positive qRT-PCR Test Results in Patients Recovered from COVID-19: Case Reports.|pdf=|usr=027}}
| |
| − | {{tp|p=33358501|t=2021. Relationship Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Etiology of Acute Kidney Injury (AKI).|pdf=|usr=027}}
| |
| − | {{tp|p=33349441|t=2021. The Association of "Loss of Smell" to COVID-19: A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33984321|t=2021. Methemoglobinemia in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33894182|t=2021. Incidence and Risk Factors for Secondary Pulmonary Infections in Patients Hospitalized With Coronavirus Disease 2019 Pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33827078|t=2021. Epidemiology of COVID-19 Infection in Hospitalized End-Stage Kidney Disease Patients in a Predominantly African-American Population.|pdf=|usr=027}}
| |
| − | {{tp|p=33827074|t=2021. Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers.|pdf=|usr=027}}
| |
| − | {{tp|p=34062121|t=2021. Placental histopathological changes in COVID-19 in term patients admitted to labor and delivery.|pdf=|usr=027}}
| |
| − | {{tp|p=34058172|t=2021. Reply to the Letter to the Editors regarding COVID-19 infection and placental histopathology in women delivering at term.|pdf=|usr=027}}
| |
| − | {{tp|p=34023315|t=2021. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33345802|t=2021. Young pregnant women are also at an increased risk of mortality and severe illness due to coronavirus disease 2019: analysis of the Mexican National Surveillance Program.|pdf=|usr=027}}
| |
| − | {{tp|p=33932627|t=2021. Vertical transmission of SARS-CoV-2: consider the denominator.|pdf=|usr=027}}
| |
| − | {{tp|p=34022227|t=2021. Presence of SARS-CoV-2 Viral RNA in Aqueous Humor of Asymptomatic Individuals.|pdf=|usr=027}}
| |
| − | {{tp|p=33989596|t=2021. Comment on: The Impact of COVID-19 on Individuals Across the Spectrum of Visual Impairment.|pdf=|usr=027}}
| |
| − | {{tp|p=33989595|t=2021. Reply to Comment on: The Impact of COVID-19 on Individuals Across the Spectrum of Visual Impairment.|pdf=|usr=027}}
| |
| − | {{tp|p=33873048|t=2021. Olfactory dysfunction in SARS-CoV-2 infection: Focus on odorant specificity and chronic persistence.|pdf=|usr=027}}
| |
| − | {{tp|p=33857779|t=2021. Does the SARS-CoV-2 pandemic really increase the frequency of peripheral facial palsy?|pdf=|usr=027}}
| |
| − | {{tp|p=33839489|t=2021. Effect of nasal corticosteroid in the treatment of anosmia due to COVID-19: A randomised double-blind placebo-controlled study.|pdf=|usr=027}}
| |
| − | {{tp|p=33838359|t=2021. Cranial nerve involvement in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33831819|t=2021. Rised sudden sensorineural hearing loss during COVID-19 widespread.|pdf=|usr=027}}
| |
| − | {{tp|p=34022619|t=2021. The impact of COVID-19 outbreak on the incidence of acute invasive fungal rhinosinusitis.|pdf=|usr=027}}
| |
| − | {{tp|p=33931269|t=2021. Is there really a correlation between viral load and olfactory and gustatory dysfunction?|pdf=|usr=027}}
| |
| − | {{tp|p=33894627|t=2021. Eight-month follow-up of olfactory and gustatory dysfunctions in recovered COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33875304|t=2021. Chemosensory dysfunction in COVID-19: Is there really a correlation with viral load?|pdf=|usr=027}}
| |
| − | {{tp|p=33846030|t=2021. The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in taste dysgeusia in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33915513|t=2021. Temporal patterns of nasal symptoms in patients with mild severity SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33940252|t=2021. Characteristics of COVID-19 smell and taste dysfunction in hospitalized patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34058068|t=2021. Successful transplantation of organs from a deceased donor with early SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33961334|t=2021. Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34061773|t=2021. Risk Factors for Death Among 120,804 Hospitalized Patients with Confirmed COVID-19 in Sao Paulo, Brazil.|pdf=|usr=027}}
| |
| − | {{tp|p=33939645|t=2021. High Mobility Group Box 1 and Interleukin 6 at Intensive Care Unit Admission as Biomarkers in Critically Ill COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34003792|t=2021. Longitudinal Serology of SARS-CoV-2-Infected Individuals in India: A Prospective Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33840089|t=2021. BMI- and age-related associations with mortality from COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33998143|t=2021. Current status of the COVID-19 and male reproduction: A review of the literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33851521|t=2021. Short-term effects of COVID-19 on semen parameters: A multicenter study of 69 cases.|pdf=|usr=027}}
| |
| − | {{tp|p=33830956|t=2021. The Society for Obstetric Anesthesia and Perinatology Coronavirus Disease 2019 Registry: An Analysis of Outcomes Among Pregnant Women Delivering During the Initial Severe Acute Respiratory Syndrome Coronavirus-2 Outbreak in the United States.|pdf=|usr=027}}
| |
| − | {{tp|p=34097436|t=2021. The "Black Fungus" in India: The Emerging Syndemic of COVID-19-Associated Mucormycosis.|pdf=|usr=027}}
| |
| − | {{tp|p=34096808|t=2021. The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34080499|t=2021. Effects of hypertension on the outcomes of COVID-19: a multicentre retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34043255|t=2021. Reply to: Neurofilament Light Chain in Patients with COVID-19 and Bacterial Pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=34036618|t=2021. Neurofilament Light Chain in Patients with COVID-19 and Bacterial Pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33836104|t=2021. Approaches to understanding COVID-19 and its neurological associations.|pdf=|usr=027}}
| |
| − | {{tp|p=34009158|t=2021. Pregnancy and COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33302306|t=2021. Impact of the COVID-19 Pandemic on Excess Perinatal Mortality and Morbidity in Israel.|pdf=|usr=027}}
| |
| − | {{tp|p=33853148|t=2021. Complicated Monochorionic-Diamniotic Twins in a Pregnant Woman with COVID-19 in the Second Trimester.|pdf=|usr=027}}
| |
| − | {{tp|p=33853145|t=2021. Mother-Infant Dyads with COVID-19 at an Urban, Safety-Net Hospital: Clinical Manifestations and Birth Outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=33940651|t=2021. Incidence of Hypertensive Disorders of Pregnancy in Women with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33878775|t=2021. Clinical and Demographic Risk Factors for COVID-19 during Delivery Hospitalizations in New York City.|pdf=|usr=027}}
| |
| − | {{tp|p=34082444|t=2021. Neonates Born to COVID-19 Mother and Risk in Management within 4 Weeks of Life: A Single-Center Experience, Systematic Review, and Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34091469|t=2021. Long-Term Decreased Exercise Capacity of COVID-19 Patients Who Received Mechanical Ventilation in Japan: A Case Series.|pdf=|usr=027}}
| |
| − | {{tp|p=34001839|t=2021. Extended Neuralgic Amyotrophy Syndrome in a Confirmed COVID-19 Patient After Intensive Care Unit and Inpatient Rehabilitation Stay.|pdf=|usr=027}}
| |
| − | {{tp|p=34086538|t=2021. The Central Role of PAI-1 in COVID-19: Thrombosis and beyond.|pdf=|usr=027}}
| |
| − | {{tp|p=34003736|t=2021. ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial PAI-1.|pdf=|usr=027}}
| |
| − | {{tp|p=34038699|t=2021. Early Bacterial Identification Among Intubated Patients with COVID-19 or Influenza Pneumonia: A European Multicenter Comparative Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33891529|t=2021. Hospital-Level Variation in Death for Critically Ill Patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33813917|t=2021. COVID-19-Induced Anosmia and Ageusia Are Associated With Younger Age and Lower Blood Eosinophil Counts.|pdf=|usr=027}}
| |
| − | {{tp|p=34081038|t=2021. Intestinal Abnormalities in Patients With SARS-CoV-2 Infection: Histopathologic Changes Reflect Mechanisms of Disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33369912|t=2021. Anticoagulant Protein S in COVID-19: The Low Activity Level Is Probably Secondary.|pdf=|usr=027}}
| |
| − | {{tp|p=33369911|t=2021. COVID-19 and Renin Angiotensin Aldosterone System: A Pharmacogenomic View.|pdf=|usr=027}}
| |
| − | {{tp|p=33346946|t=2021. Arterial abnormalities identified in kidneys transplanted into children during the COVID-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33319449|t=2021. Impact of COVID-19 in solid organ transplant recipients.|pdf=|usr=027}}
| |
| − | {{tp|p=33370503|t=2021. Persistence of SARS-CoV-2 antibodies in kidney transplant recipients.|pdf=|usr=027}}
| |
| − | {{tp|p=33350576|t=2021. COVID-19 and transplantation: Fatigue and responsibility.|pdf=|usr=027}}
| |
| − | {{tp|p=34008917|t=2021. COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: A comparative analysis from a multicenter study.|pdf=|usr=027}}
| |
| − | {{tp|p=34049454|t=2021. Arterial Thrombosis and Acute Limb Ischemia as a Complication of COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34060929|t=2021. Subacute Enteritis Two Months After COVID-19 Pneumonia With Mucosal Bleeding, Perforation, and Internal Fistulas.|pdf=|usr=027}}
| |
| − | {{tp|p=33948938|t=2021. Renal impairment and its impact on clinical outcomes in patients who are critically ill with COVID-19: a multicentre observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=33908078|t=2021. Testosterone levels in COVID-19: More data, but how do we proceed?|pdf=|usr=027}}
| |
| − | {{tp|p=33902353|t=2021. Can C-Reactive Protein to Albumin Ratio Predict In-Hospital Death Rate Due to COVID-19 in Patients With Hypertension?|pdf=|usr=027}}
| |
| − | {{tp|p=33315543|t=2021. Alcohol Consumption and the Risk of Acute Respiratory Distress Syndrome in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33315531|t=2021. Causes and Circumstances of Death among Patients Hospitalized with COVID-19: A Retrospective Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33872546|t=2021. Tissue Plasminogen Activator in Critically Ill Adults with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33872135|t=2021. Symptoms, Pulmonary Function and Functional Capacity Four Months after COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33874737|t=2021. Serum biomarkers for prediction of mortality in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34018843|t=2021. Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33941554|t=2021. COVID-19 Cardiac Injury: An Important Cause of COVID-19 Related Morbidityand Mortality.|pdf=|usr=027}}
| |
| − | {{tp|p=33939487|t=2021. In adults, NSAID use vs. nonuse in the past 4 mo was not linked to increased risk for COVID-19-related mortality.|pdf=|usr=027}}
| |
| − | {{tp|p=33377539|t=2021. Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33332607|t=2021. Pediatric Ischemic Stroke: An Infrequent Complication of SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33975857|t=2021. Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases.|pdf=|usr=027}}
| |
| − | {{tp|p=34039622|t=2021. Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group.|pdf=|usr=027}}
| |
| − | {{tp|p=33985940|t=2021. Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry'.|pdf=|usr=027}}
| |
| − | {{tp|p=33980607|t=2021. Response to: 'Correspondence on 'Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab'' by Tampe et al.|pdf=|usr=027}}
| |
| − | {{tp|p=33980606|t=2021. Correspondence on 'Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab'.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=34097753|t=2021. Long-term consequences in critically ill COVID-19 patients: A prospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34086975|t=2021. COVID-19 versus influenza A/B supeRInfectionS in the IntenSive care unit (CRISIS): Protocol for a Danish nationwide cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33988163|t=2021. Spontaneous abdominal bleeding associated with SARS-CoV-2 infection: causality or coincidence?|pdf=|usr=027}}
| |
| − | {{tp|p=33988162|t=2021. Cardiovascular impact of COVID-19: an array of presentations.|pdf=|usr=027}}
| |
| − | {{tp|p=33988145|t=2021. Could the COVID-19 Positive Asymptomatic Tobacco Smoker be a Silent Superspeader?|pdf=|usr=027}}
| |
| − | {{tp|p=33988141|t=2021. COVID-19 in transplant recipient children: An Iranian referral hospital-based study.|pdf=|usr=027}}
| |
| − | {{tp|p=33895748|t=2021. An Early Unexpected Immune Thrombotic Thrombocytopenic Purpura Relapse Associated with SARS-CoV-2 Infection: A Case Report and Literature Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33964216|t=2021. ACE2 Down-Regulation May Act as a Transient Molecular Disease Causing RAAS Dysregulation and Tissue Damage in the Microcirculatory Environment Among COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33887214|t=2021. Coronavirus Activates an Altruistic Stem Cell-Mediated Defense Mechanism that Reactivates Dormant Tuberculosis: Implications in Coronavirus Disease 2019 Pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34033751|t=2021. COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury.|pdf=|usr=027}}
| |
| − | {{tp|p=33825496|t=2021. Adrenal insufficiency in the COVID-19 era.|pdf=|usr=027}}
| |
| − | {{tp|p=34009033|t=2021. Critical appraisal of the mechanisms of gastrointestinal and hepatobiliary infection by COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33306450|t=2021. Vascular alterations among young adults with SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=34009036|t=2021. A pilot study to assess the circulating renin-angiotensin system in COVID-19 acute respiratory failure.|pdf=|usr=027}}
| |
| − | {{tp|p=33355522|t=2021. Healing after COVID-19: are survivors at risk for pulmonary fibrosis?|pdf=|usr=027}}
| |
| − | {{tp|p=33985834|t=2021. Childhood Bacille Calmette-Guerin Vaccination and Its Association With Less Severe COVID-19 Pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33357169|t=2021. Is the Angioedema Associated with COVID-19 a Real Entity, a Mimic, or Both?|pdf=|usr=027}}
| |
| − | {{tp|p=33357023|t=2021. Reply to Chan and Majluf-Cruz: Is the Angioedema Associated with COVID-19 a Real Entity, a Mimic, or Both?|pdf=|usr=027}}
| |
| − | {{tp|p=33306946|t=2021. Trends in Intensive Care for Patients with COVID-19 in England, Wales, and Northern Ireland.|pdf=|usr=027}}
| |
| − | {{tp|p=33352060|t=2021. Invasive Pulmonary Aspergillosis Goes Viral Again?|pdf=|usr=027}}
| |
| − | {{tp|p=33326353|t=2021. High Prevalence of Pulmonary Sequelae at 3 Months after Hospital Discharge in Mechanically Ventilated Survivors of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33894979|t=2021. Increased complications in patients who test COVID-19 positive after elective surgery and implications for pre and postoperative screening.|pdf=|usr=027}}
| |
| − | {{tp|p=34017547|t=2021. Changes of clinical characteristics of asymptomatic patients with positive SARS-Cov-2 nucleic acid test during treatment cycle and related risk factors.|pdf=|usr=027}}
| |
| − | {{tp|p=33293229|t=2021. Petechial lesions in a patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33903852|t=2021. Usefulness of chest ultrasound in a neonatal infection due to SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33965645|t=2021. Post-acute COVID-19 Syndrome (PACS): A public health emergency.|pdf=|usr=027}}
| |
| − | {{tp|p=34006056|t=2021. COVID-19: coagulation disorders and anticoagulant treatment in patients hospitalised in ICU.|pdf=|usr=027}}
| |
| − | {{tp|p=34006045|t=2021. A review of 92 obstetric patients with COVID-19 in the Bronx, New York and their peripartum anaesthetic management.|pdf=|usr=027}}
| |
| − | {{tp|p=33974165|t=2021. Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance.|pdf=|usr=027}}
| |
| − | {{tp|p=33990820|t=2021. Severe COVID-19 and coagulopathy: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33990816|t=2021. Estimating the impact of COVID-19-induced coagulopathy.|pdf=|usr=027}}
| |
| − | {{tp|p=33941316|t=2021. The evidence is in that asthma is not associated with severe coronavirus disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33975023|t=2021. Commentary on Eosinophilic Inflammation, Coronavirus Disease 2019, and Asthma: Are inhaled corticosteroids the missing link?|pdf=|usr=027}}
| |
| − | {{tp|p=33929309|t=2021. Lungs after COVID-19: Evolving Knowledge of Post-COVID-19 Interstitial Lung Disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33340650|t=2021. Malignancy going viral: ACE2 and TMPRSS2 expression in conjunctival neoplastic diseases.|pdf=|usr=027}}
| |
| − | {{tp|p=34054381|t=2021. Inflammatory and coagulative pathophysiology for the management of burn patients with COVID-19: systematic review of the evidence.|pdf=|usr=027}}
| |
| − | {{tp|p=34030702|t=2021. Contrasting SARS-CoV-2 RNA copies and clinical symptoms in a large cohort of Colombian patients during the first wave of the COVID-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33360731|t=2021. Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein.|pdf=|usr=027}}
| |
| − | {{tp|p=33902827|t=2021. Young Man With Shortness of Breath.|pdf=|usr=027}}
| |
| − | {{tp|p=34030779|t=2021. Pain, Swelling and Blue Discoloration of Right Hand in a COVID-19 Patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33895245|t=2021. Incidence of COVID-19 recurrence among large cohort of healthcare employees.|pdf=|usr=027}}
| |
| − | {{tp|p=33948056|t=2021. The impact of COVID-19 pandemic on gastrointestinal diseases: a single-center cross-sectional study in central Greece.|pdf=|usr=027}}
| |
| − | {{tp|p=34032899|t=2021. Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals.|pdf=|usr=027}}
| |
| − | {{tp|p=33901638|t=2021. Reply to: Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico.|pdf=|usr=027}}
| |
| − | {{tp|p=33864949|t=2021. Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico.|pdf=|usr=027}}
| |
| − | {{tp|p=33862291|t=2021. Characteristics and in-hospital outcomes of COVID-19 patients with abnormal liver biochemical tests.|pdf=|usr=027}}
| |
| − | {{tp|p=33359234|t=2021. Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission.|pdf=|usr=027}}
| |
| − | {{tp|p=33864948|t=2021. Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34057648|t=2021. Acute kidney injury in SARS-CoV2-related pneumonia ICU patients: a retrospective multicenter study.|pdf=|usr=027}}
| |
| − | {{tp|p=34036411|t=2021. Infectious events in patients with severe COVID-19: results of a cohort of patients with high prevalence of underlying immune defect.|pdf=|usr=027}}
| |
| − | {{tp|p=33988767|t=2021. Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave: insights from the COVID-ICU study : Prognosis of COVID-19 elderly critically ill patients in the ICU.|pdf=|usr=027}}
| |
| − | {{tp|p=34089104|t=2021. Short-term health-related quality of life, physical function and psychological consequences of severe COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33284682|t=2021. Simultaneous COVID-19 in Monozygotic Twins.|pdf=|usr=027}}
| |
| − | {{tp|p=33284676|t=2021. COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings.|pdf=|usr=027}}
| |
| − | {{tp|p=33900794|t=2021. Update Alert 8: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.|pdf=|usr=027}}
| |
| − | {{tp|p=34000201|t=2021. Serial SARS-CoV-2 Receptor-Binding Domain Antibody Responses in Patients Receiving Dialysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33971101|t=2021. In-Hospital Mortality in a Cohort of Hospitalized Pregnant and Nonpregnant Patients With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33971099|t=2021. Factors Associated With Risk for Care Escalation Among Patients With COVID-19 Receiving Home-Based Hospital Care.|pdf=|usr=027}}
| |
| − | {{tp|p=33872044|t=2021. SARS-CoV-2 Reinfection in a Liver Transplant Recipient.|pdf=|usr=027}}
| |
| − | {{tp|p=33872542|t=2021. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy.|pdf=|usr=027}}
| |
| − | {{tp|p=33872541|t=2021. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy.|pdf=|usr=027}}
| |
| − | {{tp|p=33824244|t=2021. Serological Evidence of Coxiella burnetii and SARS-CoV-2 Co-infection: A Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=34042528|t=2021. Alarmins, COVID-19 and comorbidities.|pdf=|usr=027}}
| |
| − | {{tp|p=33345626|t=2021. The cardiovascular aspect of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33950572|t=2021. Extensive microbiological respiratory tract specimen characterization in critically ill COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34090835|t=2021. Massive gastrointestinal bleeding in a patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34057311|t=2021. Isolation, behavioral changes and low seroprevalence of SARS-CoV-2 antibodies in patients with Systemic Lupus Erythematosus or Rheumatoid arthritis.|pdf=|usr=027}}
| |
| − | {{tp|p=33881229|t=2021. Lupus anticoagulant single positivity at acute phase is not associated with venous thromboembolism or in-hospital mortality in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33914346|t=2021. Cancer as a prospective sequela of long COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34081334|t=2021. SARS-CoV-2 infection and cancer: Evidence for and against a role of SARS-CoV-2 in cancer onset.|pdf=|usr=027}}
| |
| − | {{tp|p=33847020|t=2021. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue.|pdf=|usr=027}}
| |
| − | {{tp|p=34056820|t=2021. COVID-19 among pregnant Chinese women: case series data on the safety of vaginal birth and breastfeeding.|pdf=|usr=027}}
| |
| − | {{tp|p=34047455|t=2021. Seasonal and SARS-CoV-2 pandemic changes in the incidence of gestational diabetes.|pdf=|usr=027}}
| |
| − | {{tp|p=33958526|t=2021. Clinical impact of blood pressure variability in patients with COVID-19 and hypertension.|pdf=|usr=027}}
| |
| − | {{tp|p=34059550|t=2021. COVID-19 in a premature infant.|pdf=|usr=027}}
| |
| − | {{tp|p=34049895|t=2021. 78-year-old woman with opsoclonus myoclonus ataxia syndrome secondary to COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34039554|t=2021. Delayed manifestation of extensive COVID-19-associated coagulopathy in high-risk patient.|pdf=|usr=027}}
| |
| − | {{tp|p=34039547|t=2021. A rare case of multiple aortic thromboses associated with severe COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34035032|t=2021. Spontaneous pneumothorax as a delayed complication after recovery from COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33860221|t=2021. COVID-19: Is There a Link between Alcohol Abuse and SARS-CoV-2-Induced Severe Neurological Manifestations?|pdf=|usr=027}}
| |
| − | {{tp|p=34053402|t=2021. Frequency and predictors of no-reflow phenomenon in patients with COVID-19 presenting with ST-segment elevation myocardial infarction.|pdf=|usr=027}}
| |
| − | {{tp|p=34080948|t=2021. Heart failure as a complication of COVID-19 infection: systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33823754|t=2021. Assessment of COVID-19 deaths from cardiological perspective.|pdf=|usr=027}}
| |
| − | {{tp|p=33308093|t=2021. COVID-19 epidemic: anticoagulants treatments, another victim.|pdf=|usr=027}}
| |
| − | {{tp|p=33961537|t=2021. A confirmed case of COVID-19 reinfection with a genetically distinct strain: a case report from Belgium.|pdf=|usr=027}}
| |
| − | {{tp|p=33896399|t=2021. Antibiotic use in patients with Coronavirus disease 2019 (COVID-19): outcomes and associated factors.|pdf=|usr=027}}
| |
| − | {{tp|p=33870876|t=2021. The associations of life quality, depression, and cognitive impairment with mortality in older adults with COVID-19: a prospective, observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=33971122|t=2021. COVID-19 e Pessoas com Demencia: Uma Pandemia Silenciosa?|pdf=|usr=027}}
| |
| − | {{tp|p=33971114|t=2021. Detecao Precoce de COVID-19 em Portugal: Uso de Registos Clinicos.|pdf=|usr=027}}
| |
| − | {{tp|p=33369009|t=2021. Mortality of patients with COVID-19 who undergo an elective or emergency surgical procedure: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33368687|t=2021. Serum ACE as a prognostic biomarker in COVID-19: a case series.|pdf=|usr=027}}
| |
| − | {{tp|p=34045207|t=2021. Legacy of COVID-19 infection in children: long-COVID will have a lifelong health/economic impact.|pdf=|usr=027}}
| |
| − | {{tp|p=33931403|t=2021. Prevalence of thrombotic complications in children with SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33990387|t=2021. Nasal expression of SARS-CoV-2 entry receptors in newborns.|pdf=|usr=027}}
| |
| − | {{tp|p=34038167|t=2021. Letter by Brambilla et al Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report".|pdf=|usr=027}}
| |
| − | {{tp|p=34038165|t=2021. Response by Mackman et al to Letter Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report".|pdf=|usr=027}}
| |
| − | {{tp|p=33305544|t=2021. COVID-19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33346988|t=2021. Thrombophilia in Pediatric Patients with Multisystem Inflammatory Syndrome in Children Secondary to Coronavirus Disease 2019 Supported on Extracorporeal Membrane Oxygenation.|pdf=|usr=027}}
| |
| − | {{tp|p=34018399|t=2021. Clustering of COVID-19 Symptoms Among Iranian Patients: The Role of Preexisting Comorbidity on Latent Class Membership.|pdf=|usr=027}}
| |
| − | {{tp|p=33853387|t=2021. Pneumomediastinum in COVID-19 disease: Outcomes and relation to the Macklin effect.|pdf=|usr=027}}
| |
| − | {{tp|p=33987629|t=2021. A patient with COVID-19 and a skin rash.|pdf=|usr=027}}
| |
| − | {{tp|p=33998352|t=2021. Interpretation of myocardial injury subtypes in COVID-19 disease per fourth version of Universal Definition of Myocardial Infarction.|pdf=|usr=027}}
| |
| − | {{tp|p=33368961|t=2021. Authors' reply re: Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33827111|t=2021. Thrombohaemorhhagic balance in coronavirus disease 2019 and its management: a perspective.|pdf=|usr=027}}
| |
| − | {{tp|p=33349063|t=2021. Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers.|pdf=|usr=027}}
| |
| − | {{tp|p=34011496|t=2021. Unpacking post-covid symptoms.|pdf=|usr=027}}
| |
| − | {{tp|p=34011495|t=2021. Long covid: coding is caring.|pdf=|usr=027}}
| |
| − | {{tp|p=34006526|t=2021. Use patient reported outcome measures (PROMs) in treatment of long covid.|pdf=|usr=027}}
| |
| − | {{tp|p=33985993|t=2021. Covid-19: India sees record deaths as "black fungus" spreads fear.|pdf=|usr=027}}
| |
| − | {{tp|p=33741553|t=2021. Covid-19: Eight in 10 Wuhan residents with antibodies had no symptoms, finds study.|pdf=|usr=027}}
| |
| − | {{tp|p=34083351|t=2021. Covid-19: Antimicrobial use was high during first wave despite bacterial co-infections being rare, study finds.|pdf=|usr=027}}
| |
| − | {{tp|p=33827790|t=2021. Covid-19: One in three has neurological or psychiatric condition diagnosed after covid infection, study finds.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33305624|t=2021. IL-6 and other biomarkers as predictors of severity in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33981423|t=2021. COVID-19-induced takotsubo cardiomyopathy: Venturing beyond the obvious.|pdf=|usr=027}}
| |
| − | {{tp|p=33936591|t=2021. Predictors of Covid-19 case fatality rate: An ecological study.|pdf=|usr=027}}
| |
| − | {{tp|p=33907623|t=2021. COVID 19 pneumonia in Down syndrome patients: About 2 cases.|pdf=|usr=027}}
| |
| − | {{tp|p=33898039|t=2021. ST elevation revealing acute myocarditis with SARS cov 2 infection: Case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33898038|t=2021. Negative SARS-COV-2 pleural effusion in breast carcinoma coincide with COVID-19 infection: Case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33898022|t=2021. Cardiovascular injuries during COVID-19 infection: A PROCESS-compliant case series from the Eastern Morocco.|pdf=|usr=027}}
| |
| − | {{tp|p=33868674|t=2021. Gastrointestinal manifestations related to infection with SARS-COV-2: Appendicular syndrome (A case report).|pdf=|usr=027}}
| |
| − | {{tp|p=34075321|t=2021. Intra cardiac thrombus in critically ill patient with coronavirus disease 2019: Case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34075320|t=2021. A tale of two extremities: A dynamic case of Covid-19 induced hypokalemia and bradycardia leading into Torsade's de pointes.|pdf=|usr=027}}
| |
| − | {{tp|p=34075319|t=2021. Acute myocarditis related to Covid-19 infection: 2 cases report.|pdf=|usr=027}}
| |
| − | {{tp|p=34055331|t=2021. Case report of gastrointestinal localization of SARS-CoV-2 and open abdomen technique in an Italian emergency surgery department for gastrointestinal bleeding.|pdf=|usr=027}}
| |
| − | {{tp|p=33363723|t=2021. Pulmonary barotrauma in mechanically ventilated coronavirus disease 2019 patients: A case series.|pdf=|usr=027}}
| |
| − | {{tp|p=33894729|t=2021. Risk factors for mortality of coronavirus disease 2019 (COVID-19) patients during the early outbreak of COVID-19: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34044555|t=2021. A survey on acute kidney injury in severely and critically ill COVID-19 patients without chronic kidney disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33894714|t=2021. Determinants of mortality of patients with COVID-19 in Wuhan, China: a case-control study.|pdf=|usr=027}}
| |
| − | {{tp|p=33832321|t=2021. Considerations and perspectives on digestive diseases during the COVID-19 pandemic: a narrative review.|pdf=|usr=027}}
| |
| − | {{tp|p=33832296|t=2021. Comparison and clinical characteristics of COVID-19 between January and February 2020 in Wuhan, China.|pdf=|usr=027}}
| |
| − | {{tp|p=33832289|t=2021. Sinonasal manifestations and dynamic profile of RT-PCR results for SARS-CoV-2 in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34049860|t=2021. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.|pdf=|usr=027}}
| |
| − | {{tp|p=33903092|t=2021. Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34085542|t=2021. Angiotensin-converting enzyme-1 gene insertion/deletion polymorphism may be associated with COVID-19 clinical severity: a prospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33971169|t=2021. To do is better: prompt surgery is indicated in COVID-19 patients with complicated pneumatocele.|pdf=|usr=027}}
| |
| − | {{tp|p=33964253|t=2021. Critical COVID-19 complicating recovery from surgical repair of congenital heart disease.|pdf=|usr=027}}
| |
| − | {{tp|p=34029534|t=2021. Long term extracorporeal membrane oxygenation bridge to lung transplant after COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33347850|t=2021. Coronavirus Disease 2019 in Lung Transplant Recipients.|pdf=|usr=027}}
| |
| − | {{tp|p=33850909|t=2021. Early rehabilitation after lung transplantation with extracorporeal membrane oxygenation (ECMO) of COVID-19 patient: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33987399|t=2021. Early risk factors for extrapulmonary organ injury in adult COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33987376|t=2021. Bioinformatic and mouse model reveal the potential high vulnerability of Leydig cells on SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33987363|t=2021. Clinical features in coronavirus disease 2019 (COVID-19) patients with early clearance and prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA.|pdf=|usr=027}}
| |
| − | {{tp|p=33987328|t=2021. High risk of pulmonary embolism in acute respiratory distress syndrome related to COVID-19: an observational controlled-cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33987319|t=2021. Epidemiological and clinical characteristics of suspected COVID-19 patients in the isolation ward in Guangzhou, China: a cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33992721|t=2021. A Probable Covid-19 Case Presented with Acute Upper Limb Ischemia.|pdf=|usr=027}}
| |
| − | {{tp|p=33333197|t=2021. Risk and Management of Venous Thromboembolism in Patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34044096|t=2021. Misdiagnosed Acute Limb Ischemia in Three Nonhospitalized Patients Recovering From a Nonsevere COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33940162|t=2021. Arterial Thrombotic Sequalae After Covid-19: Mind the Gap.|pdf=|usr=027}}
| |
| − | {{tp|p=33940161|t=2021. Spontaneous Acute Aortic Thrombosis in SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33333188|t=2021. Extensive Arterial Thrombus Following Discharge after a Covid-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34067186|t=2021. Ventilator-Associated Pneumonia in Patients with COVID-19: A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34065029|t=2021. Carbapenem-Resistant Klebsiella pneumoniae Associated with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33804758|t=2021. Implications of Antibiotic Use during the COVID-19 Pandemic: The Example of Associated Antimicrobial Resistance in Latin America.|pdf=|usr=027}}
| |
| − | {{tp|p=34088341|t=2021. The impact of the COVID-19 pandemic on healthcare-associated infections in intensive care unit patients: a retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34065123|t=2021. Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=34076792|t=2021. COVID-19 disrupts spermatogenesis through the oxidative stress pathway following induction of apoptosis.|pdf=|usr=027}}
| |
| − | {{tp|p=34088621|t=2021. Spleen infarct secondary to thrombus in COVID-19-related splenic vein: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34027429|t=2021. Neurological Manifestations and their Correlated Factors in COVID-19 Patients; a Cross-Sectional Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34027427|t=2021. Corticosteroid Therapy in Management of Myocarditis Associated with COVID-19; a Systematic Review of Current Evidence.|pdf=|usr=027}}
| |
| − | {{tp|p=34027422|t=2021. Platelet and Haemostasis are the Main Targets in Severe Cases of COVID-19 Infection; a System Biology Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34027421|t=2021. Fibrinogen Dysregulation is a Prominent Process in Fatal Conditions of COVID-19 Infection; a Proteomic Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33870208|t=2021. Echocardiographic Abnormalities as Independent Prognostic Factors of In-Hospital Mortality among COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33870205|t=2021. Cardiac Complications and Pertaining Mortality Rate in COVID-19 Patients; a Systematic Review and Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33313572|t=2021. Possible Vertical Transmission of COVID-19 to the Newborn; a Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=34033432|t=2021. Fracaso multiorganico secundario a infeccion por coronavirus no COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34033411|t=2021. COVID-19: exposicion perinatal. Perspectivas.|pdf=|usr=027}}
| |
| − | {{tp|p=33749212|t=2021. Dengue en los inicios de la pandemia de COVID-19 en la Argentina.|pdf=|usr=027}}
| |
| − | {{tp|p=34075267|t=2021. Impact of Chronic Respiratory Diseases on the Outcomes of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34054194|t=2021. DESREGULACION DEL TONO VASCULAR PULMONAR Y MICROTROMBOSIS EN COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34054192|t=2021. CALCIFICACIONES PULMONARES COMO SECUELA DE NEUMONIA COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33268140|t=2021. Influenza, SARS-CoV-2 y aspergilosis pulmonar invasiva.|pdf=|usr=027}}
| |
| − | {{tp|p=33775452|t=2021. Menor frecuencia y letalidad en mujeres y en la altura por COVID-19: dos caras de una misma moneda.|pdf=|usr=027}}
| |
| − | {{tp|p=33358223|t=2021. Trichosporon asahii as Cause of Nosocomial Pneumonia in Patient With COVID-19: A Triple Co-infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33875283|t=2021. Ausencia de efectos clinicos destacables del SARS-CoV-2 sobre la afinidad de la hemoglobina por el O2 en pacientes con COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33832794|t=2021. Health Indicators in Hospitalized Patients With SARS-CoV-2 Pneumonia: A Comparison Between the First and Second Wave.|pdf=|usr=027}}
| |
| − | {{tp|p=34031097|t=2021. Autoimmune heparin-induced thrombocytopenia: a rare manifestation of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34031067|t=2021. Rhabdomyolysis and severe biphasic disturbance of calcium homeostasis secondary to COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34088694|t=2021. Acute icteric hepatitis as the first isolated symptom of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34088691|t=2021. A rare case of COVID-19 infection with laryngeal involvement.|pdf=|usr=027}}
| |
| − | {{tp|p=34088685|t=2021. Catatonic syndrome as the presentation of encephalitis in association with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34083194|t=2021. Necrotising myopathy and concurrent thyroiditis in a patient with COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34078625|t=2021. Case of COVID-19-induced vestibular neuritis in a child.|pdf=|usr=027}}
| |
| − | {{tp|p=34003031|t=2021. Early mortality outcomes of patients with fragility hip fracture and concurrent SARS-CoV-2 infection : a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34003027|t=2021. Morbidity and mortality in patients undergoing lower limb arthroplasty surgery during the initial surge of the COVID-19 pandemic in the UK at a single-speciality orthopaedic hospital.|pdf=|usr=027}}
| |
| − | {{tp|p=33908074|t=2021. Antihypertensive medications and COVID-19 diagnosis and mortality: Population-based case-control analysis in the United Kingdom.|pdf=|usr=027}}
| |
| − | {{tp|p=33899226|t=2021. Prior use of therapeutic anticoagulation does not protect against COVID-19 related clinical outcomes in hospitalized patients: A propensity score-matched cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33955543|t=2021. SARS-CoV-2 infection in patients with atopic dermatitis: a cross-sectional study.|pdf=|usr=027}}
| |
| − | {{tp|p=33837520|t=2021. Outcomes of COVID-19 in patients with skin cancer.|pdf=|usr=027}}
| |
| − | {{tp|p=34036575|t=2021. COVID-19 in patients with paroxysmal nocturnal haemoglobinuria: an Italian multicentre survey.|pdf=|usr=027}}
| |
| − | {{tp|p=34053064|t=2021. Antithrombin III deficiency-induced coagulopathy in the context of COVID-19: a case series.|pdf=|usr=027}}
| |
| − | {{tp|p=34053084|t=2021. Alpha-defensins: risk factor for thrombosis in COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34096051|t=2021. Immune responses and therapeutic challenges in paediatric patients with new-onset acute myeloid leukaemia and concomitant COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34028814|t=2021. Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33991422|t=2021. Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with pre-existing primary immune thrombocytopenia (ITP) in Spain.|pdf=|usr=027}}
| |
| − | {{tp|p=34078498|t=2021. Obesity and COVID-19: Renin-Angiotensin as a mediator of morbidity and mortality.|pdf=|usr=027}}
| |
| − | {{tp|p=34028140|t=2021. Post-surgical pyoderma gangrenosum in otherwise healthy patient with history of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34015823|t=2021. COVID-19 biomarkers and their overlap with comorbidities in a disease biomarker data model.|pdf=|usr=027}}
| |
| − | {{tp|p=34081102|t=2021. A predictive paradigm for COVID-19 prognosis based on the longitudinal measure of biomarkers.|pdf=|usr=027}}
| |
| − | {{tp|p=34090980|t=2021. Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team.|pdf=|usr=027}}
| |
| − | {{tp|p=33949300|t=2021. Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33977897|t=2021. Guillain-Barre Syndrome with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33843530|t=2021. Hearing Loss, Tinnitus, and Dizziness in COVID-19: A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34096048|t=2021. COVID-19 outcomes in hospitalized patients with active cancer: Experiences from a major New York City health care system.|pdf=|usr=027}}
| |
| − | {{tp|p=34097193|t=2021. Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?|pdf=|usr=027}}
| |
| − | {{tp|p=33904638|t=2021. Patients with COVID-19 who experience a myocardial infarction have complex coronary morphology and high in-hospital mortality: Primary results of a nationwide angiographic study.|pdf=|usr=027}}
| |
| − | {{tp|p=33945651|t=2021. COVID-19-related coagulopathy: A review of pathophysiology and pharmaceutical management.|pdf=|usr=027}}
| |
| − | {{tp|p=34037616|t=2021. Trombosis portal aguda en colecistitis incipiente. inverted question markuna consecuencia de la infeccion por COVID-19?|pdf=|usr=027}}
| |
| − | {{tp|p=33325537|t=2021. SARS-CoV-2 has not been detected directly by electron microscopy in the endothelium of chilblain lesions: reply from the authors.|pdf=|usr=027}}
| |
| − | {{tp|p=34096041|t=2021. Rectus sheath and retroperitoneal haematomas in patients with Coronavirus 2019 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33368196|t=2021. von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33326604|t=2021. Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation.|pdf=|usr=027}}
| |
| − | {{tp|p=33983098|t=2021. The role of neurosurgeons in management of post-COVID-19 syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33305996|t=2021. Spectrum of neuroimaging findings in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33914618|t=2021. Special report of the RSNA COVID-19 task force: systematic review of outcomes associated with COVID-19 neuroimaging findings in hospitalized patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34002619|t=2021. Few insights on the post-COVID-19 problem.|pdf=|usr=027}}
| |
| − | {{tp|p=34002615|t=2021. Lymphocyte/mean platelet volume ratio, a new marker; is it effective in predicting the prognosis of COVID-19 cases?|pdf=|usr=027}}
| |
| − | {{tp|p=33913737|t=2021. Breastfeeding and Coronavirus Disease 2019: A Study in Evolving Public Health Recommendations.|pdf=|usr=027}}
| |
| − | {{tp|p=33835835|t=2021. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies' Binding Capacity Between Human Milk and Serum from Coronavirus Disease 2019-Recovered Women.|pdf=|usr=027}}
| |
| − | {{tp|p=33372829|t=2021. Social Support During COVID-19: Perspectives of Breastfeeding Mothers.|pdf=|usr=027}}
| |
| − | {{tp|p=33378122|t=2021. Mortality in hospitalized patients with cancer and coronavirus disease 2019: A systematic review and meta-analysis of cohort studies.|pdf=|usr=027}}
| |
| − | {{tp|p=33878202|t=2021. An Open Letter: COVID-19 and Cancer.|pdf=|usr=027}}
| |
| − | {{tp|p=34092265|t=2021. COVID-19 infection with delayed presentation of infective endocarditis of the prosthetic pulmonary valve.|pdf=|usr=027}}
| |
| − | {{tp|p=33827743|t=2021. Pericardial effusion secondary to COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34097726|t=2021. Recovery From COVID-19-Related Olfactory Disorders and Quality of Life: Insights From an Observational Online Study.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33827250|t=2021. Impaired Right Ventricular Longitudinal Strain Without Pulmonary Hypertension in Patients Who Have Recovered From COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33970675|t=2021. Cardiovascular Evaluation After COVID-19 in 137 Collegiate Athletes: Results of an Algorithm-Guided Screening.|pdf=|usr=027}}
| |
| − | {{tp|p=33984877|t=2021. Role of ACE2 polymorphism in COVID-19: impact of age.|pdf=|usr=027}}
| |
| − | {{tp|p=33908223|t=2021. Analytical validation of an automated assay for the measurement of adenosine deaminase (ADA) and its isoenzymes in saliva and a pilot evaluation of their changes in patients with SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33307062|t=2021. A pregnancy-specific reference interval for procalcitonin.|pdf=|usr=027}}
| |
| − | {{tp|p=33986579|t=2021. Insulin Resistance in a Hospitalized COVID-19 Patient: A Case Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33356606|t=2021. Association of ACEI/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34016010|t=2021. Quantitative assessment of retinal changes in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34088719|t=2021. COVID-19 among Adults Receiving Home versus In-Center Dialysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34088718|t=2021. Renin-Angiotensin System Blockers and the Risk of COVID-19-Related Mortality in Patients with Kidney Failure.|pdf=|usr=027}}
| |
| − | {{tp|p=34031183|t=2021. Predictive Approaches for Acute Dialysis Requirement and Death in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33978370|t=2021. The Relationship between Serological Testing, Demographics, Clinical Presentation and RT-PCR Testing for COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33978369|t=2021. Endogenous Carboxyhemoglobin Concentrations in Predicting Prognosis of Patients with COVID-19 Pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33978366|t=2021. Comparison of Clinical, Laboratory and Demographic Characteristics of Patients Diagnosed with COVID-19 as Symptomatic and Atypical Symptoms.|pdf=|usr=027}}
| |
| − | {{tp|p=33865262|t=2021. SARS-CoV-2 and Human Leukocyte Antigens.|pdf=|usr=027}}
| |
| − | {{tp|p=33865257|t=2021. Clinical Characteristics, Serological and Radiological Longitudinal Changes of Patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34078708|t=2021. An investigation of the association of thromboembolic disease in patients admitted with COVID-19 in Gloucestershire Royal Hospital.|pdf=|usr=027}}
| |
| − | {{tp|p=34078702|t=2021. Streamlining the investigative process - early investigation for thromboembolic and cardiovascular disease in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34078700|t=2021. Real-time collection of data on patients with COVID-19 and thrombosis and/or haemorrhage has aided the development of thromboembolism prophylaxis guidelines at the Royal Surrey County Hospital during the COVID-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34078696|t=2021. Is there a link between the prevalence of cardiovascular disease, diabetes, kidney disease, chronic obstructive pulmonary disease and malignancies and the severity of COVID-19 within the BAME population?|pdf=|usr=027}}
| |
| − | {{tp|p=34078690|t=2021. Temporal immunological marker risk model for predicting severity of COVID-19 outcomes: early risers, late bloomers and general giants.|pdf=|usr=027}}
| |
| − | {{tp|p=34078683|t=2021. Gastrointestinal symptoms involvement in hospitalised COVID-19 patients in Liverpool, UK: a descriptive cross-sectional, single-centre study.|pdf=|usr=027}}
| |
| − | {{tp|p=34078678|t=2021. Acute kidney injury in patients admitted with COVID-19 in a south Birmingham trust.|pdf=|usr=027}}
| |
| − | {{tp|p=34078675|t=2021. Pre-admission anti-coagulation does not improve all-cause mortality in geriatric COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34078674|t=2021. Mortality associated with acute kidney injury in COVID-19 admissions to a high dependency/intensive care setting.|pdf=|usr=027}}
| |
| − | {{tp|p=34078673|t=2021. Long-term COVID-19 complications: a multidisciplinary clinic follow-up approach.|pdf=|usr=027}}
| |
| − | {{tp|p=33675593|t=2021. Inferior Colliculus's Hypermetabolism: A New Finding on Brain FDG PET and Perfusion MRI in a Patient With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33853371|t=2021. A Case Series of SARS-CoV-2 RT-PCR-Positive Hospitalized Infants 60 Days of Age or Younger From 2 New York City Pediatric Emergency Departments.|pdf=|usr=027}}
| |
| − | {{tp|p=33896114|t=2021. Laboratory predictors of severe Coronavirus Disease 2019 and lung function in followed-up.|pdf=|usr=027}}
| |
| − | {{tp|p=33704775|t=2021. COVID-19 and its cardiovascular effects: a systematic review of prevalence studies.|pdf=|usr=027}}
| |
| − | {{tp|p=34010576|t=2021. Could Poor Oral Hygiene Increase the Risk of COVID-19 Infection?|pdf=|usr=027}}
| |
| − | {{tp|p=34010189|t=2021. Balloon embolization of distal left anterior descending artery perforation in a patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33870918|t=2021. Acute Cardiac Injury in Coronavirus Disease 2019 and Other Viral Infections-A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34048372|t=2021. Optimal Patient Selection for the Prophylactic Anticoagulation Therapy in Patients With Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=34048369|t=2021. The Janus Face of Coronavirus Disease 2019-Associated Coagulopathy.|pdf=|usr=027}}
| |
| − | {{tp|p=34048368|t=2021. Return to Work After Coronavirus Disease 2019 Acute Respiratory Distress Syndrome and Intensive Care Admission: Prospective, Case Series at 6 Months From Hospital Discharge.|pdf=|usr=027}}
| |
| − | {{tp|p=34074855|t=2021. Optimal Management of Thrombotic Complications in Patients With Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=34049309|t=2021. The Long Road to Normalcy Following Survival From COVID-19-Associated Acute Respiratory Distress Syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33861553|t=2021. Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19]).|pdf=|usr=027}}
| |
| − | {{tp|p=33874873|t=2021. Cardiovascular Complications in Major 21st Century Viral Epidemics and Pandemics: an Insight into COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34077350|t=2021. Withdrawal Notice: Fatal Outcomes from COVID-19 in Diabetes Patients and its Management: Impact of Diabetes and Other Comorbidities in COVID-19|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33336824|t=2021. The renin-angiotensin system in COVID-19: Why ACE2 targeting by coronaviruses produces higher mortality in elderly hypertensive patients?|pdf=|usr=027}}
| |
| − | {{tp|p=34058978|t=2021. Nasopharyngeal Microbiota in SARS-CoV-2 Positive and Negative Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34001372|t=2021. Remission of Subacute Psychosis in a COVID-19 Patient With an Antineuronal Autoantibody After Treatment With Intravenous Immunoglobulin.|pdf=|usr=027}}
| |
| − | {{tp|p=33948082|t=2021. Acrodermatitis Continua of Hallopeau Evolving into Generalized Pustular Psoriasis Following COVID-19: A Case Report of a Successful Treatment with Infliximab in Combination with Acitretin.|pdf=|usr=027}}
| |
| − | {{tp|p=34066383|t=2021. Risk of COVID-19 in Chagas Disease Patients: What Happen with Cardiac Affectations?|pdf=|usr=027}}
| |
| − | {{tp|p=34073342|t=2021. Associations between the Severity of the Post-Acute COVID-19 Syndrome and Echocardiographic Abnormalities in Previously Healthy Outpatients Following Infection with SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33988463|t=2021. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.|pdf=|usr=027}}
| |
| − | {{tp|p=33933168|t=2021. Empiric use of anticoagulation in hospitalized patients with COVID-19: a propensity score-matched study of risks and benefits.|pdf=|usr=027}}
| |
| − | {{tp|p=33848772|t=2021. Angiotensin II: A possible target for therapeutic intervention in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34015585|t=2021. COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies.|pdf=|usr=027}}
| |
| − | {{tp|p=33996995|t=2021. Response of Healthcare Workers to COVID-19 Protocols after the Index Case at 37 Military Hospital, Ghana.|pdf=|usr=027}}
| |
| − | {{tp|p=33969118|t=2021. A Systematic Analysis on COVID-19 Patients in Inner Mongolia Based on Dynamic Monitoring.|pdf=|usr=027}}
| |
| − | {{tp|p=33937408|t=2021. Fluid and Electrolyte Disturbances in COVID-19 and Their Complications.|pdf=|usr=027}}
| |
| − | {{tp|p=33884270|t=2021. In Silico Analysis of High-Risk Missense Variants in Human ACE2 Gene and Susceptibility to SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34071308|t=2021. Clinical Assessment of Endothelial Function in Convalescent COVID-19 Patients Undergoing Multidisciplinary Pulmonary Rehabilitation.|pdf=|usr=027}}
| |
| − | {{tp|p=34063291|t=2021. Persistent Retinal Microvascular Impairment in COVID-19 Bilateral Pneumonia at 6-Months Follow-Up Assessed by Optical Coherence Tomography Angiography.|pdf=|usr=027}}
| |
| − | {{tp|p=34066385|t=2021. Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps.|pdf=|usr=027}}
| |
| − | {{tp|p=34073591|t=2021. Lower Gene Expression of Angiotensin Converting Enzyme 2 Receptor in Lung Tissues of Smokers with COVID-19 Pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33969285|t=2021. Insights into Plasmodium and SARS-CoV-2 co-infection driven neurological manifestations.|pdf=|usr=027}}
| |
| − | {{tp|p=33824972|t=2021. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry.|pdf=|usr=027}}
| |
| − | {{tp|p=34075401|t=2021. SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation by activation of acid sphingomyelinase.|pdf=|usr=027}}
| |
| − | {{tp|p=33895804|t=2021. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C.|pdf=|usr=027}}
| |
| − | {{tp|p=33338697|t=2021. Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies.|pdf=|usr=027}}
| |
| − | {{tp|p=33894687|t=2021. ABO blood groups, COVID-19 infection and mortality.|pdf=|usr=027}}
| |
| − | {{tp|p=34083499|t=2021. Association of hypercoagulation with severe acute respiratory syndrome coronavirus 2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33986186|t=2021. Leukoerythroblastosis with dyserythropoiesis in an adolescent with SARS-CoV-2-associated macrophage activation syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=34059188|t=2021. ABO blood group and COVID-19: an updated systematic literature review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33263526|t=2021. A case of Evans syndrome secondary to COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34016086|t=2021. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34078273|t=2021. Epidemiological characteristics and mortality risk factors among COVID-19 patients in Ardabil, Northwest of Iran.|pdf=|usr=027}}
| |
| − | {{tp|p=33964922|t=2021. Association of serum uric acid levels with COVID-19 severity.|pdf=|usr=027}}
| |
| − | {{tp|p=34044831|t=2021. Prognostic significance of low TSH concentration in patients with COVID-19 presenting with non-thyroidal illness syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33926382|t=2021. Clinical characteristics of SARS-CoV-2 pneumonia diagnosed in a primary care practice in Madrid (Spain).|pdf=|usr=027}}
| |
| − | {{tp|p=33962582|t=2021. The role of endoscopy and findings in COVID-19 patients, an early North American Cohort.|pdf=|usr=027}}
| |
| − | {{tp|p=33888085|t=2021. Acute surgical-like abdomen as a gastrointestinal manifestation of COVID-19 infection: a case report in Colombia.|pdf=|usr=027}}
| |
| − | {{tp|p=33957890|t=2021. Dying from COVID-19 in nursing homes-sex differences in symptom occurrence.|pdf=|usr=027}}
| |
| − | {{tp|p=34011269|t=2021. Clinical features and outcomes of COVID-19 in older adults: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33879078|t=2021. COVID-19 as the sole cause of death is uncommon in frail home healthcare individuals: a population-based study.|pdf=|usr=027}}
| |
| − | {{tp|p=33941093|t=2021. Projecting COVID-19 disease severity in cancer patients using purposefully-designed machine learning.|pdf=|usr=027}}
| |
| − | {{tp|p=34051739|t=2021. Primary meningococcal arthritis in a COVID-19 18-year-old man: a case report and review of the literature.|pdf=|usr=027}}
| |
| − | {{tp|p=34034649|t=2021. Sociodemographic determinants and clinical risk factors associated with COVID-19 severity: a cross-sectional analysis of over 200,000 patients in Tehran, Iran.|pdf=|usr=027}}
| |
| − | {{tp|p=34020617|t=2021. Symptomatic sinus bradycardia due to electrolyte imbalances in syndrome of inappropriate antidiuretic hormone (SIADH) related covid-19: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34016043|t=2021. SARS-CoV-2 PCR-positive and PCR-negative cases of pneumonia admitted to the hospital during the peak of COVID-19 pandemic: analysis of in-hospital and post-hospital mortality.|pdf=|usr=027}}
| |
| − | {{tp|p=34016041|t=2021. The health-related quality of life in Iranian patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34090358|t=2021. Comparison of renin-angiotensin-aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=34078305|t=2021. Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings.|pdf=|usr=027}}
| |
| − | {{tp|p=33832444|t=2021. Clinical and CT features of mild-to-moderate COVID-19 cases after two sequential negative nucleic acid testing results: a retrospective analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33926392|t=2021. Recovery of new-onset kidney disease in COVID-19 patients discharged from hospital.|pdf=|usr=027}}
| |
| − | {{tp|p=33926377|t=2021. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33902480|t=2021. Epidemiology, clinical characteristics, and treatment outcomes of patients with COVID-19 at Thailand's university-based referral hospital.|pdf=|usr=027}}
| |
| − | {{tp|p=33879073|t=2021. The characteristics of laboratory tests at admission and the risk factors for adverse clinical outcomes of severe and critical COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33874896|t=2021. COVID-19 in Northeast Bosnia and Herzegovina and patient's length of hospitalization.|pdf=|usr=027}}
| |
| − | {{tp|p=33845787|t=2021. Clinical characteristics and outcome of influenza virus infection among adults hospitalized with severe COVID-19: a retrospective cohort study from Wuhan, China.|pdf=|usr=027}}
| |
| − | {{tp|p=34011359|t=2021. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study.|pdf=|usr=027}}
| |
| − | {{tp|p=33980231|t=2021. Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34082752|t=2021. Renin-angiotensin system blockers and COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33910589|t=2021. What neurological and psychiatric effects does COVID-19 have on its survivors?|pdf=|usr=027}}
| |
| − | {{tp|p=34033224|t=2021. Androgenetic alopecia and COVID-19: A review of the hypothetical role of androgens.|pdf=|usr=027}}
| |
| − | {{tp|p=33993616|t=2021. Pityriasis rosea infection in a COVID-19 patient successfully treated with systemic steroid and antihistamine via telemedicine: Literature update of a possible prodromal symptom of an underlying SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33993592|t=2021. COVID-19-related chilblain-like lesions and idiopathic perniosis: Additional variables possibly influencing dermoscopic pattern.|pdf=|usr=027}}
| |
| − | {{tp|p=34053098|t=2021. The COVID-19 pandemic and associated worsening of diabetic ketoacidosis presentation in youth.|pdf=|usr=027}}
| |
| − | {{tp|p=34043837|t=2021. Severe acute respiratory syndrome coronavirus 2 as a potential cause of type 1 diabetes facilitated by spike protein receptor binding domain attachment to human islet cells: An illustrative case study and experimental data.|pdf=|usr=027}}
| |
| − | {{tp|p=33858854|t=2021. Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19: An International, Multicenter Retrospective Meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34018307|t=2021. Elevated HbA1c levels in pre-Covid-19 infection increases the risk of mortality: A sistematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34060194|t=2021. Association of obesity with postacute sequelae of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33876462|t=2021. Graft-versus-host disease-like reactions in the gastrointestinal tract in a patient with SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34039516|t=2021. COVID-19 case-fatality disparities among people with intellectual and developmental disabilities: Evidence from 12 US jurisdictions.|pdf=|usr=027}}
| |
| − | {{tp|p=33938418|t=2021. COVID-19 in Patients With a Past History of Chemical War Injury: A Cross-Sectional Study in Southern Iran.|pdf=|usr=027}}
| |
| − | {{tp|p=33934734|t=2021. Mortality Rate of Patients With COVID-19 Based on Underlying Health Conditions.|pdf=|usr=027}}
| |
| − | {{tp|p=34002684|t=2021. Clinical Characteristics and Abnormal Parameters Evolution in Patients With Novel Coronavirus Infection: A Case Series of 272 Cases in Guangzhou.|pdf=|usr=027}}
| |
| − | {{tp|p=33926610|t=2021. Characteristics of 1738 Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.|pdf=|usr=027}}
| |
| − | {{tp|p=33867007|t=2021. Clinical Characteristics of the First 100 Patients of COVID-19 in Tobruk, Libya: A Brief Report From Low-Resource Settings.|pdf=|usr=027}}
| |
| − | {{tp|p=33975666|t=2021. Association of smoking and cardiovascular disease with disease progression in COVID-19: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33866988|t=2021. COVID-19 re-infection in Shahroud, Iran: a follow-up study.|pdf=|usr=027}}
| |
| − | {{tp|p=33951659|t=2021. Are Individuals with Substance Use Disorders at Higher Risk of SARS-CoV-2 Infection? Population-Based Registry Study in Northern Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=34050643|t=2021. COVID-19 and the heart: insights from the National Societies of Cardiology Journals.|pdf=|usr=027}}
| |
| − | {{tp|p=34080005|t=2021. Going after COVID-19 myocarditis.|pdf=|usr=027}}
| |
| − | {{tp|p=33998683|t=2021. Respiratory follow-up after hospitalization for COVID-19: Who and when?|pdf=|usr=027}}
| |
| − | {{tp|p=34085949|t=2021. Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study.|pdf=|usr=027}}
| |
| − | {{tp|p=33932255|t=2021. Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings.|pdf=|usr=027}}
| |
| − | {{tp|p=33983673|t=2021. Factors associated with COVID-19 in people with Parkinson's disease: a systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33982853|t=2021. Encephalitis as a neurological complication of COVID-19: A systematic review and meta-analysis of incidence, outcomes, and predictors.|pdf=|usr=027}}
| |
| − | {{tp|p=34080271|t=2021. Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.|pdf=|usr=027}}
| |
| − | {{tp|p=34056996|t=2021. Acquired Monocular Blindness Associated with Retinitis and Optic Neuritis in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33902413|t=2021. Outcome of a HIV Positive Patient Infected with COVID-19 After an Autologous Bone Marrow Transplantation: A Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=33970839|t=2021. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm That Implicates For Therapeutic Strategies.|pdf=|usr=027}}
| |
| − | {{tp|p=34039879|t=2021. Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change?|pdf=|usr=027}}
| |
| − | {{tp|p=34027906|t=2021. Coronavirus disease 2019 and kidney injury.|pdf=|usr=027}}
| |
| − | {{tp|p=33852526|t=2021. Neuropathogenesis of acute coronavirus disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=34074938|t=2021. The solid organ transplant recipient with SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33229976|t=2021. Coronavirus 2019: clinical and neuropathological aspects.|pdf=|usr=027}}
| |
| − | {{tp|p=34097555|t=2021. Cutaneous manifestations related to the COVID-19 pandemic: a review article.|pdf=|usr=027}}
| |
| − | {{tp|p=33956605|t=2021. Management of a Child vs an Adult Presenting With Acral Lesions During the COVID-19 Pandemic: A Practical Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33891838|t=2021. Cutaneous Manifestations of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34096848|t=2021. Cutaneous Manifestations of COVID-19: Characteristics, Pathogenesis, and the Role of Dermatology in the Pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34038630|t=2021. The COVID-19 pandemic, heart and cardiovascular diseases: What we have learned.|pdf=|usr=027}}
| |
| − | {{tp|p=34021631|t=2021. HbA1c and fasting plasma glucose cannot replace oral glucose tolerance test in order to screen for hyperglycaemia in pregnancy.|pdf=|usr=027}}
| |
| − | {{tp|p=33334810|t=2021. Comparison of Diabetic Ketoacidosis in Adults During the SARS-CoV-2 Outbreak and Over the Same Time Period for the Preceding 3 Years.|pdf=|usr=027}}
| |
| − | {{tp|p=33905347|t=2021. Spike in Diabetic Ketoacidosis Rates in Pediatric Type 2 Diabetes During the COVID-19 Pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33957689|t=2021. Die "vierte Welle"? COVID-19 und konsekutive kognitive Storungen.|pdf=|usr=027}}
| |
| − | {{tp|p=33315310|t=2021. Epidemiology and clinical features of emergency department patients with suspected COVID-19: Insights from Australia's 'second wave' (COVED-4).|pdf=|usr=027}}
| |
| − | {{tp|p=34014139|t=2021. Association between Thyroid Function and Prognosis of COVID-19: A Retrospective Observational Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33853339|t=2021. Reinfekce covidem-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34049827|t=2021. Prevalence and Characteristics of Altered Sense of Smell/Taste During Covid-19 first wave: A French Nationwide Cross-sectional Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33990122|t=2021. The central role of amygdala in stress-related cardiac diseases and an update on long-COVID.|pdf=|usr=027}}
| |
| − | {{tp|p=34008835|t=2021. Prognostic value of right ventricular dilatation in patients with COVID-19: a multicentre study.|pdf=|usr=027}}
| |
| − | {{tp|p=33950864|t=2021. Serum sodium alterations in SARS CoV-2 (COVID-19) infection: impact on patient outcome.|pdf=|usr=027}}
| |
| − | {{tp|p=33377239|t=2021. The hyperdynamic circulatory profile of patients with COVID-19-related acute vascular distress syndrome. Letter regarding the article 'Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization'.|pdf=|usr=027}}
| |
| − | {{tp|p=33377206|t=2021. COVID-19 acute respiratory distress syndrome: intriguing haemodynamics of an intriguing syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=34011555|t=2021. Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33883206|t=2021. Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33368288|t=2021. Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=34030677|t=2021. Extremes of age are associated with differences in the expression of selected pattern recognition receptor genes and ACE2, the receptor for SARS-CoV-2: implications for the epidemiology of COVID-19 disease.|pdf=|usr=027}}
| |
| − | {{tp|p=34059010|t=2021. Acute kidney injury in children with COVID-19: a retrospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=34039299|t=2021. Outcomes of patients with end stage kidney disease on dialysis with COVID-19 in Abu Dhabi, United Arab Emirates; from PCR to antibody.|pdf=|usr=027}}
| |
| − | {{tp|p=33933026|t=2021. Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSD.|pdf=|usr=027}}
| |
| − | {{tp|p=34016110|t=2021. Tongue ulcer in a patient with COVID-19: a case presentation.|pdf=|usr=027}}
| |
| − | {{tp|p=33910509|t=2021. Effect of COVID-19 on childhood Mycoplasma pneumoniae infection in Chengdu, China.|pdf=|usr=027}}
| |
| − | {{tp|p=34001013|t=2021. Characteristics, clinical and laboratory data and outcomes of pregnant women with confirmed SARS-CoV-2 infection admitted to Al-Zahra tertiary referral maternity center in Iran: a case series of 24 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33902483|t=2021. SARS-COV-2 infection in pregnant women and newborns in a Spanish cohort (GESNEO-COVID) during the first wave.|pdf=|usr=027}}
| |
| − | {{tp|p=33863292|t=2021. The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33794829|t=2021. The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34059034|t=2021. Patterns and predictors of sick leave after Covid-19 and long Covid in a national Swedish cohort.|pdf=|usr=027}}
| |
| − | {{tp|p=33902513|t=2021. Clinical, radiological and functional outcomes in patients with SARS-CoV-2 pneumonia: a prospective observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=34011492|t=2021. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33952573|t=2021. Platypnoea-orthodeoxia syndrome in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33952571|t=2021. Reactive non-sexually related acute genital ulcers associated with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34011649|t=2021. COVID-19-associated central retinal vein occlusion treated with oral aspirin.|pdf=|usr=027}}
| |
| − | {{tp|p=33980571|t=2021. Exuberant spontaneous pneumothorax, pneumomediastinum, pneumopericardium and subcutaneous emphysema in COVID-19 pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33980567|t=2021. Delayed, transient and self-resolving neutropenia following COVID-19 pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33975848|t=2021. Pneumomediastinum in a patient with COVID-19 due to diffuse alveolar damage.|pdf=|usr=027}}
| |
| − | {{tp|p=33975846|t=2021. Intravenous immunoglobulin in COVID-19 associated Guillain-Barre syndrome in pregnancy.|pdf=|usr=027}}
| |
| − | {{tp|p=33975843|t=2021. Coronavirus disease 2019 (COVID-19)-associated constrictive pericarditis.|pdf=|usr=027}}
| |
| − | {{tp|p=33972302|t=2021. Combination of ectopic pancreas and intestinal malrotation presenting as non-specific right iliac fossa pain in a SARS-CoV-2 positive patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33653871|t=2021. Imaging as an alternate diagnostic modality in a presumptive case of abdominopelvic TB in a COVID-19 patient.|pdf=|usr=027}}
| |
| − | {{tp|p=34083188|t=2021. Surgical management of a COVID-19-associated necrotic pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33827885|t=2021. Leucocytoclastic vasculitis secondary to COVID-19 infection in a young child.|pdf=|usr=027}}
| |
| − | {{tp|p=33931425|t=2021. Aberrated supraventricular tachycardia associated with neonatal fever and COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33906877|t=2021. COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?|pdf=|usr=027}}
| |
| − | {{tp|p=33906867|t=2021. New-onset psychosis due to COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33893137|t=2021. Febrile neutropenia due to COVID-19 in an immunocompetent patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33893131|t=2021. Cardiorenal syndrome in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33883113|t=2021. Rare case of endogenous Klebsiella endophthalmitis associated with emphysematous prostatitis in a patient with diabetes, cirrhosis and COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33883111|t=2021. Fatal SARS-CoV-2 and Mycobacterium tuberculosis coinfection in an infant: insights from Botswana.|pdf=|usr=027}}
| |
| − | {{tp|p=33875514|t=2021. Pneumatocele after recovering from COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33875510|t=2021. Severe metabolic ketoacidosis as a primary manifestation of SARS-CoV-2 infection in non-diabetic pregnancy.|pdf=|usr=027}}
| |
| − | {{tp|p=33875508|t=2021. 'Long COVID' syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33875507|t=2021. Life-threatening DRESS syndrome with kidney damage following severe COVID-19 in a patient with Down syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33875503|t=2021. Case of right ventricular and aortic thrombi in a patient with severe COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33849880|t=2021. Internuclear ophthalmoplegia as a presenting feature in a COVID-19-positive patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33849864|t=2021. COVID-19 IgG-related autoimmune inflammatory necrotizing myositis.|pdf=|usr=027}}
| |
| − | {{tp|p=33846189|t=2021. Does withdrawal of immunosuppression in rheumatoid arthritis after SARS-CoV-2 infection increase the risk of vasculitis?|pdf=|usr=027}}
| |
| − | {{tp|p=34039689|t=2021. Rehabilitation post-COVID-19: cross-sectional observations using the Stanford Hall remote assessment tool.|pdf=|usr=027}}
| |
| − | {{tp|p=33958335|t=2021. Clinical course and outcome of patients with COVID-19 in Mumbai City: an observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=33947740|t=2021. Characteristics, outcomes and risk factors for mortality of 522 167 patients hospitalised with COVID-19 in Brazil: a retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33947725|t=2021. Relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: a rapid scoping review.|pdf=|usr=027}}
| |
| − | {{tp|p=34031110|t=2021. Symptom presentation of SARS-CoV-2-positive and negative patients: a nested case-control study among patients calling the emergency medical service and medical helpline.|pdf=|usr=027}}
| |
| − | {{tp|p=34006559|t=2021. Disease burden from COVID-19 symptoms among inpatients at the temporary military hospitals in Wuhan: a retrospective multicentre cross-sectional study.|pdf=|usr=027}}
| |
| − | {{tp|p=33980533|t=2021. Support and follow-up needs of patients discharged from intensive care after severe COVID-19: a mixed-methods study of the views of UK general practitioners and intensive care staff during the pandemic's first wave.|pdf=|usr=027}}
| |
| − | {{tp|p=33972332|t=2021. Characterisation of asymptomatic patients and efficacy of preventive measures for SARS-CoV-2 infection in a large population of Southern Italy: a cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34006036|t=2021. Diagnostic accuracy of subjective dyspnoea in detecting hypoxaemia among outpatients with COVID-19: a retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34006034|t=2021. Heterogeneity in COVID-19 patient volume, characteristics and outcomes across US Department of Veterans Affairs facilities: an observational cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34088708|t=2021. Cardiovascular-related deaths at the beginning of the COVID-19 outbreak: a prospective analysis based on the UK Biobank.|pdf=|usr=027}}
| |
| − | {{tp|p=34083350|t=2021. Characterising the long-term clinical outcomes of 1190 hospitalised patients with COVID-19 in New York City: a retrospective case series.|pdf=|usr=027}}
| |
| − | {{tp|p=33827831|t=2021. 3219 hospitalised patients with COVID-19 in Southeast Michigan: a retrospective case cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33875444|t=2021. COVID-19 in patients with hepatobiliary and pancreatic diseases: a single-centre cross-sectional study in East London.|pdf=|usr=027}}
| |
| − | {{tp|p=34059527|t=2021. Lack of association between either outpatient or inpatient glycemic control and COVID-19 illness severity or mortality in patients with diabetes.|pdf=|usr=027}}
| |
| − | {{tp|p=34083248|t=2021. Risk factors for adverse outcomes among 35 879 veterans with and without diabetes after diagnosis with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34041362|t=2021. No findings of SARS-CoV-2 in conjunctival swabs from patients at an emergency outpatient ophthalmological healthcare facility in a Swedish county hospital: a cross-sectional study.|pdf=|usr=027}}
| |
| − | {{tp|p=33827856|t=2021. Symptomatic, biochemical and radiographic recovery in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33947980|t=2021. Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS-COV-2 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33907304|t=2021. Clinical course and outcomes of COVID-19 in hematopoietic cell transplant patients, a regional report from the Middle East.|pdf=|usr=027}}
| |
| − | {{tp|p=33574506|t=2021. COVID tongue.|pdf=|usr=027}}
| |
| − | {{tp|p=33358046|t=2021. Association of frailty and mortality in patients with COVID-19: a meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34060708|t=2021. Systematic review of cases of acute myelitis in individuals with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33837630|t=2021. Prevalence, clinical characteristics and outcomes of Guillain-Barre syndrome spectrum associated with COVID-19: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33884707|t=2021. Neuro-COVID frequency and short-term outcome in the Northern Portuguese population.|pdf=|usr=027}}
| |
| − | {{tp|p=34044408|t=2021. Neurological Symptoms, Comorbidities, and Complications of COVID-19: A Literature Review and Meta-Analysis of Observational Studies.|pdf=|usr=027}}
| |
| − | {{tp|p=34077513|t=2021. Atrial fibrillation burden during the coronavirus disease 2019 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34081788|t=2021. Does autoimmune vitiligo protect against COVID-19 disease?|pdf=|usr=027}}
| |
| − | {{tp|p=33977531|t=2021. A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID-19) who developed virus or drug-related mucocutaneous manifestations.|pdf=|usr=027}}
| |
| − | {{tp|p=33838048|t=2021. Pathobiology questions raised by telogen effluvium and trichodynia in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33904234|t=2021. Carotid stiffness, intima-media thickness and aortic augmentation index among adults with SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33998773|t=2021. Neurological consequences of neurovascular unit and brain vasculature damages: potential risks for pregnancy infections and COVID-19-babies.|pdf=|usr=027}}
| |
| − | {{tp|p=34020462|t=2021. Der Zusammenhang zwischen COVID-19 und Schlaganfall: Pathophysiologie und klinische Bedeutung.|pdf=|usr=027}}
| |
| − | {{tp|p=33876439|t=2021. Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature review.|pdf=|usr=027}}
| |
| − | {{tp|p=34008322|t=2021. Coronavirus disease 2019-associated worsening and improvement of ataxia and gait in a patient with multiple system atrophy.|pdf=|usr=027}}
| |
| − | {{tp|p=33982839|t=2021. Addressing the impact of SARS-CoV-2 infection in persons with congenital bleeding disorders: The Italian MECCOVID-19 study.|pdf=|usr=027}}
| |
| − | {{tp|p=33915601|t=2021. Successful treatment of COVID-19 in a patient with severe haemophilia A on emicizumab prophylaxis in the intensive care unit.|pdf=|usr=027}}
| |
| − | {{tp|p=33951220|t=2021. Seroconversion and kinetic of anti SARS-COV-2 antibodies in 25 patients with hematological malignancies who recovered from SARS-COV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34060217|t=2021. Late thrombotic complications after SARS-CoV-2 infection in hemodialysis patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33961298|t=2021. Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33982813|t=2021. A rare but devastating cause of twin loss in a near-term pregnancy highlighting the features of severe SARS-CoV-2 placentitis.|pdf=|usr=027}}
| |
| − | {{tp|p=33896121|t=2021. The influence of HLA genotype on the severity of COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33852168|t=2021. Initiation of psychotropic medication in hospitalized patients with COVID-19: Association with clinical and biological characteristics.|pdf=|usr=027}}
| |
| − | {{tp|p=34002212|t=2021. #ESHREjc report: does SARS-CoV-2 affect male fertility?|pdf=|usr=027}}
| |
| − | {{tp|p=34088221|t=2021. Focal superior quadrant haemorrhages in post COVID-19 patient: A target for personalized medicine.|pdf=|usr=027}}
| |
| − | {{tp|p=33832345|t=2021. Survey on the impact of COVID19 in patients on immunosuppression for ocular and orbital inflammatory disorders.|pdf=|usr=027}}
| |
| − | {{tp|p=33885335|t=2021. Bilateral angle-closure during hospitalization for coronavirus disease-19 (COVID-19): A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33843287|t=2021. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33972290|t=2021. Critical care survival rates in COVID-19 patients improved as the first wave of the pandemic developed.|pdf=|usr=027}}
| |
| − | {{tp|p=33316115|t=2021. What can the hair tell us about COVID-19?|pdf=|usr=027}}
| |
| − | {{tp|p=33334189|t=2021. Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33902377|t=2021. Pulmonary fibrosis secondary to COVID-19: a narrative review.|pdf=|usr=027}}
| |
| − | {{tp|p=33955309|t=2021. Glycosylated hemoglobin as a predictor of mortality in severe pneumonia by COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33990103|t=2021. COVID-19 and Dry Eye.|pdf=|usr=027}}
| |
| − | {{tp|p=33356716|t=2021. Vertical Transmission of SARS-CoV-2 from COVID-19 Infected Pregnant Women: A Review on Intrauterine Transmission.|pdf=|usr=027}}
| |
| − | {{tp|p=34037587|t=2021. Trombosi secondaria a vaccinazione anti-COVID-19: un reale rischio clinico o tanto rumore per nulla?|pdf=|usr=027}}
| |
| − | {{tp|p=34024447|t=2021. Hepatic Manifestations of Nonhepatotropic Infectious Agents Including Severe Acute Respiratory Syndrome Coronavirus-2, Adenovirus, Herpes Simplex Virus, and Coxiella burnetii.|pdf=|usr=027}}
| |
| − | {{tp|p=33862153|t=2021. Hepatitis fulminante por reactivacion del virus de la hepatitis B (VHB) como consecuencia de la pandemia por COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34037569|t=2021. HOW EXTRAPULMONARY SYMPTOMS INVOLVING THE GASTROINTESTINAL TRACT AND ELEVATIONS IN TRANSAMINASE LEVELS CAN BE INDICATIVE OF AN EARLY PHASE OF COVID-19: A CASE STUDY.|pdf=|usr=027}}
| |
| − | {{tp|p=33340212|t=2021. Prevalence of dementia and its impact on mortality in patients with coronavirus disease 2019: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34083386|t=2021. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34083385|t=2021. Liver injury, hypoalbuminaemia and severe SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34052923|t=2021. Assessment of Taste Function.|pdf=|usr=027}}
| |
| − | {{tp|p=34028220|t=2021. [THE EXPERIENCE OF OBSTETRICIANS DURING THE FIRST OUTBURST OF COVID-19].|pdf=|usr=027}}
| |
| − | {{tp|p=33965986|t=2021. Altered Mental Status in Patients Hospitalized with COVID-19: Perspectives from Neurologic and Psychiatric Consultants.|pdf=|usr=027}}
| |
| − | {{tp|p=33863758|t=2021. Anatomical complexity does not predict outcomes after COVID-19 in adults with congenital heart disease.|pdf=|usr=027}}
| |
| − | {{tp|p=34027786|t=2021. Incidence Rate of COVID-19 Infection in Hemoglobinopathies: A Systematic Review and Meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33317358|t=2021. beta-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33368966|t=2021. Immune deficiency is a risk factor for severe COVID-19 in people living with HIV.|pdf=|usr=027}}
| |
| − | {{tp|p=33843611|t=2021. COVID-19-associated pancreatic dysfunction.|pdf=|usr=027}}
| |
| − | {{tp|p=33962477|t=2021. COVID-19, Diabetes, and Associated Health Outcomes in China: Results from a Nationwide Survey of 10 545 Adults.|pdf=|usr=027}}
| |
| − | {{tp|p=33306437|t=2021. Prognostic value of labs ordered on patients hospitalized with COVID-19.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33934887|t=2021. Anaesthesia-related drugs and SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33342538|t=2021. Hypoxaemia does not necessitate tracheal intubation in COVID-19 patients. Comment on Br J Anaesth 2021; 126: 44-7.|pdf=|usr=027}}
| |
| − | {{tp|p=33299130|t=2021. Severity of COVID-19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project.|pdf=|usr=027}}
| |
| − | {{tp|p=33976367|t=2021. Impact of active cancer on COVID-19 survival: a matched-analysis on 557 consecutive patients at an Academic Hospital in Lombardy, Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=33939462|t=2021. Addressing nutrition in the road map of recovery for those with long COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33928632|t=2021. COVID-19 infection in patients with severe aplastic anaemia.|pdf=|usr=027}}
| |
| − | {{tp|p=33836988|t=2021. Detection of SARS-CoV-2 genomic and subgenomic RNA in retina and optic nerve of patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33849909|t=2021. Physical inactivity is associated with a higher risk for severe COVID-19 outcomes: a study in 48 440 adult patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33313649|t=2021. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barre syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33856027|t=2021. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital.|pdf=|usr=027}}
| |
| − | {{tp|p=33347532|t=2021. Neurological complications in COVID-19 patients from Latin America.|pdf=|usr=027}}
| |
| − | {{tp|p=33998177|t=2021. Changes of coagulation function and risk of stroke in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33314783|t=2021. Attributing increased prevalence of facial palsy to SARS-CoV-2 requires evidence.|pdf=|usr=027}}
| |
| − | {{tp|p=33314732|t=2021. Mental health consequences of infections by coronaviruses including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).|pdf=|usr=027}}
| |
| − | {{tp|p=34022369|t=2021. Detection of SARS-CoV-2 genome and whole transcriptome sequencing in frontal cortex of COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33359380|t=2021. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms.|pdf=|usr=027}}
| |
| − | {{tp|p=33152446|t=2021. Prenatal exposure to viral infection and neuropsychiatric disorders in offspring: A review of the literature and recommendations for the COVID-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33940153|t=2021. Lifestyle risk factors and infectious disease mortality, including COVID-19, among middle aged and older adults: Evidence from a community-based cohort study in the United Kingdom.|pdf=|usr=027}}
| |
| − | {{tp|p=33870235|t=2021. COVID-19 and hyperammonemia: Potential interplay between liver and brain dysfunctions.|pdf=|usr=027}}
| |
| − | {{tp|p=33842898|t=2021. The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations.|pdf=|usr=027}}
| |
| − | {{tp|p=34027497|t=2021. Olfactory and gustatory dysfunctions in SARS-CoV-2 infection: A systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=34002170|t=2021. Akinetic mutism in COVID-19-related encephalopathy: A cytokine-mediated maladaptive sickness behavioral response?|pdf=|usr=027}}
| |
| − | {{tp|p=34095787|t=2021. SARS-CoV-2 infection with pneumonia and stroke.|pdf=|usr=027}}
| |
| − | {{tp|p=34071007|t=2021. Neurosensory Rehabilitation and Olfactory Network Recovery in Covid-19-related Olfactory Dysfunction.|pdf=|usr=027}}
| |
| − | {{tp|p=33918426|t=2021. Long-Term Brain Disorders in Post Covid-19 Neurological Syndrome (PCNS) Patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33932392|t=2021. Sphenopalatine ganglion block for refractory COVID-19 headache: a descriptive case series.|pdf=|usr=027}}
| |
| − | {{tp|p=34043944|t=2021. Chronic arthritis related to SARS-CoV-2 infection in a pediatric patient: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33992555|t=2021. Monitoring of cases of anosmia and COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33965353|t=2021. Pathophysiological relationship between COVID-19 and olfactory dysfunction: A systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=33852690|t=2021. Mental health interventions following COVID-19 and other coronavirus infections: a systematic review of current recommendations and meta-analysis of randomized controlled trials.|pdf=|usr=027}}
| |
| − | {{tp|p=33847347|t=2021. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33966886|t=2021. Comparaison des caracteristiques et des pronostics des patients avec et sans cancer actif hospitalises pour une infection a SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=34008791|t=2021. Excesso de mortes por causas respiratorias em oito metropoles brasileiras durante os seis primeiros meses da pandemia de COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33881958|t=2021. Neuroimaging Findings of Hospitalized Covid-19 Patients: A Canadian Retrospective Observational Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34035665|t=2021. Serum antibody response in COVID-19-recovered patients who retested positive.|pdf=|usr=027}}
| |
| − | {{tp|p=34055116|t=2021. Coinfections with Respiratory Pathogens among COVID-19 Patients in Korea.|pdf=|usr=027}}
| |
| − | {{tp|p=34055114|t=2021. Risk Factors for COVID-19 in Patients with Hypertension.|pdf=|usr=027}}
| |
| − | {{tp|p=33936349|t=2021. A Systematic Review and Meta-Analysis of Risk Factors Associated with Severity and Death in COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33884042|t=2021. Potential Predictors of Poor Prognosis among Severe COVID-19 Patients: A Single-Center Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34046182|t=2021. Acute Tubulointerstitial Nephritis in a Patient on Anti-Programmed Death-Ligand 1 Triggered by COVID-19: A Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=33825134|t=2021. A scoping review of COVID-19 experiences of people living with dementia.|pdf=|usr=027}}
| |
| − | {{tp|p=33929698|t=2021. Supporting breastfeeding in rural Newfoundland and Labrador communities during COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33978563|t=2021. From cellular function to global impact: the vascular perspective on COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33881277|t=2021. The requirement for surgery and subsequent 30-day mortality in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33910818|t=2021. Coronavirus Disease 2019 and Nasal Conditions: A Review of Current Evidence.|pdf=|usr=027}}
| |
| − | {{tp|p=34011758|t=2021. Orbital infarction syndrome secondary to rhino-orbital mucormycosis in a case of COVID-19: Clinico-radiological features.|pdf=|usr=027}}
| |
| − | {{tp|p=34011757|t=2021. Intracranial hypertension and visual loss following COVID-19: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34011742|t=2021. Rise of the phoenix: Mucormycosis in COVID-19 times.|pdf=|usr=027}}
| |
| − | {{tp|p=34011699|t=2021. Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34097233|t=2021. Coagulation Abnormalities Due to COVID-19 in a Child with Thalassemia: Authors' Reply.|pdf=|usr=027}}
| |
| − | {{tp|p=34039456|t=2021. Effect of coronavirus disease 2019 (COVID-19) pandemic on catheter-related bloodstream infections: Control measures should not be relaxed.|pdf=|usr=027}}
| |
| − | {{tp|p=33858547|t=2021. Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study.|pdf=|usr=027}}
| |
| − | {{tp|p=34013654|t=2021. Making scents of loss of taste in COVID-19: Is self-reported loss of taste due to olfactory dysfunction? A prospective study using psychophysical testing.|pdf=|usr=027}}
| |
| − | {{tp|p=34096193|t=2021. Assessment of patient recognition of coronavirus disease 2019 (COVID-19)-associated olfactory loss and recovery: a longitudinal study.|pdf=|usr=027}}
| |
| − | {{tp|p=33864717|t=2021. Risk factors and characteristics associated with persistent smell loss in coronavirus disease 2019 (COVID-19) patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33848404|t=2021. Prospective assessment of smell and taste impairment in a South-American coronavirus disease 2019 (COVID-19) cohort: Association with the need for hospitalization and reversibility of dysfunction.|pdf=|usr=027}}
| |
| − | {{tp|p=34043796|t=2021. Ocular transmission and manifestation for coronavirus disease: a systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=33861864|t=2021. COVID-19 and cancer: A deadly pairing.|pdf=|usr=027}}
| |
| − | {{tp|p=33861870|t=2021. Cumulative COVID-19 incidence, mortality and prognosis in cancer survivors: A population-based study in Reggio Emilia, Northern Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=34085352|t=2021. Characteristics and outcomes of hospitalised older patients with chronic kidney disease and COVID-19: A multicenter nationwide controlled study.|pdf=|usr=027}}
| |
| − | {{tp|p=34051031|t=2021. Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) /Hepatitis B virus (HBV) Co-infected Patients: A case series and review of the literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33998752|t=2021. Clinical-radiological correlations in COVID-19-related venous thromboembolism: Preliminary results from a multidisciplinary study.|pdf=|usr=027}}
| |
| − | {{tp|p=33993597|t=2021. Liver stiffness is associated with disease severity and worse clinical scenarios in coronavirus disease 2019: A prospective transient elastography study.|pdf=|usr=027}}
| |
| − | {{tp|p=33966326|t=2021. Imaging approach to COVID-19 associated pulmonary embolism.|pdf=|usr=027}}
| |
| − | {{tp|p=33977626|t=2021. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=33932073|t=2021. Changes in the respiratory function of COVID-19 survivors during follow-up: A novel respiratory disorder on the rise?|pdf=|usr=027}}
| |
| − | {{tp|p=33887873|t=2021. On the imbalanced protective arm of RAS in COVID-19: Lesson from rare genetic tubulopathies.|pdf=|usr=027}}
| |
| − | {{tp|p=33891337|t=2021. Predictive value of D-dimer/albumin ratio and fibrinogen/albumin ratio for in-hospital mortality in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33887100|t=2021. The role of hemogram parameters and C-reactive protein in predicting mortality in COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33884722|t=2021. Clinical, sinonasal, and long-term smell and taste outcomes in mildly symptomatic COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33884718|t=2021. Combined predictive performance of age and neutrophilic percentage on admission for severe novel coronavirus disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33864318|t=2021. Evaluation of the relationship between laboratory parameters and pulmonary function tests in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33999406|t=2021. Nonuremic calciphylaxis in a COVID-19 patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33880768|t=2021. Comment on "Androgens and women: COVID-19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism".|pdf=|usr=027}}
| |
| − | {{tp|p=33855708|t=2021. COVID-19 dermatological manifestations: results from the Mexican Academy of Dermatology COVID-19 registry.|pdf=|usr=027}}
| |
| − | {{tp|p=33830498|t=2021. The frequency and characteristics of itching in severe COVID-19 patients: first report.|pdf=|usr=027}}
| |
| − | {{tp|p=33963765|t=2021. International registry of dermatological manifestations secondary to COVID-19 infection in 347 Hispanic patients from 25 countries.|pdf=|usr=027}}
| |
| − | {{tp|p=33846968|t=2021. Eruptive pseudoangiomatosis and SARS-CoV-2 (COVID-19) infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33961712|t=2021. COVID-19 and dementia: A deadly combination.|pdf=|usr=027}}
| |
| − | {{tp|p=33939271|t=2021. Analysis of laboratory blood parameter results for patients diagnosed with COVID-19, from all ethnic group populations: A single centre study.|pdf=|usr=027}}
| |
| − | {{tp|p=33973726|t=2021. Original Article: Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33973723|t=2021. Original article: Soni M. Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection. Int J Lab Hematol. 2020;00:1-5. https://doi.org/10.1111/ijlh.13425.|pdf=|usr=027}}
| |
| − | {{tp|p=34000089|t=2021. The complicated relationships of heparin-induced thrombocytopenia and platelet factor 4 antibodies with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33837662|t=2021. Early hematological indicators of severe COVID-19 disease in hospitalized patients: Data from a South Asian population.|pdf=|usr=027}}
| |
| − | {{tp|p=33881804|t=2021. Laboratory divergences in concurrent diagnosis of acute myeloid leukemia relapse and COVID-19: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33855802|t=2021. Heparin dosage, level, and resistance in SARS-CoV2 infected patients in intensive care unit.|pdf=|usr=027}}
| |
| − | {{tp|p=33998110|t=2021. COVID-19 and pregnancy: A scoping review on pregnancy characteristics and outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=33340071|t=2021. Acute Meningoencephalitis in a Child Secondary to SARS-CoV-2 Virus.|pdf=|usr=027}}
| |
| − | {{tp|p=34085629|t=2021. SHEA Pediatric Leadership Council commentary: Ambulatory management of neonates born to mothers infected with severe acute respiratory coronavirus virus 2 (SARS-CoV-2).|pdf=|usr=027}}
| |
| − | {{tp|p=33866991|t=2021. Inter-hospital outbreak of Burkholderia cepacia complex VAP caused by contaminated mouthwash in coronavirus disease 2019 (COVID-19) patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33853694|t=2021. Health Care Acquired COVID-19 is Less Symptomatic than Community Acquired Disease Among Healthcare Workers.|pdf=|usr=027}}
| |
| − | {{tp|p=33939587|t=2021. Spontaneous psoas haematoma: a life-threatening complication of anticoagulation in COVID-19. A case series of four episodes.|pdf=|usr=027}}
| |
| − | {{tp|p=33939582|t=2021. Splenectomy and risk of COVID-19 infection, hospitalisation, and death.|pdf=|usr=027}}
| |
| − | {{tp|p=33969791|t=2021. Characteristics of patients discharged and readmitted after COVID-19 hospitalisation within a large integrated health system in the United States.|pdf=|usr=027}}
| |
| − | {{tp|p=33307901|t=2021. Risk factors for mortality in hospitalized patients with COVID-19: a study in Milan, Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=33620274|t=2021. Comparison of SARS-CoV-2 infections in healthcare workers with high and low exposures to Covid-19 patients in a Norwegian University Hospital.|pdf=|usr=027}}
| |
| − | {{tp|p=33849388|t=2021. Covid-19 reinfection - what could the absence of evidence suggest?|pdf=|usr=027}}
| |
| − | {{tp|p=34016284|t=2021. Aspergillosis: Epidemiology, Diagnosis, and Treatment.|pdf=|usr=027}}
| |
| − | {{tp|p=33348449|t=2021. Having gastroesophageal cancer is associated with increased risk of severe COVID-19-related events in patients with digestive tract cancer: A multicenter, retrospective, cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33368328|t=2021. Erythema annulare centrifugum with anosmia and ageusia in a SARS-CoV-2 exposed patient successfully treated with doxycycline.|pdf=|usr=027}}
| |
| − | {{tp|p=33332576|t=2021. COVID-19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases.|pdf=|usr=027}}
| |
| − | {{tp|p=33320353|t=2021. Annular lichen planus associated with coronavirus SARS-CoV-2 disease (COVID-19).|pdf=|usr=027}}
| |
| − | {{tp|p=33305352|t=2021. COVID-19 infection in pregnant women: Review of maternal and fetal outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=33829492|t=2021. Characteristics and outcomes of COVID-19 pneumonia in pregnancy compared with infected nonpregnant women.|pdf=|usr=027}}
| |
| − | {{tp|p=33896002|t=2021. Premature ovarian insufficiency secondary to COVID-19 infection: An original case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33834499|t=2021. The severity of COVID-19 among pregnant women and the risk of adverse maternal outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=34009656|t=2021. SARS-CoV-2 congenital infection and pre-eclampsia-like syndrome in dichorionic twins: A case report and review of the literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33930185|t=2021. Maternal death related to COVID-19: A systematic review and meta-analysis focused on maternal co-morbidities and clinical characteristics.|pdf=|usr=027}}
| |
| − | {{tp|p=33866551|t=2021. A snapshot of the prevalence of endocrine disorders in pregnancies complicated by coronavirus disease 2019: A narrative review with meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33377579|t=2021. Dynamics of hemogram and biochemical parameters in COVID-19 patients and their implication-A single-center prospective study in tertiary care hospital Islamabad, Pakistan.|pdf=|usr=027}}
| |
| − | {{tp|p=33314746|t=2021. Transient increase in blast count following COVID-19 infection mimicking acute leukemia.|pdf=|usr=027}}
| |
| − | {{tp|p=33977913|t=2021. Impact of influenza A co-infection with COVID-19.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33355186|t=2021. Is COVID-19-Induced Platelet Activation a Cause of Concern for Patients with Cancer?|pdf=|usr=027}}
| |
| − | {{tp|p=33360669|t=2021. Cancer patients and COVID-19: Mortality, serious complications, biomarkers, and ways forward.|pdf=|usr=027}}
| |
| − | {{tp|p=33338856|t=2021. Impact of COVID-19 infection among cancer patients treated at the Los Angeles County Medical Center.|pdf=|usr=027}}
| |
| − | {{tp|p=34069565|t=2021. COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33357843|t=2021. Comprehensive Landscape of Heparin Therapy for COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34046880|t=2021. Multivessel coronary thrombosis in a COVID-19 patient: Lungs are not always a culprit.|pdf=|usr=027}}
| |
| − | {{tp|p=33843043|t=2021. Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33346365|t=2021. Underlying heart diseases and acute COVID-19 outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=33327980|t=2021. Factors affecting COVID-19 outcomes in patients with congenital heart disease.|pdf=|usr=027}}
| |
| − | {{tp|p=34082420|t=2021. Cardio-Pulmonary-Renal Consequences of Severe COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33906662|t=2021. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.|pdf=|usr=027}}
| |
| − | {{tp|p=33968624|t=2021. Surgical treatment of ascending aorta floating thrombus in a patient with recent SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33988835|t=2021. Chronic Oral Anticoagulation and Clinical Outcome in Hospitalized COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33907899|t=2021. Spontaneous Major Haemorrhage in COVID-19 Patients: a Proposal for a Pathophysiology-Based Angiographic Treatment.|pdf=|usr=027}}
| |
| − | {{tp|p=33992734|t=2021. Commentary on the spectrum of cardiopulmonary pathology in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33895311|t=2021. A novel coronavirus meets the cardiovascular system: Society for Cardiovascular Pathology Symposium 2021.|pdf=|usr=027}}
| |
| − | {{tp|p=34088598|t=2021. The impact of COVID-19 patients with troponin elevation on renal impairment and clinical outcome.|pdf=|usr=027}}
| |
| − | {{tp|p=34053871|t=2021. Clinical impact and predictors of troponin elevation in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34049818|t=2021. Implications of Left Ventricular Function on Short-Term Outcomes in COVID-19 Patients With Myocardial Injury.|pdf=|usr=027}}
| |
| − | {{tp|p=33941484|t=2021. Complications of Late-Presenting Myocardial Infarction in a COVID-19 Patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33952432|t=2021. Systemic inflammation may induce cardiac injury in COVID-19 patients including children and adolescents without underlying cardiovascular diseases: A systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=34018126|t=2021. When Manual Analysis of 12-Lead ECG Holter Plays a Critical Role in Discovering Unknown Patterns of Increased Arrhythmogenic Risk: A Case Report of a Patient Treated with Tamoxifen and Subsequent Pneumonia in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33835386|t=2021. Scientific Hypothesis for Treatment of COVID-19's Lung Lesions by Adjusting ACE/ACE2 Imbalance.|pdf=|usr=027}}
| |
| − | {{tp|p=34007491|t=2021. COVID-19 Mortality in a Pediatric Patient with Hemoglobin SC Disease and Alpha-Thalassemia Trait.|pdf=|usr=027}}
| |
| − | {{tp|p=33927903|t=2021. Spontaneous Renal Artery Dissection in COVID-19 Pneumonia: Potential Danger of Cytokine Storm.|pdf=|usr=027}}
| |
| − | {{tp|p=33859845|t=2021. Cutaneous Vasculopathy in a COVID-19 Critically Ill Patient: A Histologic, Immunohistochemical, and Electron Microscopy Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33976619|t=2021. Clinical and Intestinal Histopathological Findings in SARS-CoV-2/COVID-19 Patients with Hematochezia.|pdf=|usr=027}}
| |
| − | {{tp|p=34094606|t=2021. Diarrhea due to SARS-CoV-2-Related Exocrine Pancreatic Insufficiency.|pdf=|usr=027}}
| |
| − | {{tp|p=33953994|t=2021. A COVID-19 Patient Presenting with Pneumothorax.|pdf=|usr=027}}
| |
| − | {{tp|p=33996162|t=2021. Posterior Reversible Leukoencephalopathy Syndrome in a Patient after Acute COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33833883|t=2021. Two Paediatric Patients with Encephalopathy and Concurrent COVID-19 Infection: Two Sides of the Same Coin?|pdf=|usr=027}}
| |
| − | {{tp|p=33859855|t=2021. Purtscher-Like Retinopathy in a Patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33959402|t=2021. COVID-19 in Children with Congenital Heart Diseases: A Multicenter Case Series from Iran.|pdf=|usr=027}}
| |
| − | {{tp|p=33936829|t=2021. Acute Rheumatic Fever in a COVID-19-Positive Pediatric Patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33986966|t=2021. COVID-19: An Emerging Culprit of Inflammatory Arthritis.|pdf=|usr=027}}
| |
| − | {{tp|p=33927911|t=2021. Lupus Pneumonitis Therapy Masks Coronavirus (COVID-19).|pdf=|usr=027}}
| |
| − | {{tp|p=33968612|t=2021. Maternal, placental and neonatal outcomes after asymptomatic SARS-CoV-2 infection in the first trimester of pregnancy: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33898274|t=2021. Rapid recovery achieved by intensive therapy after preterm cesarean section for worsening COVID-19-induced acute respiratory failure: A case report and literature review.|pdf=|usr=027}}
| |
| − | {{tp|p=34031543|t=2021. Patients with COVID-19: in the dark-NETs of neutrophils.|pdf=|usr=027}}
| |
| − | {{tp|p=34031383|t=2021. Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication.|pdf=|usr=027}}
| |
| − | {{tp|p=33850111|t=2021. Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34081913|t=2021. SARS-CoV-2 infection induces beta cell transdifferentiation.|pdf=|usr=027}}
| |
| − | {{tp|p=34081912|t=2021. SARS-CoV-2 infects human pancreatic beta cells and elicits beta cell impairment.|pdf=|usr=027}}
| |
| − | {{tp|p=33318629|t=2021. Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33969321|t=2021. Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms.|pdf=|usr=027}}
| |
| − | {{tp|p=34022129|t=2021. SARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium.|pdf=|usr=027}}
| |
| − | {{tp|p=34064487|t=2021. Hepatic Failure in COVID-19: Is Iron Overload the Dangerous Trigger?|pdf=|usr=027}}
| |
| − | {{tp|p=33918318|t=2021. The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies.|pdf=|usr=027}}
| |
| − | {{tp|p=33920604|t=2021. Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33923537|t=2021. Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33774622|t=2021. Risk Factors, and Clinical and Etiological Characteristics of Ischemic Strokes in COVID-19-Infected Patients: A Systematic Review of Literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33348338|t=2021. Thrombectomy for Treatment of Acute Stroke in the COVID-19 Pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33321492|t=2021. Ischemic Stroke in Patients with COVID-19 Disease: A Report of 10 Cases from Iran.|pdf=|usr=027}}
| |
| − | {{tp|p=33975306|t=2021. Cerebral Venous Thrombosis Associated with COVID-19 Infection: An Observational, Multicenter Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33967409|t=2021. Modeling, analysis and prediction of new variants of covid-19 and dengue co-infection on complex network.|pdf=|usr=027}}
| |
| − | {{tp|p=33367502|t=2021. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms.|pdf=|usr=027}}
| |
| − | {{tp|p=33964301|t=2021. Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33930384|t=2021. Does Endothelial Vulnerability in OSA Syndrome Promote COVID-19 Encephalopathy?|pdf=|usr=027}}
| |
| − | {{tp|p=33857475|t=2021. Hospital-Acquired Infections in Critically Ill Patients With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33745987|t=2021. Severe Intraabdominal Hypertension in Critically Ill COVID-19 Patients With Acute Kidney Injury.|pdf=|usr=027}}
| |
| − | {{tp|p=34022034|t=2021. Refractory Hypoxemia Despite Extracorporeal Membrane Oxygenation: Point-of-Care Ultrasound Is Needed for Patients With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34022033|t=2021. A 58-Year-Old Man With Coronavirus Disease 2019 Pneumonia and Undifferentiated Shock.|pdf=|usr=027}}
| |
| − | {{tp|p=34022032|t=2021. A Patient With Coronavirus Disease 2019 Pneumonia and Sudden Decompensation While Receiving Mechanical Ventilatory Support.|pdf=|usr=027}}
| |
| − | {{tp|p=34063781|t=2021. SARS-CoV-2 Myocarditis in a High School Athlete after COVID-19 and Its Implications for Clearance for Sports.|pdf=|usr=027}}
| |
| − | {{tp|p=34047034|t=2021. Acute kidney injury precipitating myocardial injury in a young male with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34047029|t=2021. Demographics, clinical characteristics and outcomes among 197 patients with COVID-19 in the Gold Coast area.|pdf=|usr=027}}
| |
| − | {{tp|p=34047021|t=2021. Risk factors for readmission following inpatient management of COVID-19 in a low-prevalence setting.|pdf=|usr=027}}
| |
| − | {{tp|p=33844415|t=2021. Prevalence of COVID-19 and seroprevalence to SARS-CoV-2 in a rheumatologic patient population from a tertiary referral clinic in Israel.|pdf=|usr=027}}
| |
| − | {{tp|p=33834578|t=2021. Acute pulmonary embolism in patients presenting pulmonary deterioration after hospitalisation for non-critical COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34086044|t=2021. Expression of the SARS-CoV-2 Receptor ACE2 in Human Retina and Diabetes-Implications for Retinopathy.|pdf=|usr=027}}
| |
| − | {{tp|p=33970787|t=2021. Not so sweet and simple: impacts of SARS-CoV-2 on the beta cell.|pdf=|usr=027}}
| |
| − | {{tp|p=33990491|t=2021. Factors Associated With Coronavirus Disease 2019 Morbidity in a Cohort of People Living With Human Immunodeficiency Virus.|pdf=|usr=027}}
| |
| − | {{tp|p=34048599|t=2021. Association of frailty with outcomes in individuals with COVID-19: A living review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34019707|t=2021. Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33861465|t=2021. Tachyarrhythmia as a possible symptom of coronavirus in a neonate diagnosed with transposition of the great arteries.|pdf=|usr=027}}
| |
| − | {{tp|p=33982333|t=2021. Type A aortic syndromes in COVID-19 positive patients: Case series from a UK multicentre study.|pdf=|usr=027}}
| |
| − | {{tp|p=33974311|t=2021. A case of a pregnant patient with COVID-19 infection treated with emergency c-section and extracorporeal membrane oxygenation.|pdf=|usr=027}}
| |
| − | {{tp|p=34008009|t=2021. Normal Adrenal and Thyroid Function in Patients Who Survive COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34028884|t=2021. Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan's experience.|pdf=|usr=027}}
| |
| − | {{tp|p=33951227|t=2021. The role and significance of angiotensin-converting enzyme 2 peptides in the treatment of coronavirus disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=34080711|t=2021. Comparison of the clinical characteristics of patients with novel coronavirus pneumonia between China and overseas.|pdf=|usr=027}}
| |
| − | {{tp|p=33899251|t=2021. Dental biofilm of symptomatic COVID-19 patients harbours SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33908637|t=2021. Pharmacological Predictors of Morbidity and Mortality in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33991171|t=2021. Self-case report of oral and skin lesions associated with positivity of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33977625|t=2021. Unilateral deep vein thrombosis with gangrene involving the ascending aorta with sepsis and pulmonary thromboembolism-a pertinent cutaneous marker of severity of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34077629|t=2021. Skin disorders associated with the COVID-19 pandemic: A review.|pdf=|usr=027}}
| |
| − | {{tp|p=33977903|t=2021. The Barts Health NHS Trust COVID-19 cohort: characteristics, outcomes and risk scoring of patients in East London.|pdf=|usr=027}}
| |
| − | {{tp|p=34049602|t=2021. COVID-19 and TB: a progression-regression conundrum.|pdf=|usr=027}}
| |
| − | {{tp|p=33337790|t=2021. COVID-19 and the Eye: A Comprehensive Review of the Literature.|pdf=|usr=027}}
| |
| − | {{tp|p=34044512|t=2021. Toxic epidermal necrolysis and role of immune dysregulation in a patient affected by coronavirus disease.|pdf=|usr=027}}
| |
| − | {{tp|p=34092646|t=2021. Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care.|pdf=|usr=027}}
| |
| − | {{tp|p=33310111|t=2021. A surge in the incidence of telogen effluvium in minority predominant communities heavily impacted by COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33368150|t=2021. Clinical and Virological Follow-Up of a Cohort of 76 COVID-19 Older Hospitalized Adults.|pdf=|usr=027}}
| |
| − | {{tp|p=34049961|t=2021. High Incidence of Circuit Clotting in Critically-ill COVID-19 Patients Treated With Renal Replacement Therapy.|pdf=|usr=027}}
| |
| − | {{tp|p=34088853|t=2021. High SARS-CoV-2 Viral Load in Urine Sediment Correlates with Acute Kidney Injury and Poor COVID-19 Outcome.|pdf=|usr=027}}
| |
| − | {{tp|p=33998968|t=2021. Can virus-virus interactions impact the dynamics of the covid-19 pandemic?|pdf=|usr=027}}
| |
| − | {{tp|p=33908317|t=2021. Letter to the Editor: COVID-19 utilization of ACE-2 receptor to enter the host cell.|pdf=|usr=027}}
| |
| − | {{tp|p=33331065|t=2021. Congenital heart disease and incremental risks of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34091532|t=2021. Angiotensin-converting enzyme 2: a key enzyme in key organs.|pdf=|usr=027}}
| |
| − | {{tp|p=33927144|t=2021. Pericarditis in patients with coronavirus disease 2019: a systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=33949887|t=2021. COVID-19 and Acute Myocardial Injury and Infarction: Related Mechanisms and Emerging Challenges.|pdf=|usr=027}}
| |
| − | {{tp|p=34032198|t=2021. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience.|pdf=|usr=027}}
| |
| − | {{tp|p=34074933|t=2021. Clinical significance of olfactory dysfunction in patients of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34019015|t=2021. A Cerner Real-World Data Study of Spinal Muscular Atrophy Patients With Positive COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34019009|t=2021. A Case of Elsberg Syndrome in the Setting of Asymptomatic SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33315693|t=2021. New-Onset Seizures in Three COVID-19 Patients: A Case Series.|pdf=|usr=027}}
| |
| − | {{tp|p=33331072|t=2021. The Risk Factors for the Exacerbation of COVID-19 Disease: A Case-control Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34085538|t=2021. Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C).|pdf=|usr=027}}
| |
| − | {{tp|p=33902097|t=2021. COVID-19 in Patients With Rheumatic Diseases: Is There a Need to Worry?|pdf=|usr=027}}
| |
| − | {{tp|p=34019476|t=2021. Obstructive sleep apnea and COVID-19 clinical outcomes during hospitalization: a cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33340224|t=2021. Severe hyperalgesia and pain during botulinum toxin injection avoiding application in a patient 1 week after COVID-19 infection.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=33852058|t=2021. Pediatric anti-NMDA receptor encephalitis associated with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33969266|t=2021. COVID-19 pneumonia: current evidence of chest imaging features, evolution and prognosis.|pdf=|usr=027}}
| |
| − | {{tp|p=34018998|t=2021. Coronavirus disease 2019 in pregnant and non-pregnant women: a retrospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=33879756|t=2021. Single-cell analysis of angiotensin-converting enzyme II expression in human kidneys and bladders reveals a potential route of 2019 novel coronavirus infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33853711|t=2021. An Insight of the First Community Infected COVID-19 Patient in Beijing by Imported Case: Role of Deep Learning-Assisted CT Diagnosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33853705|t=2021. Association Analysis of Hyperlipidemia with the 28-Day All-Cause Mortality of COVID-19 in Hospitalized Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33957805|t=2021. Early experiences of rehabilitation for individuals post-COVID to improve fatigue, breathlessness exercise capacity and cognition - A cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33849706|t=2021. Trombosis de la vena mesenterica superior como unica manifestacion de la infeccion por SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=34059464|t=2021. Non-surgical spontaneous pneumoperitoneum in a COVID-19 positive patient with severe bilateral pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33994409|t=2021. Evaluation of High-Sensitivity Cardiac Troponin T Levels in Japanese Patients Recently Recovered From Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33952834|t=2021. Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk Factors.|pdf=|usr=027}}
| |
| − | {{tp|p=33952833|t=2021. Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors.|pdf=|usr=027}}
| |
| − | {{tp|p=34011824|t=2021. Incidence and Clinical Features of Venous Thromboembolism in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan.|pdf=|usr=027}}
| |
| − | {{tp|p=33854006|t=2021. Impact of Concomitant Novel Coronavirus Disease 2019 in Patients With ST-Elevation Acute Myocardial Infarction.|pdf=|usr=027}}
| |
| − | {{tp|p=33856918|t=2021. COVID-19 and Cardiovascular Disease: From Bench to Bedside.|pdf=|usr=027}}
| |
| − | {{tp|p=33332151|t=2021. COVID-19 Myocardial Pathology Evaluation in Athletes With Cardiac Magnetic Resonance (COMPETE CMR).|pdf=|usr=027}}
| |
| − | {{tp|p=34056570|t=2021. Takotsubo syndrome during the COVID-19 pandemic, state-of -the- art review.|pdf=|usr=027}}
| |
| − | {{tp|p=34056569|t=2021. Rate of COVID-19 infection in patients with ST-segment elevation myocardial infarction.|pdf=|usr=027}}
| |
| − | {{tp|p=33842874|t=2021. Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors.|pdf=|usr=027}}
| |
| − | {{tp|p=33875979|t=2021. Classical and Counter-Regulatory Renin-Angiotensin System: Potential Key Roles in COVID-19 Pathophysiology.|pdf=|usr=027}}
| |
| − | {{tp|p=33967027|t=2021. Pregnancy and delivery considerations during COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33941601|t=2021. What is causing the 'long-hauler' phenomenon after COVID-19?|pdf=|usr=027}}
| |
| − | {{tp|p=33941600|t=2021. Post-acute sequelae of SARS-CoV-2 infection: Caring for the 'long-haulers'.|pdf=|usr=027}}
| |
| − | {{tp|p=33323363|t=2021. Update to coagulopathy in COVID-19: Manifestations and management.|pdf=|usr=027}}
| |
| − | {{tp|p=34018412|t=2021. Thrombotic Events in COVID-19: Inquires About the Deleterious Procoagulant Effect of Corticosteroid Therapy.|pdf=|usr=027}}
| |
| − | {{tp|p=34011194|t=2021. The Meaning of D-Dimer value in Covid-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33928791|t=2021. Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients?|pdf=|usr=027}}
| |
| − | {{tp|p=33926262|t=2021. Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression.|pdf=|usr=027}}
| |
| − | {{tp|p=33906462|t=2021. Blood Viscosity at the First Clinical Presentation in Fatal and Non-Fatal COVID-19: An Observation.|pdf=|usr=027}}
| |
| − | {{tp|p=33874753|t=2021. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33835872|t=2021. Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33827287|t=2021. ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33860871|t=2021. Autonomic dysfunction following COVID-19 infection: an early experience.|pdf=|usr=027}}
| |
| − | {{tp|p=34022172|t=2021. Biochemistry tests in hospitalized COVID-19 patients: Experience from a Canadian tertiary care centre.|pdf=|usr=027}}
| |
| − | {{tp|p=33964035|t=2021. A novel study on SARS-COV-2 virus associated bradycardia as a predictor of mortality-retrospective multicenter analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33973673|t=2021. The prognostic significance of electrocardiography findings in patients with coronavirus disease 2019: A retrospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=34084515|t=2021. New disease and old threats: A case series of COVID-19 and tuberculosis coinfection in Saudi Arabia.|pdf=|usr=027}}
| |
| − | {{tp|p=34084493|t=2021. A case of concomitant pulmonary embolism and pulmonary tuberculosis in the era of COVID 19, a matter of cautious approach.|pdf=|usr=027}}
| |
| − | {{tp|p=34084492|t=2021. Secondary sclerosing cholangitis as a complication of severe COVID-19: A case report and review of the literature.|pdf=|usr=027}}
| |
| − | {{tp|p=34084480|t=2021. A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a "spontaneous" complication?|pdf=|usr=027}}
| |
| − | {{tp|p=34084470|t=2021. Cytomegalovirus haemorrhagic colitis complicating COVID-19 in an immunocompetent critically ill patient: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34026190|t=2021. Right atrial mass in a patient with COVID-19 pneumonia: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=34026168|t=2021. Presence of SARS-CoV-2 in plural effusion with COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34026131|t=2021. Unusual imaging findings of SARS-CoV-2 in HIV-positive patient : A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33936706|t=2021. Fatal invasive pulmonary aspergillosis in an immunocompetent patient with COVID-19 due to Aspergillus terreus: A case study.|pdf=|usr=027}}
| |
| − | {{tp|p=33936683|t=2021. Sudden sensorineural hearing loss in COVID-19: A case report and literature review.|pdf=|usr=027}}
| |
| − | {{tp|p=33936663|t=2021. SARS-CoV-2 infection complicated with cold agglutinin disease and myositis.|pdf=|usr=027}}
| |
| − | {{tp|p=33936607|t=2021. COVID-19, when fourteen days are not enough-A case series of affected healthcare workers.|pdf=|usr=027}}
| |
| − | {{tp|p=33860295|t=2021. High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33957095|t=2021. ACE I/D polymorphism in Czech first-wave SARS-CoV-2-positive survivors.|pdf=|usr=027}}
| |
| − | {{tp|p=33939954|t=2021. Clinical laboratory evaluation of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33958887|t=2021. A Working Hypothesis on Vesicular Lesions Related to COVID-19 Infection, Koebner Phenomena Type V, and a Short Review of Related Data.|pdf=|usr=027}}
| |
| − | {{tp|p=33889006|t=2021. A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33972057|t=2021. Pediatric COVID toes and fingers.|pdf=|usr=027}}
| |
| − | {{tp|p=33972048|t=2021. COVID-19: The experience from Iran.|pdf=|usr=027}}
| |
| − | {{tp|p=33972045|t=2021. Clinicopathologic correlations of COVID-19-related cutaneous manifestations with special emphasis on histopathologic patterns.|pdf=|usr=027}}
| |
| − | {{tp|p=33972039|t=2021. COVID-19: The experience from Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=33992101|t=2021. Severe hyperglycemia and insulin resistance in patients with SARS-CoV-2 infection: a report of two cases.|pdf=|usr=027}}
| |
| − | {{tp|p=34079379|t=2021. Positive Predictive Value of ICD-10 Diagnosis Codes for COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34079378|t=2021. Smoking and COVID-19 Infection and Related Mortality: A Prospective Cohort Analysis of UK Biobank Data.|pdf=|usr=027}}
| |
| − | {{tp|p=34040447|t=2021. Cancer and SARS-CoV-2 Infection: A Third-Level Hospital Experience.|pdf=|usr=027}}
| |
| − | {{tp|p=34079918|t=2021. Biological attributes of age and gender variations in Indian COVID-19 cases: A retrospective data analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33997479|t=2021. Hematological profile and biochemical markers of COVID-19 non-survivors: A retrospective analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33937584|t=2021. Clinical review of COVID-19 patients presenting to a quaternary care private hospital in South India: A retrospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=34034806|t=2021. Blood DNA methylation and COVID-19 outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=33931952|t=2021. Oral manifestations of COVID-19 patients: An online survey of the Egyptian population.|pdf=|usr=027}}
| |
| − | {{tp|p=33931901|t=2021. Development of sacral/buttock retiform purpura as an ominous presenting sign of COVID-19 and clinical and histopathologic evolution during severe disease course.|pdf=|usr=027}}
| |
| − | {{tp|p=33978234|t=2021. Skin manifestations as potential symptoms of diffuse vascular injury in critical COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33745200|t=2021. Augmented interferon I signaling in a patient with COVID toes.|pdf=|usr=027}}
| |
| − | {{tp|p=33881190|t=2021. Severe skin ulcer in systemic scleroderma due to severe acute respiratory syndrome coronavirus 2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34036626|t=2021. Severe acute respiratory syndrome coronavirus 2 and herpesvirus in oral lesions in patients with severe coronavirus disease 2019: Viral interaction?|pdf=|usr=027}}
| |
| − | {{tp|p=33893710|t=2021. New-onset diabetes in "long COVID".|pdf=|usr=027}}
| |
| − | {{tp|p=33855813|t=2021. Diabetic ketoacidosis drives COVID-19 related hospitalizations in children with type 1 diabetes.|pdf=|usr=027}}
| |
| − | {{tp|p=34036642|t=2021. Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34033181|t=2021. Urticarial vasculitis revealing immunolabelled nucleocapsid protein of SARS-CoV-2 in two Brazilian asymptomatic patients: the tip of the COVID-19 hidden iceberg?|pdf=|usr=027}}
| |
| − | {{tp|p=34014574|t=2021. Detection of a second outbreak of chilblain-like lesions during COVID-19 pandemic through teledermatology.|pdf=|usr=027}}
| |
| − | {{tp|p=33987893|t=2021. Heterogeneous red-white discoloration of the nail bed and distal onycholysis in a patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33982355|t=2021. Androgenetic alopecia in women and men is not related to COVID-19 infection severity: a prospective cohort study of hospitalized COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33914986|t=2021. Adamantiades-Behcet's disease (Behcet's disease) and COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33914975|t=2021. Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of Dermatology.|pdf=|usr=027}}
| |
| − | {{tp|p=34058019|t=2021. Acute postinfectious pityriasis rubra pilaris as a cutaneous manifestation in COVID-19: a case report and its dermoscopic features.|pdf=|usr=027}}
| |
| − | {{tp|p=34050995|t=2021. Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34062018|t=2021. Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry.|pdf=|usr=027}}
| |
| − | {{tp|p=33872431|t=2021. Incidence and prognosis of COVID-19 in psoriasis patients on biologic therapy: a multicentre retrospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33871106|t=2021. COVID-19-triggered sarcoidal granulomas mimicking scar sarcoidosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33871076|t=2021. Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2?|pdf=|usr=027}}
| |
| − | {{tp|p=33866618|t=2021. Under-representation of people of African ancestry in publications on the cutaneous manifestations of COVID-19: coincidence or physiology?|pdf=|usr=027}}
| |
| − | {{tp|p=33866610|t=2021. Penile ischaemia secondary to COVID-19: why should the dermatologist be concerned?|pdf=|usr=027}}
| |
| − | {{tp|p=33830556|t=2021. Nail changes as manifestation of systemic disease in COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33991637|t=2021. Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy.|pdf=|usr=027}}
| |
| − | {{tp|p=33992699|t=2021. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020.|pdf=|usr=027}}
| |
| − | {{tp|p=34098050|t=2021. Healthcare workers acquired COVID-19 disease from patients? An investigation by phylogenomics.|pdf=|usr=027}}
| |
| − | {{tp|p=34097930|t=2021. ACE I/D polymorphism and epidemiological findings for COVID-19: One year after the pandemic outbreak in Europe.|pdf=|usr=027}}
| |
| − | {{tp|p=34023882|t=2021. Minor allele of Intercellular adhesion molecule-1 (ICAM-1) polymorphism (rs5498 1462A>G) is associated with SARS-CoV-2 infection and related mortality.|pdf=|usr=027}}
| |
| − | {{tp|p=33978754|t=2021. Persistence of Antibody and Cellular Immune Responses in COVID-19 patients over Nine Months after Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34089610|t=2021. Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33978762|t=2021. Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.|pdf=|usr=027}}
| |
| − | {{tp|p=33872433|t=2021. Cause of death based on systematic post-mortem studies in patients with positive SARS-CoV-2 tissue PCR during the COVID-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=34096654|t=2021. Lipoprotein(a) and SARS-CoV-2 infections: susceptibility to infections, ischemic heart disease and thromboembolic events.|pdf=|usr=027}}
| |
| − | {{tp|p=33935140|t=2021. Evaluation of Nasal Mucociliary Clearance Time in COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33375865|t=2021. Estimating the susceptibility to SARS-CoV-2 infection with rituximab use for pemphigus vulgaris.|pdf=|usr=027}}
| |
| − | {{tp|p=33377313|t=2021. Skin manifestations reported in association with COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33907074|t=2021. Sudden Death After Electroconvulsive Therapy in the Context of Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33982613|t=2021. Antibodies Against SARS-CoV-2 in Human Milk: Milk Conversion Rates in the Netherlands.|pdf=|usr=027}}
| |
| − | {{tp|p=34074967|t=2021. Cardiovascular system in the sars-CoV-2: impact of therapies.|pdf=|usr=027}}
| |
| − | {{tp|p=33885396|t=2021. Ultrasonography as a diagnostic aid for a neonate with gingival swelling in a COVID-19 neonatal intensive care unit.|pdf=|usr=027}}
| |
| − | {{tp|p=34052242|t=2021. Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies.|pdf=|usr=027}}
| |
| − | {{tp|p=33858556|t=2021. Central Nervous System Manifestations of COVID-19: A Critical Review and Proposed Research Agenda.|pdf=|usr=027}}
| |
| − | {{tp|p=33306225|t=2021. The association between blood groups and COVID-19 infection: a study from the UK Biobank.|pdf=|usr=027}}
| |
| − | {{tp|p=33372300|t=2021. Chronic rhinosinusitis is associated with prolonged SARS-CoV-2 RNA shedding in upper respiratory tract samples: A case-control study.|pdf=|usr=027}}
| |
| − | {{tp|p=33341978|t=2021. Gastrointestinal bleeding in hospitalized COVID-19 patients: a propensity score matched cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34039677|t=2021. Impact and role of pulmonary embolism response teams in venous thromboembolism associated with COVID-19.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=34079323|t=2021. COVID-19 Disease Outcomes: Does Gastrointestinal Burden Play a Role?|pdf=|usr=027}}
| |
| − | {{tp|p=33955313|t=2021. The effect of RAAS inhibitors on acute hypoxemic respiratory failure and in-hospital mortality in the hypertensive Covid-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34089403|t=2021. Unbiased identification of clinical characteristics predictive of COVID-19 severity.|pdf=|usr=027}}
| |
| − | {{tp|p=33891214|t=2021. Kidney disease and COVID-19 disease severity-systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34057613|t=2021. Nationwide survey of the coronavirus disease 2019 prevention and treatment systems for kidney disease patients: a study of Japanese Society of Nephrology-certified educational facilities.|pdf=|usr=027}}
| |
| − | {{tp|p=33957034|t=2021. Babies born to mothers positive for SARS-CoV-2 - Are they in danger?|pdf=|usr=027}}
| |
| − | {{tp|p=33338005|t=2021. Incidence of COVID-19 in an Italian cohort of patients with systemic lupus erythematosus: an observational survey.|pdf=|usr=027}}
| |
| − | {{tp|p=33989790|t=2021. Proton Pump Inhibitor Use Is Not Strongly Associated With SARS-CoV-2 Related Outcomes: A Nationwide Study and Meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33882344|t=2021. Serum Lipase Elevations in COVID-19 Patients Reflect Critical Illness and not Acute Pancreatitis.|pdf=|usr=027}}
| |
| − | {{tp|p=34029750|t=2021. Liver Injury in Severe COVID-19 Disease: Need a Closer Look!|pdf=|usr=027}}
| |
| − | {{tp|p=34004326|t=2021. Significant Liver Injury During Hospitalization for COVID-19 Is Not Associated With Liver Insufficiency or Death.|pdf=|usr=027}}
| |
| − | {{tp|p=34000377|t=2021. SARS-CoV-2-Induced Pancreatitis is a Rare but Real Entity.|pdf=|usr=027}}
| |
| − | {{tp|p=34059140|t=2021. Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34029929|t=2021. Complications in COVID-19 patients: Characteristics of pulmonary embolism.|pdf=|usr=027}}
| |
| − | {{tp|p=33836413|t=2021. Interstitial lung abnormalities and pulmonary fibrosis in COVID-19 patients: a short-term follow-up case series.|pdf=|usr=027}}
| |
| − | {{tp|p=33972145|t=2021. Pulmonary cavitation in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33341452|t=2021. Ischemic gastrointestinal complications of COVID-19: a systematic review on imaging presentation.|pdf=|usr=027}}
| |
| − | {{tp|p=33857826|t=2021. Pulmonary cavitations as an atypical CT finding in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33932872|t=2021. Does COVID-19 cause an increase in spleen dimensions? Possible effects of immune activation, hematopoietic suppression and microthrombosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33865171|t=2021. Abdominal Computed Tomography Angiography and Venography in Evaluation of Hemorrhagic and Thrombotic lesions in Hospitalized COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33930555|t=2021. IFN-alpha levels in ruxolitinib-treatead Aicardi-Goutieres patient during SARS-CoV-2 infection: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33956972|t=2021. Risk Factors For Infection And Health Impacts Of The Covid-19 Pandemic In People With Autoimmune Diseases.|pdf=|usr=027}}
| |
| − | {{tp|p=33956935|t=2021. Role of epithelial-endothelial cell interaction in the pathogenesis of SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33949670|t=2021. SARS-CoV-2 infection among healthcare workers in South Africa: a longitudinal cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33949665|t=2021. SARS-CoV-2 RNAemia predicts clinical deterioration and extrapulmonary complications from COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33949655|t=2021. SARS-CoV-2 viral load kinetics in symptomatic children, adolescents and adults.|pdf=|usr=027}}
| |
| − | {{tp|p=33973000|t=2021. Trends over time in the risk of adverse outcomes among patients with SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33977298|t=2021. Adverse Pregnancy Outcomes, Maternal Complications, and Severe Illness Among US Delivery Hospitalizations With and Without a Coronavirus Disease 2019 (COVID-19) Diagnosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33909072|t=2021. Late Conditions Diagnosed 1-4 Months Following an Initial Coronavirus Disease 2019 (COVID-19) Encounter: A Matched-Cohort Study Using Inpatient and Outpatient Administrative Data-United States, 1 March-30 June 2020.|pdf=|usr=027}}
| |
| − | {{tp|p=33539504|t=2021. Thrombosis and COVID-19: Controversies and (Tentative) Conclusions.|pdf=|usr=027}}
| |
| − | {{tp|p=33912905|t=2021. Development and validation of the long covid symptom and impact tools, a set of patient-reported instruments constructed from patients' lived experience.|pdf=|usr=027}}
| |
| − | {{tp|p=33900406|t=2021. One in every three COVID-19 reinfections result in hospitalization in the US.|pdf=|usr=027}}
| |
| − | {{tp|p=33895814|t=2021. Re-infection with SARS-CoV-2 in Patients Undergoing Serial Laboratory Testing.|pdf=|usr=027}}
| |
| − | {{tp|p=33893487|t=2021. COVID-19 can be complicated by immune-encephalopathy rather than encephalitis.|pdf=|usr=027}}
| |
| − | {{tp|p=33893486|t=2021. Medium-term outcome of severe to critically ill patients with SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33911856|t=2021. Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33675512|t=2021. The case of a liver-transplant recipient with severe acute respiratory syndrome coronavirus 2 infection who had a favorable outcome.|pdf=|usr=027}}
| |
| − | {{tp|p=33835416|t=2021. Nonbacterial thrombotic endocarditis in a patient with gastric cancer and SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34079619|t=2021. Electrolyte abnormalities in patients hospitalized with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34079618|t=2021. Acute kidney injury in 3182 patients admitted with COVID-19: a single-center, retrospective, case-control study.|pdf=|usr=027}}
| |
| − | {{tp|p=33904618|t=2021. Half-year follow-up of patients recovering from severe COVID-19: Analysis of symptoms and their risk factors.|pdf=|usr=027}}
| |
| − | {{tp|p=33861190|t=2021. Co-infection in critically ill patients with COVID-19: an observational cohort study from England.|pdf=|usr=027}}
| |
| − | {{tp|p=34042189|t=2021. Factors associated with hospital readmissions among patients with COVID-19: A single-center experience.|pdf=|usr=027}}
| |
| − | {{tp|p=34032294|t=2021. Viral coinfections in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34032292|t=2021. Evaluation of long-term radiological findings, pulmonary functions, and health-related quality of life in survivors of severe COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34019703|t=2021. Evaluation of the relationship between KIM-1 and suPAR levels and clinical severity in COVID-19 patients: A different perspective on suPAR.|pdf=|usr=027}}
| |
| − | {{tp|p=34019701|t=2021. Evaluation of the prognostic role of NLR, LMR, PLR, and LCR ratio in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33990978|t=2021. COVID-19 encephalitis and Wernicke's encephalopathy.|pdf=|usr=027}}
| |
| − | {{tp|p=33990975|t=2021. The natural course of COVID-19 patients without clinical intervention.|pdf=|usr=027}}
| |
| − | {{tp|p=33990973|t=2021. Association of GSTM1 and GSTT1 gene polymorphisms with COVID-19 susceptibility and its outcome.|pdf=|usr=027}}
| |
| − | {{tp|p=33990971|t=2021. Consider differentials before diagnosing SARS-CoV-2 associated Guillain-Barre syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33974301|t=2021. SARS-CoV-2 prevalence and maternal-perinatal outcomes among pregnant women admitted for delivery: Experience from COVID-19-dedicated maternity hospital in Jammu, Jammu and Kashmir (India).|pdf=|usr=027}}
| |
| − | {{tp|p=33974276|t=2021. Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state.|pdf=|usr=027}}
| |
| − | {{tp|p=33951196|t=2021. Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathy patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33945642|t=2021. Lymphopenia and lung complications in patients with coronavirus disease-2019 (COVID-19): A retrospective study based on clinical data.|pdf=|usr=027}}
| |
| − | {{tp|p=33930189|t=2021. The breadth of concomitant virological features in a family cluster outbreak of COVID-19 pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33851749|t=2021. Prolonged presence of replication-competent SARS-CoV-2 in mildly symptomatic individuals: A report of two cases.|pdf=|usr=027}}
| |
| − | {{tp|p=33851742|t=2021. Reply to: The antibody response to the glycan alpha-Gal correlates with COVID-19 symptoms.|pdf=|usr=027}}
| |
| − | {{tp|p=33851741|t=2021. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child.|pdf=|usr=027}}
| |
| − | {{tp|p=34081354|t=2021. Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID-2019) in 23 countries.|pdf=|usr=027}}
| |
| − | {{tp|p=34081337|t=2021. The demographic characteristics, prognosis, and relationship with cancer subtypes of hospitalized COVID-19 patients with malignancy: A single-center experience.|pdf=|usr=027}}
| |
| − | {{tp|p=34081332|t=2021. Diagnose SARS-CoV-2 associated Guillain-Barre syndrome upon appropriate criteria and after exclusion of differentials.|pdf=|usr=027}}
| |
| − | {{tp|p=34081331|t=2021. Vertical transmission of SARS-CoV-2: A prospective cross-sectional study from a tertiary center.|pdf=|usr=027}}
| |
| − | {{tp|p=34061374|t=2021. An updated meta-analysis on the association between tuberculosis and COVID-19 severity and mortality.|pdf=|usr=027}}
| |
| − | {{tp|p=34050953|t=2021. COVID-19 pneumonia in kidney transplant recipients: A promising treatment algorithm in the absence of a disease-specific drug.|pdf=|usr=027}}
| |
| − | {{tp|p=34042195|t=2021. Prior immunosuppressive therapy is associated with mortality in COVID-19 patients: A retrospective study of 835 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33837966|t=2021. Red cell distribution width is associated with mortality in non-anemic patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33830538|t=2021. Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33830530|t=2021. Association between the HLA genotype and the severity of COVID-19 infection among South Asians.|pdf=|usr=027}}
| |
| − | {{tp|p=33822390|t=2021. Risk factors for bacterial infections in patients with moderate to severe COVID-19: A case-control study.|pdf=|usr=027}}
| |
| − | {{tp|p=33792956|t=2021. Different incidences of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without non-azithromycin antibiotics: A retrospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=33792943|t=2021. Unilateral submacular hemorrhage: Novel presentation of COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33788265|t=2021. The link between microglia and the severity of COVID-19: The "two-hit" hypothesis.|pdf=|usr=027}}
| |
| − | {{tp|p=33782993|t=2021. COVID-19 encephalopathy: Clinical and neurobiological features.|pdf=|usr=027}}
| |
| − | {{tp|p=33768594|t=2021. Factors associated with SARS-CoV-2 infection in patients attending an acute hospital ambulatory assessment unit.|pdf=|usr=027}}
| |
| − | {{tp|p=33764543|t=2021. Fetal and placental infection with SARS-CoV-2 in early pregnancy.|pdf=|usr=027}}
| |
| − | {{tp|p=33755238|t=2021. Outcomes among 10,314 hospitalized COVID-19 patients at a tertiary care government hospital in Delhi, India.|pdf=|usr=027}}
| |
| − | {{tp|p=33749850|t=2021. Reinfection or reactivation: Genome-based two distinct SNP profile of SARS-CoV2 repositivity in an Indian case.|pdf=|usr=027}}
| |
| − | {{tp|p=33724490|t=2021. What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33724483|t=2021. An evaluation of patients with a previous endemic coronavirus infection during the COVID-19 pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33710652|t=2021. Impact of gender on patients hospitalized for SARS-COV-2 infection: A prospective observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=33710650|t=2021. Case series of SARS-COV-2 infection in pregnant African women: focus on biological features.|pdf=|usr=027}}
| |
| − | {{tp|p=33704811|t=2021. CKD patients: A high-risk category for severe COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33926967|t=2021. Sex differences in the induction of angiotensin converting enzyme 2 (ACE-2) in mouse lungs after e-cigarette vapor exposure and its relevance to COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34006572|t=2021. COVID-19 reinfection: a rapid systematic review of case reports and case series.|pdf=|usr=027}}
| |
| − | {{tp|p=33913413|t=2021. Sudden hearing loss and coronavirus disease 2019: the role of corticosteroid intra-tympanic injection in hearing improvement.|pdf=|usr=027}}
| |
| − | {{tp|p=33973511|t=2021. Subglottic and tracheal stenosis associated with coronavirus disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33969775|t=2021. Early human milk lactoferrin during SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33771080|t=2021. Clinical characteristics and risk factors for SARS-CoV-2 infection in pregnant women attending a third level reference center in Mexico City.|pdf=|usr=027}}
| |
| − | {{tp|p=33752563|t=2021. Maternal mortality from COVID 19 among South African pregnant women.|pdf=|usr=027}}
| |
| − | {{tp|p=33706649|t=2021. The effect of real-time polymerase chain reaction cycle threshold values on perinatal outcomes of pregnant women with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34096434|t=2021. Modified lung ultrasound scoring system to evaluate the feasibility of pregnant women with COVID-19 pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33550866|t=2021. SARS-CoV-2 detection in human milk: a systematic review.|pdf=|usr=027}}
| |
| − | {{tp|p=33550858|t=2021. Clinical features and risk factors associated with acute respiratory distress syndrome in pregnant women diagnosed with COVID-19: a multi-center case-control study.|pdf=|usr=027}}
| |
| − | {{tp|p=33535850|t=2021. Risk factors for severe and critical Covid-19 in pregnant women in a single center in Brazil.|pdf=|usr=027}}
| |
| − | {{tp|p=33645395|t=2021. Maternal, neonatal and placental characteristics of SARS-CoV-2 positive mothers.|pdf=|usr=027}}
| |
| − | {{tp|p=33530804|t=2021. Perinatal outcomes in pregnant women with COVID-19 in Siberia and the Russian Far East.|pdf=|usr=027}}
| |
| − | {{tp|p=33602025|t=2021. Clinical manifestation and maternal complications and neonatal outcomes in pregnant women with COVID-19: a comprehensive evidence synthesis and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33792466|t=2021. Maternal and perinatal outcomes in pregnant women with confirmed severe and mild COVID-19 at one large maternity hospital in Chile.|pdf=|usr=027}}
| |
| − | {{tp|p=33750249|t=2021. A region-specific clustering approach to investigate risk-factors in mortality rate during COVID-19: comprehensive statistical analysis from 208 countries.|pdf=|usr=027}}
| |
| − | {{tp|p=33368339|t=2021. Bilateral premacular sub-hyaloid hemorrhage-unmasking COVID-19 induced pancytopenia.|pdf=|usr=027}}
| |
| − | {{tp|p=33350488|t=2021. Predictors of mortality in 217 COVID-19 patients in Northwest Ohio, United States: A retrospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=33325107|t=2021. East-West differences in clinical manifestations of COVID-19 patients: A systematic literature review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33325049|t=2021. Controversy over smoking in COVID-19-A real world experience in New York city.|pdf=|usr=027}}
| |
| − | {{tp|p=33368412|t=2021. Co-infection of malaria and early clearance of SARS-CoV-2 in healthcare workers.|pdf=|usr=027}}
| |
| − | {{tp|p=33368357|t=2021. Beyond silent hypoxemia: Does COVID-19 can blunt pain perception? Comment on "The neuroinvasive potential of SARS CoV2 may play a role in the respiratory failure of COVID 19 patients".|pdf=|usr=027}}
| |
| − | {{tp|p=33336825|t=2021. COVID-19 and anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis: Are we facing an increase in the prevalence of autoimmune encephalitis?|pdf=|usr=027}}
| |
| − | {{tp|p=33331656|t=2021. Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses.|pdf=|usr=027}}
| |
| − | {{tp|p=33314206|t=2021. Evaluation of maternal serum afamin and vitamin E levels in pregnant women with COVID-19 and its association with composite adverse perinatal outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=33314141|t=2021. Evaluation of serum hepatic enzyme activities in different COVID-19 phenotypes.|pdf=|usr=027}}
| |
| − | {{tp|p=33300152|t=2021. Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33300137|t=2021. Immunohistochemical expression of angiotensin-converting enzyme 2 in minor salivary glands during SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=34094522|t=2021. Successful treatment of a COVID-19 patient with thrombotic microangiopathy.|pdf=|usr=027}}
| |
| − | {{tp|p=34094520|t=2021. Arterial oxygen saturation and hypoxemia in hemodialysis patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33841874|t=2021. 128 days of SARS-CoV-2 viral shedding in a haemodialysis patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33841852|t=2021. Therapeutic dilemmas in dialysis patients hospitalized for COVID-19: balancing between nihilism, off-label treatment and side effects.|pdf=|usr=027}}
| |
| − | {{tp|p=34083176|t=2021. COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic.|pdf=|usr=027}}
| |
| − | {{tp|p=33303623|t=2021. A case of COVID-19 reinfection in the UK.|pdf=|usr=027}}
| |
| − | {{tp|p=34035654|t=2021. SARS-CoV-2 and Pre-existing Vascular Diseases: Guilt by Association?|pdf=|usr=027}}
| |
| − | {{tp|p=33953633|t=2021. Aseptic Meningitis after Recovery from SARS-CoV-2 in an Allogeneic Stem Cell Transplant Recipient.|pdf=|usr=027}}
| |
| − | {{tp|p=33911911|t=2021. A Case of SARS-CoV-2 Clinical Relapse after 4 Negative RT-PCR Tests in Greece: Recurrence or Reinfection?|pdf=|usr=027}}
| |
| − | {{tp|p=34015528|t=2021. Long COVID and the brain network of Proust's madeleine: targeting the olfactory pathway.|pdf=|usr=027}}
| |
| − | {{tp|p=33933565|t=2021. Personalized prophylactic anticoagulation in hospitalized patients with Covid-19 - The role of anti-Xa monitoring.|pdf=|usr=027}}
| |
| − | {{tp|p=33915287|t=2021. Clinical characteristics and factors associated with hospital admission or death in 43 103 adult outpatients with coronavirus disease 2019 managed with the Covidom telesurveillance solution: a prospective cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=33901669|t=2021. Prevalence and clinical significance of relative bradycardia at hospital admission in patients with coronavirus disease 2019 (COVID-19).|pdf=|usr=027}}
| |
| − | {{tp|p=33901667|t=2021. Long-term outcomes of patients following hospitalization for coronavirus disease 2019: a prospective observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=33359539|t=2021. Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator.|pdf=|usr=027}}
| |
| − | {{tp|p=33316400|t=2021. Long COVID-19-it's not over until?|pdf=|usr=027}}
| |
| − | {{tp|p=34020326|t=2021. Simultaneous bilateral mechanical thrombectomy in a patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33338825|t=2021. Guillain-Barre Syndrome and COVID-19: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33341456|t=2021. Possible immunity, inflammation, and oxidative stress mechanisms of Alzheimer's disease in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33934968|t=2021. Critical illness myopathy and polyneuropathy in Covid-19: Is it a distinct entity?|pdf=|usr=027}}
| |
| − | {{tp|p=33875374|t=2021. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=34020890|t=2021. Myopathic changes in patients with long-term fatigue after COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33934924|t=2021. Feeding intolerance in critically ill patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34024509|t=2021. Visceral adiposity, subcutaneous adiposity, and severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34040339|t=2021. Ocular Findings in Patients with COVID-19: Impact on Eye Banking [Letter].|pdf=|usr=027}}
| |
| − | {{tp|p=34007145|t=2021. Evaluation of Anti-SARS-CoV-2 IgA in the Conjunctival Secretions of COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33880013|t=2021. Ocular Manifestations of Hospitalized COVID-19 Patients in a Tertiary Care Academic Medical Center in the United States: A Cross-Sectional Study.|pdf=|usr=027}}
| |
| − | {{tp|p=34037853|t=2021. Dental calculus-a reservoir for detection of past SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34094003|t=2021. One Hundred Twenty-Day Mortality Rates for Hip Fracture Patients with COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33855294|t=2021. Possible Involvement of Central Nervous System in COVID-19 and Sequence Variability of SARS-CoV-2 Revealed in Autopsy Tissue Samples: A Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=34066311|t=2021. SARS-CoV-2-Associated Obliterative Arteritis Causing Massive Testicular Infarction.|pdf=|usr=027}}
| |
| − | {{tp|p=33358500|t=2021. Men and women affected by Sars-CoV-2 pneumonia: same CT features but different outcome.|pdf=|usr=027}}
| |
| − | {{tp|p=33879323|t=2021. Risk of acute pulmonary embolism in COVID-19 pneumonia compared to community-acquired pneumonia: a retrospective case-control study.|pdf=|usr=027}}
| |
| − | {{tp|p=34052904|t=2021. Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs.|pdf=|usr=027}}
| |
| − | {{tp|p=33826045|t=2021. Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?|pdf=|usr=027}}
| |
| − | {{tp|p=33881142|t=2021. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?|pdf=|usr=027}}
| |
| − | {{tp|p=33835096|t=2021. Prevalence and Persistent Shedding of Fecal SARS-CoV-2 RNA in Patients With COVID-19 Infection: A Systematic Review and Meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33931961|t=2021. Interactions between ibuprofen, ACE2, renin-angiotensin system, and spike protein in the lung. Implications for COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33336440|t=2021. SARS-CoV-2 infection increases tacrolimus concentrations in solid-organ transplant recipients.|pdf=|usr=027}}
| |
| − | {{tp|p=33349940|t=2021. Healthcare resource use among solid organ transplant recipients hospitalized with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33852652|t=2021. Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review.|pdf=|usr=027}}
| |
| − | {{tp|p=34059502|t=2021. Incidence de la COVID-19 sur les issues de grossesse: examen systematique et meta-analyse.|pdf=|usr=027}}
| |
| − | {{tp|p=33891280|t=2021. Early life stress and neural development: Implications for understanding the developmental effects of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33911322|t=2021. Pityriasis rubra pilaris post-infection due COVID-19: case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33850296|t=2021. Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features.|pdf=|usr=027}}
| |
| − | {{tp|p=33846513|t=2021. Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.|pdf=|usr=027}}
| |
| − | {{tp|p=33930765|t=2021. The incremental burden of invasive pneumococcal disease associated with a decline in childhood vaccination using a dynamic transmission model in Japan: A secondary impact of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33936563|t=2021. Laboratory indicators in COVID-19 and other pneumonias: Analysis for differential diagnosis and comparison of dynamic changes during 400-day follow-up.|pdf=|usr=027}}
| |
| − | {{tp|p=33957951|t=2021. A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=34001181|t=2021. Distinct temporal characteristics of circulating alveolar epithelial and endothelial injury markers in ARDS with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34074313|t=2021. COVID-19 ARDS is characterized by higher extravascular lung water than non-COVID-19 ARDS: the PiCCOVID study.|pdf=|usr=027}}
| |
| − | {{tp|p=33902676|t=2021. Implications of cardiac markers in risk-stratification and management for COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33888132|t=2021. Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units.|pdf=|usr=027}}
| |
| − | {{tp|p=33879175|t=2021. Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33874987|t=2021. The impact of frailty on survival in elderly intensive care patients with COVID-19: the COVIP study.|pdf=|usr=027}}
| |
| − | {{tp|p=33874973|t=2021. Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study.|pdf=|usr=027}}
| |
| − | {{tp|p=34079951|t=2021. Outcome Improvement Between the First Two Waves of the Coronavirus Disease 2019 Pandemic in a Single Tertiary-Care Hospital in Belgium.|pdf=|usr=027}}
| |
| − | {{tp|p=34079947|t=2021. Characteristics, Comorbidities, Complications, and Outcomes Among 802 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 in a Community Hospital in Florida.|pdf=|usr=027}}
| |
| − | {{tp|p=33821521|t=2021. Maternal and perinatal outcomes and placental pathologic examination of 29 SARS-CoV-2 infected patients in the third trimester of gestation.|pdf=|usr=027}}
| |
| − | {{tp|p=34004043|t=2021. SARS-CoV-2 associated with death in an infant with congenital chylothorax.|pdf=|usr=027}}
| |
| − | {{tp|p=33856079|t=2021. CHILDREN WITH CYSTIC FIBROSIS HOSPITALISED WITH COVID-19: MULTICENTRE EXPERIENCE.|pdf=|usr=027}}
| |
| − | {{tp|p=33908112|t=2021. Acute parotitis in a 4-year-old in association with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33876522|t=2021. Fatal meningococaemia in a SARS-CoV-2-positive adolescent.|pdf=|usr=027}}
| |
| − | {{tp|p=33834497|t=2021. Salivary glands are a target for SARS-CoV-2: a source for saliva contamination.|pdf=|usr=027}}
| |
| − | {{tp|p=33938523|t=2021. Receptor-binding Domain Severe Acute Respiratory Syndrome Coronavirus 2-specific Antibodies in Human Milk From Mothers With Coronavirus Disease 2019 Polymerase Chain Reaction or With Symptoms Suggestive of Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=34047369|t=2021. A more holistic view could contribute to our understanding of 'silent hypoxaemia' in Covid-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33880871|t=2021. Antibody-mediated platelet activation in COVID-19: A coincidence or a new mechanism of the dysregulated coagulation system?|pdf=|usr=027}}
| |
| − | {{tp|p=33826233|t=2021. Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study.|pdf=|usr=027}}
| |
| − | {{tp|p=33830623|t=2021. Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality.|pdf=|usr=027}}
| |
| − | {{tp|p=34053187|t=2021. ADAMTS13 regulation of VWF multimer distribution in severe COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34018658|t=2021. Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis.|pdf=|usr=027}}
| |
| − | {{tp|p=34080011|t=2021. Acute Kidney Injury in Hospitalized Children with COVID19.|pdf=|usr=027}}
| |
| − | {{tp|p=34050766|t=2021. Gastrointestinal Manifestations of Pediatric Coronavirus Disease and Their Relationship with a Severe Clinical Course: A Systematic Review and Meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34081145|t=2021. Severe Coronavirus Disease Pneumonia in Pediatric Patients in a Referral Hospital.|pdf=|usr=027}}
| |
| − | {{tp|p=34082588|t=2021. Arteriovenous fistula as the vascular access contributes to better survival of hemodialysis patients with COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33934161|t=2021. Vertical Transmission of COVID-19: A Case Report and Review of Literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33764952|t=2021. COVID-19 and Cognitive, Emotional Aspects of Post-Intensive Care Syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33298508|t=2021. Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist.|pdf=|usr=027}}
| |
| − | {{tp|p=34083395|t=2021. Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives.|pdf=|usr=027}}
| |
| − | {{tp|p=33906935|t=2021. Neurological diseases and risk of mortality in patients with COVID-19 and SARS: a territory-wide study in Hong Kong.|pdf=|usr=027}}
| |
| − | {{tp|p=33879534|t=2021. Hypothyroidism is associated with prolonged COVID-19-induced anosmia: a case-control study.|pdf=|usr=027}}
| |
| − | {{tp|p=33540185|t=2021. Parkinson's disease after COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33848701|t=2021. Olfaction and anosmia: From ancient times to COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33935221|t=2021. Pathology of the Brain and the Eye in Severe Acute Respiratory Syndrome Coronavirus-2-Infected Patients: A Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33813532|t=2021. Embolic abducens palsy and central retinal artery occlusion in a patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33560704|t=2021. Orbital Inflammation With Optic Perineuritis in Association With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33560703|t=2021. Optic Nerve Infarction in a Patient With Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33999887|t=2021. SARS-CoV-2 Impairs Vision.|pdf=|usr=027}}
| |
| − | {{tp|p=33935220|t=2021. Afferent and Efferent Neuro-Ophthalmic Complications of Coronavirus Disease 19.|pdf=|usr=027}}
| |
| − | {{tp|p=33843248|t=2021. Etiologies of Delirium in Consecutive COVID-19 Inpatients and the Relationship Between Severity of Delirium and COVID-19 in a Prospective Study With Follow-Up.|pdf=|usr=027}}
| |
| − | {{tp|p=33782356|t=2021. Alteration of Smell Sensation: Brief Review With Implications for Nursing Care During the COVID-19 Pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33789937|t=2021. Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34016729|t=2021. Postinfectious Neurologic Complications in COVID-19: A Complex Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=33645405|t=2021. A COVID 19 positive preterm mother and infant: a case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33852540|t=2021. COVID-19-Related Circumstances for Hospital Readmissions: A Case Series From 2 New York City Hospitals.|pdf=|usr=027}}
| |
| − | {{tp|p=34016876|t=2021. Response to Letter: The Effect of Helicobacter pylori on the Presentation and Clinical Course of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34016875|t=2021. Letter to the Editor: The role of Helicobacter Pylori Infection in COVID-19, Cause or Coincidence?|pdf=|usr=027}}
| |
| − | {{tp|p=34001788|t=2021. Thoracic Air Leak Syndrome, Pulmonary Aspergillosis, and COVID-19 Pneumonia After Allogeneic Stem Cell Transplantation in a Child With Myelodysplastic Syndrome.|pdf=|usr=027}}
| |
| − | {{tp|p=33930009|t=2021. Clinical Implications of Hematologic and Hemostatic Abnormalities in Children With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33902069|t=2021. Acute Lymphoblastic Leukemia Diagnosis Following Infection With SARS-CoV-2: Pure Randomness or Reproducible Causation?|pdf=|usr=027}}
| |
| − | {{tp|p=33902067|t=2021. SARS CoV-2 Antibody Persistence During Induction Chemotherapy for Pediatric T-Cell Acute Lymphoblastic Leukemia.|pdf=|usr=027}}
| |
| − | {{tp|p=33885040|t=2021. A 10-Year-Old Girl With Late Acute Lymphoblastic Leukemia Recurrence Diagnosed With COVID-19 and Treated With Remdesivir.|pdf=|usr=027}}
| |
| − | {{tp|p=33960219|t=2021. The Impact of Anticoagulation on COVID-19 (SARS CoV-2) Patient Outcomes: A Systematic Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33984837|t=2021. Does Higher Self-Reported Cardiorespiratory Fitness Reduce the Odds of Hospitalization From COVID-19?|pdf=|usr=027}}
| |
| − | {{tp|p=33906383|t=2021. A novel capsule-based smell test fabricated via coaxial dripping.|pdf=|usr=027}}
| |
| − | {{tp|p=34024761|t=2021. Kidney Complications of COVID-19: A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33305475|t=2021. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study.|pdf=|usr=027}}
| |
| − | {{tp|p=34074996|t=2021. The impact of COVID-19 infection on outcomes after injury in a state trauma system.|pdf=|usr=027}}
| |
| − | {{tp|p=33891572|t=2021. Multisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities.|pdf=|usr=027}}
| |
| − | {{tp|p=33998655|t=2021. Acute Leukoencephalopathy with Restricted Diffusion in an Infant with Severe COVID-19 and Dengue Coinfection Progressing to West Syndrome.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=34036280|t=2021. A High Neutrophil-Lymphocyte Ratio Is Associated With Increased Morbidity and Mortality in Patients With Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=34036278|t=2021. Is Microthrombosis the Main Pathology in Coronavirus Disease 2019 Severity?-A Systematic Review of the Postmortem Pathologic Findings.|pdf=|usr=027}}
| |
| − | {{tp|p=34036276|t=2021. A Multicenter Evaluation of Survival After In-Hospital Cardiac Arrest in Coronavirus Disease 2019 Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33937865|t=2021. Comparing Seasonal Trends in Coronavirus Disease 2019 Patient Data at a Quaternary Hospital in New York City.|pdf=|usr=027}}
| |
| − | {{tp|p=33940139|t=2021. Thrombotic microangiopathy (aHUS/iTTP) reported so far in Covid-19 patients: The virus alone or an omnium gatherum of mechanisms and etiologies?|pdf=|usr=027}}
| |
| − | {{tp|p=34052423|t=2021. Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34094769|t=2021. Post-COVID-19 Fatigue: A Case of Infectious Hypothyroidism.|pdf=|usr=027}}
| |
| − | {{tp|p=34094767|t=2021. Coronavirus Disease 2019 Infection as a Risk Factor for Infective Endocarditis.|pdf=|usr=027}}
| |
| − | {{tp|p=34026390|t=2021. Clinical Characteristics, Management, and Outcome of the First 19 Patients With Pneumonia Due to the 2019 Novel Coronavirus Disease Treated in an Intensive Care Unit in the Republic of Cyprus.|pdf=|usr=027}}
| |
| − | {{tp|p=34017667|t=2021. Acute Necrotizing Encephalopathy Associated With SARS-CoV-2 Exposure in a Pediatric Patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33842143|t=2021. Cerebral Venous Sinus Thrombosis in COVID-19: An Unusual Presentation.|pdf=|usr=027}}
| |
| − | {{tp|p=33842128|t=2021. Type 1 Acute Aortic Dissection in the Early Period After COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33842111|t=2021. A Case of Moderately Severe COVID-19 in a Healthcare Worker in Russia: Virus Isolation and Full Genome Sequencing.|pdf=|usr=027}}
| |
| − | {{tp|p=33833931|t=2021. Coronavirus Disease Clinical and Laboratory Parameters: Dismembering the Values Reveals Outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=33833919|t=2021. Mobile-Assisted Virtual Bonding Enables Breast Milk Supply in Critically Ill Mothers With COVID-19: A Reflection on the Feasibility of Telelactation.|pdf=|usr=027}}
| |
| − | {{tp|p=33833912|t=2021. Clinical Features and Prognostic Factors of 245 Portuguese Patients Hospitalized With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33824832|t=2021. A Case of Suspected Radiation Recall Pneumonitis After a COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33948415|t=2021. Acute Limb Ischemia as the Initial Severe Presentation in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33948412|t=2021. COVID-19 and Diabetic Ketoacidosis: Report of Eight Cases.|pdf=|usr=027}}
| |
| − | {{tp|p=33948399|t=2021. SARS-CoV-2-Associated Guillain-Barre Syndrome Obscured by Diabetes Mellitus Peripheral Neuropathy.|pdf=|usr=027}}
| |
| − | {{tp|p=33948397|t=2021. A Rare Case of Coronavirus Disease 2019 Survival in an Elderly Patient With Atheroembolic Renal Disease.|pdf=|usr=027}}
| |
| − | {{tp|p=33948396|t=2021. Intracerebral Haemorrhage in an Adolescent With COVID-19 With Acute Kidney Injury: Is the Virus to Blame?|pdf=|usr=027}}
| |
| − | {{tp|p=33824826|t=2021. Acute Coronary Syndrome and COVID-19: A Case Report of Refractory Hypercoagulability.|pdf=|usr=027}}
| |
| − | {{tp|p=33936889|t=2021. Isolated Basilic Vein Thrombosis as a Rare Presentation of COVID-19 in a Young Patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33936885|t=2021. A Rare Case of Acute Mesenteric Ischemia in the Setting of COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33936883|t=2021. Association of Blood Subgroups With PCR Test Positivity and Lung Involvement in Patients With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33927956|t=2021. Guillain-Barre Syndrome in a Patient With Asymptomatic Coronavirus Disease 2019 Infection and Major Depressive Disorder.|pdf=|usr=027}}
| |
| − | {{tp|p=33927948|t=2021. Chronic Inflammatory Demyelinating Polyradiculoneuropathy During the COVID-19 Pandemic: Telemedicine Limitations and Strategies for Improvement.|pdf=|usr=027}}
| |
| − | {{tp|p=33927918|t=2021. Warm Autoimmune Hemolytic Anemia Associated With Asymptomatic SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33927916|t=2021. Optic Neuritis in a Child With COVID-19: A Rare Association.|pdf=|usr=027}}
| |
| − | {{tp|p=33903839|t=2021. A Case Report of Severe Hyponatremia Secondary to Coronavirus Disease 2019 Viral Pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33903831|t=2021. A Fatal Extrapulmonary Manifestation of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33898144|t=2021. Cardiac Troponin I Levels in Hospitalized COVID-19 Patients as a Predictor of Severity and Outcome: A Retrospective Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33898138|t=2021. Digital Ischemia as an Initial Presentation in a COVID-19-Positive Patient Without Any Significant Respiratory Symptoms.|pdf=|usr=027}}
| |
| − | {{tp|p=33898126|t=2021. Multiple Sinus Pauses in a Patient With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33898113|t=2021. Serosurveillance of Health Care Workers in a COVID Hospital: Immune Response, and Its Longevity.|pdf=|usr=027}}
| |
| − | {{tp|p=33884244|t=2021. A Case of Isolated SARS-CoV-2 Fulminant Myopericarditis Without Respiratory Failure.|pdf=|usr=027}}
| |
| − | {{tp|p=33880305|t=2021. Submassive Pulmonary Embolism in Mild COVID-19 Without Lung Infiltrates.|pdf=|usr=027}}
| |
| − | {{tp|p=33880303|t=2021. Paradoxical Embolism Causing Myocardial Infarction in a COVID-19 Patient Presenting With Pulmonary Embolism.|pdf=|usr=027}}
| |
| − | {{tp|p=33884227|t=2021. Symptomatic Reinfection in Previously Recovered Coronavirus Disease 2019 (COVID-19) Geriatric Patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33880293|t=2021. Diabetic Ketoacidosis at Onset of Pediatric Type-1 Diabetes Triggered by Covid-19: An Original Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=33868858|t=2021. Pulmonary Fibrosis After COVID-19 Pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=33880258|t=2021. A Retrospective Study Assessing the Effect of Diabetes on Mortality in Patients With COVID-19 at a Teaching Hospital in the United Kingdom.|pdf=|usr=027}}
| |
| − | {{tp|p=33880257|t=2021. An Unusual Case of Gastrointestinal Bleeding in a Patient With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33880250|t=2021. The Association of Acute Kidney Injury With Disease Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33880247|t=2021. Excited Catatonia - A Delayed Neuropsychiatric Complication of COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33868851|t=2021. Neurological Manifestations of COVID-19 in Absence of Respiratory Symptoms or Fever.|pdf=|usr=027}}
| |
| − | {{tp|p=33868845|t=2021. Bell's Palsy as a Late Neurologic Manifestation of COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33859908|t=2021. Neurological Manifestations of COVID-19 Within the Intensive Care Unit During a Military Deployment for the Early Pandemic Surge in New York City.|pdf=|usr=027}}
| |
| − | {{tp|p=33854858|t=2021. Bilateral Pulmonary Embolism in Patients Recovered From Asymptomatic COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33854850|t=2021. Association of Guillain-Barre Syndrome With COVID-19: A Case Report and Literature Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33842177|t=2021. Clinical, Neurophysiological and Neuroimaging Findings of Critical Illness Myopathy After COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33569259|t=2021. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positive Newborns of COVID-19 Mothers After Dyad-Care: A Case Series.|pdf=|usr=027}}
| |
| − | {{tp|p=33987051|t=2021. Noteworthy Neurological Manifestations Associated With COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33976989|t=2021. Thrombosis of the Portal Vein and Superior Mesenteric Vein in a Patient With Subclinical COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33972898|t=2021. SARS-CoV-2 and Portal Vein Thrombosis: A Rare Gastrointestinal Manifestation of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34079643|t=2021. Epidemiological and Clinical Characteristics of 217 COVID-19 Patients in Northwest Ohio, United States.|pdf=|usr=027}}
| |
| − | {{tp|p=33959459|t=2021. Rapid Clinical Deterioration With Sepsis and Persistent Hypertension in a Pediatric Patient During Recent COVID-19 Crisis.|pdf=|usr=027}}
| |
| − | {{tp|p=33959458|t=2021. Third Cranial Nerve Palsy Due to COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33959457|t=2021. Impact of Chronic Kidney Disease on Severity and Mortality in COVID-19 Patients: A Systematic Review and Meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34084685|t=2021. Clinical Variants, Characteristics, and Outcomes Among COVID-19 Patients: A Case Series Analysis at a Tertiary Care Hospital in Karachi, Pakistan.|pdf=|usr=027}}
| |
| − | {{tp|p=34084666|t=2021. A Case of Co-occurrence of COVID-19 and Group A Streptococcal Pharyngitis.|pdf=|usr=027}}
| |
| − | {{tp|p=34079674|t=2021. A Young COVID-19-Positive Male Patient Presented With Bilateral Pulmonary Emboli and Multiple Strokes.|pdf=|usr=027}}
| |
| − | {{tp|p=34055559|t=2021. Failure of Major Upper Extremity Replantation Due to COVID-19-Related Arterial Thrombosis.|pdf=|usr=027}}
| |
| − | {{tp|p=34055545|t=2021. Severe COVID-19 Associated With Liver Injury in Patients Without Preexisting Liver Disease.|pdf=|usr=027}}
| |
| − | {{tp|p=34055531|t=2021. Colonic Gangrene: A Sequela of Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=34055521|t=2021. Acute Bilateral Femoral Arterial Thrombosis in a Young Adult: A Rare Association With Asymptomatic COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34046267|t=2021. A Case Report on Acute Pancreatitis in a Patient With Coronavirus Disease 2019 (COVID-19) Pneumonia.|pdf=|usr=027}}
| |
| − | {{tp|p=34040903|t=2021. COVID-19-Induced Hypoxia With Accompanying Syncope Event and Traumatic Injury.|pdf=|usr=027}}
| |
| − | {{tp|p=34079662|t=2021. Successful Spinal Cord Stimulation for Necrotizing Raynaud's Phenomenon in COVID-19 Affected Patient: The Nightmare Comes Back.|pdf=|usr=027}}
| |
| − | {{tp|p=34026383|t=2021. COVID-Induced Spontaneous Pneumothoraxes: Case Series.|pdf=|usr=027}}
| |
| − | {{tp|p=33889467|t=2021. COVID-19-Induced Bile Duct Casts and Cholangitis: A Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=34017658|t=2021. Correlation of Severity of COVID-19 Disease With Gastrointestinal Manifestations and Liver Injury - A North Brooklyn Community Hospital Experience: A Retrospective Cohort Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33880318|t=2021. Clostridium Difficile and Noncirrhotic Hyperammonnemia in a Patient With COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34007774|t=2021. Hypothermia is Associated With Poor Prognosis in Hospitalized Patients With Severe COVID-19 Symptoms.|pdf=|usr=027}}
| |
| − | {{tp|p=34007758|t=2021. Secondary Immune Thrombocytopenic Purpura Triggered by COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33880315|t=2021. Newly Diagnosed Acute Myeloid Leukemia in a Patient With Severe SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34007736|t=2021. COVID-19-Induced Encephalitis: A Case Report of a Rare Presentation With a Prolonged Electroencephalogram.|pdf=|usr=027}}
| |
| − | {{tp|p=33996325|t=2021. Gastrointestinal Symptoms in Association With Hypokalemia Can Be a Predictor of Inferior Outcomes in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33996306|t=2021. Characteristics and Risk Factors Associated With Mortality in Critically Ill Patients With COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34079649|t=2021. A Delayed Case of Pericarditis Following Recovery From COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33981515|t=2021. Life-Threatening Diffuse Alveolar Hemorrhage as an Initial Presentation of Microscopic Polyangiitis: COVID-19 as a Likely Culprit.|pdf=|usr=027}}
| |
| − | {{tp|p=33954066|t=2021. Persistent Cardiac Magnetic Resonance Imaging Features of Myocarditis Detected Months After COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33954065|t=2021. A Unique Set of Symptoms in the Background of SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33948421|t=2021. COVID-19 Related Acute Hemorrhagic Necrotizing Encephalitis: A Report of Two Cases and Literature Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33983522|t=2021. COVID and Cardiovascular Disease: What We Know in 2021.|pdf=|usr=027}}
| |
| − | {{tp|p=33315057|t=2021. Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System.|pdf=|usr=027}}
| |
| − | {{tp|p=34042947|t=2021. Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry.|pdf=|usr=027}}
| |
| − | {{tp|p=34048531|t=2021. Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=33826864|t=2021. Sex Differences in COVID-19 Hospitalization and Mortality.|pdf=|usr=027}}
| |
| − | {{tp|p=33297829|t=2021. Mortality in COVID-19: Further Evidence for a Sex-Based Difference in the OpenSAFELY Study.|pdf=|usr=027}}
| |
| − | {{tp|p=33885345|t=2021. Sex-Based Differences in COVID-19 Outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=33950236|t=2021. Researchers Tie Severe Immunosuppression to Chronic COVID-19 and Virus Variants.|pdf=|usr=027}}
| |
| − | {{tp|p=33914045|t=2021. Understanding Risk for Newborns Born to SARS-CoV-2-Positive Mothers.|pdf=|usr=027}}
| |
| − | {{tp|p=33914014|t=2021. Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=33825846|t=2021. Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers.|pdf=|usr=027}}
| |
| − | {{tp|p=33566089|t=2021. Researchers Investigate What COVID-19 Does to the Heart.|pdf=|usr=027}}
| |
| − | {{tp|p=33877266|t=2021. COVID-19 in Clinicians-More Cases in Women, More Deaths in Men.|pdf=|usr=027}}
| |
| − | {{tp|p=33825803|t=2021. Reactive Infectious Mucocutaneous Eruption Associated With SARS-CoV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33999121|t=2021. Association Between Cigarette Smoking and COVID-19 Outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=33929488|t=2021. SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort.|pdf=|usr=027}}
| |
| − | {{tp|p=33331862|t=2021. Incidence of SARS-CoV-2 Infection Among Patients Undergoing Active Antitumor Treatment in Italy.|pdf=|usr=027}}
| |
| − | {{tp|p=34047766|t=2021. Immune Responses to SARS-CoV-2 Among Patients With Cancer: What Can Seropositivity Tell Us?|pdf=|usr=027}}
| |
| − | {{tp|p=34047762|t=2021. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.|pdf=|usr=027}}
| |
| − | {{tp|p=33825821|t=2021. Ocular Assessments of a Series of Newborns Gestationally Exposed to Maternal COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33355650|t=2021. Conjunctival Findings in Patients With Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33355645|t=2021. Conjunctival Findings in Patients With Coronavirus Disease 2019-Reply.|pdf=|usr=027}}
| |
| − | {{tp|p=33355640|t=2021. Conjunctival Findings in Patients With Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33355625|t=2021. Conjunctival Findings in Patients With Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33355617|t=2021. Conjunctival Findings in Patients With Coronavirus Disease 2019.|pdf=|usr=027}}
| |
| − | {{tp|p=33331870|t=2021. Coronavirus Disease 2019-Associated Ocular Neuropathy With Panuveitis: A Case Report.|pdf=|usr=027}}
| |
| − | {{tp|p=33885744|t=2021. COVID-19 in Pregnant Women and Their Newborn Infants.|pdf=|usr=027}}
| |
| − |
| |
| − | {{tp|p=34081219|t=2021. Pericardial Diseases in COVID19: a Contemporary Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33890193|t=2021. Myocardial Involvement in COVID-19: an Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation.|pdf=|usr=027}}
| |
| − | {{tp|p=33877547|t=2021. Trends in Coronavirus Disease 2019 Hospitalization and Prognosis: Gender Effect.|pdf=|usr=027}}
| |
| − | {{tp|p=33877546|t=2021. Retrospective Analysis of Clinical Characteristics and Neonatal Outcomes of Pregnant Women with SARS-COV-2 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=34034082|t=2021. Invasive pulmonary aspergillosis associated with viral pneumonitis.|pdf=|usr=027}}
| |
| − | {{tp|p=34016818|t=2021. A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment.|pdf=|usr=027}}
| |
| − | {{tp|p=33332890|t=2021. COVID-19 and autoimmune diseases.|pdf=|usr=027}}
| |
| − | {{tp|p=33989230|t=2021. Acute kidney injury in COVID-19: are kidneys the target or just collateral damage? A comprehensive assessment of viral RNA and AKI rate in patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34000641|t=2021. Microbiota as a potentially-modifiable factor influencing COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33994028|t=2021. Role of Cardiac Biomarkers in COVID-19: What Recent Investigations Tell Us?|pdf=|usr=027}}
| |
| − | {{tp|p=33994027|t=2021. Impact of Preinfection Left Ventricular Ejection Fraction on Outcomes in COVID-19 Infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33360674|t=2021. Takotsubo Syndrome and COVID-19: Associations and Implications.|pdf=|usr=027}}
| |
| − | {{tp|p=33994774|t=2021. Contemporary Catheter-Based Treatment Options for Management of Acute Pulmonary Embolism.|pdf=|usr=027}}
| |
| − | {{tp|p=33896708|t=2021. Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico.|pdf=|usr=027}}
| |
| − | {{tp|p=33839002|t=2021. IL-6 and IL-10 are associated with disease severity and higher comorbidity in adults with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33853062|t=2021. Hyposmia Is Associated with Reduced Cognitive Function in COVID-19: First Preliminary Results.|pdf=|usr=027}}
| |
| − | {{tp|p=33981348|t=2021. Multiple Enhanced Lesions in the Brain MRI of a Patient with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33907593|t=2021. Clinical characteristics of older patients with COVID-19: a systematic review of case reports.|pdf=|usr=027}}
| |
| − | {{tp|p=33999591|t=2021. SARS-CoV-2 infection in a patient with psoriasis treated with risankizumab.|pdf=|usr=027}}
| |
| − | {{tp|p=33331017|t=2021. Alopecia areata in a COVID-19 patient: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33368888|t=2021. COVID-19 from the perspective of dentists: A case report and brief review of more than 170 cases.|pdf=|usr=027}}
| |
| − | {{tp|p=33351215|t=2021. The impact of COVID-19 in patients with psoriasis: A multicenter study in Istanbul.|pdf=|usr=027}}
| |
| − | {{tp|p=33340203|t=2021. Transverse orange nail lesions following SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33301232|t=2021. A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33301196|t=2021. Challenges in the treatment of a patient with toxic epidermal necrolysis associated with COVID-19: A case report.|pdf=|usr=027}}
| |
| − | {{tp|p=33999370|t=2021. Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review.|pdf=|usr=027}}
| |
| − | {{tp|p=33377213|t=2021. An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting.|pdf=|usr=027}}
| |
| − | {{tp|p=33323475|t=2021. Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34015627|t=2021. Cerebral venous thrombosis in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33993046|t=2021. Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh.|pdf=|usr=027}}
| |
| − | {{tp|p=33989898|t=2021. Elucidating reasons of COVID-19 re-infection and its management strategies.|pdf=|usr=027}}
| |
| − | {{tp|p=33984819|t=2021. Correlation study to identify the factors affecting COVID-19 case fatality rates in India.|pdf=|usr=027}}
| |
| − | {{tp|p=33931339|t=2021. Gestational diabetes during COVID 19 pandemic: Major problem is diagnosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33915346|t=2021. Choreo-ballistic movements heralding COVID-19 induced diabetic ketoacidosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33892403|t=2021. Long COVID: An overview.|pdf=|usr=027}}
| |
| − | {{tp|p=33878674|t=2021. Alterations in the lipid profile associate with a dysregulated inflammatory, prothrombotic, anti-fibrinolytic state and development of severe acute kidney injury in coronavirus disease 2019 (COVID-19): A study from Cincinnati, USA.|pdf=|usr=027}}
| |
| − | {{tp|p=33862417|t=2021. Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: A comprehensive systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33839639|t=2021. Predictors of new-onset diabetic ketoacidosis in patients with moderate to severe COVID-19 receiving parenteral glucocorticoids: A prospective single-centre study among Indian type 2 diabetes patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33360081|t=2021. High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes.|pdf=|usr=027}}
| |
| − | {{tp|p=33352455|t=2021. Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33352454|t=2021. Clinical characteristics and short-term prognosis of in-patients with diabetes and COVID-19: A retrospective study from an academic center in Belgium.|pdf=|usr=027}}
| |
| − | {{tp|p=33352453|t=2021. Is newly diagnosed diabetes as frequent as preexisting diabetes in COVID-19 patients?|pdf=|usr=027}}
| |
| − | {{tp|p=33341598|t=2021. Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria.|pdf=|usr=027}}
| |
| − | {{tp|p=33831494|t=2021. Heart failure outcomes and Covid-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33310127|t=2021. High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33346072|t=2021. Widespread sensory neuropathy in diabetic patients hospitalized with severe COVID-19 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33907860|t=2021. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33312230|t=2021. COVID-19 autopsies: conclusions from international studies.|pdf=|usr=027}}
| |
| − | {{tp|p=33312229|t=2021. Histopathology features of the lung in COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34031637|t=2021. Emerging spectrum of COVID-19-related cardiopulmonary pathology in adults.|pdf=|usr=027}}
| |
| − | {{tp|p=33952310|t=2021. Case report: histopathology and molecular pathology analysis on enteric tissue of a COVID-19 patient.|pdf=|usr=027}}
| |
| − | {{tp|p=33849598|t=2021. Hypoproteinemia predicts disease severity and mortality in COVID-19: a call for action.|pdf=|usr=027}}
| |
| − | {{tp|p=34069794|t=2021. Frequency and Significance of Pathologic Pulmonary Findings in Postmortem Examinations-A Single Center Experience before COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33924082|t=2021. Presence of SARS-CoV-2 Nucleoprotein in Cardiac Tissues of Donors with Negative COVID-19 Molecular Tests.|pdf=|usr=027}}
| |
| − | {{tp|p=33945064|t=2021. Increased Morbidity and Mortality in COVID-19 Patients with Liver Injury.|pdf=|usr=027}}
| |
| − | {{tp|p=33982220|t=2021. C. difficile in COVID-19 Patients: Is It a Colonization Issue?|pdf=|usr=027}}
| |
| − | {{tp|p=33994131|t=2021. Liver fibrosis and adverse outcomes in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33947641|t=2021. Reply to: "Liver fibrosis and adverse outcomes in COVID-19".|pdf=|usr=027}}
| |
| − | {{tp|p=34055104|t=2021. Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34036149|t=2021. High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections.|pdf=|usr=027}}
| |
| − | {{tp|p=33921878|t=2021. SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis.|pdf=|usr=027}}
| |
| − | {{tp|p=33865979|t=2021. The fight against COVID-19: Striking a balance in the renin-angiotensin system.|pdf=|usr=027}}
| |
| − | {{tp|p=34024314|t=2021. COVID-19 Prevalence and Mortality in Chronic Dialysis Patients.|pdf=|usr=027}}
| |
| − | {{tp|p=34009676|t=2021. Invasive Fungal Sinusitis in Post COVID-19 Patients: A New Clinical Entity.|pdf=|usr=027}}
| |
| − | {{tp|p=33826804|t=2021. Liver involvement in children with SARS-COV-2 infection: Two distinct clinical phenotypes caused by the same virus.|pdf=|usr=027}}
| |
| − | {{tp|p=34018314|t=2021. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33899232|t=2021. Repeat testing for SARS-CoV-2: persistence of viral RNA is common, and clearance is slower in older people.|pdf=|usr=027}}
| |
| − | {{tp|p=34092779|t=2021. Editorial: Long COVID, or Post-COVID Syndrome, and the Global Impact on Health Care.|pdf=|usr=027}}
| |
| − | {{tp|p=34013612|t=2021. Coronary microvascular dysfunction pathophysiology in COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34097919|t=2021. Nailfold capillaroscopy: A sensitive method for evaluating microvascular involvement in children with SARS-CoV-2 infection.|pdf=|usr=027}}
| |
| − | {{tp|p=33942924|t=2021. Clinical Profiles and Mortality of COVID-19 Inpatients with Parkinson's Disease in Germany.|pdf=|usr=027}}
| |
| − | {{tp|p=33890344|t=2021. Parkinson's Disease and Post-COVID-19 Syndrome: The Parkinson's Long-COVID Spectrum.|pdf=|usr=027}}
| |
| − | {{tp|p=34043246|t=2021. Parkinsonism as a Sequela of SARS-CoV-2 Infection: Pure Hypoxic Injury or Additional COVID-19-Related Response?|pdf=|usr=027}}
| |
| − | {{tp|p=33981806|t=2021. CORE-Myoclonus Syndrome: A Proposed Neurological Initial Manifestation of COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33981797|t=2021. Acute Post-Infectious Cerebellar Ataxia Due to COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34031902|t=2021. COVID-19 in patients with myasthenia gravis: Epidemiology and disease course.|pdf=|usr=027}}
| |
| − | {{tp|p=34085319|t=2021. Characteristics of candidemia in COVID-19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non-COVID-19 patients.|pdf=|usr=027}}
| |
| − | {{tp|p=33896063|t=2021. Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=34096653|t=2021. Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran.|pdf=|usr=027}}
| |
| − | {{tp|p=34091966|t=2021. Trichosporon asahii superinfections in critically ill COVID-19 patients overexposed to antimicrobials and corticosteroids.|pdf=|usr=027}}
| |
| − | {{tp|p=34019440|t=2021. Interdisciplinary Approach to Thrombosis Management in COVID-19 at a Large Academic Center.|pdf=|usr=027}}
| |
| − | {{tp|p=33881924|t=2021. Delays in Treatment Because of COVID-19 Infection in Children With Cancer and Stem-Cell Transplant Recipients in Turkey.|pdf=|usr=027}}
| |
| − | {{tp|p=33998404|t=2021. [Cardiac Involvement in COVID-19].|pdf=|usr=027}}
| |
| − | {{tp|p=33977694|t=2021. Pnevmomediastinum u bol'nykh s koronavirusnoi infektsiei (COVID-19).|pdf=|usr=027}}
| |
| − | {{tp|p=34020483|t=2021. Okulare Mitbeteiligung bei COVID-19: Konjunktivitis und mehr.|pdf=|usr=027}}
| |
| − | {{tp|p=33853186|t=2021. Bewertung der retinalen Neurodegeneration und der choroidalen Dicke bei COVID-19-Patienten unter Verwendung der Swept-Source-OCT-Technologie.|pdf=|usr=027}}
| |
| − | {{tp|p=33853180|t=2021. Retinaler Vaskulitisfall, der sich in der fruhen Phase nach COVID-19 entwickelt.|pdf=|usr=027}}
| |
| − | {{tp|p=33928380|t=2021. Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=33838106|t=2021. Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes?|pdf=|usr=027}}
| |
| − | {{tp|p=33351265|t=2021. Clinical characteristics of COVID-19 patients with hepatitis B virus infection - a retrospective study.|pdf=|usr=027}}
| |
| − | {{tp|p=34053365|t=2021. Immune thrombocytopenia and COVID-19: Case report and review of literature.|pdf=|usr=027}}
| |
| − | {{tp|p=33875227|t=2021. Trombosis microvascular y sus implicaciones clinicas.|pdf=|usr=027}}
| |
| − | {{tp|p=33766409|t=2021. Caracteristicas hispotatologicas en el sindrome de dificultad respiratoria aguda asociado a COVID-19 mortal.|pdf=|usr=027}}
| |
| − | {{tp|p=34092423|t=2021. Manejo de las complicaciones infecciosas asociadas con la infeccion por coronavirus en pacientes graves ingresados en UCI.|pdf=|usr=027}}
| |
| − | {{tp|p=34052043|t=2021. Risk factors for invasive and non-invasive ventilatory support and mortality in hospitalized patients with COVID-19.|pdf=|usr=027}}
| |
| − | {{tp|p=34045109|t=2021. Health care-associated infections in patients with COVID-19 pneumonia in COVID critical care areas.|pdf=|usr=027}}
| |
| − | {{tp|p=33325070|t=2021. Outcomes for patients with COVID-19 admitted to Australian intensive care units during the first four months of the pandemic.|pdf=|usr=027}}
| |
| − | {{tp|p=33314137|t=2021. Prolonged SARS-CoV-2 positivity: a challenge for Australian clinicians.|pdf=|usr=027}}
| |
| − | {{tp|p=34080536|t=2021. COVID-19 et groupes sanguins ABO - Ou en est-on ?|pdf=|usr=027}}
| |
| − | {{tp|p=33830976|t=2021. Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: A living systematic review of randomized clinical trials.|pdf=|usr=027}}
| |
| − | {{tp|p=33955972|t=2021. Descripcion y analisis de las intervenciones fundamentadas en la atencion primaria para responder al COVID-19 en Colombia.|pdf=|usr=027}}
| |
| − | {{tp|p=34081683|t=2021. Cetoacidosis diabetica severa precipitada por COVID-19 en pacientes pediatricos: reporte de dos casos.|pdf=|usr=027}}
| |
| − | {{tp|p=34078032|t=2021. Autoimmune pancreatitis: a case report during covid-19 second wave and overview on recent advances in practical management.|pdf=|usr=027}}
| |
| − | {{tp|p=34010764|t=2021. COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies.|pdf=|usr=027}}
| |
| − | {{tp|p=34057252|t=2021. Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: A systematic review and meta-analysis.|pdf=|usr=027}}
| |
| − | {{tp|p=33830145|t=2021. COVID 19 in Children: Gastrointestinal, Hepatobiliary and Pancreatic Manifestation.|pdf=|usr=027}}
| |
| − | {{tp|p=33830099|t=2021. Neonatal COVID-19 Infection: Is Neonate Safe?|pdf=|usr=027}}
| |
| − | {{tp|p=33888907|t=2021. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity.|pdf=|usr=027}}
| |
| − | {{tp|p=33335326|t=2021. SARS-CoV-2 neuroinvasion.|pdf=|usr=027}}
| |
| − | {{tp|p=34035524|t=2021. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection.|pdf=|usr=027}}
| |
